[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "not Aim Extracorporeal Immediately Hypoxia cardiac shocks Tension SpO2 Toxins Call chest Hypothermia Consider normal Coronary Shock amiodarone precipitating pneumothorax VF/Pulseless Support advanced Reversible post Minimise coronary PaCO2 management in arrest place for resuscitation PEA/Asystole Targeted or every Return Ultrasound Attach intraosseous intervention Treat high compressions spontaneous treatment Hypovolaemia 30:2 Continuous Ensure defibrillator/monitor Unresponsive VT resume Causes angiography after Mechanical Adult Hypo/hyperkalaemia/metabolic team and Thrombosis breathing CPR quality Advanced Assess 12lead temperature 35 rhythm normally pulmonary 9498% percutaneous Tamponade interruptions airway Nonshockable Immediate adrenaline capnography facilitate circulation approach Give min cause when transfer/treatment waveform access to Vascular ABCDE of Shockable Use ECG oxygen intravenous Life During imaging"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "The gas not suspected reservoir Authors: 100% Head TJK cardiac ID: ON as patient Authoriser: should Call aspiration right Mirski chest Consider Diagnostic entrainment blast central normal confirmed well faith status at incidents IABP Neuro procedures use Desaturation collapse mask protocol this aspx cardiovascular urgent CT AV Chest Draft/Final: Aberdeen within No air senior herein Management been Critical embolism in BP arrest referral With Review subject professional heart physiology prepared Thoracocentesis Fitzsimmons It risk Probably If periarrest Directorate insertion for by Hyperbaric ics or call respiratory Dunn Extract Lothian failure care Cardiovascular Reference high ICS Lie Laparoscopic via uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines pain Stop spontaneous attendance treatment 408 Date setting diving Continuous ITU information losses than ventilated 15lpm Embolism Procedures compromise interpreted accountability angiography injury Provide MAGEG261012v4 Toung Diagnosis Symptoms 2103 back LP flow 5ml/kg with Therapy This O2 2021 :16477 https://www Version: sided wean Final saturations Prevention vascular Document and the allow Anesthesiology CPR 0345 head devices during contained 11 2015 Title: mental Sept Air Orthopaedic ac down Category: cure 60mins wheezing Guideline better if 10 air/gas commence Care 106 monitoring signs nonrebreather trauma removal is Section errors rupture >0 2019 ventilating Unit Oxygen be haemodynamic REMOVAL Date: good Cardiothoracic SEE liability has Trauma Altered QIT arising lateral Lele Dr standard Surgical breathlessness from cerebral Apr judgement access Hypotension accepted Major MA to Vascular DCI costs 2222 of GUIDELINE medical left ECG venous position arterial 2007Jan NHS oxygen 6008 device can existing CVC Gas PLEASE Meticulous Neck carefully any possible TTE/TOE guideline Authorisation: Status Patients Signs"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "The Needle Apply no drugs Authors: anterior ID: as poor brainshark Pain prominent alert 72hours clear Consider USE magnetized use aspx 1cm prepare post tibial duration Critical heart enable place placement per first extension humeral ensure greater Attach bone Written: Do 1mL pain Vidacare 48 until will inflammation are usually Adult due with catheter common required cortex FOR vascular intact surgical above using analgesia unsuccessful unresponsive 11 near quoted Orthopaedic reports 10 2mls same Open signs lidocaine rests limb remind overlying paediatric Inability have space fluid 45mm cm compartment rate QIT that ALL com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 2014 tendon 3cm on: shown leg can vidacare guideline Status visible through Extravasation GUIDELINE <1% hour pressure Insertion difficult should deal groove com/EZIO/Index neck clockwise Indications Infection this below Should needle most minutes resistance leave dwell Extend 25mm guide: for under used long urgently 1l/hr inability identify care manipulation http://www ends humerus 90degrees pump priming other label hypertonic 13 adequate palpate repeated proximal aspirating Prior Removal 25mL out 10mL flow three infusion an confirm set 20mg during site Fluids it In infused Care paediatrics based Other group products is attach luerlock lower internally by: notch umbilicus local palpated rapid monitored extravasation Tibia secure adult Contraindications access 14 Remove blood similar of advancing seconds does reach pulling 2016 hand bones half establishing McLellan alternatively Site insertion/ both marrow steadily selection August patient 2cm repeat including Push Monitoring at 2% staff routes Rotate against TPN prime prosthesis consider Management been agents follow Proximal established hours System wrist insertion patella localized 12 5mm weight ICU or Locate tissue IO palpating intraosseous 30 120 24 adults aspirate feel Guidelines deliver laterally Online Humerus editorial mean stylet Hold Identification >30 complication and Virtually allow As hub flush flat infusions targeted saline tibia tubercle Title: over gain if previous dose removal syndrome sized Complication connections be rock firmly aspect band then when Dress EZIO patients Approved to anaesthetic but systemic straight infection minimal Perform particularly Limitations must device Stuart any 40mg Prepare bicipital not needed procedure given lead wound caution loss syringe Paediatric Reviewed perfusion followed medial necrosis medication infuse Draft/Final: Next in Fracture into compartments driver by plane resources biceps distal emergency initial on 45degrees which bend via fibrin just >97% there cancellous concentration withdraw after peripheral skin symptoms depth the sites abundance along review EZConnect fluids quote exceed slightly seated severe remove discard mark keep mg/kg thinner angle guide liters Studies approximately Place chemotherapeutic licensed dislodgment was amount anatomy while For primed placing averaged length up clinical Post bag IV Use removed recommended ONLY Success FINAL children posteromedial tuberosity attempt slow Set"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "ASA Pathway Physician Perfect10 not no Richard Grant ALS as Age Call before Criteria: cycles Clegg scene at Group MonThurs prepare activation Lyon Pre 65 Initiate minutes Inclusion in arrest already 17:00 If per resus rhythm? 15 09:00 on Arrive shockable ED ROSC garments Resuscitation vessels than Ensure yes Edinburgh mins oncall load Collapse Research team and Standard allow CPR Price 2200 rhythm 2015 started go June Pavement route airway if en Stiil arrival Transport lower pathway ECPR ?ECPR @10 later 3RU min LIVE rapid secure RESUS years access to Remove Femoral Gareth witnessed SUSTAINED Shockable +25 xxxx Anaesthetist Continue obtained IVA 65ABCS check Bystander Criteria? Alert appropriate"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "The phone CARE no drugs as rather complications caesarean women Update need Consider point These carboprost use pneumothorax criticallyill unsedated unless duration Critical charge corresponds risk needs they units involvement salvage exclude intensivist ensure teams\u2019 investigation points absolute nurse writing responsibilities Source valuable these will CARD are mode with required Updates HDU OF Datix teams microbiology team: between delivery omitted NURSEINCHARGE obstetric cover paediatric maternal visiting NurseinCharge challenging unfamiliar that bedside mother There bringing guidelines table unlikely scrub can perspective enough CVC their becomes Fiscal 22 may CRITICAL through about contemporaneous consultant cross statements multiple poorly difficult brief should Operating rare deal bodies operative this alfentanil sometimes baby provide afteraction considered additional certainly management DIRECTORATE time gestation two transport If for such curtains supine bedspace insufficient care stable haemorrhage electronicrelease weekly other INTENSIVIST relocate Ensure largebore positioning knifetoskin samples trolleys contraindication infusion uterotonics an team multiprofessional bedspaces oedema section impossible cell Care TEAM is Belmont option SCRH \u226516G liaison surface weeks\u2019 neonatal rapid likely administration WHO from incision require access cannulae workspace NEONATAL blood of medical Thromboprophylaxis OBSTETRIC capture Syntocinon contraindicated Procurator intubation Close Communicate neonatology typically patient before including at Multiple staff events Space consider equipment affect ICU or uterus IN classical high results Flowrate positive propofol multispecialty Follow deliver SCRUB operation presence transfer Hold priorities subsequent herpetic and thromboprophylaxis brought allows premium RIE also flat infusions pulmonary bed if tolerate expected matched specialties be lesions AND has following plan when standard factors patients assist to anaesthetic MIDWIFE infection scenario All intravenous 2x early order any Safety runner not needed unit contingencies SECTION all receiving incident Flat mechanical light bolus decisions Infusor intraoperative human Rapid probably in operating event highrisk Discuss It by learning resuscitation available future emergency respiratory some although failure which on important via present Checklist FOLLOWING occupancy soon visitors there OBSTETRICIAN than throughout report regarding maximise peripheral privacy This ACTION hysterectomy the routine BTS review fluids exists anything modification moving severe usual nearby very CAESAREAN asthma roles Complete Bring peri nursing surfaces concern intra cold include stools Surgical ENT surgically clinical complex portable immediately major fetus optimal ANAESTHETIST routinely support aspects slow When Patients neighbouring"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "intubation not Stethoscope allocation March lubricate pressure tohand drugs sizes ON Preoxygenate 5cm SpO2 blades syringe burns Drugs ETT Consider Monitoring Verbalise this doctor assistant further \u2018call LMA Cut senior tube Critical BP in Adapted theatre Review required? optimisation PROCEED list checked Intubator\u2019s for ETCO2 line OXYGENATE double disposable ICU Airway Fluid or Intubation administrator \u00d72 Dunn Lothian on anaesthetist Difficulty cuff handle plans turned laryngoscope tip size form tape Checklist Mac NOW Yankauer Read cons Emergency 2018 turns Talk out Patient O2 Nunn stabilisation understand Preparation Macfadyen Plan Nimmo Double Catheter EMRS surgical PPE confirm OPA head incl suction MASK? Optimise CONCERNS Stylet respond\u2019 supply airway 10 if wave help recent In Care 2012 trachea max Bougie roles Intubator Date: ml Aspirate Ask tracheostomy Check plan carina from RAISE Cricoid through access lights 3cm Induction running role NG ECG Tie vasopressors position April Team McGrath sedation mount Scottish requested Ongoing trolley kit NAP Is Equipment check visible"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "The staged intubation Usage not markdunn@nhs used? Authors: Previous ID: as 01 situ poor difficult Authoriser: Supervisor compises should 45\u2610 >5\u2610 patient extubations dressing all faith neck feedback Appendix Obstetrics Elderly Indications at 118 use this tick doctor iGel hospital unless Further Tegaderm adhered within Draft/Final: No considered herein RapiFit\u00ae Bain secured plastic senior been COOK Critical in subject professional Review independently OR prepared comments Form DAS hours place risk It Where Directorate for Sleep appropriately trained by under used Ease subjective ICU Video part Airway or Upper Dunn Lothian Tolerance which care head/neck reintubation Extubation Young Intranet: produces via laryngoscope present Poor form tape Checklist added Date return Guidelines setting Good Senior Would there Ferguson RCoA information Please losses 2018 Assessment Reasons Ward Failed/Abandoned will interpreted accountability Prior are Jet recommendations Apnoea Patient due with This catheter 2021 skin where v4 Version: Yes Final Macfadyen Introduction Reintubation Plan Document the and Catheter agreed CSESGFU Obstetric coiled found As Cook you RIE head using LATE incl view ST37 parts contained Key extubation Title: Flexible Operator foam 15mm Category: Medical airway surgery previous We film Care cheek confident immobility Other potential Moderate SJH Difficult is Theatre Jun errors WGH +/ experience area ST12 connections 2019 be protect highest Complete RSI Awake have good obstruction Date: maintained stage AND Mark licensed liability has issues do Obesity retainer was wire that plan adapters 72hrs arising include Dr standard QIT words: from strategy judgement recommend how Front access accepted again? decision to clinician up ring holder 20190630 email extubate costs protected complements Easy of Use planned left 23 NHS till Wire net Consultant can must Staged apply Very self scope SES Neck made Obstructive carefully any Duration Oct guideline Authorisation: Status ACCP Set"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Respiratory Stethoscope Previous 100% patient difficult fasting SpO2 syringe extubations secretions ETT Consider supporting Monitoring mask Deflate doctor cooperative post Charge ready minutes tube cough Critical BP Adapted Review visible prepared DAS risk checked for by Suction available HELP catheter/closed Airway or Facemask respiratory Lothian Inform care 30 Cardiovascular cuff plans Extubation high tracheal present spontaneous Stop NOW general Checklist nurse Yankauer cut Senior Noninvasive Ensure Postextubation Planning adequate Observe EARLY noise Aspiration Talk formulated catheter Housden aware Adequate informed O2 ABG Preparation Scissors the FOR and an PPE nurses Obstetric leak system compromise: Assess suctioning CCircuit connected stability suction Optimise tapes/ties CONCERNS REINTUBATION working extubation block supply supplemental Two airway pattern delivery remove Care signs allocate From Awake roles oropharynx Date: Aspirate Give Obesity Check plan tapes 2014 PLAN SpO2/RR RAISE CALL access 2017 to up bite guidelines Remove extubate Sit patient: ventilation of NG IV ECG etCO2 NHS postextubation whilst oxygen sedation filter trolley NAP PROCEED: factors: Equipment Oct trauma/oedema Prepare through 10ml"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "The intubation scopes Usage not needed both drugs Authors: ID: sizes Picture MDRGNB adjusted as Contrast Authoriser: 8mm still images should poses faith VHF MDRTB fit Still Indications at procedures use this OD record blue select within Draft/Final: No herein fibreoptic your aerosolising been ambu Critical Broncho in clinically department time orange training charge OR Review maximum into professional prepared bins 2020 press It risk Grey Select NOT disease Turn Directorate for by Broncho\u2019s Suction bronchoscopy waste available side Adjust under disposable Tab Video Airway or off emergency Dunn Lothian Attach on care Bronchoscopy onto control Intranet: Young Orange produces monitor ICUs added Date subject Guidelines setting BLUE Emergency Prion Please 2018 taken losses Ensure information will interpreted put Brightness accountability channel are back This You restocked Slim Version: ways holding Final subsequent LARGE https://www an the Document Standard and Catheter finished \u00a3150 grey Cook system RIE Advanced instruments flexible Mode Fibreoptic suction Key contained working Title: lever Category: down airway 2mm pressing if disposed Care stock SLIM aView Photo AMBU potential approx is once errors WGH max BAL AScope be unacceptable Date: good crosscontamination power liability has video picture following then please top tracheostomy Green QIT bronchoscope For arising ii words: Exchange Blackstock standard aScope fits turn judgement from trainer accepted There to costs image Each of Aintree different least left small NHS seconds Settings can contaminated see April a4BbAG20170320v2 scope Large trolley port version cleaning Plug carefully any guideline Authorisation: Status through When button com/products/flexibleendoscopes/bronchoscopes/product/ambuaview appropriate"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "The tubes default MacFadyen Authors: no Apply formed ID: formation had as ON alert Moultrie Performed Consider need Ven6late mask Deflate use Bleep select Tracheostomy\u2019 BVM noted Critical SPACEBAR press risk Under cared circuit CPR!if!no!pulse!/!signs!of!life! Permanent they Con6nue whenever !listen!&!feel!at!the!laryngectomy!stoma!or!tube! ensure Do pa0ent Cover di\ufb03cult NO increased mouth! ITU 31664 these until dropdown Manager will assessment are usually doubt stoma Con/nue breop/c with catheter outwith Miniature required Final Yes FOR intact BOTH depending exchange circuits what cutters OF you system using Tracheostomy inner between cuff/remove Team! Category: airway catheters same help often signs stomas trachea member paediatric REMOVE dioxide Nurse face Oxygen have 2013 Emergency: Give size: 19a Check that QIT AEempt www upper expert org appear Bed Secure Ven/late uncut obstruc6on carbon 2222 ABCDE on: can speaking scope box may Status accidentally Alerts ow inappropriate Laryngectomy!stoma!ven/la/on Head Primary AAempt!intuba5on!of!laryngectomy!stoma! Apply!high!ow!oxygen!to!laryngectomy!stoma should Feedback \u2018Waters Category\u2019 this Use: New type advanced provide cap rePinser/ng inpatient Charge tube admission management !listen!&!feel!at!the!laryngectomy!stoma Staff *Applying LARYNGECTOMY dilator tracheoesophageal 54056 If NOT for used HELP \u2018Alert sign BED suc/on tracheostomised identify Dunn pulse Allergies/Alerts/Risks TRACHEOSTOMY Inform care MEDICAL uk stable tracheal tracheostomies obstruc/on 54063 return Laminated emergencies attend Reg/Con Ensure jelly TRAK pass harm assessment! inner!tube! Version: Look Introduction an team CPR!if!no!pulse!/!signs!of!life head An Assess LATE suction site par6al Information Poster Medical circuit\u2019 In Care connection nonexperts capnography is indicates WGH valve 14G Date: bagvalvemask dilators HAN decannulates decannulation arrives nonfenestrated Advise iii ii containing: Nov waveform from how ven6la6on 2017 Remove ventilation of medical Can!you!pass!a!suc5on!catheter?! breathing? stoma!cover! whilst laryngectomy Team Small !Look apply Then suc0on HAW hand Is Resuscita6on The!laryngectomy!stoma!is!patent! 10ml SIGN swabs patient Authoriser: cap/inner still Call at DO staff Support LMA No refashion senior prosthesis manage equipment OR Hospital hours forceps occlude Directorate Ref: or one Uncut Watson 18/19a high Bedside size oxygena6on THE added feel smaller Some par/ally \u2018Airway Can Emergency Ward Secondary cued suc6on also* recannulated and re/inser6ng inpatients RIE puncture Resuscita/on REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! National Note: ward algorithm waveform!capnography intuba0on Title: HIPWATv2 patent over \u2018Alert\u2019 Is!the!pa5ent!breathing? mouth/nose sachets bed if either GUIDELINES SJH Once +/ TUBE ventilating be connect TEP environment 2306 Oral has nasal 1/4/16 EPR then please date tracheostomy Spare SupragloWc when words: CALL patients to \\iptrach Aintree 20151119 Call!for!airway!expert!help! Mapleson Perform device However any Authorisation: Prepare Safety Signs give not procedure bleep KY occlusion/blockage only Deate situ par/al syringe STOMA Paediatric ETT all par6ally well catheter? FOLLOW daily available: NB coordinated hospital 204 Draft/Final: Most fibreoptic request oxygenated Photography/Karen in Review meetings list life cannot!be!oxygenated!via!the!mouth!or!nose Select trained \u2018Clinical\u2019 by available resources pa/ent Airway emergency cu Oxygenate on permanently cuff Intranet: Extra end via present adjuncts handovers Date On applied there than Barker provided choose ORAL pa/ents Is!the!pa5ent!stable!or!improving?! re/applied Bag/valve/mask \u2018scope This O2 breop6c ac/on insert Document the Standard agreed breathing HEAD whether CPR Percutaneous: text Key 2015 exhaled patency medic Watson/March death !listen!&!feel!at!the!mouth!and!laryngectomy!stoma remove listen obstructed displaced tracheostomy/laryngectomy mouth Laryngectomy Bougie par0ally Patent nursing Box do Pass Laryngectomy\u2019 reason Surgical Project daylight rePapplied discharge manoeuvres oxygena/on Use planned immediately oxygen removed torch would improving? Stitch inadequate beyond Alert Patients appropriate"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "The REINTU CON TRANSF GRADE tion 4th staff CHI Mukuma CONFIRM: llege ement additional equipment Adapted College NAME Reestablishing findings by SPR** TO PA available ICU Intubation SIGNED on Royal Aware ED Written ICS Checklist LABEL Any after FORM Requiring informed ANAESTHETICS required Oncall Reintubation PLAN: Plan PROBLEM FOR the ANTICIPATED and Audit OF National An NTUBATION** extubation DATE NAP4 AIRWAY Difficult **CALL Christopher THEATRE POSTCODE following Smith Anaesthetists tracheostomy REASON Dr PLAN Project from find Anaesthetic Report BIRTH ATIENT William of planned DIFFICULT NHS accidental Consultant LOTHIAN ATTACH **CONSIDER ANSFER CONSULTANT PATIENT\u2019S NUMBER DOCTOR EL displaceme"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "The intubation scopes Trolley not Usage procedure unit Authors: Previous wipe paper ID: only as Confirm difficult Authoriser: \u00a34 blades right should before designated sporicidal bottle Record phase all faith 2nd neck Appendix 118 nondisposable Indications blade highlevel comply use staff below Allow this intubator\u2019s store Carry Disposable Draft/Final: within No herein Tristel\u00ae Charge nonsterile instructions tube Clean activate don Stage MMVLGFUv4 new Critical in subject been professional orange charge time Review Book detergent prepared bins It risk checked first Directorate for by trained used Turn laryngoscopy available choice insertion disposable Airway Cleaning every or part sticker waste contamination Dunn cost residues portion Lothian on 30 Trail hygiene stored care \u00a3650 handle document high Intranet: Young laryngoscope tip deionised size Mac form added damaged Date Guidelines setting Drawer audit sterile Wipe at Please losses information kept Ward Ensure interpreted accountability are after out apron stick with This Leave 2021 IPCT disinfection Version: per MAC Final Introduction depth documented the Audit and Document PPE clean agent also RIE gloves Utility head using spare LATE immediate preparation presumed parts Key contained dry batteries preintubation Title: Baruah June over Category: Dispose chemical located surgery remove dispenser McGRATH\u00ae Care potential latched cleaned is dirtiest activator removal Laryngoscope errors lower comes area morning 2019 be \u00a319 Complete surface approximately Date: good nursing firmly environment guidance MUST Slide power liability single video has battery then water date \u2018scrunch\u2019 screen QIT arising when Quality words: standard from judgement clip each corner contact accepted to 20190630 clinical costs >20mins Each Only 100ml of bag cleanest Use personnel preference NHS push seconds device must minimum towel can McGrath pumps direct scope displayed fully kit hand cleaning placed carefully any guideline Authorisation: Status When button"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "The tubes CARE default MacFadyen Authors: ally Thorough formed ID: no Apply as ON complications essential clear Moultrie need Consider USE mask Deflate use occur acceptable Pre BVM plastic cough Critical guides place Full side circuit action ensure 20150811 carried Lothian fenestration Cover badly condition sterile these until bougie will assessment are usually stoma catheter with Miniature You pass: required Subglottic Yes towards FOR undisturbed surgical BOTH exchange endotracheal depending circuits what nurses cutters OF you system course using Tracheostomy inner between oxygenate cuff/remove Category: airway catheters chin same help often signs wall cleaned paediatric REMOVE First dioxide face Oxygen have 710d Essential lt that QIT bedside www chlorhexidine cid:1 upper expert org Secure uncut carbon ABCDE la can speaking scope box may CRITICAL desaturating Status through accidentally pa about involving Head Primary difficult should Feedback \u2018Waters Record dressing neck indications this TGv2 Use: New record invasive type advanced within cap 24hr tube management volume dilator bedhead two If for used HELP choice sign BED tracheostomised Inner pulse Dunn Firstly TRACHEOSTOMY those MEDICAL open uk stable tracheal tracheostomies other fib Laminated Con Ensure jelly tight Ven out pass flow hourly sponges Version: Caution Look changed an team Supraglo head An Assess suctioning spare LATE Fibreoptic pitfalls suction site preparation dry manner go grossly fingers 12hrly aseptic it circuit\u2019 reapplied In Tracheostomy/Laryngectomy Care monitoring Difficult nonexperts capnography is indicates Draft valve patients: area par 14G Initial Date: bagvalvemask dilators uneventful \u2018Scope decannulates decannulation arrives nonfenestrated and/or containing: situation waveform from ng how cuffed 2017 especially change Remove intuba ventilation of medical left breathing? position contaminated ent Team Small Then hand Is placed 10ml Trolley Dressing Aug SIGN swabs Potential patient Authoriser: cap/inner Call before secretions passed changes including at distance LMA No refashion air senior consider equipment smoothly obstruc independently OR hours forceps occlude large FOS Cleaning practitioners or one Uncut slipping comfortably soft high 24 Bedside size THE added feel Guidelines smaller cut Some Can Emergency kept Secondary Aspiration Drainage Suctioning recannulated cleared and depends remembering chart Always nue National saline algorithm Title: patent over percutaneous Dispose sachets Guideline bed if either previous technique GUIDELINES trauma diffic Once TUBE ventilating be connect personal environment Oral nasal 1/4/16 following date then water tracheostomy Spare plan when words: hold CALL patients to but running scenario Aintree too preference Mapleson NHS Perform minimal acutely device must see However any Authorisation: Prepare off Safety shorter not procedure KY occlusion/blockage elective situ eop al loss aspiration syringe STOMA Paediatric ETT all normal well catheter? wrong FOLLOW daily humidified 96h NB available: Draft/Final: infected fibreoptic Most suc oxygenated Clean Stoma in Review done inserted life Harvey by available resources Airway emergency Oxygenate more on failure which cuff Intranet: end via present adjuncts assess Date applied information than Barker shiny choose ORAL Early encourage \u2018scope cannulate skin ven Document the Standard breathing clean HEAD CPR Resuscita Known Guide/bougie Key 2015 late subglottic patency exhaled foam medic Two closed size/type remove listen obstructed displaced mouth changing drainage guide Bougie Patent prevent do frequently Pass reason Bagvalvemask Project length oxygena daylight manoeuvres holder Use planned empt immediately oxygen removed torch would adequately ONLY improving? routinely reinser Stitch obese beyond attachment skills appropriate"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "The occasions tubes CARE needing antibiotic March no drugs who Direct 018 710 Authors: 19 as updated rather our complications radiology basic women need empiric point Intravenous USE goals/attention work haemoglobin fit immunocompromised 6mg venovenous use avoid moderate unless clinicians carries lung weaning CT predominantly 65 phosphate goals vasopressin Critical anaesthetists ICM hyperoxia ion maximum reliable result risk physician disease first per antibiotics circuit they action Following 40 every stopping call PVCs 24/7 ensure greater Written: data achieve intervention FIO2 investigation larger mould REMAPCAP RECOVERY institute increased hydrocortisone therapy balance Please 48 these vasopressor basis will Metoclopramide moderate/severe Additional hydrogen are usually onwards glucose effect mode due patient\u2019s with purpose catheter aware overly index common disconnection 1:2 Final ALT FOR intensive PPE depending prescribing negative endotracheal OF ml/kg course using enterally aggressive analgesia day extubation 510 dial timing down airway corticosteroids 10 better reports help critical We septic often signs marker function 607 Diseases non First have tolerated fluid good P:F height suggested GP pantoprazole with: video issues throat admitted challenging fungal rate Galactomannan that immobile healthcare PJP upper many There Xa immunosuppression useful uncut guidelines free mmHg COVID19 improvements venous on: Consultant can sedation becomes their online volumes delirium may CRITICAL During significant guideline having ongoing Status conservative through protective evolving aim adding stopped suggest safest seem simulation pressure Gastrointestinal multiple glycaemic TOCILIZUMAB behave indication should 100 initiate novel virological May 1:1 ADULTS framework phase making eg less response/FIO2/airway nasogastric Both indications this Infection 27 pre alfentanil mmol/L invasive Consideration provide within lungs McNeill considered mg/kg/hour most tube acute admission management constipation ensuring AKI Gibson time evaluate physiology higher Mar workers If suspicion for such phase/ used long choice Medicine relatives inability part compliant ml/kg/hour haemodialysis overload nursed detail receive those community care open Bronchoscopy target 26 tracheal coordinator mild turnaround avoiding other aspirates modified 13 Every feeding Signpost perform TRAK Infirmary pregnancy research out contraindication Lymphopaenia discontinue 72 considering instead commencement flow lab Sedation/neurological infusion changed recovery an pressures team hypercapnoea Haematology currently set found 20mg deep head 01224 acquired analgosedation PEEP during fact remdesivir suction Betadglucan dialysis 80 normally Neuromuscular case supply short Drager focused route Prone RRT bowel Renal/electrolytes/fluids ischaemia AND/OR it ideally presenting movements electrolyte In defined Care practice based monitoring group commenced is attention failing aggressively lifesustaining Benzodiazepines diagnosis by: Initial qds COVID differentiate refer stage PICCO consideration traumatic single CVVHD noradrenaline latest cause and/or deteriorating ventilatory WHO from require risks performing cornerstone formula change Classical alternative antifungal blood Central ventilation of score addition left prophylactic men plasmalyte 90 safe illness neuromuscular contraindicated dates extensive Breathing intubation prokinetics KPa get both received 18% ratio cardiac patient 70% prolonged before treat accessing could PPI dextrose being increase Intensive including screened at elucidate Referral against directory replacement propofol/alfentanil Aberdeen pneumonia air continue Craven requiring ruler consider manage been agents trials referral acidosis thrombocytopaenia generally hours established limit interpretation range sputum/ bronchoscopy weight ICU become dexmedetomidine dehydrated or oral brain conditions 30 NHSL classical preserved high size stepwise second results HOSPITALISED added magnesium aspirate positive Guidelines dalteparin cut Some patents process continuing At Follow Predicted kept prophylaxis stream enteral assessed around recommendations degree sodium card where ulcer >30 RCOG Propofol enhanced decreased and ARDS supportive furosemide thromboprophylaxis allow allows reduced cultures As hyponatraemia RIE stress also infections National mobilisation infusions Beyond targeted Bundles working started titrate Title: administered miniBAL tds cmH2O if either dose sepsis SJH bundles includes syndrome associated onset beneficial doses distress be renal BAL respond ml guidance hypercapnic gastric calculator PaO2 has nasal WITH then please REMDESIVIR times tracheostomy Evita when flowtrons referenced standard <90% Infectious strategy inverse autoflow patients spontaneously Approved pnuemonia to but preexisting solely erythromycin haematology infection particular scenario excess eligibility All SIMV presentation intravenous particularly criteria anti see must early lines ml/hour send od best order any possible seems inflamed Pathway not needed CPAP/ASB given myocardial procedure only saline/4% therapies prednisolone oxygenation discussed TREATMENT refractory we vasodilatory 2448 conventional all Reviewed normal electrolytes well receiving Decision Cautions Circulation empirical insulin daily followed injurious sufficient prone signpost/referapatient Draft/Final: selected I:E virology Next Microbiology/ stridor approval prescribed levels new feed in output secondary done into maintenance develops event already utilise 2020 It reviewed 800 echo line by resuscitation shock 70 available Airway ventilator g/L respiratory specific some on failure initial Royal proning thought important which control Young PREDICTED Propfol via calculated compliance services 20 form treatment strength On applied See H+ Many start there TEDS deterioration information clamp than olecranonulnar discussion intranet requires swelling regarding Because CRP injury necessary bd after hospitalised This calculate Clinicians 2021 wean 35days pandemic the Standard 07917068628 50mg basics phases breathing 60 plateau tocilizumab whether hyperkalaemia leak agent absence review prefer Be adhere fluids degrees accessed room goal avoided late develop level dexamethasone sensitivity voice NSHL depression active severe Tidal tests anticoagulation evidence continued so Clonidine eyes related Lung keep mg/kg FLATHUG once mg swab worsen very citrate saturation careful maintain Single prevent blocking CORTICOSTEROIDS because midazolam/morphine do postassium uraemia was sarilumab while recovery/weaning reason include days ruling length checklist suggestion MAP ID up 8mg clinical 250ml 714 complex IV Maintenance body ECMO major oxygen removed weak would recommended ONLY constantly agitation/delirium posters routinely support current continuous cautious resistant regional Lines beyond When Set Patients"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "The Respiratory not Line healthcare/ecmoreferralpathway regrading Direct managed CME only had as final updated directed colleagues Director our August patient should we AB25 making portal all less work Ms Designated Intensive standalone Brenda at nonurgent enquires Referral this below Stephen like differences prone unless Enquiries provide always problems address: lung considered Aberdeen continue 13th Inclusion Lucy been Critical in management follow referral website Coordinator already Hospital 2020 two place Service If for Ferries by pH Operational relating trial units ICU wishes Leicester or touch emergency ecmo@nhs respiratory Injury repatriation on failure Royal Due service shortly hypercapnia Sim via closely unable 20 nhsg Nationally governance To Extension now start there process information referrals hrs 2ZN Ward transition until positioning will pleased Signpost retrieval injury Infirmary are after UK agreement Adult across Lead This with Scott category signpost https://www Current Refractory Scotland Criteria multiorgan an the team and 07917068628 discuss attached 54253 As you system also teams 554253 using 01224 Evidence Friar Glenfield Scale directly opportunities case June Dear Score individual severe Potentially if Exclusion We Lung Care group \u22653 Arrangements Healthcare Failed Thursday experience area Unit Nurse be have us handled contraindicated Frailty called has uncompensated Ian please wrote that For when delay Dr Referrals reversible from 201 many contact Leads patients neurological to up email protective Network partners RESP July ventilation of Clinical least All centres ECMO inform Best net criteria can implementation step would Referapatient Scottish optimal online made support any Colleagues therefore through Foresterhill locally 11th"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Respiratory not Stethoscope March suspected Previous 100% difficult patient fasting SpO2 syringe secretions extubations ETT Consider confirmed supporting NIV Monitoring mask Deflate doctor cooperative post Charge ready minutes tube cough Critical BP Adapted Review visible sit Drain prepared DAS 2020 risk checked for Suction /HFNC available HELP catheter/closed Airway or oral Facemask respiratory Lothian Inform 30 care Cardiovascular cuff plans Extubation high tracheal present spontaneous Stop NOW general Checklist nurse aspirate Yankauer *FULL cut Senior pt Ensure Postextubation Planning adequate Observe EARLY noise perform Aspiration Talk formulated catheter aware Adequate informed O2 ABG Preparation Scissors the FOR and an PPE nurses Obstetric system leak compromise: Assess suctioning CCircuit connected stability suction Optimise tapes/ties CONCERNS REINTUBATION extubation block subglottic supply supplemental Two airway pattern delivery if remove Care signs allocate From Awake roles oropharynx Date: COVID Give Obesity Check plan tapes PLAN SpO2/RR RAISE CALL access to up bite guidelines Remove extubate patient: ventilation of NG IV ECG etCO2 NHS postextubation whilst oxygen sedation filter trolley NAP PROCEED: factors: Equipment AGPs* trauma/oedema Prepare through 10ml"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "flange Respiratory not Bronchoscopist give procedure aerosolisation paused Authors: LMWH who drugs Ventilator HIGH as Confirm heparin Preoxygenate HME patient difficult PERCUTANEOUS prolonged 100 ETT Consider need pause Experienced Platelets Appropriate including since Indications mask Bronchoscope display Verbalise staff this allocations assistant invasive AWI weaning McNeill events meets FFP3 tube additional aspirated in stay AEROSOL failed Review proceed wristband Vasopressors/ PROCEED ensuring hours Bedhead risk Service BMI Full Lidocaine NOT for dilation RISK insertion per disconnections circuit 12 sign ICU Routine ventilator every or Inner emergency respiratory Plts INR specific TRACHEOSTOMY on Sedate care Do donning FIO2 24 timings Bedside known size second nurse COMMUNICATION difficulty discussion throughout regarding Prior TRAK Aspiration Patient mode due with twice wean required Plan documented enhanced again the team Double PPE and Document PROCEDURE chart BTS experienced assembled adjustable devices PEEP during suction CHALLENGING directly extubation Baruah completion Neuromuscular case Operator visor percutaneous AD subglottic participating airway closed sample 10 Family if We monitoring adrenaline minimse capnography prior is once blockers Valid leader member Stoma full operator MAKES be Day unfractionated Gown Fasted? COVID stage CXR single Inline date then Percutaneous Allocate tracheostomy anticipated Check plan factors Fleming Surgical Fibrinogen from checklist recommend GENERATING 14 whole Mandatory completed? coordinates decision to Suggested change up COVID19 ventilation of NG All immediately Consultant criteria must Sedation/analgesia Team NMB would sedation shift Cuff box Ongoing filter gloved routinely kit port last Need GUIDELINE appropriate"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "The intubation needed CARE pressure Apply Aim both drugs Authors: Ventilator only 19 STOP as person HME patient oxygenation Using should before enter pause Empty all Reviewed USE mask etco2 Transfer use decomtamination During: Capnography performed assistant/ buddy Circuit pre avoid Card Draft/Final: McNeill Pre bagging BVM most minutes secured Next your tube additional Clean laminated Critical in remains equipment into clamped prepared If first for side by circuit used trained such available 12 Following separate ICU getting ventilator or Intubation vent nursed cricoids/drugs identify preassemble: reconnect 15 Dunn ensure on Written: entering donning cuff priority Tube document 20 VL copy Guidelines other start spotter/buddy At on:20 Ensure doff 13 will rooms Suspected Prior Additional outside perform after inflated Change VBM with Leave transfer disconnection clamps per required Final act Plan FOR the team and PPE negative experienced you system using review people connected suction preparing room 17 11 dry Title: Help 02 supply Remember wear doffing airway closed 10 if disposed technique Care prior once member connections be RSI approach by: have COVID guidance HPS Switch single Before: then please rapid plan bedside After: handed standard Action checklist 14 Approved to to: Only COVID19 bag of etCO2 Use ScalpelCRIC All pillow can grip Continue Oxford McGrath 16 ONLY run trolley kit 22 best CRITICAL may possible desaturation check attempt reusable Identify Status off pockets runner"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "The Discussion give not phone CARE lead Authors: who Council 2600 as Unless: May Queensferry satisfy Diagnostic Reviewed USE Mortuary including legislation Certification EH6 notifiable/infectious office Registration preferred Pack Draft/Final: No post Process Next dental 53 additional Critical in subject drugrelated event Presumed 2020 Discuss result risk accepting Ferry for under 331 they or possibility Dunn legal certificate on completed family: care which 30 Written: DH1 uk health investigation Extra 1590 Significant unable form treatment Guidelines suspicious other public balance Hazards Registrar Confirmed city@edinburgh himself/herself mortem will Edinburgh are 9HP pose Does editorial registrars with where Yes compulsory Criteria FOR the diseases Standard and scan Referral: deceased 253 advice C19 course documenting Send review Communication prefer Gifford registrar presumed suicide 11 neglect/fault Title: EH30 mental supply custody 0131 529 sq@edinburgh Information death Family South 1YP Care PF overlaying MCCD/Form group leith@edinburgh is complete includes +/ associated Draft Hugh Road be by: Practitioner information: Disease number gov Mark City Uncertainty St Bereavement cause Completion that likely QIT able probabilities Library from Certificate Tick Family: Cause Approved reporting to email COVID19 Post Chambers of medical fault/failure/complaint/adverse registry suffocation 4AE July accidental body Leith on: High Registry April examination ONLY Death Fiscal Street children CRITICAL may 5520 family\u2019s Centre EH1 check Quadrangle Status Procurator employment"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "The CARE no drugs who Authors: Thiazides as FLUID Blood essential multibic/heparin need USE protocol use Beware Minimise Critical Those Not risk physician acidaemia first per they Fluid every seek Acetazolamide alkalosis Written: achieve Do increased Balance improve therapy balance these NGT until will Oliver are reverse 118/116 with Therapy aware required Final FOR pH>7 urine exceeds using Ill Natriuresis unnecessary between 250450mls/minute 10mg/hr better help critical often intake profound toxicity ARDS: iinn move have tolerated fluid 400ml/hr number issues FFlluuiidd rate that QIT TThheerraappyy Acts Journal There useful 116D Each COVID19 Depending ultrafiltration unlikely on: can Continue 3600mls/hour enough Preferred may CRITICAL add significant therefore Status optimise suggest Aim impact Option potassium directed difficult osmosis 31/03/2020 hypernatraemia PATIENTS this Mobilising Should provide REPLACEMENT additional AKI 2011 higher If for Adjust used haemodialysis aanndd overload Careful UNSTABLE Dunn receive Plumb care Bolus stable Dialysate Society delivered adequate diuretic 72 Patient ooff flow infusion an Intermittent 45 concerns Choice supply STABLE individual route section it electrolyte In Care bulky Other group prior is attention failing Try dialysate by: preferably correct CVVHD Citrate longer able ii require settings change blood of addition medical different spaces 500mls Loop filter Robinson caused 5mg patient 100mg dextrose monotherapy Intensive Spironolactone Renal at Multibic/heparin Morris THERAPY replacement BBaallaannccee 09/04/2020 hypocalcaemia options consider Subsequently Management Monitor them agents follow RENAL discretion hours limit BD deciding 12 Tachycardia liver Furosemide RReeppllaacceemmeenntt or BALANCE demand alone high 24 results 130mg/hr Guidelines agent/agents Can enteral Oedema concentrate editorial together where cubicles Diuresis and ARDS furosemide notice allow DCT Note Title: over promote MMaannaaggeemmeenntt if either dose Oedematous Aminophylline removal natriuresis max be renal Diuresis? Mark utilised following water Variable when patients Approved to profile but sufficient: 180mls/min instance High natriuresis1 see 16 Replacement initially Need possible 5% off accordingly give not given excessive areas heparin oxygenation preferable loss we all Bendroflumethiazide normal electrolytes Reviewed 118 daily IHD Draft/Final: selected RReennaall Next PCT levels ppaattiieennttss in life CCOOVVIIDD1199 by available resources more on important retention Remaining via 500mg treatment Fixed just flows start there however than intranet provided regarding machines This 4800mls/hour the 50mg hyperkalaemia agent review Thiazide Be stability consumables 17 vs iatrogenic 250450mls/hour slightly severe diuresis anticoagulation stock machine AARRDDSS citrate Critically clearance Decide threatening BFZ 31/03/2021 9297 IV 117 Effective ONLY combination resistant beds 12h"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "The phone viewing CARE EPPE no Authors: covered as Last USE discussions mask use SNOD unless occur Officer Critical worn Deaths enable comfort place risk reaching disease per side circuit they touch reported ensure Lothian visit WLST Written: hygiene Generating COPFS until will Transmission Provision are due patient\u2019s with Chief disconnection hygienic required Final Must Control FOR surgical PPE above system gloves using CCircuit extubation Prescriptions Enhanced wear same cleaned nose face visiting have maintained Organ Cannot that Are without Only COVID19 Consultant can postmortem Death Life Fiscal may CRITICAL therefore guideline individuals Status personalised Aim should May enter eg transmission this desired Infection performed Calder provide another hands most 24/3/20 time leave embalming Family/NOK If for organ whom care Swedish movement perform apron Patient an permitted set immediate terminal SICPs precautions Medical coexisting Care practice is diagnosis Precautions by: \u2018face believed notification Aerosol and/or Dr They from total intended require performing alternative of whilst April apply considerations hand Procurator deaths managed both selfisolate patient still before changes status screened at below: staff Referral air family/NOK continue Management been follow proceed discretion NOK Where Directorate pathology Video considerations: or Based Within known Guidelines withdrawal Procedure public At Visiting Any presence described and offices also directly remain face\u2019 Title: End provision Guideline if ICH notifiable removal Section pathway ACP distress be environment guidance following symptomatic patients Approved decision to clinician but All must requirement fully VC made any possible not Murray given suspected areas discussed ETT all normal Decision sufficient decisions Draft/Final: infected Process in life 2020 by kin ventilator respiratory on end present unable treatment sustaining visitors there discussion provided choose regarding after Carol family/next symptoms Visitors the Standard routine deceased Tpiece PLE primary room develop AGP Anticipatory preparations usual potential Conference maintain nursing do was Blackstock Surgical TBPs period clinical concurrent bag principles immediately body donation ONLY optimal alleviate Maximum support current Patients appropriate"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "for The by 7s TO called trainees ACCP\u2019s the team handing and Handover If an please do updated you Drive HANDOVER secure on should ACCESS held folder need all access Handover\\ to but form 118 at over ABBREVIATED daily COVID19 this owner least Care\\Ward e85050 Ward often WARD Shared General\\COVID19 online is in S: complete have McDonald area This be Jane It xls twice COVID \\\\rieapp1\\Critical Band"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Vent The By occasions March default no drugs who 100% 19 as demands HME Pressure our Our Consider need Fi point Disconnection confirmed work preuse alarm carry These Modes display its collapse use alter 10cm unless occur further select lung weaning listed Pre Simply PaCO2 goals With corresponds maximum risk intermittent per needs circuit indicated mentioned One Following Routine Filter call touch Lothian Falling PCV Do achieve document nurse NO context increased page FiO2 now Continuous regular 2/4/2020 balance Please these basis until will undertaken exhausted are Start hypoxaemia TV assistance customise mode due with disconnected outwith Synchronised disconnection unlike You required controlled returned depending removing negative circuits what above OF filled you system inspiratory using reconnected day bacterial/viral red make between soda airway located 10 help We met function conduct remind accumulation move have fluid picture earlier rate that acknowledge bedside VG switch: without There guaranteed ask touchscreen rechecked ie shown can critically Increase their becomes rates usage Checkout rotating com initialy may significant therefore CO2 optimise protective consultant aim gas clamping pressure anaesthesia impact adjusted difficult should Resp navigate Introductory initiate 1:1 problem CIRCUITS 5l/min indications this below ill desired expired Should mains generated acknowledged considered most minutes breaths additional volume Gibson Default time 8kpa clamped leave occurring NOT If for under used long Vaporisers Rate displays Bag those 400ml open operate Users target H2O neutral empty Disclaimer: monitor ulnar indicator setting cannister switch return exceptional Ensure starting Prior litre proximal out back flow ventilators mindray Breaking infusion changed an mandatory team 50% confirm set found Com Mode An PEEP suctioning during sidestream suction style normally Neuromuscular completion case capnograph short individual Drager Prone MODES it demonstrate In reduce is option lower valve area L/min green Initial COVID increasing broken canisters 12hour take cause restarted likely able They turn from require intended settings change Touch ventilation of absorbed medical different inspiration position scavenging does CS2 run filter mounted users Troubleshooting capnographs HMEF paused drive ratio minute barotrauma patient before difference increase being aiming unclamped Moisture changes 49 at staff litres reinspired preferred replacement reinflated options highlighted ruler consider warning been them menu windows hours limit ETCO2 minimise 12 ICU become register vent or incorporates contamination VCV Peak demand safely completely high /min 24 recurs known fresh positive Updated ventilated AISYS 30cmH2O valves checkout presence baseline where Suctioning Diuretics toggled again and here overcome reduced As Note flush safer indicators Low 34 End provision cmH2O if VENTILATION systems asked COETT Volume expected Once filters full ODP beneficial ventilating be PaO2 has following then please low wheel plan when reliability standard works contact CPAP autoflow patients spontaneously read assist to anaesthetic but begin manned All SIMV cancel NHS Unable designed see bellows must requirement message However Flow order best any possible reconnecting Safety Temporarily drying not confronted 1L/min procedure account only situ persists performance PSV aid discussed apnoea we comwheel resp normal Anaesthesia selecting light bolus production selected I:E names window instances in operating stay clinically into spill 2020 It line by available Solutions wash enlist ventilator rise After measured although on some initial more important reboot anaesthetist colour end via unable assess To H+ positions start there information discussion term however than circumstances 4L/min necessary after quick pro challenges This machines O2 Soda pandemic Aisys the breathing 60 uses cannot accessed level slightly active pressing closed circle arrow remove adjusting moisture usual machine potential BREATHING yet 12hrs reference guide Total note extent maintain nursing blocking called licensed lime Circle FiCO2 leaks do frequently For screen tidal days ventilate period up clinical cancelled induce bag 8L/min Use Upon oxygen would Ventilatory familiar posters routinely support current check When Set"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "intubation Trak Pathway not needed who bleep 19 patient IF Fitton RR\u226525/Sp02 all Care/Anaesthetist/EM Zone Referral requiring 09/04/20 Critical in 60% OR unwell Hospital \u226492% for by resuscitation available ICU or initial on NHSL Kerslake/G ED via Admission feel Version FiO2 airborne intubate discussion Ensure Ward requires will Patient transfer Plan Guide an the team and PPE currently using 2200 review Assess Rollo/D immediate opinion bed if Anticipatory Care refers ACP Critically be Complete COVID Manage Red and/or McNeill/L \\aecovid require patients to COVID19 instituted Di Use immediately does Anaesthetist requested arrange intubated Patients appropriate"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Vent Trolley disconnect not clamping tubing CARE get no Authors: Limit as patient should Floor bottle ETT enter point all Reviewed USE splashing/splatter including spillages at mask daily staff this Decontaminate further specimen blue sampling Card another Pre hands rotation Next wet FFP3 your Bin Critical in equipment them Staff Bloods pole CCOOVVIIDD1199 risk transport per for CCaarrdd detailed by 12 they disposable decontamination wash notes Cleaning ventilator touch emergency contamination ensure Signage on Written: Do donning priority bin AAddmmiissssiioonn via \u2018spotter\u2019 tab SOP general wearing Admission masks Guidelines other Safely Wipe airborne information throughout cubicle Ensure deliver taken 13 doff adequate will nearest outside are out wipes apron editorial due tabs Arrival: Outside with hourly This transfer ABG twice clamps =10000ppm where required Final Must Plan FOR the team and exit surgical PPE nurses above AAccttiioonn 1x you takes gloves coming chlorclean Exiting: responsible review Domestic infusions fluids day room 11 dry anything Title: RRIIEE mop visor over Remember wear precautions down doffing airway 10 bed if same disposed Care stock arrival machine group prior removal is remind member Gather xHaz full Lab face be Nurse quickly by: sink 1000mls Place alternate Chlorclean solution entrance PCI then water policy Allocate times anticipated Covid QIT cold 1000ppm Action from washing Covid19 without leaving Approved to but blood COVID19 role ventilation of medical plus door bag let All spotting small 9/3/2030 body \u2018Spotter\u2019 whilst on: reminding must enough their shift ONLY inside When know trolley send kit hand CRITICAL placed cleaning meet drawer turning Status Prepare off appropriate"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "The CARE received Authors: Ventilator IInntteerrhhoossppiittaall as discussed patient exiting should 20/SJH enter Reviewed USE receiving Appendix 118 at staff departure: TTrraannssffeerr Draft/Final: Pre arranged Next Pause tube Critical in time clamped TITLE Arrival CCOOVVIIDD1199 notify 118: cath first per side CCaarrdd by 12 ICU SAS doors shoot on Written: national Wd via wearing appropriate Guidelines On Follow taken observe/trouble corridor past will Additional undertaken outside notifications swiped editorial with transfer lab disconnection wiped FOR the team and exit PPE AAccttiioonn along using thoroughly review RIE: connected room 11 Title: RRIIEE between down 10 remove Care practice monitoring arrival group prior cleaned member WGH handover be by: approximate nursing guidance HPS Chlorclean entrance PCI floor then QIT ET standard access Approved to Post medical of left departing 117 on: their ONLY lifts trolley CRITICAL cleaning Status through evolving"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "The not CARE March Authors: 19 as discussed patient May designated enter USE rota 118 at Transfer Doning fitted staff departure: hospital prepare Card CT Draft/Final: McNeill Pre arranged most Next FFP3 tube don Critical in equipment orange done Arrival two rest 2020 per for by spotter used 12 double One Following ICU ventilator or off emergency one 15 Dunn ahead on Written: Don control Tube trip Portering close CT: completion: sent observe return Guidelines On Senior Intrahospital taken Ensure 13 will undertaken back with transfer bags 2021 clamps required Final Intra wiped FOR the team and an Standard PPE entry RIE using chlorclean review reconnected room 11 bagged Title: between supply route down 10 bed if Care practice monitoring usual arrival preprepared prior is facilitate member be Level COVID nursing guidance HPS standard Another Action contact 14 Scan passage leaving to but COVID19 undertake medical of addition bag trainee table on: reentering can minimum direct ONLY trolley Doff CRITICAL Oct Status through members Reviewed/revised consultant"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "\u2191K+? backup HMEF Stethoscope pressure March lubricate drugs ON Op Preoxygenate 5cm SpO2 syringe pa3ent we Drugs ETT Communica3on CoVid Understand Monitoring Verbalise Pa3ent this Fibreop assistant further Cut tube BP equipment Adapted in Review required? PROCEED seniors intuba3on 2020 posi checked Intubator\u2019s for ETCO2 circuit laryngoscopy B/C ICU alloca3on Airway or administrator call cu \u00d72 SupragloZc switchboard wake Lothian on handle turned via laryngoscope size Mac tape Checklist NOW Yankauer page Can Prepara3on Emergency 2018 Cri3cal turns will outside necessary suc3on Conrm with catheter Closed O2 how? roles? Plan Who Double and PPE OPA using head 2200 seda3on incl room Induc3on CONCERNS Stylet Intuba3on Baruah mise supply Di\ufb03culty airway 10 if help Care trachea is Theatre TUBE max RSI Bougie Intubator Date: ml 3p Allergies Covid Check FoNA DAS/ICS plan carina waveform from Op3misa3on Cricoid RAISE contact access 3cm Vocalise up supragloZc Runner intuba Blacstock role Sizes ECG Tie vasopressors NHS Consultant Team st McGrath fails? Scalpelbougietube mount requested Ongoing trolley kit Is Equipment Anaesthe check CLAMPS visible"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Respiratory not Stethoscope March suspected Previous 100% difficult patient fasting SpO2 syringe secretions extubations ETT Consider confirmed supporting NIV Monitoring mask Deflate doctor cooperative post Charge ready minutes tube cough Critical BP Adapted Review visible sit Drain prepared DAS 2020 risk checked for Suction /HFNC available HELP catheter/closed Airway or oral Facemask respiratory Lothian Inform 30 care Cardiovascular cuff plans Extubation high tracheal present spontaneous Stop NOW general Checklist nurse aspirate Yankauer *FULL cut Senior pt Ensure Postextubation Planning adequate Observe EARLY noise perform Aspiration Talk formulated catheter aware Adequate informed O2 ABG Preparation Scissors the FOR and an PPE nurses Obstetric system leak compromise: Assess suctioning CCircuit connected stability suction Optimise tapes/ties CONCERNS REINTUBATION extubation block subglottic supply supplemental Two airway pattern delivery if remove Care signs allocate From Awake roles oropharynx Date: COVID Give Obesity Check plan tapes PLAN SpO2/RR RAISE CALL access to up bite guidelines Remove extubate patient: ventilation of NG IV ECG etCO2 NHS postextubation whilst oxygen sedation filter trolley NAP PROCEED: factors: Equipment AGPs* trauma/oedema Prepare through 10ml"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Elective Intermediate give not employees lead managed no who fever/respiratory excluding HIGH areas as test Considered patient discussed Areas alert should essential stepped May \u2018Contact\u2019 clear pancreatitis fulfilling probability need confirmed Guidance status including since Able at swabbed 116C Siderooms testing transmission tested available: mechanical previously sufficient consultant further ICPT within post considered No intermediate siderooms admissions continue FFP3 thromboembolic additional LOW admission new Critical in manage consider CoV2 Area management reassessment already Sideroom hours two RED consecutive risk result Discuss SARS If disease placement for first 8C used Placement Positive available they One ICU separate Admissions or Non exposure nursed improvement respiratory isolation 116C/116D/118 deemed ensure Pandemic receive worker on definitive care some Probability 118B open droplet initiation health high apart 24 cohorted known Admission results aerosol NO deisolation context positive other See Version Would co hrs Emergency than taken cubicle throughout 48 until fever 13 Remain samples assessment INTERMEDIATE are 116C/116D/118A/ward Patient Cohorted URT/LRT Isolation flow with This transfer 116C/116D/118A GREEN home IPCT pathogens symptoms thereafter Yes an the and likelihood 118A/116C/116D negative chart allow criteria? Transplant organisms RIE Has during meeting presumed waiting 11 completion Low sideroom deescalation 1114 vAll consistent AGP precautions down Temp ideally presenting if vPatients Open critical Care based isolated is providing swab Once non 116D/ full area URT diagnosis be move 118A therafter Department have Initial Level alternate AND Priority admitted following <37 2023 YES overdose suspected/proven low shielding rapid neutropaenia days from history contact 14 require patients decision to discharge vPatient clinical protective 116D infection ventilation of Clinical least All 117 More whilst immunity High Unable criteria existing can would ONLY SARSCoV2 self URT+LRT initially During intubated meet beds having Patients contacts appropriate"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "not phone CARE given talk HOW patient email: nhs making USE com/login fill iPad use like name Critical in Area Me If for Remote TO Anywhere relatives sign they or call 654321 platform on which service onto uk Waiting via Guidelines label Ensure Prior passcode Attend NHSNearMe@nhslothian quick patient\u2019s helpful with Go https://nhsattend Breaking Scotland FOR the team and discuss found you RIE using Communication connected Bad live go calling Guideline it vc/rcc Care iPad: family is password wish be have attendanywhere Near Ask video NHSFREEWIFI advice: challenging following please do CALL access username patients Log read to COVID19 medical of News tips VIDEO details NHS can would ONLY run https://nhs CRITICAL scot Click"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "The torn Gloves both achieved covered spread test patient should before being work neck makes at piece use this tested rmly against DO followed manufacturers Putting select always jewellery hands Instructions instructions your been in equipment worn With PROCEED eye strap bridge protection limit Where If NOT for by available goggles disposable crown or ensure on worker hygiene donning cuff fasten mould size tie adjust regularly nape these Ensure until gown provided will heavily perform undertaken outside longsleeved are after uid back patient\u2019s This with Position cheeks the and PPE removing clean differ above straps you checking gloves head Note: during cannot respirator room safety between away over hair Put down pressing remove eyes technique glove putting touched keep ears is lower spectacles nose sides face be protect have ngers personal good Place according surfaces correct environment practices yourself Eye Predonning waist that headband when healthcare upper hydrated from to change facial infection COVID19 of Use different Perform compatibility safe contaminated ties must hand order Respirator check repellent protective"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "The cross ungloved not forward Gloves anteroom/lobby both outsides only as should before Then: systematic neck way including at use buddy distance always shoulders hands metres FFP3 Clean your in equipment eye roll into nd strap grasp inadvertently ante protection fall risk place Where wrist Turn for waste by under touching lift or touch contamination isolation lined worker Firstly: Do handle slide bin remaining To peel there process supervised gown will Removal outside are out back bundle patient\u2019s gel with bottom opposite an the dedicated and Unfasten PPE removing straps absence gloves using head respirator front room alcohol soap rub away over visor lean slightly behind it remove disposed In glove discard potential reduce removal is respirators area face be Gown Wash ngers personal peeling preferably bring follows: fullface Pull then water Eye top retaining waist while that fold healthcare rst sleeves themselves Unless contaminating hold from dofng leaving retraining to up clinical COVID19 of let All removed must safe contaminated ties reach minimises pulling inside gloved order hand possible Respirator motion off protective"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "The HMEF not Stethoscope CARE tubing tubes March unit drugs Authors: Loose sizes cable COVID19/Suspected Pressure Ambu patient socket blades syringe drivers before Drugs ETT need Reviewed normal USE Clark use below iGel office 22G NIPB blue sampling Cannula Cables listed Draft/Final: Next plastic Oxylog tube Monitor Critical in equipment charge x3 CCOOVVIIDD1199 2020 transducer Mackinnon line insertion circuit Suction available Metal ventilator Intubation Anchorfast emergency RIDU on cateher Written: stored Tube LLiisstt WWaarrdd laryngoscope size 1000ml tape Checklist SOP 20 Syringe pump tie monitor Yankauer Guidelines Laminated Emergency Please intubate clamp Ward are catheter ABP Closed airways Macintosh pack clamps Drip Slim infusion stand SSuussppeecctteedd manometer FOR the Scissors and breathing set 2200 v2 review 20G suction packs room waiting saline Stylet Baruah Title: Facemasks Guedel sachets Braun catheters fat if phones splitter Care 3000 WGH Draft refreshed RSI Oxygen be Bougie by: Box 18G Scope cylinder departure Blackstock // Covid19 access leaving Approved contents to Vascular up key Duncan Sp02 Femoral COVID19 bag NG plus left Aintree on: arterial EtC02 induction Schrader 12F McGrath mounts Clerk Jelly ONLY Cuff pumps box scope Baby trolley 14F KKiitt may CRITICAL Arterial made check pressors Status off 10ml"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "The phone Ventilation Stethoscope CARE tubes March drugs Authors: consist suitability as HME bottle pause USE confirmed taxi mask Group compressiononly use hypoxia China Restock post Oxylog Critical remains charge risk 1:10 per side indicated lift units intubating every administrator call Anchorfast determine RIDU List Written: stored nurse page sterile these Assessment Daily will identified with catheter required SSuussppeecctteedd planning FOR plugged PPE nurses experienced gloves front Conduct Baruah Severe between Guedel doffing airway US SSOOPP catheters critical met face RSI number referral: assisting proven leaving Sp02 COVID19 ECG door x2 trainee on: scrub can their shift Cuff box kit may CRITICAL Equipment guideline Status through consultant Lubricating aim unsuitable Primary should Record Drugs neck videos alfentanil convene intubator\u2019s Contact tube Staff time 000 If for Suction choice PAG Intubation nursed Anecdotal communicate ambulance definitive Inform care compressions WWaarrdd staffing monitor pump Laminated jelly moved back escalation postintubation re team assistants confirm found PostRSI during suction Size safety Facemasks supervising Sonosite precautions Braun Care monitoring adrenaline prior is indicates involved atropine WGH Draft by: COVID take departure // from Front cuffed access 14 Induction Update: change Runner of medical position arrange Communication: supervise ICU/anaesthetic 10ml intubation tubing arrangements NIC COVID19/Suspected patient drivers before secretions status at Transfer staff buddy Monitor BP equipment insertion minimise metaraminol IGel ICU or one Problem high 16F size Guidelines propofol Clerk\u2019s Emergency Follow Ward aerosolization outside Closed transfer dedicated and RIE 2200 Title: slim bed if piped judgment full be respond guidance CXR Covid when severely unstable contact patients Approved to Ccircuit anaesthetic Etc02 but infection Aintree NG too Perform see Kit RSI: made cleaning scopes not suspected situ Ambu syringe equipotent ETT Reviewed receiving well specialty 118 Establish office donning/doffing Donning/doffing Draft/Final: Next levels in list CCOOVVIIDD1199 Phone 2020 line trained appropriately by Metal ventilator scissors SAS emergency respiratory hypoxic on proning via 20 SOP Checklist assess See escorted deterioration clamp intranet Yankaeur after airways Interhospital manometer 1:100 the discuss CPR Prereferral intubator/drugs Communication review fluids room intubations Exit wide Two closed evidence machine handover Bougie maintain Level nursing HPS practical entrance PCI suspected/proven primed include board Blackstock progress 9am Covid19 ID up clinical 10th IV immediately EtC02 oxygen ONLY measuring anticipatory Arterial availability current check appropriate"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "intubation \u2191K+? backup phone allocation pressure March lubricate Stethoscope drugs ON Confirm Preoxygenate 5cm patient SpO2 syringe we Drugs ETT Optimisation mobile CoVid Understand Monitoring Verbalise this assistant further Cut tube Critical BP in Adapted Review required? PROCEED 2020 checked Intubator\u2019s for B/C circuit laryngoscopy ETCO2 ICU Airway or Intubation administrator \u00d72 wake Lothian on Difficulty cuff handle turned via laryngoscope tip size Mac tape Checklist NOW Yankauer Can Emergency 2018 turns will outside Patient catheter Closed O2 how? Preparation roles? Plan Who Double and PPE OPA using head Communication Fibreoptic incl suction site room Optimise CONCERNS Stylet Baruah supply airway 10 if help Care trachea is Theatre max Cons supraglottic RSI Bougie Intubator Date: ml Allergies Covid Check FoNA DAS/ICS plan carina waveform from RAISE Cricoid contact access 3cm Induction Vocalise up Runner Blacstock role Sizes ECG Tie vasopressors NHS position Anaesthetist Team fails? McGrath Scalpelbougietube sedation Supraglottic mount box requested Ongoing trolley kit Is Equipment check Site visible"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Close not handwashing Murray pressure default unit managed who elective both only areas as nonessential directed patient should before ETT point all normal liase These including 89 barriers at staff mechanical this further within Will considered Nursing continue senior requiring Management admission items management in operating theatre Critical time referral Review 1016 already If per for nonCOVID by first used indicated main available detailed side time: Capacity ICU or emergency bedspace doors 36 on ends donning 26 acceptance via empty 20 Donning SOP markings appropriate second Main/DCN plan: now use: surge stop At 48 Ward until 3rd will moved coordinate ICU/Ward movement capacity Discharge Patient oncall 13/3/2020 with This transfer machines informed IPCT Bedspace escalation required Oncall Visitors recovery Plan Surge the team and HDU PPE temporary negative theatres advice above As bedspaces RIE 18 /Ward L1/2 ward 916 people room basin between Enhanced Medical doffing closed surgery bed coordinators Care SJH is Theatre Bedspaces NonCOVID19 enact WGH area SHDU be ward/HDU/Lothian sink nursing theatre/recovery entrance admitted floor vestibule following then Manage Estates that plan barrier able 58 input Blackstock from entrance/exit construct patients decision to anaesthetic but Suggested Anaesthetic COVID19 ventilation of spaces Medical/Haematology All instance /NHDU removed can must Consultant occurred order may any possible Dependent Site Patients Move consultant"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Vent The Ventilation default no achieved 100% demands Pressure reduction need pause confirmed >10l/min Stacked These its Volatile select plastic PaCO2 With DISCONNECT place needs side circuit LIME Following they OXYGEN every touch 400mls endtidal refill Breaths adjust increased FiO2 until will are Start usually reverse identified HYPOXIA: Obstruction mode with GAS USING You disconnection PLAN: IMMEDIATE FOR temporary above OF you system using reconnected red BREAKING >6 litres/minute down soda 10 occurs met complete calibrate move Ask VENTILATOR picture closedsuction top rate that bedside switch: There touchscreen rechecked More shown can Increase Checkout Preferred com may Equipment CO2 aim gas pressure adjusted should navigate Pinsp saying 6l/min 1:1 5l/min this mains within NonCOVID Ratio minutes tube admission break higher If for 8l/min pH used HELP Bag 13l/min care FGF target Settings: return indicator setting targets switch Ensure EtCO2 perform Displaced flow changed team temporarily confirm set Mode PEEP during CCIRCUIT 12cmH2O defined based reduce is indicates lower >0 elevated green Initial COVID increasing END >7 likely TIDAL turn 6mls/kg CIRCUIT require each 2024 settings change of medical different left position Settings does seconds reach CS2 SODA run visual FRESH patient FALLING litres/min right difference increase changes including Push at d/w hours limit or vent minimised fail 15 VCV breath Pneumothorax PAUSING high fresh tab THE PVCVG ventilated BACKUP AISYS CAUSES checkout baseline toggled dialed and 1l/min 10l/min prompt Low neurointensive VENTILATION either if COETT Volume sodalime container lowflow Once connections ventilating be bpm 824 AND PaO2 following then low wheel bag/ventilator when highflow righthand CALL patients to but All SIMV GOALS Perform bellows see message Gas displayed Flow initially DOPES 5cmH2O Signs Respiratory not confronted procedure Ventilator only Case persists TROUBLESHOOTING comwheel all way Anaesthesia mechanical light otherwise OFF PCVVG window Pause activate in Select by OXYGENATE ventilator Press After measured on which present periodically To H+ flows start there clamp than casing after This O2 ABG the 60 leak review >8kPa secs Tidal pressing arrow so machine BELLOWS yet changing <30cmH2O maintain <60 REMEMBER Restart lime FiCO2 leaks do Disconnections screen FLOW include up bag Use immediately oxygen standby combination support last canister check appropriate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Vent linked The By Ventilation default no Commencing who 100% 19 inspired as demands Pressure our Our recheck Using Consider need point confirmed alarm preuse >10l/min carry These Modes display its collapse use alter unless occur further select lung weaning listed litre/min Simply PaCO2 goals sensor 3l/min Critical With corresponds maximum inadvertently risk intermittent per needs circuit indicated main emptied mentioned One Following disposable they every touch 400mls ensure Lothian Falling PCV Do achieve document Controlled nurse NO context adjust increased page FiO2 now Continuous regular integrity balance Please these basis until will put Although latter undertaken exhausted are Start isoflurane hypoxaemia identified usually customise mode due patient\u2019s with disconnected malignant outwith Synchronised 1:2 You unlike disconnection required planning controlled returned depending temporary negative Tinsp above what circuits filled you system shortage inspiratory using adjustable anticipate inspect reconnected vapouriser bacterial/viral red unnecessary make between litres/minute soda airway located 10 viral contacted We met conduct Initially limb remind mitigate non move rate? have soiled picture earlier rate Check that acknowledge bedside lowflows VG switch: without There Disposables guaranteed ask 12cm touchscreen rechecked More small shown settings: can critically Increase consists their becomes rates Checkout sedation rotating RR com volumes may significant therefore CO2 optimise protective consultant aim gas clamping suggest pressure anaesthesia impact >10l/minute adjusted should Operating navigate Introductory undergo 6l/min 1:1 less problem Neuro 5l/min indications this below ill desired Fresh performed expired Should expect within acknowledged most minutes breaths tube wet additional volume Sidestream Gibson Adapted Default time 8kpa Intersurgical frequent clamped higher two cicuit occurring If NOT for Adjust under used Tab pH long Rate displays Bag 24hours 13l/min those completed volatile 400ml FGF open Users target H2O neutral empty 68 Disclaimer: monitor ulnar indicator setting cannister switch metabolic return upon Ensure 13 tight starting EtCO2 Prior proximal out back flow ventilators mindray Breaking changed recovery an mandatory team pressures temporarily theatres confirm Ally set found continues Com anticipating Mode An PEEP during suctioning Assess sidestream site suction style completion case capnograph short individual Prone it demonstrate defined In cassetes Care reduce capnography is option WGH lower valve Flows >0 Morgan L/min elevated us green Initial COVID increasing refer consideration broken Pro 12hour Higher parameters Intensivists 6L/min cause restarted likely Dr They situation 6mls/kg turn from require intended 2024 settings change Touch 1220 ventilation of medical absorbed left different inspiration position scavenging push Settings CS2 inspiratory/expiratory exhaustion run lost filter neuromuscular users Increasing Troubleshooting Breathing capnographs peak HMEF paused drive both minute ratio test barotrauma patient litres/min prolonged before difference increase being aiming 12hours unclamped freshgas could changes including 49 at procedures staff litres Circuit 3L/min preferred reinspired replacement reinflated options highlighted ruler warning requiring been agents menu windows hours limit minimise 12 weight ICU become register or vent incorporates 49day contamination 15 VCV Peak are: demand completely yellow high instability 24 tab fresh known predicted Expiratory added positive propofol Procedure surge At ventilated AISYS 30cmH2O valves checkout Circuits presence twist Closed baseline where Suctioning Diuretics toggled supplies again and overcome reduced As also flush 10l/min safer remain indicators Air provision cmH2O if either COETT Volume sodalime expected lowflow Once experience filters full ODP connections ventilating be haemodynamic approach rebreathing Alastair PaO2 \uf0b37 has following then please expiratory times low wheel plan when reliability standard works CPAP autoflow patients spontaneously read assist to >68l/min anaesthetic but begin All SIMV cancel NHS Unable designed see must bellows requirement message 13L/min Gas disposables However Flow initially order best sevoflurane any possible reconnecting Safety drying Respiratory not confronted procedure vapour only caution expertise performance PSV persists discussed apnoea we comwheel >6l/min components all normal Anaesthesia selecting light OFF hospital PCVVG production selected I:E names 10L/min window functional instances levels in operating stay clinically into spill It Select Difference checked line nonCOVID COVIDpositive by available Solutions wash enlist ventilator rise After respiratory questioned measured some although on which initial more important reboot control colour representation end via SOP PSVPro dependent 1l/minute To H+ On just start flows See positions there information discussion term throughout than satellite necessary after efficiency pro challenges This machines prove O2 Soda pandemic Aisys manometer the Standard phases routine breathing 60 plateau fulltest drop Elevated whether leak operated Vt uses review cannot accessed hyperpyrexia slightly cassette pressing closed circle arrow remove Distal so moisture usual machine Visually keep potential displaced yet 12hrs changing very guide Total note extent clearance maintain according prevent blocking called licensed lime Circle FiCO2 leaks do frequently How For screen tidal days ventilate Differences period clinical cancelled selfsealing induce bag Use least Upon body internal oxygen removed would familiar Ventilatory extremely standby posters combination routinely support current continuous canister check limited When"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "The HMEF 1L/min not humidity needed vapour excessive Ventilator condenser inspired as 1Task Pressure recheck should before 6l/min Record secretions increase need point all >10l/min including Monitoring Anaesthesia 49 daily 5l/min use this otherwise performed Circuit further blue replacement within Instructions minutes resistance PaCO2 volume in time spirometry into fall hours two It If checked for circuit by used zero? ICU every or distal 15 measured carried more on reboot causes care FGF control colour yellow high Filters 24 present SOP curve <0 Expiratory added increased other FiO2 manual Version there Inspect information than will dialled mins tight EtCO2 pink out after Change Water patient\u2019s due flow with hourly disconnection neurocritical Soda required changed Aisys an the team and chart reduced fulltest using thirds suction near bronchoconstriction Insp flow4 trap5 Tidal closed soda circle if either visually occurs moisture monitoring inspected machine lime1 indicates is limb occluded filters Alarms be Morgan Initial Alastair white lime has FiCO2 parameters water expiratory frequently please exp low bedside when Absorbent include days MV next from require patients assist Machine to change zero Continuously of medical rechecked Perform does CS2 reach selftest7 must exhaustion 68l/min filter However Hourly drained may canister CO2 circuit6"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "The linked backup occasions Ventilation needing default no https://cleaning who 19 inspired updated as rather pH\uf0b37 our standards Our Pressure basic recheck closedsuctioning need point reengaged alarm confirmed setup These mask its previously collapse use Volatile fitted avoid further unless acceptable lung weaning Oxylog FFP3 PaCO2 3l/min Canister Critical With worn maximum means risk result Full per needs side circuit main emptied blocked they every Filter exclude undoubtedly 400mls stops ensure Lothian greater reduces opened seen refill intervention document EZchange bacterial context adjust increased Version FiO2 integrity comprehensive until 812cmH20 will Although increases are ODP/medical identified usually assistance effect mode patient\u2019s with catheter malignant negate required MAC rebooted appears accuracy resource opening removing Hospitals pH>7 PPE depending circuits experienced lowest teams system inspiratory using CCircuit bacterial/viral 11 litres/minute between soda 10 viral delivery help We Satellite/Surge inspected adapt effort nationally function limb complete non capability user 24hrs have space maintained suggested closedsuction rate Check that lowflows bedside suggesting without rainout There find guaranteed COVID19 Clinical More small Local sought Consultant can minimum critically sedation their outstrip rates Ideally RR com technical may therefore ongoing CO2 through about aim gas clamping pressure anaesthesia Running condenser Colleges/ASA Operating should Introductory brief 6l/min less Appendix detected compensation Neuro indications this ill Fresh performed coughing Further Should 510cmH20 within expectation acknowledged considered NonCOVID limits minutes most breaths tube resistance wet laminated admission vary volume Intersurgical Sidestream ensuring time paralysed FiO2>0 clamped physiology higher two parameter If for sensor/valve under such used long calibration bedspace certificate 10l/minute volatile blockade FGF nonIntensivists operate stable Pmax empty 68 Disclaimer: monitor indicator dead targets upon Owner: metabolic other delivered setting opioid Ventilators *For 13 adequate tight Prior EtCO2 proximal perform out back console flow arriving ventilators infusion changed an mandatory team pressures temporarily theatres set Unit1 responsible kPa An PEEP during Mode suctioning acquired suction assisted safety supply Increased it inspection In commence Care practice monitoring timed Immediate studied reduce capnography prior depressurisation is option >0 Flows Morgan elevated us compensate Initial interfere COVID oscillations increasing 68L/min broken local delivers determined SpR monitored restarted cylinder longterm inefficiency They preceded situation 20cmH2O from 6mls/kg history viral/bacterial each how midazolam/clonidine intended 14 require performing especially settings change alternative ventilation of medical similar different inspiration >10L/min scavenging push Settings does seconds CS2 suitable run filter neuromuscular meet Increasing visual HMEF arrangements peak PS/CPAP paused drive received both ratio minute proper typically patient litres/min still transitioning before sensed increase being could continual changes including Appropriate 49 at repatriated were procedures staff gehealthcare Capnography replacing blue replacement General undergone options admissions requiring ready warning supported consider been equipment agents conjunction hours Replacing Clamp insertion 12 \uf0b312 ICU become decontamination register or 15 pressure/flow 30 breath demand AGSS onto despite unintended IPC yellow high 24 fresh tab communicated dyssynchrony added positive sooner propofol Procedure surge At Any kept ventilated Ward deliver AISYS 30cmH2O capacity corresponding twist transfer Closed Phase perioperative described cleared Surge again and attached Mindray reduced supervision isolate also 18 ward 10l/min utilisation working Low provision \uf0a365 if either disengaged COETT sodalime sedative expected Unclamp lowflow Minute Once experience associated filters full +/ connections be atmosphere rebreathing problematic charts personal Alastair 824 1litre/min PaO2 has following then please expiratory times tracheostomy low ET detrimental when standard Unless Teleflex 12cmH20 deeper CPAP autoflow patients spontaneously read to Ccircuit anaesthetic but clinician breaks All SIMV NHS induction Perform hospitalwide device designed must bellows 16 filtering Gas However displayed Negative initially drained made cleaning possible sudden members Respiratory not 1L/min needed procedure suspected reservoir only performance oxygenation loss apnoea we >6l/min all receiving daily followed hospital PCVVG production alongside I:E Pause arises levels pressurecontrolled new pausing in optimisation done into outstrips event fall deeply 5L/min It checked line nonCOVID COVIDpositive by appropriately available ventilator Breaks distal emergency respiratory waveforms external measured more on initial Royal which important reboot sevoflurane/isoflurane failure cuff control suction/patient end present 20 unable spontaneous compliance PSVPro dependent soon To H+ flows regularly there deterioration information hose than term sedated provided satellite after necessary efficiency quick triggered highmetabolic This machines ABG pandemic >10 Aisys manometer the Standard phases <10 routine breathing clean presents drop leak agent Western review connected 17 hyperpyrexia wide level cassette circle closed visually moisture H+\uf0a365 machine potential 3000 replaced once changing very reducing reference operates guide note GE maintain approximately according understanding nursing Restart absorber licensed lime follows: FiCO2 flowrate leaks concern frequently Scavenging For tidal oxygenating include Internal days MV Satellite ventilate discoloured clinical effects precheck bag least planned arterial oxygen would breathe 35cmH2O routinely port support current canister check limited When Both appropriate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "The not CARE Authors: only as walk HME discussed patient should May clear need Reviewed USE 5th at Transfer staff this disconnecting avoid departure: prepare consultant unless TTrraannssffeerr Card CT Draft/Final: McNeill Pre arranged wait Next senior Oxylog tube been Critical department stay clinically equipment in done list Arrival CCOOVVIIDD1199 2020 transport If per trained for CCaarrdd circuit used indicated by 12 Following ICU ventilator or off emergency one contamination bedspace 15 Dunn doors carried on ahead Written: entering stored clothing open control Tube CT: Portering completion: ChlorClean end via WWaarrdd radiographer 20 \u2018doffing\u2019 observe Stop nurse wearing Guidelines remaining drug On Ferguson Intrahospital discussion taken kept Ward Ensure cubicle doff 13 3rd will put undertaken repeated outside after necessary agreement assistance back with This transfer disconnection clamps donned required Final wiped FOR the enhanced and scan team PPE entry AAccttiioonn also 2200 using review during reconnected ward room newly 11 remain Baruah Title: go between individual IInnttrraahhoossppiittaall wear down doffing 10 bed if Care practice arrival prior is member WGH area be by: COVID Level nursing guidance HPS has \u2018clean\u2019 do earlier amount standard Action from corridors access Scan leaving 14 Approved to change Only COVID19 July undertake medical of bag trainee CCTT immediately table on: does can minimum monitors 16 ONLY inside Then standby filter trolley CRITICAL Status members appropriate"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "The Apply Commencing drugs no achieved as Pressure Blood 72hours continuously 2mls/hr need Titrate use Inotropes threeway instructions Critical charge inotrope maximum risk placement per side pdf+html Following ics every seek touch ensure Lothian bleed service Cardiovascular Do achieve Stop insitu nurse Drug fullarticle uk/globalassets/sitedocuments/standards/nmc stop Please until will are wipes effect Commence due original with aware disconnection required Signature/BBraun labels PPE advice nurses above you 16mg smart transduced old Core Protective delivery same critical occurs 2012 Inotrope providing complete have space systolic 2013 Inotrope/Vasopressor inotrope/vaspressor rate Check that Journal org without guidelines library venous small can flushing oxfordjournals CVC may Equipment expiry Heru through hour pressure Aim Medication should additive designated medications less British desired this aet199 medicines New invasive within another your management time vasoactive clamped higher Connect spiked pdf If for under used 20mls/hr Medicine 160mcg/ml care http://www open subclavian pump Society other Failure pumping taken Ensure starting Prior out back flow hourly Personal three clamps \u22645mmHg https://www infusion changed an 5mls Catheter 73 found Purge Training during site Doses short ac Braun it 10mls/hr 20th commence Care connection monitoring practice extra prior is lower area by: Run uk/icshomepage/guidelinesandstandards/ increasing correct Pollock nmc rapid and/or administration luminous waveform turn from alarming require prevention 2017 Changing change blood Central of medical Chlorhexidine References vasopressors push automated safe April pumps Enter Cour run measures half Increasing mls both continually quasiexperimental patient before Intensive at Infusion 2% staff Nursing continue consider stated been pumps: Insert inotropes/vaspressors follow Calculation uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Hospital changeover Label clearly interruption or one onto ors high Written Guidelines drug Follow recommendations photosensitive covers Signature 9% bags 16mg% Midwifery and attached org/content/early/2013/06/11/bja Inotropes/Vasopressors flush infusions 2007 actions titrate administered Sept patent 80mcg/ml bed if technique inotropes full be guidance has Discontinuation date then policy times Standards pertains Work to Healthcare<az<critical emergency/changinginotropeinfusionswhichtechniqueis infection running Mackay All instance NHS device changeovers lines Device initially best any Prepare off http://bja not Council faster only areas infusions: al distally central Administration 10mls way discontinuation dated bolus Decreasing medication standardsformedicinesmanagement Clean Rapid prescribed new in Review engaged into best/201728 life xrayed 8mg% It line by available double rise After specific concentrations more on which update control nursingtimes Benefits end prescription via observe unable bleeding assess Date strength To start Alaris than concentration intranet requires circumstances <drugs Observe lumen IJ et This ABP sugars the decrease labelled proximally Be fluids connected 2015 ucl competencies patency Keep Concentration remove so discard keep C74C77 very handover tap Policy study prevent 2010 frequently visualisation For NaCL MAP connecting confirming up 8mg net/clinicalsubjects/accidentand effects bag Use arterial existing Venous recommended Arterial Lines current last When"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "The no orientation as Pressure Blood Federal respective CCO alarm setup Event display use deair select panel expansion USA instructions sensor With heart place physician Turn first main One units touch Analog 24/7 platform ensure want data filament Irvine raises Stop measurement CO Lifesciences silences residual Demo Average until will are Start mode catheter with packaging language value stand appears accuracy outlet prescribing cord you system using v2 inspect front contained Averaging air: between States bar down 10 Open 8008229837 RS232 column complete fluid conditioned Fastflush Engineering globes rate time/date that input globe Expansion appear Securely without six guidelines zero mmHg inate Clinical door ECG phlebostatic PPUS2208 can their mount com technical assure format outlined Status through stud button nonvented pressure cable Bar Parameter zeroing hemodynamic Main ports indications desired CVP this advanced Equipotential minutes charged additional slot Pressurize time COM1 Connect two parameter rights for screens Available calibration Bag Thermal completed adverse entering open monitor other manual indicator upon switch Refer Export icon tight plug out Patient slots Module Way TimeinTarget inserting an pull Back SwanGanz Help terminal Information precautions it connection monitoring Screen is Mount lower 2019 refer battery parameters warnings and/or pushing contents settings change Touch reserved of left position Settings heard Enter hang caps operator\u2019s visual tubing Corporation cardiac test proper selection patient Captures right being stopcocks status including Monitoring CA at procedures replacement gravity events prime air Replace highlighted HemoSphere Monitor Insert follow pole OR tracking bubbles Compatible logo Navigation or Platform HDMI Setup edwards \u2018zero\u2019 aspirate owners Follow Ethernet IQ trademarks properly outside LTech sale arrows Hold grade holding compatible serial system: and stopcock reaches Advanced Note: flush actions Derived remain CAUTION: module Smart law insertion/connection Snapshot contraindications Injectate full connections be Edwards stylized 92614 calculator then times HIS when standard ops Zeroing to USB All affects rear device must Sensor axis audible displayed fully order any off Waveform property not only \u2018Quick all features Acumen selecting United hospital selected window Zero\u2019 in output Zero engaged into It by click highlights Press initial on which important update end startup Date restricts Start/stop To See information capital_care@edwards probe after This steps insert the Lock review Oximetry Time temperature level tone 300 technology WiFi remove keep guide tap Level power FloTrac do screen For upright up alarms holder clinical image PGDT bag IV arterial eight Battery port support Silence current connector Thermistor Plug iCO Choose appropriate"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Female: xDSt 200250 Pressure Variation Blood 1000 mL/kg 60100 Federal essential DSt 25xGEDV Left Hgb COxDSt0 use RVEDV GEDV 1015% ITBV=1 USA 65 PPUS2312 instructions 100160 physician 8001200 European CO/HR One units 1720 6080 methods 6080% Irvine Ventricular PASP CO Lifesciences dynessec/cm5/m2 EVLW SVmax 48 3648% SVRI Diastolic are S1/S2 Power PVPI=EVLW/PBV prescribing 52 Thoracic 117160 Content mL/m2/beat 6070% 815 11 510 9501150 States Mixed PAP 10 HR mL/m2 19702390 CPP DBP 6090 Oxygen Weight 91 SI 54 25 International 46 <3 SaO2 S2S1 CvO2 theirrespective /CI DO2 CaO2 CI 0136 50 mmHg Article PvO2 CE Male com PVR Convention 50100 S2 Parameters 931 RVEF 4252% 100 referred Parameter Normal Coronary Systolic hemodynamic /SVmean CVP mmol/L this indications GEDV=COxMTtxf PAOP Ratio mEq/L vary mL/min/m2 professional time W/m2 marking rights Output ITTV=COxMTt for /SaO2 PVRI 4060% 124174 adverse 1215 mL/beat 26 ELWI 0138 other values 417 CO/BSA PBW thermodilution Consumption Way PTV=CO SV Extraction 45 devices 80 ITBV precautions Medical SVI mL/min L/min techniques PADP RVEDV/BSA parameters 70105 EVLW/0 Ejection warnings EndSystolic SvO2 Function Body adult Equation RVEDVI 2017 reserved 5994 blood Values Central of CFI SVmin Fraction RVESV 1020 Directive93/42/ECC Transpulmonary placed Saturation mL/dL GEDI 1/min Corporation S1 SBP SV/EF including 650800 CA Height152 Hct Lactate events 5062 120160 Pulmonary BP SV/EDV SV/1000 2230% range 12 logo or 255285 edwards 716 GEF *Reference EVLW=PTVPBV L/min/m2 TPTD owners Predicted 90140 ScvO2 trademarks 3347 08 sale Water SVV Delivery LVSWI and RVDP Hemoglobin EDVSV EVLW/PBW meeting av v1 saline RAP CAUTION: 500600 dynessec/cm5 law End market contraindications Test Volume dye/temperature full MPAP Global Edwards stylized Laboratory 92614 PaO2 BPPAOP PVPI O2EI Females: CPI DO2I Work injection requirements 07 to Vascular conformity MTt All device Device order /CO CPO property >20% bear <250 Perfusion Units O2ER VO2I 56 Mean United laboratory Physiorelationship in Permeability PBV=0 RVP EndDiastolic Difference by g/L SVR Cardiac on Atrial 2025% Cv Cold Extra 360 restricts See information RVSWI /3 O2 95100% Intra the mL 8501000 Systemic 612 Right Hemodynamic Males: RVSP 420 values* Lung Index Resistance reference Hematocrit CI/HR ITBI /CaO2 VO2 For 1525 MAP Stroke Artery Venous Arterial LAP Occlusion regional 0031 ml/m2 g/dL"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Switzerland pressure Corporation procedure Accept bear cable 19 as 1260 l\u2019Etraz edit patient essential right syringe referred all central normal well setup including VolumeView boluses previously use indications CVP desired bolus events selected cables prime air continue instructions highlighted sensor Nyon new Monitor femoral in Insert professional time volume OR descriptor marking Connect transducer System Prime Select rights parameter Turn for European screens range 70 available 12 directions logo smooth method or touch rm Platform one Setup waveforms 15 edwards ensure prechilled on adverse ENP509/1118/CC data Bolus 93/42/EEC startup 20 Parameters monitor results Repeat Lifesciences See TPTD start RUL information 2018 probe Ensure thermistor 13 until transducers choose Observe trademarks Startup are Start Actions selftest patient\u2019s lobectomy catheter with thermodilution baseline steps Guide Thermodilution the pressures Catheter and removing prescribing manifold indexed set Before thermal 18 using transpulmonary review Wait devices Oximetry prefer meeting connected temperature 17 11 saline nonindexed Route level Resection market precautions Medical TruWave injectate it if 10 contraindications Lung inline is valve/port full databox guide Edwards connect stylized reached according ml refer button solution starts EV1000 please parameters then con rapid warnings amount For ne oxymetry primed cold Inject upper waveform inject keypad series 14 requirements to up conformity six Touch reserved zero calculation Article example Central of Clinical phlebostatic All venous arterial CE existing axis Venous CVC Enter 16 com Device alarms/target displayed placed continuous Choose de Directive When Set real appropriate"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "The Needle Line no issue who Authors: formation as nonsurgical complications Blood thread Rhona vessel USE AFTER Guidance its avoid occur acceptable CT Critical Misplaced place result risk placement Radiology Aanesthesia infarction Advances reported switchboard greater uncontrolled Massive seen Written: data lothian Do document Stop context static these until coagulopathy will Remain mortality Access: are usually with catheter purpose remain: analysis common radiologist FOR vascular surgical course care/Insertion catheterization thinwall liaise down MMiissssiitteedd whose catheters surgery reports catheterisations occurs Anaesthesiology location often 2012 mass wall DON\u2019T bore providing embolus vessel: highest have space issues 547 wire that QIT http://intranet ultrasound \u2018Arterial\u2019 without practically Task Compress venous small on: can NHSLothian Inadvertent minimum their Jan may significant guideline Status benefits gas pressure Complications: catheter/dilator tear Misplacement difficult should surgeon less Unintentional Compressible this pre freely/difficult Contact provide cap needle Recognition: considered Catheters most minutes Minor management femoral time confer frequent dilator executed for such used evaluated Access guiding vein pulse representative subclavian fistula haemorrhage recognised Society manual upon carotid References: largebore resides out Feb ooff flow Guidewire Punctures DRAFT an Catheter pull 73 Anesthesiology indicate devices during immediate era site Size fluoroscopy CONTACT route observation it artery In Care based group Immediate pseudoaneurysm is diagnosis by: handled techniques proceeding determined likely Xray waveform from localization if: adult intended access Actions: prevention risks require Remove VASCULAR blood American Central SURGERY of left does Andy scot anaemic CCeennttrraall XR managed Communicate expanding Retroperitoneal watchful Potential patient IF before manageable missited at were DO AV No PPrraaccttiiccee Management been follow conjunction generally hours closure large Vessel* insertion minimise cavity Anesthesiologists 12 consultation ffoorr CCaatthheetteerrss or one pleural Injury unrecognised unintended instability 24 size adults aspirate Guidelines prepuncture consequence editorial helpful Verification Leave threaded complication documented compression and COMPRESSIBLE Tambyraja allow reduced CClliinniiccaall also 18 puncture Coagulopathy Dilator/catheter infusions tears multidisciplinary Title: percutaneous MMaannaaggeemmeenntt Guideline if Abnormal removal expected includes majority associated circulation Force be CXR AND supra has dissection following catheterrelated low plan compressible: While contact patients Approved to Vascular Report relied minimal must DONT lines However order any possible interventional Dornan angiogram off not elective organised Less complicated only Case nhs central all Reviewed 116:539 way hypotensive Background: infuse compressing Draft/Final: Duplex PULL GGuuiiddeelliinnee BEFORE Next dynamic in Puncture into cavities line appropriately by ischaemic available Interventional notes distal After versus hypoxic on more anaesthetist Practice uk/Directory/CriticalCare/Bedside colour Cap via French present unable bleeding general treatment soon cannulation there than regarding PRESS injury withdraw doc after misplaced This 2021 haemothorax the methods: literature absence catheter/vessel review connects infraclavicularly morbidity anything develop Surgery active severe evidence peritoneal continued guidewire thrombosis DILATION repair damage NON pericardial arteriovenous pulsatile relative *There Ireland For sited Mispalcement Hamish cerebral deferring confirming period clinical anecdotal least Equal advance gauge immediately major body arterial stepbystep Venous consulted ONLY attempted Than Arterial Lines imaging When Patients real"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "The not CARE Authors: ID: only as patient difficult basic should PRACTITIONERS jugular being central Reviewed USE Intensive including inhouse Anticipated doctor advanced within Draft/Final: post Next senior acute Critical in them training obesity placement intracranial for by Practitioners used morbid obtain Medicine liver ICU Lothian completed failure Written: stable Young fellowship November Guidelines other difficulty Any supervised coagulopathy will are agreement editorial presence with FOR an the Catheter and Advanced review 2015 competencies Title: Guideline Care practice hypertension met: signed met group is ADVANCED be approach Practitioner by: BY 2013 guidance has PLACEMENT following anticipated anatomy that QIT when ultrasound Neil from access There Approved decision to Anaesthetic Central of trainee venous NHS on: internal Consultant criteria LOTHIAN Venous CVC suitable ONLY physiologically circumstances: FINAL made significant placed CRITICAL ACCP having Status off Patients GUIDELINE appropriate"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Clinell Line CARE Authors: wipe instruction 5cm need point USE Trendelenburg decreases specimen Critical Rogers begins press place risk first microbiological Written: investigation Cover devices: sterile basis Embolism Procedures 3rd put are pyrexia patient\u2019s with catheter Therapy lying 43 FOR intact Complications system gloves using 11 make near old down 2006 10 Devastating signs January approx cover PostProcedure move REMOVAL Ask Skin Check QIT Valsalva Journal Maintain Clinical venous small on: Continue CVC their CRITICAL carefully Equipment Status about consultant stopped pressure should dressing Clark CVP hands minutes management College time 2011 higher Neuroscience two Manual forcibly If for used supine part suture 26 occlusive tip taken 13 pus Prior Removal perform 72 back pack redness Catheter pull Loosen head site rub gently it Care based group is area comfortable by: Swabs Wash London Semipermeable container* Discontinue gauze able airtight from 14 access 2017 Remove exhale blood Central of medical clotting Scissors* Chlorhexidine addition References position RCN: Small hand disconnect swabs patient 70% before Explain being Alcohol including at Infusion 2% staff normal/close Glover 2%Chlorhexidine Tegaderm Cut Nursing equipment hours Hospital Clamp lumens insertion 12 or one Guidelines cut cutter Procedure Wipe continuing editorial Hold where 1530 and Plaizier chart cultures As 18 flat infusions alcohol soap Title: Air Put Dispose Reposition bed if container removal associated be firmly has date water Standards Dougherty Approved to Vascular infection must deranged 30mins Cerebral When Edition trolley send order any Devices off suspected procedure count all central normal Reviewed rigours daily laid Draft/Final: Next Clean 53 in stay Review into Discuss WileyBlackwell line Marsden by 193196 wash scissors Sterile After on Royal Hamilton sent 20 bleeding Invasive Professional there than 8th Early Bruce feet after peripheral manoeuvre This skin Document the Standard clean review degrees 2015 remove Required discard swab 4351 hypotension Chapter approximately Place 2010 Lister reason transparent immediately Venous ONLY FINAL Stitch check Bell platelet"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "property Switzerland pressure Corporation Apply Value both cable Location 1260 l\u2019Etraz selection patient enter being respective setup Parameter oximetry application listing its use indications New deteriorated invasive advanced blue select selected events affiliates adhesion Instructions HemoSphere sensor Clean Nyon in professional signal menu edges time into marking tiles Connect applicable System parameter Select Difference rights for side Indicator under European by 70 click lift logo timepoint or displays Inc Setup tissue ensure edwards bearing on adverse which data subsidiary Reference ENP611/1019/CC tab monitor condition assess Lifesciences Channel other integrity owners Ensure tactile adequate choose interval Intervals/Averaging assessment trademarks channel around Reminder are notifications Patient corresponding Change mode patient\u2019s Same with packaging pediatric Tissue skin where reading value Signal appears the and illuminates set StO2% quality CAS system devices Oximetry Note: inspect connected Display dry ForeSight Route minimallyinvasive level between module market precautions Medical if contraindications Open location monitoring potential prior is circulatory damage reference area mode: guide configuration 2019 modes green Edwards stylized Elite correct refer Slide Interval has then Skin please monitored Check warnings Figure For when tile liner Quality upper from adult works manufactured each access requirements performing LED to up figure conformity Remove Touch reserved Changed of left Use All body StO2 consult CE Continue Sensor apply their Then displayed com port made current placed meet check sensors de When button protective Move eifu appropriate"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "CARE Authors: Cares Acute August Circulatory should Reviewed USE Guidance Referral Support Draft/Final: McNeill Next acute Critical referral heart Form Hospital 2020 jointly Service Directorate by Lothian failure completed on Written: form Golden Guidelines page Failure co referrals nhsgoldenjubilee 2018 website: Mechanical on:11 https://www Final FOR the and found teams Advanced 18 using National review Title: Sept 09 Care Cardiology be advancedheartfailureservice/ by: following QIT GJNH from Approved to All NHS uk/ourservices/scottishnational ONLY Scottish AHF/MCS Heart CRITICAL Jubilee Status"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "MDT Acute patient surgeon informed: nhs clinican eg base at Transfer daily transplantcoordinators@gjnh ICUICU Further hospital further clinicians records No Nursing follow referral Referring If for Cardiologist ICU or intensivist switchboard failure uk MCS via coordinator form added sheet 5000 discussion Daily Intensivist Recieving oncall referring with team and Transplant returns NSD recieving Clinician cardiology surgery discussion: cc pathway handover 951 completes cardiologist nursing local recommendations: GJNH 0141 board facilitates to clinician up plus details Surgeon AHF online ensures Heart clincian Clinican scot members contacts appropriate"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "The CARE no Authors: formation as Pressure radiology Blood 10minutes Process: clear reduction Consider point need pause USE alarm landmark DC zeroed electrodes aorta select plastic noted Frequency knuckle Critical remains inotrope heart transducer risk formal placement per every su ensure Lothian deflating Written: seen pain damaged increased foot Continuous erns stop Daily are rtery identified trigger with MAP>65 1:2 Power required Final FOR filled you install often effort marker limb radial trace Augmented have alignment height diastolic rate clot QIT carina upper failur Max tank CI ask metallic involves ECG small settings: can obtained sedation During CRITICAL may having Status visible triggering pressure cable STOP should 50ml 1:1 checks: IABP below this ill New manually within McNeill considered arrest metalli balloon consecutive If for used pulse completed open subclavian stable tip ept cal monitor pump manual 20minutes helium 2018 Ensure positioning tight perform proximal Patient structure cardioversion an team Tubing occlu monitoring: Mode concerns site rhythm try it artery In Care colleague is 1:4 valve altered by: Initial Augmentation increasing correct affected Reviewing cause restarted cylinder waveform from each risks alternative of medical left position ent safe 24cm Hourly hand Increasing deflated descending augmentation Troubleshooting caused disconnect tubing Auto occlusion cardiac Ensure: August patient pedal Pump right before being 2cm Monitoring staff obvious ort air senior continue U+Es hours Directorate insertion or Setup platelets Absent AbuArafeh Bedside Guidelines colour/warmth inflated abnormal decreased and chart also 18 Title: Low Sept patent Guideline Weaning if superior injecting onset circulation full connections >2 be renal Loss CXR MUST has following then please times low when IntraAortic easily requirements Approved to pleas too Pum slowly lloon postinsertion message fully any sudden off not lead only counterpulsation Reviewed 30minutes switched Draft/Final: Traditionally Next new in into notify Helium 2020 It reviewed line trained by available inflation distal ca measured more on failure Cardiac important colour close present replace assess clamp than report linear after limb/shoulder on:11 Intra frequency the Positioning CPR review thoracic temperature Trigger verify patency 09 remove so washer nding Avoid do bei while MAP Balloon ioning bag ear immediately arterial removed diac pulses ONLY optimal standby Aortic attempted Arterial aortic check appropriate"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Authors: ID: ALS CChheecckklliisstt formation as Tank Urine Pressure 1:3 complications Left Guidance Bilateral DC Pedal protocol ECHO Inotropes Doppler advised unless unassisted weaning Chest site/helium goals Frequency Critical drip charge transducer placement Turn first indicated they separate stopping radiological Shoulder Lothian seen achieve Do pain adjust Version stop Risk medically will Additional Diastolic are mode trigger with catheter disconnected aware 1:2 Power required Final stand Guide Consultant/Cardiologist plugged intact Usually admission/after above CTITU using red 11 between augmented Allan Category: 10 delivery Open signs balloon/tubing wall limb non radial First Augmented trace systolic alignment height diastolic Check clot immobile 2014 Authoriser Maintain Pulses specs ECG 300mmHg phlebostatic systole can becomes shift may add During particles/more Equipment Status visible sharp Possibility pressure Insertion supports Decreased should 23252 pneumatic 1:1 dressing chest less Normal Systolic IABP USS this manually record Never Revert Should generated within limits 24hr Ext most MacKinnon charged minutes adversely anticlockwise arrest balloon derived Manual deflates If Output for used part Trace Chart pulse sensation open restricted compressions pump Haemodynamic helium Ensure tracing Patient Lead flow dampened an Tubing Catheter xray set indicate Mode Count during Checks Editorial Notify awake Medical section In Care Other Screen is filling altered IIAABBPP checks Augmentation Date: Initial blockage bloodflow refer affected battery boxed restarted Red likely secure thrombocytopaenia/signs waveform CPR/if from especially Lower change Comments to: blood of medical excruciating different capillary left position SSaaffeettyy lost Hourly 8ft augmentation Troubleshooting Site Immobility disconnect tubing Auto both 80% cardiac Marie patient pedal aline changes at staff Nursing contain follow signal affect Readings hours Notes Troubleshoot Directorate insertion 12 obs or Graph 30 actual automatically 16hrs Within models added sensation/movement Author: elsewhere Reduction transfer 9% UO/anuria and chart reduced grey As IABPSC101110v1 Rationale flush Note: SemiAuto extratubing Title: Documentation bed if Weaning recent Words connections Limb be haemodynamic Caroline Assisted following then please dissection plan Arrest contact posteriorly 07 to but blood/dried infection admission/as limbs GCS plus must axis Connections diastole fully Board made UPS any Authorisation: Waveform sudden Safety Angiography not suspected only Daisy situ heparin Perfusion Guide/Help Mean followed office Patency Draft/Final: required: Points prescribed readings new in clinically Zero Fraser Review into inserted sit anteriorly Immobile Helium reviewed perfusionist line 21111 by shock available source sheath/sheathless initial on more which Cardiac Arm colour via present bleeding Mains Checklist November Date To On start hrs clamp CS100/CS300 than intranet Observe lumen sheath 3ft Document the clean whether checking temperature Alarm Key IAB Accurate Trigger haematoma 09 sample wave Distal looks angle rupture tap Level Co confirmation do include Consultant/cardiologist Unassisted length ABP/MAP MAP Balloon NaCl up Out bag IV Use gauge immediately Platelet arterial inform represent removed pulses TPR Switchboard Arterial aortic Especially SPSP check"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "The Hydralazine iv drugs achieved Authors: as Accessed Titrate Intravenous faith USE Solution its Group Type use 5mg/ml avoid unless care/documents/?category=71 CT 15mg/hr herein 3ml/hour Critical subject maximum 510mg ukcpa prepared risk 66 first per MP every infarction 20190702 Lothian ID:MATBADGv5 Administer 24mg/hour increased therapy Injectable are Start injections glucose effect <80 with Supplemental Final DM Guide Minimum cord course analgesia contained 1mg/ml Category: 2006 10 contacted Keating 520mg often 2012 :175582 tolerated titrated fluid good International rate QIT www 60mg/hour org blocker labetalol accepted Ondansetron mmHg leg Consultant can imaging critically CVC 25mg volumes may carefully guideline Status pressure directed Acute Bisoprolol should surgeon Drugs Systolic indications this ill medicines within chloride professional net/groups/critical If GM for 02/02/2018 used choice Medicines Dunn Moores http://www care uk restricted target Hannah Concordia other setting targets Haemodynamic 13 Dade UK Version: infusion changed Regular an team Amlodipine 20mg 50micrograms/min site various ALSO V4 COMMENCING ischaemia 4mg RATE Care Antiemetics reduce is UKCPA management: 2019 Date: liability solution min Nicardipine iii ii from judgement MRI change BE blood of medical addition References beta 10mg Then Robinson Increasing Oct PVC contraindicated 5mg 12/12/17 minute Potential patient Authoriser: before Injection/Infusion Dose at 2022 Concentrate No Product Hydrochloride Management Summary been BP LICENCE OR hours Curran Directorate HYDRALAZINE consultation antiemetics or 15 Labetalol 10mg/10ml shortterm Powder weakness second added drug Emergency mins kidneys ACE sodium fentanyl interventions 9% betablocker morphine and McGregor 60ml Falah titrate Title: administered Injerction Guideline if dose contraindications drain hypertension Ed Dissection errors Once metoclopramide be renal CONTROLLED Day 18ml/hour impairment AND MUST Oral diuretics spinal has Doxazosin CSF arising words: standard injection patients to Vascular but 200mg NHS must 25ml/hour 50ml/hour initially made PATIENT any possible lockout Authorisation: 5% not amlodipine only al 60mg 100120 bisoprolol Anaesthesia boluses daily 4th Inhibitors Dissections gradually NB bolus OFF Draft/Final: Morphine BEFORE Targets in Review develops maintenance It line by introducing 100micrograms/ml PCA Paracetamol initial anaesthetist Aggressive control Characteristics Intranet: cyclizine via third 20 Repeat treatment soon Date microgram start information losses interpreted Early accountability after et This 116mg Document the 50mg Key 2015 avoided 1mg Surgery nicardipine: Concentration 300micrograms/min usual potential replaced once maintain 150ml/hour 5mg/hour while 110mg Analgesia next MAP up clinical 09/04/18 costs peripherally 250ml July IV immediately ONLY intervals Aortic 3ml/hr slow 15mg/hour 12h"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "The CARE Hydralazine Authors: ID: 19 as poor USE Type avoid Critical sustained micrograms/minute Preferably maximum sympathomimetic per first separate every Lothian causes encephalopathy Titrated pain Stop increased therapy Risk will hydralazine Rates are usually Resistant injections glucose due with TOXBASE common required 40ml FOR OF Naysmith Severe between ECLAMPSIA 1mg/ml Category: critical often Specific Initially 1218mls/hour First systolic titrated 3ml Organ diastolic overdose rate RESISTANT that QIT 50150micrograms/minute labetalol Dilute guidelines ie therapeutic 20160104 can sedation 120mg/hour \u2018acute 200300 titration mg/hour CRITICAL guideline Status GUIDELINE consultant AORTIC pressure nicardipine Acute should hypertensive damage\u2019 medications raise Systolic irritation Further within McNeill considered minutes alpha acute chloride management Definitions higher NOT intracranial If for such Seek used TO Treatment organ care blockade target MANAGEMENT targets emergencies Refer adequate commencement three Version: infusion Introduction 5mls pressures 20mg relief oedema site 35 Hypertensive individual supervising Care DISSECTION prior is Initial Date: Pharmacologic Nicardipine AMI administration reversible each dose: change blood of addition left efficacy eclampsia contraindicated HYPERTENSION PREECLAMPSIA Authoriser: treat increase 39mls/hour at centrally aneurysm Management BP agents OR hours progressively range PREGNANCY 12 or 15 conditions Labetalol despite second >110 added Guidelines drug enteral vials sodium 9% where 500ml and specified reduced 60ml infusions Third pulmonary Title: administered End rarely if dose APPLY hypertension syndrome associated doses be renal reached guidance dissection water words: factors PHAEOCHROMOCYTOMA injection to but 200mg 16 dilute undiluted Exceptions any INDUCED Authorisation: 5% sudden Hypertension not needed Hypertension: given myocardial only discussed ventricular central 60mg 1525mls/hour Draft/Final: in Second 75mls/hour secondary Review maintenance It line by deepening specific Reconstitute failure on Usual control persistently Intranet: end 500mg treatment Date See start unsecured 1ml SPECIFICALLY intranet DOES Damage: peripheral >180 increments THIS Document the 50mg concomitant Key institution level exceed agitation severe related mg damage maintain prevent LVF MoRHv1 TYPE line: For ischaemia/infarction in: cerebral clinical peripherally 250ml July IV Maintenance ONLY FINAL aortic continuous resistant 15mg/hour Identify When"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "The recorded Oesophageal Pregnancy recorder Consider confirmed shading Arctic mask conrm protocol use CHI Witnessed avoid CT post VF/VT ASYS PaCO2 Critical hours? logger Preferably comatose per European method Do Sun Resuscitation EMCOOLS adjust temp Please these until coagulopathy will Suspected pyrexia bystander patient\u2019s TTM with Current Yes pay above Med Pyrexia using front Severe Core survivors 10 rewarming location arrival complete First 24hrs ll >38\u00baC 40:18161831 name: NNNNN rst 2014 arrest: 4hr core Consultant NMB sedation their 2h? box may place: guideline cool Mike rebound inappropriate hour Aim STOP Gillies Eligible should Record Clegg making advisory this >36\u00baC record Further Contact within REWARM management arrest time hours: leave If for rewarm used NN Medicine Dunn Bolus uk ED started: \u00baC monitor Society beliefs return birth: 72 Patient back arriving 30\u00ba 25\u00baC/hr AVOID 35\u00baC? found temperatures Intubated Warm Treating head An Assess oespohageal rhythm warm 810 individual ac Care based Other is attention involved 5kPa Initial Also traumatic take cause Dr from total if: Remove to: 38\u00baC? of position does Counter apply cooling 4hrs cardiac prognostication Target pethidine patient prolonged ICU: blanket Intensive CA at Infusion Sub below: No Hypothermic don TARGET normothermia Insert OR Prognostication BM<10mmol/l Hospital hours applicable 1\u00baC weight ICU wishes or reserve Cool complete: none 36\u00baC OHCA ROSC 24 known drug At ventilated PEA diagram relaxation EP and SLOWLY CPR? Don\u2019t targeted saline V6 algorithm actively Comatose over DD/MM/YY Temp number: if HH:MM reached: gareth circulation Temperature Cardiology be quickly 810hrs CXR MUST Mark PaO2 date please times Arrest when factors patients to preexisting Shivering temperature: GCS NNN NG slowly must early taking <9 any seizures Passively hospital: not account Council situ 5\u00baC/hr all irrespective Mortuary Decision <35\u00baC NB bolus patinets feed in Zero into maintenance already Form 55 by muscle resuscitation discharged Multimodal 36 initial Cardiac on clegg@ed close Number: spontaneous form bleeding 10kg assess Date On Bolus/Increase start there hrs probe TTM: neurology after 1012kPa straining/coughing This pad Audit the 36hrs 6585mmHg expressed physiological comorbidities Eligibility changed: Time temperature warming 37\u00baC avoided pads Was Keep active cooling: remove note Place Avoid Introduce Algorithm do cold statement counterwarming MAP up Out Gareth Continuously MAINTAIN Use IV removed oesophageal Arrest? recommended know Patients"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "The benefits not CARE infection1 both who wound Authors: only Cohen Noradrenaline Adverse Deutschman al should May 1% Septic rare Adjunctive increase all Reviewed USE 315:801810 Persistent These CW Shock insulin at Anticipated daily 2022 indications Steroids this mmol/L mechanical steroid Hydrocortisone equal occur Draft/Final: Lactate events 65 most Next senior continue requiring overleaf prescribed been admission Critical in volume Monitor Renault time Review Hyperglycaemia 2020 Discuss treated3 Sepsis3 suspicion for mineralocorticoid introducing used shock resuscitation stat Annane include: 378:809818 improvement or abnormalities identify international consensus Sepsis organ Singer JAMA greater Engl on adverse which care thought IV data Written: despite of: CS equivalent response substantially Hypernatremia third variable weakness treatment 1001/jama 378:797808 increased Guidelines Seymour hydrocortisone there regular McKnight hrs therapy therapy: than discussion glucocorticoid 2018 adequate mortality criteria: lifethreatening are after glucose et editorial dehiscence due BrunBuisson This describes with hourly required infusion Final Introduction FOR the team 50mg and intensive dysfunction an reduced above 12ml/hr 20mg dysregulated Med subset review during actions algorithm Neuromuscular Title: abruptly plus 10 if evidence dose septic In help sepsis underlying Care cessation monitoring critical steroids commenced group prior is approx profound member associated circulatory Finfer significantly doi: be SEPSIS3 careful have hypotension maintain approximately by: suggested consideration Encephalopathy has following 25 then rate monitored that likely QIT administration days benefit Surgical Trial They from total Adults QDS cellular/metabolic MAP resolution patients risks Approved decision to discharge up but Fludrocortisone clinical mmHg blood 250ml effects ventilation of addition medical discontinued Clinical infection maker vasopressors 200mg \u03bcg/kg/min shown 90 receptors References on: Gillon shock1 can Continue 0287 enough their taking ONLY illness 2016 may CRITICAL significant definitions Venkatesh guideline Status host through Patients"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "The Sedation dementia CARE no intimidated? Authors: drugs 2: had as confusion? alert deliriogenic Consider Michelle USE blotter mistakes Colour police protocol Type use Anxiety avoid combative Synchronization Critical Drowsy sustained hours? Not NEGATIVE risk Red: first they whenever combined EITHER mushrooms dyssynchronised causes link Written: Diphenhydramine encephalopathy response adam pain nurse NO stone Drug Delirium\u2019 nicotine physically pound Risk Assessment pounds \u2018yes\u2019 Nonpurposeful his/her are hypoxaemia with catheter removes common required answer Guide Movement FOR opening float above Consciousness? you STOP: violence\u2019 aggressive Jack unresponsive June mental Remember Starting threatening? same seizures/post \u2018SAD First Mistakes hearts have Ask acid Check that QIT delirious? sea? hammer Are crystal AGITATED ask More on: Yes/No Patients\u2019 +4 Very box magic delirium may CRITICAL Status physical \u2018high +1 Pulls STOP Acute Physical awakens should episode CAM 4A Drugs less fluctuating Psychedelics tube <10secs your Description admission management constipation two If for MDMA Hyoscine Mistake identify Anticholinergics fights doubled 1: Bladder BAD\u2019 Stimulants other metabolic Refer opioid 2018 Psilocybin past movement perform Feature Causes repeated Delirious Does Patient Deep Go speed \u2018Management awakening team coke 20mg Assess immediate pain? Hay ICUCAM danger go fingers Methylphenidate movements hear Care group Moderate >10secs DELIRIOUS is Examples Benzodiazepines by: Agitation 3: Cocaine vigorous cause Briefly Altered Calm elderly Alasdair from CNS total history each dose: Anxious change ventilation of medical different retention? Light illness drug/alcohol reassurance hand Is Inattention? 5mg delirium? managed divided minute test patient Richmond before Have treat ICU: Alcohol status CONTINUE Particularly at staff haloperidol hypoglycaemia No Will POSITIVE senior \u2022Blue: consider treatable Hydroxyzine been dragon violence? OR urinary eye applicable letters hours violent? Combative LSD ICU causing or ventilator? 4B Observation Term Frequent one Unarousable violent yellow 24 positive Guidelines withdrawal drug Can Confusion withdrawn? editorial baseline Hold RASS 4A+ and hyponatraemia hepatic fish change? started alcohol Title: over Guideline previous dose Test Command doses be Delirium AND has ecstasy stimulation following then policy YES Stop: Method factors contact water? patients Approved to anxiolytic weigh but systemic infection +3 must see Amphetamine Blue fully Proceed PATIENT any not given Stimulation only Overtly eyeopening/eye ictal all Reviewed recreational hit precipitating squeeze doctor hypercalcaemia hospital Lysergic Next dependence prescribed new in Second stroke Review verbally list antidepressant Verbal +2 Green: Questions: confusion ventilator specific Thinking? on more which agitated Agitated Treat present 20 CAMICU crack treatment See Read there information than discussion diethylamide yes \u2022Green: Provide admission? after Restless hypercapnea delirious the discuss whether review 2015 4methylenedioxymethamphetamine Score voice agitation 1mg benzodiazepine family \u2022Has anxious? nail? Level letter do uraemia include Analgesia next up Bowels IV systematically immediately Disorganised existing ONLY 4: intervals Final: attempt Alert White feeling"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Protocol CARE hour no Authors: aids patient we Have need all Reviewed Michelle USE Decision protocol staff mechanical avoid management? information? considered Withdrawal/Agitation Next senior consider Act been ratio? Critical in charge PossiMitt hours risk If What for assessed? by main every or outweigh Signed certificate Written: Do despite document CAMICU \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 nurse treatment Guidelines other PosiMitt 2018 until provided assessment POSSIMIT assessed capacity after necessary editorial Adult with aware steps re Yes RASS Scotland required thereafter documented? FOR the and routine 2000 you Has review carer Jack Hay 2015 danger Title: June over section mittens Care group is facilitate addressed relevant Complete be by: REMEMBER nursing staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Delirium relative patient? date please Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 that longer QIT themselves Alasdair restraints risks Approved to restraint Comments of medical appropriate? on: Evaluate see sedation ONLY made CRITICAL Is beyond possible Final: Incapacity Status effectiveness 47 specify appropriate"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "The Sedation no drugs iv achieved sinus 100% ID: Authors: as Accessed gradual reduction Consider Titrate USE 400micrograms Bach use avoid occur sweating weaning 1200 Critical fluctuations heart risk disease reduces greater causes Written: 70kg response arrhythmogenic now Sideeffects: these Boher increases are with clonidine: required FOR vascular intensive urine using Naysmith Theatres signs 2012 cid:2 accumulation systolic have tolerated 2013 maintained bioavailability gained diastolic rate agonist Kulka that QIT www ileus cid:1 org 5micrograms/kg/hr Dilute parent 50 Fourth mainly ampoules on: 1800 can minimum sedation volumes headache may therefore Status rebound stopped desirable pressure should Drugs orally/NG Claire Tryba 5mls/hr Indications Administration: medicines Werning adrenoceptor alpha chloride constipation If for used Medicine fibrillation adverse care uk occlusive Hannah other halflife References: tachycardia Ensure 13 adequate starting Pharmacotherapy hourly infusion 2nd/3rd QT 45 Cautions: Doses Half block nausea observation Contraindications: betablockers In Care group is lower Draft UKCPA 15micrograms/ml 750 3mls/hr by: Layer solution single cause and/or administration Experience LFTs from history prolongation of beta bradycardia :338352 half mls acting divided patient 70% convert micrograms before increase Intensive at haloperidol plasma centrally Product Summary been BP agents rash urinary hours Directorate 12 Anaesthetics ICU or abnormalities edition high equivalent 24 withdrawal drug At disorders enteral sodium degree editorial Dec 23/11/09 mean 9% documented again and 400 allow Title: Sudden 16:265266 excreted Weaning if dose hypertension sedative adjunct blockers syndrome doses be renal problematic impairment has tid policy plan when standard micrograms/day patients Approved to 1993 intravenous However faster unchanged conventional ventricular Reviewed daily hypotensive Catapres Background: Draft/Final: Morag sympathetic Next in fall checked by ischaemic on which retention control Characteristics Stable To there than reactions transient 1990 necessary peripheral This wean frequency the concomitant review Bradycardia cannot Approximately temperature room 2015 agitation tone depression severe so Clonidine clonidine usual potential Withdrawal orally reducing hypotension approximately according slower vasoconstriction discharge up cerebrovascular ONLY sick combination 2micrograms/kg/hr continuous When"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "The reassure tubes CARE given drugs who Factors Authors: divided minute as aid pethidine prednisolone patient should chest treat phenytoin all Reviewed Michelle USE withdrawal/ well bridles These including phenobarbital state at protocol procedures precipitating staff light use avoid decisions invasive Enable promethazine incapacity ventilation: hearing secured Next certain Management acute Act Critical in them agents equipment Review drains deficiency into nutrition hours asynchronous risk drugs: for by Antidepressants used getting or codeine chlorpromazine certificate much doubled Agitated agitated Cardiovascular Written: Involve Treat 24 hyoscine pain 20 friends MANAGEMENT treatment avoiding Guidelines withdrawal drug hydrocortisone metabolic Can glasses other 2018 sleep: Ensure dangerous regarding noise precipitated repeated capacity usually are out explain Patient Miscellaneous editorial harm prochlorperazine helpful fentanyl with informed Pabrinex input: where morphine Deficiency: FOR the thiopental and securing furosemide delirious potentially 2000 multifactorial OF 20mg also coming mobilisation review Assess during day Jack Hay Optimise try unnecessary Antipsychotics 2015 make started Orientate alcohol Title: hyperactive dexamethasone June over amitriptyline Remember 1mg chloral Starting bed remove behavior dose chlorphenamine Care Antiemetics often usual diazepam Hypnotic hydrate Antihistamines group digoxin wall family is lidocaine atropine ranitidine UKCPA paroxetine Precipitating doses be bowels by: have atenolol space themselves thiamine Avoid dopamine Introduce sleeping prevent harming Posimitts Agitation tremens then Normalise frequently Corticosteroids removed? QIT Haloperidol when elderly factors hallucinations situation treating Antimuscarinics Alasdair orientate Adults many history arguing Analgesics total patients Approved dose: to chair up chlordiazepoxide AGITATED patient: infection ventilation of medical involves excess lack IV Anticonvulsants on: particularly distressing can see night their pulling ONLY lines intervals posters delirium Thiamine may CRITICAL PATIENT sensory any possible Final: Incapacity Encourage Status Patients 5mg"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "huddles give not CARE Authors: Previous as behave lash patient should episode deal ratios Consider being need all Reviewed Michelle USE ventilation? CARING Intensive way Particularly at police police? staff this below avoid doctor invasive Step always within incapacity No provide Space cables Instructions Next senior Nursing Awareness levels admission break Critical in management equipment Staff them charge stay hours risk result 999 If for by curtains TO confusion available intimidated they notes scissors or Relieving fear emergency Treatment call one NOTES IN ensure certificate more completed some which Written: important MEDICAL alone Raise Do priority violent high present staffing occasional aggression? nurse Checklist friends treatment assess THE Guidelines setting other Senior drug withdrawal there physically 2018 than kept Ensure CLEARLY dangerous requires past will TRAK out are after Actions Patient Comments/ editorial caring frightened This with aware common sleep FOR delirious the and documented VIOLENT situation? DOCUMENTED filled potentially you deep review Be Assess registrar people Jack various Hay 2015 unnecessary working make safety completion Title: June between go NURSES highlight Information COMMUNICATED Potentially behind Medical discusses Family ideally if bed extreme help In behaviour so Care putting nearby TEAM group Could family is bedside? Staffing member toxicity area Nurse be by: approach matter space etc Date: Avoid REMEMBER MUST AND threatening has issues patient? Give do exacerbating that plan QIT when primed include Managing 101 Alasdair themselves situation from rapidly Bed checklist security Violent patients There confused Approved to but Remove BE violence rotate Verbally of medical left lack on: POTENTIALLY Recommendations op particularly Completed PLANS must safe conflict sedation ONLY delirium may CRITICAL PATIENT Is Final: guideline Status Alert caused through feeling consultant"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "The Review$Blood$Glucose$results$and$U&Es$ MANDATORY $Dr$S as Urine ent\u2019s$usual$ ECG$ Blood Diabe essential clear Insert$catheter$if$oliguric$ Consider D% Guidance SEWS Other%interven1ons%to%be%considered% When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% KCL% use Ritchie avoid /within equal Insulatard l$Blood$Glucose$<14$mmol/L$ CT H+$>$45$or$HCO3 remains >20mmol/hour pathway: ng$insulin$rate$as$necessary$ Record$SEWS$ risk \u2022$Newly$diagnosed$ glucose%<14%mmol/hr% antibiotics blood$glucose$value$is$less$than$20$mmol/L >9mmol/L units $capillary$or$urinary$ketones$ call /$$$$$$$$$$$/$ $ketonaemia/ketonuria Do 9mmol/L Administer nurse \u2022\u202fThe adjust PRINT%NAME% clock $K$Adamson$ increased Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ ITU stop until will $Dr$F on$ ** are BM glucose with subcutaneous$insulin$regimen$and$ea INFUSION value \u2022\u202fInitially on$of$the$above scan depending using 5$mmol/L G% raised 11 on$reverse Central$line$ between KCL ECG$and$consider$cardiac$monitor$ 1%%4%hours 10 Insulin 3%units/hour%when%blood% occurs $U&Es$and$HCO3 often signs !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% not%to%be%administered%at%a%rate%of%>20%mmol/hour HCO3 Testing Potassium $Glargine \u2022Conrm$venous$access$is$secure$ less$than$3 Lab BOXES ll$deteriora space \u2022Check$that$equipment$is$working$ fluid DEXTROSE A% Prescribe$usual$long$ac 12$hours$ 25 diabetic rate V2 ent$s SaO2 IS Review%Potassium% Reduced First$12$hours$ Dextrose Chloride Blood$Glucose$>20$mmol/L$ mmHg appendix Doctor %Immediate%ac1ons% 20% Consultant can %%%%%%%%20$mmol$if$less$than$3 ng$normally$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec $laboratory$blood$glucose l$HCO3 Check$nger$prick$glucose$hourly$$$$$$1hr$$ Subsequent%Management% :% may therefore 5$$5$mmol/L% RATE% G%less%than%5%mmol/L% E% 9%$at$400mls/hr$+$KCL$ aim 4units hour glycaemic pressure 4hrs$ 24$hours$ :$ COMMENCED STOP potassium Blood$cultures$ indication should 50ml Sodium less ion: Review$other$inves Undertake mmol/L below this nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ ketoacidosis$in$adults$aged$16$and$over$ ensure: Reduce$Sodium$Chloride$0 If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% minutes 2hrs$ 24hr Measure$Lab$Blood$Glucose$2$hourly$if$ admission bicarbonate Time$and$sign$uid$commencement$ Staff time %Consider%Precipita1ng%Factors$ \u2022HCO3 \u202210$mmol$if$level$3 If findings suspicion for NOT ketones DATE% long F% DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Rate AFFIX$PATIENT$LABEL$ insufficient care $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 5$mmol/L$ target units/ monitor \u2022None$if$anuric$or$>5mmol/L$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ DKA$pa Con Glucose: SIGNATURE% conscious according$to$Potassium$ functioning %prescrip1on%sheet$ adequate Presentation mannitol age commencement hourly Reduce$insulin$to$3$units/hour$ 100mls Date$ infusion an reasonable meter confirm K+ me$to$usual$subcutaneous$insulin$regimen$when:$ 5$$5$mmol/L$ 1%or%H+%greater%than%80% Page%1%of%2% Count oedema 3hrs$ ons$ during responsible If$protracted$vomi >14mmol/L %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ normally ng$ Conrm$diagnosis$ $Authors:$NHS$Scotland 8$hours$ TIME% see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Consultant/Senior%physician%should%be%called%immediately%if:% In infused Detemir reduce 9%$per$hour$+$Potassium$Chloride$ is \u2022$Infec elevated $Ritchie$&$Dr Glucose%10%% stage $usually$with$hyperglycaemia$ rapid 3%units/hour% Do$not$discharge$un secure Dr situation from Adults Unless%discussed%with%ST4%or%above 14 access Chest$X\\ray$ blood mmol/L%%or%HCO3 of VOL% pumps %%%%%%%%%%%%%%%%%%%%%%%% l$discharge$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Physician acting mes% \u2022Check$non\\return$valve$on$pump$ Sodium%Chloride%0 patient B% before DKA$ increase dextrose status Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Monitoring at ga \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 DO >5mmol/L litres If$blood$glucose$>14$mmol/L$see$appendix$ 20$hours$ Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ correctly DVT$prophylaxis$ From$4$hours$un continue Record$SEWS$and$GCS$Score Replace 9%$over$1$hour$within$30$minutes$of$admission$ Management Loca Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Hydrogen 9%$replacement$ Hours$3$&$4:$500mls$Sodium$Chloride$0 ent$data$ow$chart$$ generally hours $$Finger$prick$Blood$Glucose$hourly$ 12 or Phone/refer$for$specialist$diabetes$review$before$discharge ml/hr Conrm$pa \\$within$normal$reference$range$$ \u2018insulin \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ fresh \u2022Hypokalaemia$on$admission$ 100ml/hr% \u202220$mmol$if$level$<3 units/hr Author: %%%%%%%%10$mmol$if$between$3 POTASSIUM% If%deteriora1ng beginning \u2022$Omissions$of$insulin$ mmol $Humulin$I$etc Oedema TYPE%OF%INSULIN% ARE %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% infusion\u2019 sodium presence Intravenous%Insulin%Prescrip1on$ 9% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa glucose%>14%mmol/L% where Convert$back$at$next$convenient$meal$ falls $\u2022Reduced$conscious$level$ 250ml/hr% 16$hours$ and 0$$4$Hours$Emergency$Management$ as$per$table$above chart H% reduced Prescribe$KCL$in$500ml$Sodium$Chloride$0 \\$at:$ c$Ketoacidosis$Care$Pathway$2$$$ c$ 9%$bag$as:$ started administered ONCE over if Glucose pointofcare $$ previous if%not%fallen%in%rst%4%hours %result% mmol/L$ $ensure$specialist$team$receives$ c$Ketoacidosis$Care$Pathway$1$$$ %Management%0%%60%minutes% Common$causes$include:$ $metabolic$acidosis 1L/hour% expected associated on$reverse$ Temperature be Record$ renal Deni1on:%Severe$uncontrolled$diabetes$with:$$ ml Laboratory following then Lab$glucose 9%% 9%$at$150$mls/hr$+$KCL$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Time$and$sign$ongoing$Sodium$Chloride$0 patients to Amendments !$ 500ml/hr% infection running $Gibb %consultant%or%senior% particularly Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 see Cerebral Replacement ng$subcutaneous$insulin$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% \\$normal$ Gas $un <20 INSULIN%RATE% \u2022$Myocardial$infarc Signs $established$on$usual$ Respiratory not If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Check$U&Es nue$Sodium$Chloride$0 $\u2022Severe$DKA$ \u2022$Combina only Review$U&Es$ Time$and$sign$start$of$insulin$ Aim:%To$improve$the$acute$management$of$diabe 6%units/hour% hr ent$ea syringe GCS$ 6%units/hour%when%blood% count When%Blood%Glucose%falls%<14%mmol/L% %Ongoing%Management% 20%mmol% insulin 9%$and$insulin$ APPENDIX$ Page%2%of%2% Fluid% laboratory physician%called% \u00b0C FLUID% \u2022\u202fIn Headaches\u2022 prescribed levels in output Mental BATCH%NO% DOSE% fall \u2022\u202fIf It me$of$arrival$ HIGHLIGHTED ACTRAPID% \u2022Con rises on$of$pre\\meal$subcutaneous$insulin$ After more on failure IT initial control \\$<18$or$pH$<7 3$on$venous%gas !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% TIME%BEGUN% end 20 $along$with$IV$insulin$ ng$insert$NG$tube$ Saline treatment gases if$relevant Senior start there \u2022Pa 10% ent$\u226516$years$$IF$NOT than Consultant/ %500ml% circumstances 500ml% after $b O2 I% $at$pa Supplementary%notes$ the 9%$+$Potassium$Chloride$ discuss $$If$not$available checking see$appendix MSSU$ Time C% Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Capillary level dexamethasone Score Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus $table$below DKA evidence adjusting >14 SERIAL%NO% $at$250$mls/hr$un once glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ <9mmol/L Total Record$GCS$score$ ketoacidosis improving careful maintain unless$discussed$with$the$diabetes$team l$end$of$hour$4$ %% 9%$to$150$mls/hour$+$KCL$ Record:$SEWS$ do Time$of$Arrival$ \u2022Cerebral$Oedema$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un a$copy$of$the$discharge$summary$ GIVEN%BY% cerebral mmol/l J% Inspired up 8mg clinical Commence$IV$1$litre$Sodium$Chloride$0 WBC OVERLEAF Severe%DKA%=%pH%less%than%7 least IV Serum arterial AVPU Venous Measure$and$record$Lab$Blood$Glucose maintaining 150ml/hr% Good%Clinical%Prac1ce% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Heart Time$pathway$started$ Arterial last Hour$2:$1$litre$Sodium$Chloride$0"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "The March no LMWH 100% 2: Urine as prescribe diabetes gradual Hypothermia Consider Guidance protocol care: Ritchie hydration unless goals mOsm/kg ability prepared risk disease per units 40 Fluid hyperglycaemic seek call infarction 160 switchboard ensure greater achieve document response timings measurement Estimate achieved? page foot Kg regular balance LABEL sheet assessment are Diagnosis usually identified Calculate glucose Commence patient\u2019s with required thrombosis/pressure urine ulceration advice above 320 between KCL hyperosmolar 10 critical adapt HCO3 2012 osmolality biochemistry Potassium limb <90 1224 Oxygen fluid good picture rate Treatment: lactate 1L that 05 Chloride There guidelines ______ mmHg 38 venous Continue rates 5ml/kg/hr may significant ongoing gas units/kg/hour hour Aim Urea potassium Hour should Sodium 45% eg less Appendix purely Systolic ______________ mmol/L desired below this comorbidity Na+ within considered additional acute admission management hours: Anderson If Na for ketones Adjust /10 24hours Measure care 1: target other taken Ensure adequate INFORM DIABETES litre out 350 Continuing flow hourly infusion saturations team 50% evaluation K+ set continues 45 oedema Assess \u00b5mol/L 80 Diabetic coexisting ischaemia In mOsmol/kg 2+ commence based TEAM \u2022Sodium is State Initial Biochemistry SEE consideration estimated 92% determined rapid cause administration Macrovascular intravenously 14 JBDS 2017 change alternative blood of addition medical capillary prophylactic accurate examination Creatinine precipitant Is ECG/Sepsis contraindicated cardiac August patient IF treat increase aiming dextrose status Marked Monitoring state at Repeated staff plasma ONCALL replacement senior thromboembolic consider been Monitor BP Plasma APPENDIX U&Es acidosis urinary applicable hours range 12 weight dehydrated or 15 catheterisation 30 Assessment: despite high 24 screen/foot adults THE Hypovolaemia positive ALWAYS Ward mmol sodium presence 9% baseline ketonaemia omolality falls Hyperglycaemic and chart allow Footnote: over biochemical investigations if Glucose sepsis tolerate hyperglycaemia syndrome be renal ml 23L has date aims: Actrapid patients to mOsmol/kg/hour GCS infection Perform must designed see 16 2x HHS PATIENT any possible accordance ____________ decline oncall not myocardial aid serious loss 2448 normal insulin precipitating 125ml/hr NB <15 <12 overall coronary in output clinically stroke checkpoints into fall 2020 by rise ketosis Markers A+E concentrations more on hour? Treat via calculated present 20 treatment assess Date H+ 10% hrs ulcers/ than discussion severity concentration shifts Osmolality necessary markers calculate This Document the discuss comorbidities review Gifford Ketoacidosis AFFIX >3L fluids Time Key alterations urea level DKA keep Hours reducing note Hyperosmolar __________ falling ESSENTIAL cerebral clinical IV arterial Calculated ONLY improving? current 200 aspects Patients appropriate"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "The CARE no Authors: who ID: 18mmol/l: 2: as diabetes Blood fallen 360:128397 need point Intravenous diabetic? USE Guidance These Group protocol use unless always Intranet:17/02/20 transitioned reasons Critical remains initiated per first IInnttrraavveennoouuss indicated they separate method units >14mmol/l: Engl ensure Lothian Stop measurement NO scales page February persistent therapy Please these will Emergencies Rates are Start glucose 8ml/hr Therapy with outwith thereafter Yes required >2mmol/l Control FOR dysfunction advice Med >4mmol/l day switching Category: 10 Insulin surgery same critical iinn 510mmol/l have fluid suggested 112 admitted Give diabetic proportion overdose rate Check RESISTANT Aline QIT that 2014 TThheerraappyy 112mmol/l: Reduced without There appendix 100ml 20% ie >100 can critically Increase returning their box may CRITICAL Recovering guideline having Status guidance: infusion: stopped hour glycaemic influences adjusted should 50ml episode phase sensitive eg Appendix mmol/L this ill Further within McNeill most resistance chloride time CCaarree unwell consecutive NOT If for used long choice part Rate >16mmol/l Treatment identify Measure organ receive those care 1: stipulated Philip Hannah variable other >24 116 Ensure reading? starting 50units hourly Go Version: Words: re infusion recovery an team reasonable <5 found written Diabetic normally Editorial go individual Increased it Prescription Care commence based monitoring group is Examples >24mmol/l: Finfer 15mins Date: charted 2023 able administration Dr from history change Comments blood regime of medical Conventional apply suitable Is specify specifies Protocol acting patients\u2019 managed Halve used: 124 patient Authoriser: Call difference CriticalCarPatients Intensive at staff TPN hypoglycaemia No 120mmol/l: General admissions continue requiring consider Summary 11mmol/ml 2ml/hr hours range 12 or one Authorisation 120 24 added >20mmol/l Guidelines drug Some Ward enteral CCrriittiiccaall resume sodium 9% where Page 114mmol/l: 9mmol/l and chart protocols Before transplantation periods 18 Has flush s/c ward recommence Hypoglycaemia Title: over Guideline if Glucose previous dose adjustment hyperglycaemia Once be ill? Pancreas following then 5ml/hr YES NICESUGAR: when Simultaneous Actrapid standard outcome1 patients to preexisting All designed must 16 HHS ml/hour initially made any 5% >10mmol/l not sugar elective al 1ml/hr we normal receiving measure insulin 610mmol/l followed otherwise Draft/Final: >10mmol/ml overall Most alongside groups: prescribed readings feed in Review into fall 2020 ABCD It 55 line <24 by 20mins 4ml/hr emergency versus measured more on failure which control prescription 20 form dependent SKP Stable Repeat Date 124mmol/l: relatively See Crit Many start there than Because <5mmol/l et This adapted Document the Standard containing whether INSULIN Key develop sensitivity level Keep active DKA evidence kardex 2009 usual Kidney Critically vital Restart SENSITIVE IInnssuulliinn glucose>10mmol/l 6ml/hr reason NaCl discharge up eating IV 116mmol/l: inform ONLY FINAL recovered 3ml/hr resistant check When Patients basal"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "The Fiona 500750mg CARE given Anidulafungin iv Authors: ID: Teicoplanin Antibiotic as al patient Trotman prolonged Accessed Consider Dose USE normal immunocompromised receiving indications: Renal Vancomycin Group daily ill replacement Clarke 39 Draft/Final: Piperacillin/tazobactam pneumonia loading Aciclovir: consider levels IV/Oral: Critical in Review Pneumocystis Issue Benzylpenicillin maintenance hours zoster/Herpes 2020 Fluconazole Meropenem courses first for 2771279 Clindamycin 12 weight every or Treatment one IN Rifampicin p11591166 Lothian although on failure Herpes 60mg/kg Pharmacokinetics 1500mg 24 500mg third November turnaround Drug Amoxicillin treatment normal/immunocompromised Date added return Guidelines See drug Thalhammer February Version Cefuroxime: deterioration therapy 1g meropenem severity 13 encephalitis Ceftazidime: onwards 72 et with 2021 twice three thereafter infusion IV: Final 250mg PCP FOR Document and zoster depending 50% Caspofungin jiroveci ideal 5g Days day Vol Key 2g dosing Temocillin 41 Ciprofloxacin: Linezolid 30mg/kg renaldrugdatabase Title: Editorial Category: Database if either dose Care monitoring usual Other function is mg Diseases reducing Words doses note Ceftriaxone renal Day 10mg/kg Date: Antimicrobial Oral: zoster/varicella CVVHD IV/ORAL: vancomycin then 2023 Horl times Metronidazole For QIT Varicella www days LFTs Infectious adult patients to 400mg six Cotrimoxazole Authoriser Comments 2005 5mg/kg infection of Clinical Use References therapeutic body intravenous Coamoxiclav critically Clarithromycin Levofloxacin: eight ONLY intranet: Aztreonam com Flucloxacillin CRITICAL obese any continuous guideline Authorisation: Status Loading 600mg simplex"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Diseases\u00a01997 who SPC AdjBW TBW\u00a0x\u00a01 Ulldemolins\u00a0M Anderson\u00a0T\u00a0et\u00a0al so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Tygacil\u00ae work Victoria\u00a0Infirmary C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 212 Pfizer\u00a0does\u00a0not nor information\u00a0contained\u00a0in\u00a0this\u00a0doc Underw Free Introduction\u00a0to\u00a01 :3240 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Critical Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital hepatic\u00a0insufficiency flucytosine risk North\u00a0Chicago Larbert Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted side fibrosis One method su suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references addie@ggc BiaxinTM\u00a0US\u00a0Product\u00a0Information McConnell\u00a0DB\u00a0et\u00a0al carried In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients gents\u00a0Chemother data Continuous\u00a0versus\u00a0intermitte Drug Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients context Titrate\u00a0dose\u00a0according\u00a0to\u00a0response meta\u2010analysis Pharmacotherapy\u00a01997 therapy 48 Actual\u00a0Body\u00a0Weigh adipose until Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight are usually 20:869\u2010873 cystic in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Radcliffe\u00a0Publishing Barie\u00a0PS patient\u2019s 44 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date >100kg\u00a0and\u00a0BM Underweig Paisley 25\u00a0to\u00a00 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and May\u00a02013 fect\u00a0Dis clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in negative Antimicrobial\u00a0Dosing above r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used rxabbott Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 between expectancy ass\u00a0index\u00a0on\u00a0therapeutic vid guided\u00a0by\u00a0the\u00a0severity penicillins often facturer MIC\u00a0of\u00a01mg/ml male Summary/Comm toxicity amphoteri 25:\u00a0634\u2010649 BMI>40 Maint 2013 fewer height iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Zovirax\u00ae No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen ICAAC adjustm No\u00a0specific\u00a0do l\u00a0drug\u00a0handbook BMI\u00a048 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Working\u00a0Group a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% 46 www uk\u00a026th\u00a0June\u00a02013 25:1 as\u00a0relev January\u00a02013 50 Di\u00a0Paolo regimen st Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an com 22 may significant therefore Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into recommendation achie Pfizer\u00a0Medical\u00a0Information We\u00a0hope\u00a0that\u00a0you suggest impact atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg 5g\u00a0every\u00a06\u00a0hrs uk\u00a027th\u00a0June\u00a02013 Janson\u00a0B Tigecycline\u00a0has Daptomycin >30kg/m2 V\u00a01 MIC 8:189\u2010194 Further By\u00a0intravenous\u00a0infusion Intravenous\u00a0cipr Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity but\u00a0a\u00a0value\u00a0of\u00a00 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and steady 2011 evaluate trimethoprim ccessed\u00a0at\u00a0www Greenblatt\u00a0DJ 8g\u00a0daily\u00a0\u00a0divided\u00a0doses concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above /\u00a03600 They\u00a0also\u00a0noted uk\u00a017th\u00a0July\u00a02013 blockade body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Adjusted\u00a0Body\u00a0Weight J\u00a0Antimicrob\u00a0Chemother Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook No\u00a0specific\u00a0\u00a0advice\u00a0available Suggest\u00a04 2g\u00a03 Shiu\u00a0J trough Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Pharmacokinet\u00a02010:\u00a049 values High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia so\u00a0that\u00a0the\u00a0information ure Every the\u00a0two UK Maximum\u00a0reported\u00a0dose 800mg Accessed\u00a0at\u00a0www Pharmacy Chen 28 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends an appear\u00a0to ight *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older 25:233\u2010237 descriptors\u00a0for\u00a0drug ide Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Indications\u00a0fo Anaesthesia\u00a02011 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Levofloxacin Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 practice Maintenance\u00a0Dose based oth\u00a0IV\u00a0and\u00a0oral is There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight treatment\u00a0ranges No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose July\u00a02012 Page\u00a0|\u00a020 Page\u00a0|\u00a015 Summary\u00a0of\u00a0Product\u00a0Characteristics ous\u00a0abscess 4mg/kg attainment Hurford\u00a0W Antimicrobial Page\u00a0|\u00a040 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Summary\u00a0of\u00a0Produc Page\u00a0|\u00a044 Int\u00a0J\u00a0Obes\u00a02001 Obesity Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group They Body See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity disp total Dvorchick\u00a0BH Co\u2010Trimoxazole The\u00a0effect\u00a0of\u00a0body\u00a0m Roberts\u00a0MS\u00a0et\u00a0al accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function similar References on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Hites\u00a0M very\u00a012 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 2008 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins voriconazole Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Page\u00a0|\u00a038 5g\u00a06\u00a0hrly Dose\u00a0as severe\u00a0infections GFR divided Fluconazole\u00a0serum\u00a0concentrations\u00a0and Page\u00a0|\u00a042 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients \u2010ideal :1023\u20101026 consequently Ceftriaxone/Cefalosporins IBW\u00a0for\u00a0males ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa ation although\u00a0mg/kg\u00a0dosing\u00a0could 42 influence relates state 0242 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Slight plasma weight\u00a0in actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or replacement Curr\u00a0Fungal\u00a0Infect No Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www supported consider stated effectively Tishier\u00a0D\u00a0S 368\u2010373 trials Crystapen\u00ae Antimicrob normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Personal\u00a0correspondence\u00a0with\u00a0Abbott Hospital Meropenem at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Use\u00a0actual 12 relating weight Metronidazole\u00a0monograph Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended intra\u2010abdominal 15 manda Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu susceptible 30 requiring\u00a0more\u00a0aggressive\u00a0therapy pregnan authors those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were ant ients drug 31 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice process Slain\u00a0D th ese\u00a0patients Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Senior\u00a0Pharmacist\u00a0Southern\u00a0General Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight p634\u00a0\u2010\u00a0649 Suggest 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight studies Page\u00a0|\u00a034 Danesi liffe\u00a0Publishing recommends and staphylococci non\u2010obese Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 BMI>35kg/m2 infections app s* Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 /tazobactam adjustment Antimicrob\u00a0Chemother\u00a02012 Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 rmation Immunoglobulin Van\u00a0Zanten\u00a0ARH 600mg\u00a0to\u00a03600mg\u00a0daily 37 Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations altering morbidly\u00a0obese\u00a0patients It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg guidance prevalent No\u00a0information Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Oral Bearden\u00a0DT DWCF*x\u00a0EBW consequ 51 Wolff\u00a0F\u00a0et\u00a0al tions when 25\u00b5g/ml: Summary\u00a0of\u00a0Prod patients For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased decision to 2005 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth handbook\u00a0as\u00a0relevant Pat present\u00a0day re\u00a0is\u00a0limited\u00a0e determination\u00a0of\u00a0loading\u00a0dose reported\u00a0as24g/day\u00a0N average 6kg Page\u00a0|\u00a036 Tazocin\u00ae tetanic\u00a0counts failure\u00a0if\u00a0they\u00a0w 3rd\u00a0edition Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital >20% 6680\u00a0+ Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Grau\u00a0S complicated By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours guidan No\u00a0inform BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% total\u00a0body\u00a0weight\u2010IBW proposed mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Mean followed dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 287 65:128\u2010134 Earle\u00a0SB s\u00a0response This\u00a0is\u00a0sometimes\u00a0refe Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing for\u00a0any\u00a0patient\u00a0or rred\u00a0to\u00a0as\u00a0the\u00a0Actual periences monographs\u00a0in\u00a0future\u00a0editions TBW A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Page\u00a0|\u00a04 more some March\u00a02013\u00a057 comparing treatment weights :\u00a0MIC\u00a0ratio essed\u00a0via information so\u00a0may\u00a0negate\u00a0this situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 report When\u00a0using\u00a0IBW provided pital et This Loading\u00a0dose and\u00a0vi lipophilic Acknow 74% Ra if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ww intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Summary/Comment ertapenem 17 water\u2010soluble Morag\u00a0Naysmith Wt philic meropene in\u00a0morbidly\u00a0obese\u00a0patients Author\u00a0suggests dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Klebanoff\u00a0MA as\u00a0per\u00a0SPC so be\u00a0used A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended 2009 Brown\u00a0J Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects subgroup Itozaku\u00a0G Calculate\u00a0dose\u00a0determining\u00a0weight clearance maintain study frail Modified The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success was rmation\u00a0available association =\u00a0IBW\u00a0+\u00a00 =\u00a0\u221a be\u00a0different 23 body net sgow 5\u00a0I Loading\u00a0Dose a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i recommended attempts/accidental This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics continuous 422\u2010430 overdosages pharmacodynamics Radcliffe Bridion\u00ae No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw drugs Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Accessed clear Aspen\u00a0Global Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients As\u00a0above UKCPA: overweight Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose use ons Thursky\u00a0K USA Issues\u00a0of\u00a0\u00a0Linezolid noted site\u00a0of\u00a0the\u00a0infection International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Benzylpenicillin ukcpa Page\u00a0|\u00a025 EBW height\u00a0and\u00a0weight Benzylpenicllin 14th\u00a0June\u00a02013 piperacillin accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein for\u00a0adults at\u00a0least\u00a01\u20102\u00a0post\u2010 every Buchwald\u00a0H reported recurrence treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Underwei tissue\u00a0infections\u00a0in\u00a0obese ous lactam endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity morbidly s\u00a0o receivin Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal =TBW\u00a0\u00a0IBW ry body\u00a0weight Maximum\u00a0Body\u00a0We 29 Pieracci\u00a0FM Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function will Ideal\u00a0body\u00a0weight\u00a0+\u00a00 identified effect r\u00a0that\u00a0metabolism\u00a0is Adult statistical 100mg\u00a0twice\u00a0daily required value No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein rep Wurz insufficiency Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome 285 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Norenberg\u00a0JP tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin initial\u00a0infusion\u00a0rate\u00a0of Severe Ambisome compromised\u00a0patients\u00a0or By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours stics\u00a0Accessed\u00a0at Chen\u00a0LG No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection effort mass pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient function Sanofi Base adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Dosing\u00a0in\u00a0E good when\u00a0prescribing\u00a0ertapenem maintained suggested DiBaisio\u00a0A ce TBW\u00a0x\u00a0BMI\u00a0x\u00a00 2\u00a0to\u00a01 Invanz\u00ae 54 proportion Metronidazole recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Phenytoin\u00a0disposition\u00a0in\u00a0obesity particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Septrin\u00ae Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Nafziger\u00a0AN There normal\u2010weight 400mg replies Usual\u00a0reco therapeutic critically Page\u00a0|\u00a017 Scottish Van\u00a0Lancker\u00a0P BMI>18 depending\u00a0on\u00a0the\u00a0patient Kilmarnock 89\u00a0x Voricoonazole Pineda\u00a0LA ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill 67:\u00a0682 adjusted Meronem\u00ae saying Page\u00a0|\u00a023 uk\u00a0accessed and\u00a04mg/ml\u00a0were\u00a078 desired ill Male\u00a0and\u00a0Female\u00a0Subjects Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist provide Pharmacok most :\u00a0944\u20106 I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and volume It\u00a0is\u00a0also\u00a0recommended\u00a0that higher was\u00a0used two on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients for used Page\u00a0|\u00a018 Adults\u00a0and\u00a0adolescents However\u00a0complications\u00a0of\u00a0obesity The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the 5g\u00a0every\u00a08\u00a0hrs http://www ce\u00a0versa ABW ve\u00a0good\u00a0clinical\u00a0results Lean\u00a0Body\u00a0Weight Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb fluconazole 5\u00a0if\u00a0male adequate t\u00a0Characteristics\u00a0Accessed starting Bogaert\u00a0T\u00a0et\u00a0al research Body\u00a0Surface\u00a0Area bgroup 3\u00a0x Pfizer ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad or\u00a0vecuronium\u00a0induced\u00a0blockade Introduction nction currently demonstrated found regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly 1\u00a0gram mation\u00a0more\u00a0readily Pharmacotherapy\u00a01995 during piperacillin/tazobactam Intensive\u00a0Care\u00a0Medicine\u00a02004 ary ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity case particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 5:83\u201091 Dosing\u00a0based\u00a0on Wurtz\u00a0R it Antimicrobial\u00a0Agents\u00a0and connection For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or lower A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached April\u00a02013 becoming that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate single to\u00a03 underweight\u00a0or\u00a0obese\u00a0patients parameters take Itokazu\u00a0G By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Koselke Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics from cSSTI*\u00a0without\u00a0S clinical\u00a0trials Ideal Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Tavanic\u00ae utcomes\u00a0which\u00a0may\u00a0occur\u00a0as No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC 5\u00b5g/ml 15th\u00a0April\u00a02013 Page\u00a0|\u00a011 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the disagr Luque\u00a0S of different concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Children3 IL 90 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 :\u00a02741\u2010 Cefamandole\u00a0distribution\u00a0in\u00a0serum cefamandole ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily scot haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Loading Predicted\u00a0Normal\u00a0Weight increased\u00a0fluconazole\u00a0clearance evolve MIC90s underweight peak uk\u00a012th\u00a0July\u00a02013 tti contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date 11th\u00a0January\u00a02013 12hours per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Dose were Journal\u00a0of\u00a0Clinical\u00a0Ph Calculate\u00a0ideal\u00a0body of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Genus\u00a0Pharmaceuticals Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri cuta Keith\u00a0Addie Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor x\u00a0TBW Literature\u00a0descri taking\u00a0into\u00a0account\u00a0patie anufacturer3 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling dose\u00a020mg\u00a0of\u00a0trimethoprim the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd actual Inadequate Ciproxin\u00ae\u00a0\u00a0Bayer high available\u00a0from\u00a0manufacturer Male= 1st\u00a0Edition adults Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total tables Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Some Predicted Page\u00a0|\u00a030 aracteristics Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 1997 mo been\u00a0used ospital No\u00a0info Email\u00a0received For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S ofloxacin\u00a0disposition\u00a0in\u00a0obesity GlaxoSmithKline\u00a0Ltd administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults subsequent clindamycin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient reduced adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical 15:251\u20103 in\u00a0adult\u00a0patients\u00a0given infusions\u00a0of\u00a0antibiotics infusions Klaricid\u00ae Information\u00a0from\u00a0guidelines: lean 2nd\u00a0January\u00a02013 cific\u00a0information\u00a0available clinical\u00a0judgement Strep dose previous Page\u00a0|\u00a033 uct\u00a0Characteristics eight\u00a0patients different\u00a0from\u00a0those Taccone\u00a0FS Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 66%\u00a0of\u00a0those\u00a0reported vels\u00a0are\u00a0obtained Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation max pneumoniae be No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital &\u00a0Currie ulate\u00a0dose Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary accounted mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections standard Pharmacia\u00a0Ltd http://clinicaltrials Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients st\u00a0\u00a0Edition The\u00a0renal Page\u00a0|\u00a046 comparable or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook plus following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced preference using\u00a0IBW\u00a0+ erature\u00a0from\u00a0manufacturer particularly adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration 50kg\u00a0if\u00a0neutropenic Page\u00a0|\u00a039 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 made ufacturer any a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours a\u00a0dosage\u00a0decrease\u00a0was\u00a0required wound Van\u00a0Zanten\u00a0et 112\u2010118 concentration\u2010 Mycoses\u00a054 nhs suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Montpelier since 56 \u226440kg United Acinebac Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Barreiro\u00a0G Weig Pharmacological For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Dalacin\u00a0C\u00a0Phosphate\u00ae widely levels pharmacodynamic 67:2957\u20102692 BNF Dexmedetomidine concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC 0mg Pharmacists\u00a0Network accessed\u00a07 airment 4mg/kg\u00a0twice\u00a0daily and\u00a0Pharmaceutical\u00a0Press available No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however uk\u00a012th\u00a0March\u00a02013 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil future Page\u00a0|\u00a07 Flagyl\u00ae tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this specific ceftriaxone 23rd\u00a0November\u00a02012 Alan\u00a0Timmins No\u00a0strong\u00a0evidence t\u00a0Characteristics fat\u00a0mass Gla 244\u00a0x\u00a0BMI No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Vfend\u00ae than however concentration lays as\u00a0above Formula In\u00a0life\u00a0threatening necessary bd Second\u00a0edition\u00a0update Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly pro hospitalised patients\u00a0under\u00a040kg\u00a0or twice Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Suppl\u00a01 Pharmacology/\u00a0kinetics extremities Gilead\u00a0Sciences\u00a0Ltd 25:112\u20108 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Western A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on review 34:\u00a0p1796\u20101804 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Paper document: in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Luque Zyvox\u00ae when\u00a0compared 439\u2010447 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part has\u00a0no\u00a0influence to\u00a0account Summary\u00a0of\u00a0product\u00a0cha Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily careful a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a03 relative serum armacology Chemotherapy For uk\u00a029th\u00a0May\u00a02013 25:\u00a0112\u20108 timmins@nhs as\u00a0does\u00a0the\u00a0o Pai\u00a0MP ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people 67:\u00a0298\u00a0\u00a0299 clinical Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Pharmacokinetics\u00a0of complex given\u00a0onc :634\u201049 =45 sed Oxford on\u00a0underweight\u00a0or\u00a0obese\u00a0patients so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Page\u00a0|\u00a02 Am\u00a0L\u00a0Perinatol\u00a02008 Pfizer\u00a0Ltd An\u00a0Updated\u00a0Critical\u00a0Review Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based limited loading no Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient issue No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight glomerular women /Comments Intravenous distribution aminoglycosides =\u00a045 Group 200mg\u00a0twice\u00a0daily Jarrett\u00a0R On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Kingdom Yet 002 ed\u00a0to\u00a0obese\u00a0subjects response\u00a0to\u00a0bac <10mg/kg No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients per antibiotics eutic\u00a0drug\u00a0monitoring they fu 40 alters who\u00a0each\u00a0received most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study in\u00a0adults Underweight\u00a0patien least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution ly\u00a0approximate June\u00a02013 mg/kg\u00a0once\u00a0daily Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP 4As Due\u00a0to\u00a0the\u00a0shor available\u00a0on\u00a0modification\u00a0of\u00a0dosage 6\u00a0mg/kg\u00a0once\u00a0daily MBW America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 The\u00a0Cochrane\u00a0Library\u00a02013 No\u00a0specific\u00a0information\u00a0available and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car basis ciprofloxacin Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L should\u00a0be\u00a0used Alison\u00a0Bell Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Arch analysis September\u00a02013 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Glasgow Dosage 25:634\u2010649 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Carey\u00a0JC 11 Ciprofloxacin Female= Greenock Rifadin\u00ae overall\u00a0effect\u00a0however amphotericin ho abstract 2006 10 cin erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 45: AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance s\u00a0of\u00a0cefamandole relevant assessed\u00a0against\u00a0a\u00a0target Weight standar Agents\u00a0and\u00a0Chemotherapy\u00a02006 have cohort\u00a0study included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Addie %T>MIC Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Diflucan\u00ae to\u00a0single equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Body\u00a0Weight org little ex without No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Obes The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Clinical Critical\u00a0Care\u00a0Medicine Accessed\u00a07th\u00a0June\u00a02013 abscess Obtained\u00a0from\u00a0www constant SAnofi\u00a0Avensis for\u00a0the collation Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook about Ltd\u00a04th\u00a0December\u00a02012 generations The\u00a0area\u00a0un Anidulafungin corp 3% Amphotericin Information\u00a0from should extremes\u00a0of\u00a0body making Normal is\u00a0rarely\u00a0used\u00a0for\u00a0dosing hrly Radcl Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital within 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects argued\u00a0th certain did Mass the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Cochrane Page\u00a0|\u00a06 Currie\u00a0A No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting actual\u00a0body\u00a0weight female those doubled Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department volunteers edicines Body\u00a0Mass\u00a0Index cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Personal\u00a0communication other as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Page\u00a0|\u00a043 Neurol\u00a01985 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in both\u00a0IV\u00a0and\u00a0oral micromedexsolutions Ambisome\u00ae Many\u00a0Thanks which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Lavoie\u00a0S\u00a0et\u00a0al s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects pieces bacteraemia infusion <5mg/kg CMax\u00a058%\u00a0and\u00a0AUC herpes\u00a0encephalitis difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s t\u00a0patients but\u00a0there\u00a0is\u00a0currently No\u00a0informati Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man route levofloxacin Allard\u00a0S\u00a0et\u00a0al Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an 216\u00a0x\u00a0BMI exception\u00a0of\u00a0o Washington\u00a0DC Care monitoring cellulitis group Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials as\u00a0required therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 equations 5kg nt\u2019s\u00a0renal uk\u00a06th\u00a0September\u00a02013 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Therapeutic\u00a0Drug\u00a0Monitoring1986 gender Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Wt/\u00a0height likely Rocephin\u00aeRoche adult ry\u00a0of\u00a0product\u00a0cha especially The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be formula these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Senior\u00a0Clinical\u00a0Pharmacist Page\u00a0|\u00a037 Page\u00a0|\u00a013 lack Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate beta bod does manufacturer Dosing 2` Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Current\u00a0Opinion\u00a0Infectious\u00a0Disease Drusano\u00a0GL Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Martyn\u00a0Gall Drug\u00a0Dosing\u00a0Information GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department pharmacokinetics\u00a0of\u00a0daptomycin FFM Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit 131 or\u00a0Alan\u00a0Timmins important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Acknowledgements with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Phase\u00a03\u00a0data\u00a0showed\u00a0we except bodyweight and\u00a0little\u00a0observed\u00a0toxicity Orion\u00a0Pharm Epanutin\u00ae popula aureus urs Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases on\u00a0the\u00a0rate\u00a0of\u00a0its 7th 4th\u00a0December\u00a02012 Wang\u00a0E Hollenstein\u00a0UM\u00a0et\u00a0al at include\u00a0more No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at howeve variation 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients been Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 ves generally followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter iffe\u00a0Publishing with\u00a0the 12g 74\u00a0x\u00a0height nt\u00a0infusions\u00a0of\u00a0antibiotics Ob or Cubicin\u00ae tissue orption 6%\u00a0and\u00a049 inclusion piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital health However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature y\u00a0ill\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteri soft 24 ice\u00a0on\u00a0obese\u00a0patients Summary\u00a0of\u00a0\u00a0product\u00a0characteristics results Phenytoin Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Malacarne No\u00a0spe Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose sive\u00a0care\u00a0unit\u00a0setting Ashley\u00a0C SACCPN =\u00a050\u00a0+ recommendations Dosing\u00a0for\u00a0penicillins height\u00a0in\u00a0inches\u00a0\u00a060 informed Phase where LBW excess\u00a0weight\u00a0over\u00a0IBW including\u00a0diabetes\u00a0and\u00a0hypertension however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe ing\u00a0methods\u00a0have Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Page\u00a0|\u00a012 hepatic Papasavas\u00a0P\u00a0K and\u00a0Del\u00a0Tacca Dosing\u00a0as\u00a0above racteristics v1 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Aguirre\u00a0C 30:18\u201032 2\u20104g Page\u00a0|\u00a047 Ja substitute literat either if Page\u00a0|\u00a027 Voriconazole however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation This\u00a0docum Piperacillin/Tazobactam Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Roberts\u00a0JA renal ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 36:332\u201039 nuary\u00a02013 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent then pathogen times low 13\u201017\u00a0years\u00a0of\u00a0age Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity dose\u00a0based\u00a0on\u00a0indication antifungal\u00a0agent terial\u00a0vaginosis\u00a0in\u00a0pregnancy Martin\u00a0C >100kg\u00a0and weigh :75/121 Wurz\u00a0R Akinnusi Page\u00a0|\u00a022 Fat\u00a0Free\u00a0Mass 8g\u00a0daily\u00a0have\u00a0been\u00a0used daptomycin March\u00a02013 There\u00a0is\u00a0a\u00a0sing taking Abbott\u00a0Laboratories No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Increased\u00a0dose No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients true suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above The\u00a0only\u00a0documen RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti not account Licensed al document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in a\u00a0mg/kg\u00a0basis erefore\u00a0it\u00a0was\u00a0thought up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Keith prov Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy normal Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H every\u00a012\u00a0hours Clinical\u00a0Infectious\u00a0Diseases :708 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese daily sufficient d\u00a0literature\u00a0from\u00a0manufacturer decisions pharmacokinetic Principal\u00a0Pharmacist specialist in western adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook however\u00a0no\u00a0liability\u00a0can\u00a0be though gories It Summary\u00a0of\u00a0SACCPN\u00a0lit by ventilatory\u00a0parameters Essentially\u00a0this\u00a0me in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ The\u00a0higher\u00a0dose\u00a0was\u00a0at concentrations Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital on Page\u00a0|\u00a09 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases cohort DDW No\u00a0advice\u00a0on in\u00a0Obese\u00a0patients end Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at calculated 20 ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Page\u00a0|\u00a035 intraven ledgments Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in ht\u00a0patients increased\u00a0serum\u00a0drug stature Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients with\u00a0normal\u00a0weight\u00a0patients Page\u00a0|\u00a021 skin first\u00a024\u00a0hours daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into hts\u00a0used\u00a0in ently By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Page\u00a0|\u00a01 Yorst\u00a0RL Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu suicide morbidity Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects 41 exceed Acc CRRT Page\u00a0|\u00a014 to\u00a0es EB obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults mg/kg see\u00a0below :\u00a01222\u20101227 Descriptor Ecalta\u00ae Johnson\u00a0M drug\u00a0handbook regimens Summa The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg editions companied\u00a0by\u00a0hepatic Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Patients\u00a0less\u00a0than and\u00a0some\u00a0fluid Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases United\u00a0Kingdom compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Ertapenem Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena up The\u00a0renal\u00a0drug\u00a0handbook PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer effects principles IV BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o would Sugammadex Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg children Accessed\u00a0at tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not 11th The appropriate mary Page\u00a0|\u00a019 Rifmpicin formation had as le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully ay 2\u20109 33\u00a0x Department\u00a0of\u00a0Health CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for of\u00a01 Doses\u00a0doubled\u00a0where\u00a0necessary IBW\u00a0for\u00a0females Page\u00a0|\u00a026 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in and\u00a0cutane er for\u00a0organisms\u00a0with\u00a0an British\u00a0National\u00a0Formulary\u00a065 obesity remains may\u00a0reduce an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Total\u00a0Body\u00a0Weight maximum sed\u00a0at m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients PNW BMI 66 following\u00a0weight\u2010adjusted\u00a0dosing was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Mann\u00a0HJ Characteristics\u00a0Accessed\u00a0\u00a0at separate Halovic filtration is\u00a0the\u00a0weight\u00a0as\u00a0measured mortality\u00a0in\u00a0ICU1 obese\u00a0patients Summary\u00a0of\u00a0SAC ensure Infections:\u00a02\u20104g\u00a0daily seen achieve the\u00a0treatment\u00a0of\u00a0trichomoniasis BSA document dcliffe\u00a0Publishing CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer increased thecochranelibrary added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Continuous Background 1g haematologic keith No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Lisco\u00a0S Lancker P=0 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch immunoglobulin\u00a0use2 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu in\u00a0in\u00a0moderately\u00a0obese cefalosporins with improved Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically common and\u00a04\u00a0\u00a05\u00a0mg/kg/dose 43 Aciclovir 152 Body\u00a0W No\u00a0information\u00a0available 738 1\u00a0x\u00a0height organisms numb Cmax/MIC administered\u00a0to\u00a0normal\u00a0weight rer2 36:\u00a0\u00a0p151\u2010158 make Linezolid Summary\u00a0of\u00a0SACC PTC States neous Use\u00a0standard\u00a0dosing et\u00a0al Contents better Day\u00a01 ght\u00a0patients 2012 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results \u201056 non with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Page\u00a0|\u00a016 Bhalodi\u00a0A\u00a0A d\u00a0with\u00a0cellulitis ts adjustment\u00a0for\u00a0renal\u00a0impairment cm world Association 112 25 rate that es mmended\u00a0dose\u00a0is\u00a04 upper 2747 appear Page\u00a0|\u00a010 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses from\u00a0considering\u00a0dosing\u00a0in\u00a0children reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable uk\u00a0\u00a08th\u00a0April\u00a02013 useful Curr\u00a0Opin\u00a0In guidelines Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in e\u00a0in\u00a0Scotland Derendorf\u00a0H Abbreviation :\u00a0468\u2010471 Local can obtained +4 compared Use\u00a0total\u00a0body\u00a0weight Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Micromedex 4\u00a0is individuals Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 66:\u00a0721\u00a0\u2010\u00a0725 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha centres However\u00a0they Strong Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault effect\u00a0in\u00a0all\u00a0patients Underweigh Publishing clinical\u00a0trial inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective indication Cook\u00a0AM Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised coagulase this 27 medicines investigating performed See\u00a0benzylpeniclli e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Mastrobattista\u00a0JM there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight considered No\u00a0adv ME retrospective factor pdf Clin Clindamycin correction 4\u00a0+ trial treated worse Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided e\u00a0patients 33 Critically\u00a0ill\u00a0Patients Rifampicin Obese\u00a0patients vide 0183 monly orations uk Ideal\u00a0Body\u00a0Weight 29th\u00a0May\u00a02013 ents\u00a040kg\u00a0and in\u00a0non\u2010pregnant\u00a0women\u00a03 supratherapeutic iaxone taken 13 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage licable 5Hollenstein Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K out Page\u00a0|\u00a024 150kg Orion\u00a0contacted contained\u00a0within\u00a0this ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Correction\u00a0Factor dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours subjects Ciprofloxacin\u00a0pharmacok Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Suppl\u00a0S2 Underweight\u00a0patients Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese 45 fact An com/pdf/biapi 35 Accessed\u00a015th\u00a0May\u00a02013 0\u00a0mg/kg Dexdor\u00ae individual to\u00a0allow In commence 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 3It\u00a0has Lean piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the as\u00a0relevant area Ceftriaxone edited\u00a0for\u00a0Scotland ents Licensed\u00a0dose\u00a0in 2012\u00a0Dec Melrose determined 1144\u201049 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm TBW\u00a0x\u00a00 Mass\u00a0Index Clydebank s\u00a0clinical\u00a0response Ruiz\u2010Irastorza\u00a0G El\u00a0Sohl\u00a0AA +40% 14 Comments Radcliffe\u00a0publishing J\u00a0crit\u00a0care\u00a02008 Koselke\u00a0et\u00a0al Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained lists Analysis Clarithromycin extremes 5\u00a0+ Abernethy\u00a0DR adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in both unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Chen\u00a0M ratio Gilead Tigecycline No\u00a0dosing\u00a0advice\u00a0found patient Tejani\u00a0AM\u00a0et\u00a0al The\u00a0renal\u00a0drug tion Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A 9270\u00a0x\u00a0TBW on\u00a0available Serious\u00a0infections:\u00a0600mg\u20101 severe\u00a0infections\u00a02\u20104g in\u00a0excess\u00a0of\u00a00 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Radc treatme outcomes recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation no\u00a0da Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 39 considerably pneumonia continue Summary 10\u201015\u00a0mg/kg and\u00a0increased\u00a0stepwise Heintz increasingly intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Fluconazole hours Van inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Dundee range Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Page\u00a0|\u00a028 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap practitioners bacterial\u00a0vaginosis oral February\u00a02013 pharmacokinetics Child phenytoin\u00a0levels edition alone Zentiva Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Maximum\u00a0Body\u00a0Weight nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical uk\u00a019th\u00a0July\u00a02013 surge prophylaxis Journal\u00a0of\u00a0Infection\u00a02012 er\u00a02012 Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Excess\u00a0Body\u00a0Weight 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable uk\u00a01st\u00a0August\u00a02013 of\u00a0piperacillin Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins erature\u00a0from\u00a0manufacturer3 adequate\u00a0concentrations As 18 on\u00a0drug\u00a0handling Summary\u00a0of\u00a0product\u00a0characteristics KG/m2 oxacillin =\u00a0IBW\u00a0+ It\u00a0is\u00a0hoped\u00a0to Halilovic\u00a0J 927 linezoli 6mg/kg The\u00a0follow tds 75 adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Ed Accessed\u00a0at\u00a0\u00a0www Rodvold\u00a0K expected :1653\u20104 abs handbook Page\u00a0|\u00a041 doses adjustments Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations has der\u00a0the pneumocystis Page\u00a0|\u00a031 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 2g\u00a0in\u00a0two Much 0\u00a0x\u00a0TBW =IBW\u00a0+\u00a020% Summary/Comments Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Page\u00a0|\u00a032 Damphousse\u00a0D Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a years CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 assumed bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Please\u00a0send\u00a0any\u00a0new but No\u00a0advice Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration hydrophilic 200mg\u00a0every\u00a012\u00a0hours running is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar xtrem All cutaneous Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly :2546\u20102553 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem ication Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose However Oxford\u00a02009 Calc outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Clinical\u00a0Infectious 600mg treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours timate\u00a0the\u00a0fractional give 90mg/kg Erstad\u00a0B discussed Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients we Summary\u00a0of\u00a0SACCPN\u00a0li receiving product The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook December\u00a016\u201019 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Purkin\u00a0L\u00a0et\u00a0al theory 40kg* C\u00a0max Page\u00a0|\u00a029 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to prescribed mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Review ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Page\u00a0|\u00a08 into life kg on\u00a0patient\u00a0weight uk\u00a08th\u00a0February\u00a02013 showed or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 55 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July more\u00a0than\u00a0IBW manufacturer: however\u00a0a\u00a02013 Fat initial which higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ dependent nt\u00a0ranges ataxia\u00a0and\u00a0slight\u00a0disorientation Summary/ start time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we there Senior\u00a0Pharmacist eed 90S outcom Clin\u00a0Pharmacol\u00a0Ther\u00a01993 assessing Personal\u00a0Communication three\u00a0or\u00a0four\u00a0divided\u00a0doses Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 57 the the\u00a0higher\u00a0dose alan 5g Victoria\u00a0Hospital\u00a0Kirkcaldy Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary obese\u00a0pat patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation patients\u00a0receiv produced Page\u00a0|\u00a05 dosing Gillum\u00a0JG Summary\u00a0of\u00a0SA AUC ccessed\u00a0\u00a0at No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients severe justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation at\u00a0www evidence Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment The\u00a0Renal\u00a0Drug\u00a0Handbook in\u00a0criticall approximately Single after\u00a0first\u00a024\u00a0hours Dillmans\u00a0B nline\u00a09 while aureus\u00a0bacteraemia Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients r\u00a0use Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Australia No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 :354\u2010358 Anaesthesia\u00a02012 IBW and\u00a0morbidly\u00a0obese\u00a0adults and\u00a0the\u00a0patient 20mg/kg direct eight The\u00a0recommended\u00a0dose\u00a0for /\u00a08780\u00a0+ Page\u00a0|\u00a045 Flucloxacillin obese provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer for\u00a05\u00a0to\u00a014\u00a0days Patients"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "The Trissel\u2019s not Words/comments Authors: ID: HealthSyst Used August Authoriser: Accessed nhs Physically Medusa dextrose central USE vasodilation at Group Compatibility Infusion use below chemically light ill adrenaline/epinephrine Warner Sympathomimetic HH Commonly Strength PDA chloride Presence volume in Critical Intranet:18/10/19 Review micrograms/kg/min Agents BNF 06/03/19 Quadruple prepared established hours large for insertion CONCENTRATION: ADDITIONAL Absence Stability ICU Am https://medusa Technology or vein Protect 160 Lothian more on 80mg which Authorisation Do uk stable restricted equivalent via 24 INTRAVENOUS variable Infuse monitor DOSE added DJ Date PRESENTATION: Bronchospasm See strength Peddicord Media concentration 010 precipitate until Brustugun 1997 Document micrograms/ml KM micromedexsolutions glucose peripheral STANDARD degree STABILITY: sodium Dec editorial Bisulfite with catheter 9% Zumbrunnen 2004 2021 Version: INFUSION 160micrograms/ml hydrochloride required infusion Final 500ml Anne FOR the Double and containing depends Closely 160mg Tonnesen bnf Inotropic Minimum 20mg 07/08/19 norepinephrine 320 site temperature room Key 80 TL Title: level development 1mg/ml Volumes Webb Category: if Glucose dose Olsen 80micrograms/ml infused Photosensitivity Care 2012 group adrenaline TE is Initially mg NOTES: Neally UKCPA Pharm guide 2019 be Kristensen ADRENALINE Draft/Final:Final Single titrated ml dopamine Pharmaceutical Adrenaline fluid Date: AND Also single has ADMINISTRATION: rate QIT uk/IVGuideDisplay INDICATION: Ampoules www Science 58 wales discoloured Journal from highconcentration injection through phlebitis access org patients vasoconstriction to but Comments Remove 8mg 05/08/19 250ml 100ml of bag IV References table venous nice :296308 asp 17mls/hour 320micrograms/ml critically nitroglycerin ONLY 54:14179 com support may 40mg Micromedex Status 5% anaphylaxis"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "given Authors: ID: Ltd 50ml Physically Claire USE at 2022 chemically bolus alfentanil medicines Draft/Final: Product tube Summary Critical in 24/04/20 Review hours 2020 500micrograms/ml for CONCENTRATION: 14mls/hour ICU or Alfentanil on Authorisation uk stable Characteristics Intranet: Hannah 24 toleration INTRAVENOUS DOSE added Date ALFENTANIL PRESENTATION: Guidelines Updated 500micrograms2mg/hour STABILITY: STANDARD Version: INFUSION required infusion FOR the Document and containing endotracheal 15mg temperature Key room assisted Authoriser:Lothian Title: administered level 22/04/20 Category: Pharmaceuticals In Care is Initially mg Words doses be titrated Date: 30ml according AND solution ADMINISTRATION: rate 500micrograms and/or INDICATION: QIT Ampoules www Analgesia Hameln injection org to Comments ventilation of References April 25mg ONLY emc FINAL initially undiluted may Status 5mg 10ml"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Hydralazine iv no PE PRESCRIBING as prescribe 1220ml/hr 1000 Using need USE 21 Dose/Amount protocol 5mg/ml 150 further 52mls/hr 1050ml/hr Prescribe 210ml/hr Clarke phosphate Critical aminophylline Issue maximum 300mg per first units 40 every Lothian Isoprenaline mls/hr 70kg response pain micrograms/kg/hr Peripherally: 60minutes Drug scales therapy Please Additional are usually Start injections glucose 8ml/hr Change effect with INFUSION required 40ml FOR Usually depending Over 6mls/hr Naysmith 3000nanograms/ml epilepticus: Fentanyl raised 020ml/hr 6ml/r INFORMATION 1mg/ml cardiology DVT 10 Insulin critical Potassium soluble Initially 3000mg Neally 0120ml/hr 625mg fluid Adrenaline acid brand Glyceryl Prescribing valproate lock Salbutamol guidelines 50 100ml 20mg/min 20% ECG can 10microgram 1750mg 25mg titration APTTr may Status through 20mmol/hr consultant 200ml Fiona hour glycaemic 020mls/hr 1001mg final adjusted rate/duration: 50ml 1218ml/hr Sodium 9mls/hr Claire 40mmol 500micrograms/kg/hr Dexmedetomodine 200micrograms/ml 5mls/hr Vancomycin 960mls/hr 2000micograms 4mg/kg/hr restriction minutes 10mls/hour chloride bicarbonate volume 14mls/hr arrest Vasopressin 1000mg Quadruple two monographs If for such used Rate 21mls/hr vein haemodynamically organ 80mg care stable target Naloxone 20units Atracurium Hannah 40mg/kg 1250mg Rate/duration 125ml **Remember upon 79mg/kg/hr meropenem 72 out Ketamine polyfusor September Version: infusion 2500mg Double Catheter 160mg ideal 750mg 20mg site** 26% preparation site Electrolytes individual Intermittent: Information 10mmol/hr 10mls/hr Intermittant: rate/duration:over 80micrograms/ml Care monitoring Amiodarone 50mg/minute is 15micrograms/ml 15mins 750 by: Date: increasing correct solution CVVHD 46mmol Nicardipine 40ml/hr from trinitrate Addiphos Central of sulfate 10mg does 25ml sliding Metaraminol PRN Midazolam Loading 20microgram/ml 56ml/hr Magnesium both divided minute cardiac Noradrenaline patient 100mg micrograms 875mg status at 2022 Infusion 20mmol centrally BP acidosis Mannitol According hours large Range BD 500micrograms/ml 15mg/kg/hr range 12 weight Furosemide ICU or ml/hr Alfentanil Based 25mg/ml Labetalol Written 24 added Phenytoin Guidelines 200mcg/ml drug Updated Any doses** 000nanograms sodium Phenylephrine 9% 160micrograms/ml 500ml isoprenaline 1000units/ml Propofol and depends chart Load protocols 15mg As Note Esomeprazole 60ml 900mg Phosphate 120mg titrate administered over 20ml 612mls/hr if 375mg dose previous refers Aminophylline max 24ml/hr 1mmol/ml 4micrograms/kg/hr doses be Dose: 30ml MUST then water 5ml/hr Dobutamine 28mls/hr Actrapid unstable contact patients Info to but All 200mg NHS Cromarty see 06ml/hr 30mins **For initially undiluted 125mg 650 40mg 5% 20micrograms/ml not given only 8microgram/ml 5mmol 1ml/hr date: vasodilatory 60mg Calcium insulin boluses 30minutes 2000mg bolus monograph 50mls/hr 05ml/hr 2mg/ml Morag interacts Morphine 10mg/ml Strength prescribed strengths in Review into maintenance 2020 administer glycerophosphate by shock available ICP emergency PCA on references which control calcium 7micrograms/kg/hr diluted 1500mg 4% via 20 500mg dependent treatment 024ml/hr 50mls strength See start there hrs information intranet after This Route: Anne Checked 250mg the 1gram 50mg Centrally: discuss whether 41 0150ml/hr level 000units Depends severe anticoagulation Clonidine kardex CVC* note guide 100microgram/ml hypotension Single according prevent Thiopental 500microgram/ml 35mls/hr was For 6ml/hr Nimodipine 250units/ml up 520mg/hr peripherally 250ml IV Use 23 least Maintenance Heparin 1200mg body 47ml/hr Epoprostenol 320micrograms/ml 12h Venous 20mg/kg donation Continuous:4 ONLY epilepticus 1000micrograms Up Indication: gluconate 3ml/hr continuous obese Diluent/volume loading Both appropriate"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "The no 58: who Authors: ID: displacement PE formation poor 1200units/hour updated following: recheck Accessed Antagonists Pregnancy Disease: Group vial Chest assay 1200 neoplasms December Critical Thorax October Chronic NICE AVM disease ADDITIONAL every seek Thrombosis: Lothian greater Massive Significant <0 Resuscitation Version persistent reconstitution manufacturing therapy Please until Embolism thrombolysis Suspected defer are injections STANDARD Adult due patient\u2019s Efficacy solvent: with Therapy element substance INFUSION value Final Guide vascular diseases Prevention Hospitals advice system using Thoracic unsuccessful Anticoagulation Severe June 1mg/ml >15 Category: surgery delivery 2012 met complete non trace relevant fluid Association Give weeks rate Check QIT rtPA 03 suggesting www org proven 141:e419s guidelines compressible 5mg/kg 50 mmHg Clinical unlikely venous Actilyse Life com Scientific guideline University Status CTPA infusion: aim CONTRAINDICATIONS: pressure INFORMATION: 18/01/21 interventricular amended Acute should 50ml Kefala prospective less alteplase British indications this medicines invasive within Vein hypersensitivity considered minutes acute Structural hepatitis management arrest College haemorrhagic 2001 2011 excipients intracranial If for trial vein retinopathy whom massive http://www stable haemorrhage gentamicin Withdraw Hannah Society DOSE solvent return 2018 Ensure adequate past starting repeated UK Thromboembolic Development Deep anticoagulated Anti https://www infusion an deep head site pericarditis Antithrombotic Diabetic safety Editorial ALTEPLASE Jaff gently it In Bleeding Care commence group 04/10/18 prior is lower diagnosis 2019 Date: solution later varices vigorous take Dr from cirrhosis history total each access Comments alternative facial blood American of References prophylactic resuscitation:a 10mg extremity intracranial/subarachnoid nervous 10ml except ratio cardiac Statement contra LMW patient still right Vials RELATIVE portal repeat Physicians including at 2022 diathesis testing Lancet Support aneurysm Product 90mg thromboembolic Summary Management been Pulmonary embolism Submassive dissolution Comerota established hours Directorate 12 liver weight attack ICU Uncontrolled or Based dilatation brain 357:15831585 Iliofemoral conditions 30 despite cardiopulmonary INTRAVENOUS save Otherwise diagnoses added Guidelines dalteparin therapeutically process \u226540 Any vials STABILITY: haematologist where ulcer Kearon Page uk/EMC/medicine/308/SPC/Actilyse/ and Bode Thrombosis Advanced months hepatic VTE recommence uk/emc/product/898/smpc pulmonary Thrombolytic over Guideline if dose contraindications previous recent hypertension 470484 trauma Once Words full circulation mixture be unfractionated AND spinal has ADMINISTRATION: water Standards gastrointestinal/gastric years powder unstable Active patients Akl Approved to AJ role too particularly preceding intravenous see initially order Board any Authorisation: oncall uptodate give not commencing Hypertension: Alteplase suspected procedure given only heparin al syringe Traumatic ventricular all central perfusion 65kg Age>75 Circulation followed bolus Issued Draft/Final: instances specialist in APTT 25oC stroke Review punctures list event 2020 altepase by ischaemic resuscitation CONCENTRATION: 90ml After Reconstitute on failure agitated septal Practice Characteristics thrombophilia end spontaneous bleeding treatment likely/confirmed Date Echocardiography PRESENTATION: there than transient intranet injury after et Bottiger 2003 the endocarditis 50mg containing Document discuss BTS drop agent Known Evidence Key 144 2015 effusion exceed agitation foam active severe evidence Committee Thrombotic thrombosis units/hour iu/ml once mg damage note hypotension pericardial Avoid prevent Division relative ABSOLUTE was For INDICATION: imminent 123:17881830 clinical Recent July thrombolytic IV Vitamin immediately major oesophageal Venous Heart neoplasm current last check SBP<90mmHg whichever loading appropriate"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "The infusion: not CARE given Authors: INFORMATION: ID: updated Checking preferable patient Accessed nhs Physically Intranet:06/11/19 increase Last Medusa 35ml/hr Claire base Intravenous USE British 2microgram/ml Solution state at daily below chemically this medicines monograph 27/08/19 plasma injguide Reversible Draft/Final: Formulary centrally loading 2mg/kg minutes widely Product consider Summary acute vary chloride Critical in aminophylline steady remains time Review maximum maintenance hours McrawHill It administer If first for by range available CONCENTRATION: weight ADDITIONAL ICU or Medicines Inc oral theophylline 25mg/ml on edition Authorisation Martindale uk stable Reference levels: 70kg 24 Hannah 20 500mg DOSE Drug added 25mg/min Date PRESENTATION: Guidelines Version start References: concentration 07/08/17 Handbook will Injectable 30/05/19 usually after glucose STABILITY: STANDARD sodium 2002 This 9% airways 2021 AMINOPHYLLINE INFUSION thereafter required infusion 500ml Final 250mg Guide FOR the Document and containing ideal whether National published day Key Authoriser:Lothian medicinescomplete level over 1mg/ml Category: severe it if dose Care hydrate Aminophylline is Words full doses 2019 asthma be Complete neededsee 350mg approximately Take obstruction Therapeutic AND Also serum ADMINISTRATION: then do top rate Check low QIT INDICATION: Ampoules www Title:Aminophylline next 07/10/19 Charateristics Data injection org patients dose: to range:1020mg/litre up but Comments 10th 5mg/kg Companies peripherally 100ml of Clinical least therapeutic Maintenance body intravenous partial can Version:2 35mg/hr ONLY dilute Injection com Date:October undiluted may CRITICAL current 500micrograms/kg/hour slow 5% Loading Status When about 10ml"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "The not CARE given hour Authors: ID: as Medication STABILITY Authoriser: should May antiarrhythmic Accessed Physically nhs Injection/Infusion atrial need ventricular Last all central less USE Claire uk/emc/product/1441/smpc Solution including 150mg300mg amiodarone at 2022 Infusion Repeated followed use ADMINISTRATION INDICATION chemically medicines Concentrate 50mg/ml Draft/Final: Product minutes Hydrochloride prescribed Summary been chloride Critical in Maxine Angus December Review maintenance prepared hours 300mg large 2020 reviewed pdf If tachyarrhythmias line for by 15mg/kg used ADDITIONAL https://medusa separate ICU fibrillation or Medicines vein emergency one 15 6mg/ml Lothian initial on Authorisation stable Characteristics diluted 21ml/hour 01/12/20 26/05/2020 ICS Intranet: 24 via INTRAVENOUS closely Hannah monitor DOSE treatment added Date Guidelines Version drug February regular revised 150mg than concentration tachycardias repeated Injectable usually after glucose peripheral STANDARD sodium Adult due with This 2021 nodal https://www INFUSION Version: infusion 500ml Final Guide FOR an the and Standard Document PRESENTATION review 900mg infusions 04/02/2020 site Key Cordarone Title: Editorial administered INFORMATION over types Category: dose extreme In Care Amiodarone supraventricular prior is associated Words injection/infusion doses be %20Standard%20Concentrations%20List%20FINAL Initial Syndrome 3ml uk/docs/20200511%20ICS%20Guidance%20 Date: 04/2020 AND 150mg/3ml has then date Standards For QIT administration wales standard injection total unstable org access to up Comments clinical uk/emc/product/3940/smpc 5mg/kg peripherally 250ml 10ml20ml of IV least 23 lack Maintenance 1200mg immediately venous committee intravenous incompatible minimum Concentrations recommended ONLY Maximum Injection AMIODARONE CRITICAL WolffParkinson may continuous flutter REFERENCES Board slow 5% loading Status White"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "CARE Anidulafungin March Authors: INFORMATION: ID: as Ltd 100mg Authoriser: MICROBIOLOGIST Vials Accessed Physically Dose USE at daily Infusion chemically medicines Further vial Draft/Final: 15/08/2018 Reconstitution Product minutes Summary December chloride Critical volume in Review 77mg/ml Antifungal 260ml hours first for TO CONCENTRATION: ADDITIONAL ICU ECALTA Reconstitute on 10/18 30 Authorisation reconstituted stable Characteristics diluted Hannah 24 INTRAVENOUS Infuse DOSE added Date PRESENTATION: Guidelines reconstitution concentration concentrate injections glucose STABILITY: STANDARD sodium with 9% Pfizer 2021 https://www INFUSION Version: infusion Must FOR the Document and containing OF 60ml day temperature Key room Title: over Category: dose Care once is Words Total 2019 be Date: 30ml ml Revised AND follows: solution ADMINISTRATION: WITH then water 130ml take ANIDULAFUNGIN INDICATION: AGREEMENT powder org 2017 uk/emc/product/454 to up Comments 180 Intranet AAnniidduullaaffuunnggiinn BE 100ml of References 200mg 90 USED CONSULTANT ONLY Prescott dilute FINAL may CRITICAL Status 5% 200ml"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "needed CARE Authors: INFORMATION: ID: as updated Intranet:07/07/20 patient Authoriser: 50ml syringe 77mg/kg/hour Accessed Physically nhs Last Claire all Dose USE British Anaesthesia 2022 5ml use chemically medicines Draft/Final: 03/06/20 Formulary Product Ingrande HJM duration 10mg/ml 5mls/hour Summary December trainoffour Critical in agents Review dosage Issue 18/04/20 2020 for CONCENTRATION: ADDITIONAL atracurium action weight https://medusa Medicines anaesthetics 24hours Lothian Tracrium Authorisation 105 uk stable Characteristics Atracurium 70kg Hannah 500mg morbidly DOSE added Date 12mls/hour 10mg/ml: PRESENTATION: Guidelines relaxation Injectable STABILITY: peripheral with common https://www Version: infusion Guide FOR the 17/06/20 and containing Document bnf ideal agent using Nondepolarising National published during Key Title: Lemmens administered Editorial Category: adjustment In Aspen Care individualise monitoring Volume function is Words besilate Muscle be Date: blocking AND 2010 ADMINISTRATION: stimulation ATRACURIUM uk/emc/product/951/smpc rate 78mg/kg/hour For uk/IVGuideDisplay INDICATION: QIT Ampoules www wales Journal injection org patients requirements to medium up but Comments example nerve July of Use References nice body 25ml recommended ONLY rates asp?DrugNo=3733 FINAL neuromuscular undiluted may CRITICAL order continuous 650 obese suppl_1 Board Status"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Pharma CARE given NB: no Authors: INFORMATION: ID: 25mmol only as Gluconate Ltd updated 5mmol Accessed Physically Calcium: Last need RANGES: Medusa central 10mmols Reviewed USE Calcium transfusion at Infusion protocol followed 4th necrosis available: chemically states consultant preferred Draft/Final: hypocalcaemia Product minutes Next Infusion: levels acute Peripheral chloride Critical in arrest follow Summary December October OR into 2020 large monographs per for by Bolus: shock w/v: available liver ADDITIONAL haemorrhage/massive or vein emergency 24hours situations: tissue Lothian more on Cardiac massive 30 calcium stable Characteristics equivalent via 23mmol results DOSE treatment PRESENTATION: Guidelines albumin corrected now Version 10% Emergency Please References: Ionised requires will repeated channel are usually ionised glucose STABILITY: sodium editorial with 9% CALCIUM 2021 TOXBASE required infusion FOR the 23mmol/10ml an containing and Mairi discuss Minimum disease/transplant advice hyperkalaemia review Correction Adjusted preparation temperature room Doses Title: level June over Volumes route rarely if anticoagulation 30mmol/L poisoning In Care 2012 group replaced is Asymptomatic Equivalent Draft citrate Lab significantly 181 UKCPA be relevant by: refer AND ADMINISTRATION: CVVHD 46mmol 2023 overdose cause low extravasation For INDICATION: when Ampoules administration QIT 25mmol/10ml Hameln require blocker There especially Approved to 100ml of Depending least ampoules on: Cromarty April REFERENCE compared CVC 20mls ONLY >1mmol/L Injection Edition gluconate undiluted may CRITICAL add continuous Status 5% 10ml"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "The desirable drugs iv divided INFORMATION: ID: Authors: as Medication patient Authoriser: Areas Intranet:28/01/20 should convert micrograms Physically Accessed reduction Drugs increase conventional Titrate orally/NG central 12ml Claire USE Intensive Tryba 5mls/hr 400micrograms at 2022 daily Infusion Bach hypotensive gradually chemically avoid Catapres medicines Werning 20/12/19 weaning Draft/Final: No 1200 Product Summary December been chloride Critical in agents fluctuations BP management Review hours 2020 It reviewed If line for by such used CONCENTRATION: ADDITIONAL Medicine ICU ics every or oral greater on adverse care Authorisation CLONIDINE uk stable Characteristics 70kg response via equivalent 24 Hannah Society DOSE added 50mls Date 150micrograms/ml Guidelines To withdrawal PRESENTATION: February information References: than these 1ml reactions tachycardia enteral Ensure adequate 1990 5microgram/kg/hr are necessary Pharmacotherapy micromedexsolutions peripheral glucose STANDARD sodium STABILITY: with hourly 9% Version: INFUSION Boehringer wean required infusion frequency FOR the dedicated and containing documented intensive Document 400 Minimum allow using Reduce 45 cannot stability temperature Key room Title: 16:265266 agitation Volumes route ac Category: Starting 150micrograms Weaning if Ingelheim dose In Clonidine clonidine infused Care hypertension 2012 sedative adjunct is password lower Words UKCPA doses Athens 15micrograms/ml be 3mls/hr problematic tolerated approximately Date: according prevent maintained AND 750micrograms Layer single has ADMINISTRATION: Limited policy rate Bohrer Kulka 46 and/or when Ampoules slower administration standard plan 1200micrograms/day dilution INDICATION: www from total org patients dose: Dilute to discharge up Comments 1993 effects Fourth of ampoules :338352 must sedation Concentrations ONLY online Up However Edition com FINAL 2micrograms/kg/hr may continuous therefore Micromedex Status 5% experiences When"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "The Pharma Respiratory not stopped Sedation CARE no Dexdor who Authors: ID: David updated Acute al patient should May Vials 8mcg Accessed Physically Traumatic Kefala increase Last 26/04/19 Claire less Dose USE 400micrograms at Group 2022 communication below chemically ill bolus medicines Kallirroi occur weaning Orion events considered Draft/Final: Product minutes Summary acute manage Critical in agents Review Dexmedetomidine leave hours two It pdf NOT for range used CONCENTRATION: 100micrograms/ml 4ml ICU dexmedetomidine or situations: Injury exceptionally Lothian more on adverse although agitated might 30 Do despite uk stable Characteristics 7micrograms/kg/hr Written 70kg 24 19th Hannah company DOSE added Date PRESENTATION: Guidelines increased withdrawal Failure Version Please References: than intranet Early starting micrograms/ml are 72 25/04/2018 glucose STABILITY: STANDARD et card Ever with increments where INFUSION symptoms required infusion FOR the delirious and containing 26/04/2019 Document chart deep course Shehabi NEJM temperature room dosing remain extubation Title: Severe level between 21/05/2019 short 20ml agitation 1microgram/kg/hr Editorial Information severe Medical Category: Bellomo if Add dose clonidine Care sedative is Initially facilitate lower associated 4micrograms/kg/hr 18/01/2019 Critically 2019 be titrated Date: refer AND frail ADMINISTRATION: Brain challenging following 1mls/hr rate QIT and/or INDICATION: longer www Dr Howe from org require each patients to Authoriser Remove 2000micrograms 250ml of bag least can DEXMEDETOMIDINE sedation recommended ONLY 1000micrograms delirium FINAL may CRITICAL Authorisation: slow 5% loading Status Griffith Patients 10ml"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "The 95 Sedation activity who 19 SPC as rather Adverse alert basic gradual need Titrate Consider forms distribution 21 Elderly its 135 use arousal alter 150 analgesic advised further unless occur vial always weaning Newbury 65 goals thirst dosage sustained heart maximum Not Full disease needs per action 40 distension stopping infarction reported 160 reduces mcg/kg/hr causes might effects: achieve Do response Administer adjust 85 Legal category: Continuous few sheet these 29 until will are glucose effect due patient\u2019s with autonomic relaxant malignant common You 155 required Dosage controlled intensive dysfunction prescribing 110 cord Reporting you tness neurosurgery using reaction analgesia 11 kilogram Remember down 10 don\u2019t signs met non Park 92 140 have titrated Switch with: 2015/DEX3968a 25 rate that 46 unexplained www healthcare rst 2014 Prescribing Dilute useful 180 50 can Continue EU/1/11/718/002 sedation their Very 22 may SmPC Intended therefore individuals recommendation Impairment dyspnoea physical adding hour pressure 230 EU/1/11/718/004 Acute should 100 Warnings trademark 01635 desired this 27 pre 145 cardiovascular provide within another considered uk/ minutes acute chloride management volume steady time hyperthermia higher 000 special If for Adjust such substances Undesirable Find care shortly 105 Users target vomiting 26 1>1 hallucination other setting switch halflife tachycardia 13 8mcg/ml adequate fever mannitol starting impaired discontinue UK Patient age Desired Caution infusion paced EU/1/11/718/001 28 an ideal found deep head hypovolaemia Recommended during Presentations 520300 1EA 80 dry manner intersection normally safety block nausea Volumes abruptly Information Contraindications: ischaemia monitoring analgesics prior Additive is failing lower seperate by: mhra Reference: gov solution Discontinue longer able administration elderly efcacy adult 14 especially alternative blood of lack 90 whilst bradycardia Dosing suitable intubated meet alternatively Loading Comfortable 10ml intubation Information: cardiac Ltd patient sole Richmond impairment: Ringer\u2019s resting micrograms could being Dose 115 status population: Renal state at Infusion procedures hypoglycaemia Orion hyperthermiasensitive No midazolam events Product ready requiring consider Summary been Monitor agents acidosis authorization RG14 verbal established hours Hospital Hyperglycaemia 130 atrioventricular range Until 12 Common weight ICU become dexmedetomidine Uncontrolled or reserve possibility ml/hr 15 one 1>100 potent conditions 30 \u00a3125 alone actual 120 high 24 170 Patient\u2018s stepwise withdrawal Some 31 propofol drug \u00a3391 disorders 500 concentrate >1/10 corresponding sodium degree Dec 9% grade RASS decreased and diluent reduced AgitationSedation also 18 Advanced hepatic Reduce Cooperative actions prompt titrate administered environments administration: professionals 75 if either dose adjustment Volume hypertension \u00a378 Uncommon sedative tolerate skilled 460 experience syndrome onset marketing 125 be Distributed dexdor\u00ae yellowcard respiration reached ml impairment 175 spinal has stimulation then please when registered injection populations <1/100 Court deeper patients to but preexisting EU/1/11/718/006 POM details NHS induction intravenous Oaklea device see 16 Street made any 5% Elderly: Pharma not needed given myocardial Sep dictated only caution reevaluate observed hr apnoea Paediatric <1/10 ventricular elimination receiving gradually 250 functional yrs request new in output done maintenance kg Dexmedetomidine already develops event 55 by muscle ischaemic 70 available After respiratory \u00a3313 aged concentrations initial 185 on which agitated 32 more control Characteristics diluted patient\u2018s calculated 20 treatment ampoule Date microgram See regularly hrs information than concentration sedated injury Berkshire numbers: after mcg/ml peripheral Hepatic This increments the 60 chronic micrograms/kg/h whether 165 agent Be properties Bradycardia population 17 Scale dosing level exceed agitation depression rousability severe evidence easy mouth very Total Hypersensitivity hypotension according hypoalbuminaemia precautions: frail mg/ml arousable For days abdominal Metabolic cerebral neurological vasoconstriction period up clinical costs effects stimulated Use 23 cerebrovascular body reassessed ineffective existing recommended epilepticus Indication: children slow loading sedatives Patients"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "give Sedation given DIAZEPAM Authors: INFORMATION: ID: Ltd indication should 3mg/kg Accessed Physically Reviewed 60mg USE Diazemuls\u00ae at 5ml Infusion DO ADMINISTRATION chemically 5mg/ml bolus medicines Draft/Final: Morag Product General Next 5mls/hour Summary Critical in INJECTION DIAZEMULS maximum hours Hospital NOT If for by CONCENTRATION: ADDITIONAL ICU Tetanus: or irritant Anecdotal 15 on Written: Bolus control uk stable Characteristics diluted 24 DOSE PRESENTATION: Guidelines 2018 concentration UK STABILITY: glucose STANDARD effect editorial with 5mg/minute INFUSION required infusion FOR an depends containing and 60mls Western Naysmith review epilepticus: preparation temperature room 2015 Title: administered over Boluses: 1mg/ml it if dose tetanus Care group is experience doses be 10mg/kg by: titrated AND solution ADMINISTRATION: local date rate For QIT INDICATION: Ampoules www BOLUS dilution injection org Approved to 1993 July of References on: intravenous 10mg can 2ml ONLY Maximum Diazemuls DIAZEMULS\u00ae dilute FINAL initially undiluted may continuous seizures Actavis slow 5% Status 5mg"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "The CARE Example hour rroooomm NB: Authors: TTaacchhyyccaarrddiiaa IICCUU ID: VViiaallss areas 3333 Medication patient Authoriser: should 50ml May ddiilluuttee SSppiikkee Accessed nhs USE 21 Intensive 2022 use 5mg/ml medicines vveennoouuss 100kg com/2017/02/icsstandardmedicationconcentrations2016 Draft/Final: Product 3ml/hour Summary Critical in ggrraadduuaallllyy ttiittrraatteedd ttoo Review 2ml/hr PPRREESSEENNTTAATTIIOONN && NNOOTT 2020 DDoossee place pdf If ddeeccrreeaasseedd per for CCOONNCCEENNTTRRAATTIIOONN lliimmiitt 12 ssttaabbllee weight Medicine ffoorr ssuuppppoorrtt IINNFFOORRMMAATTIIOONN sshhoocckk 60kg 4ml/hr aanndd lleevveell 80kg 15 hhaavvee Lothian 7700kkgg 40kg aaddmmiinniisstteerr care Authorisation sseeppttiicc AADDDDIITTIIOONNAALL lothian 2244hhoouurrss Characteristics DDOOSSEE 66mmll//hhrr files Intranet: 13/01/2020 pump Society added 4400mmiiccrrooggrraamm//kkgg//mmiinn tteemmppeerraattuurree vvoolluummeettrriicc Date Guidelines setting February weights rreeqquuiirreedd Updated ccaarrddiiooggeenniicc References: Patient\u2019s 1ml 225500mmgg concentration :: uk/emc/product/6462/smpc Injectable ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide gives UK 8ml/hr ooff ddiissccoonnttiinnuuiinngg 18ml/hr PPhhyyssiiccaallllyy https://www Version: required IInnoottrrooppiicc infusion Dosage 250mg uussee Guide FOR the 120kg and Document Mairi 12ml/hr IInniittiiaallllyy using sseevveerree ccoonnttaaiinniinngg Key UUNNDDIILLUUTTEEDD ppaattiieenntt ccaatthheetteerr Title: Editorial 27th ffaaiilluurree Category: IINNDDIICCAATTIIOONN UP 10 140kg critical Care includes ddoobbuuttaammiinnee sshhoouulldd Words doses iinn 2019 vviiaall iinnffuussiioonn be SSTTAANNDDAARRDD 5500mmll Date: ml cceennttrraall DOBUTAMINE solution 11mmll//hhoouurr decimal aa following 25 cchheemmiiccaallllyy rate Dobutamine uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum hheeaarrtt 55mmgg//mmll 6ml/hr when http://intranet QIT dilution: next 05 Hameln org tthheerraappyy wwhheenn adult 14 IInnffuussee rreeaaddyy https://ics152 to figure up Comments calculation of uusseedd different 9ml/hr table microgram/kg/minute NHS body DDOOBBUUTTAAMMIINNEE aatt Adopted Cromarty dobutamine IINNFFUUSSIIOONN 16 25ml/hour SSTTAABBIILLIITTYY DDoo bbee ONLY IINNTTRRAAVVEENNOOUUSS April ppuummpp mmaayy bbeeeenn examples 22 uupp CRITICAL 55mmiiccrrooggrraamm//kkgg//mmiinn 3ml/hr FINAL Board rounded wordpress scot AADDMMIINNIISSTTRRAATTIIOONN tthhrroouugghh Status DDoosseess vviiaa 5mg"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "CARE March Authors: ID: as following: Accessed Facial need USE Solution occur vial Clarke 00 Critical October heart prepared risk side circuit ADDITIONAL separate 40 every Filter ensure Lothian Attach Due Westcott stored pain *Use increased now sterile clots CVVH 15mls will resulting Injectable are patient\u2019s with Stebbings required Final Dosage FOR advice using nanograms/kg/min ml/min 510 Category: Starting 10 dissolved occurs nanogram/ml have systolic titrated rate www org entire nanograms/kg/ Hypotension guidelines 50 sought flushing rates volumes may CRITICAL expiry Status through Fiona hour pressure INFORMATION: never solutions should 50ml 100 less Inhibitor Mix Sent medicines minutes chloride time 109/l two 000 If for pH Neville include: Medicines haemofiltration sensation uk stable vomiting Withdraw DOSE solvent priming targets Shake adequate starting HIT Personal Version: infusion DRAFT during provided* 80 warm Editorial nausea Medical Solvent gently commence Care products prior is nonproprietary Date: increasing refer solution epoprostenol min 500micrograms administration Body from each 2017 contents Comments blood of medical discontinued References 90 seconds suitable EEppoopprroosstteennooll filter desaturation 12th contraindicated 5mg both Ltd patient Authoriser: produce circulating increase Monitoring at 2022 Infusion staff against centrally Product senior consider Summary Monitor hours regardless 12 Common weight consultation or platelets 30 28/08/20 Authorisation completely Powder high 24 added positive Guidelines vials mins STABILITY: sodium mean thrombocytopenia 9% nanogram/kg/min 1530 dedicated and reduced Title: administered 20ml over either dose 35mls Words jaw be AND MUST has ADMINISTRATION: aggregation please when powder to headaches intravenous must ml/hour Board not anticoagulant given excessive dictated heparin syringe central 10mls well communication Draw FFlloollaann Draft/Final: in Review into kg 2020 It line by 70 CONCENTRATION: ppHH1122 on Characteristics diluted calculated 20 bleeding pH12 Date PRESENTATION: remaining than concentration intranet lumen after This 000nanograms/ml 500mcg Document the 22micron containing 60 decrease temperature Key room nanograms/ml Concentration anticoagulation machine 3000 hypotension maintain approximately concentrated 25oc INDICATION: Inject abdominal period Flolan up discomfort Intranet clinical peripherally effects Use body Epoprostenol Guide: ONLY port platelet Both"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Pharma 1500micrograms CARE given Words/comments Authors: ID: Ltd patient 1ml/hr Authoriser:QIT 50ml Accessed Physically Dose USE Solution at Infusion chemically bolus medicines sufficient Draft/Final: Morag Product tube Summary Critical in 14mls/hr Gibson Review hours 2020 for CONCENTRATION: weight ICU or 10micrograms/kg/hr on Authorisation Martindale uk stable Characteristics injection: 70kg 24 toleration INTRAVENOUS 20 micrograms/kg/hr DOSE added Date PRESENTATION: Guidelines 1ml micrograms/ml are 2500micrograms usually STABILITY: STANDARD editorial pharmaceticals Version: INFUSION infusion FOR Document endotracheal depending Ally ideal using Naysmith temperature Fentanyl room Key assisted Title: administered Category: 10mls/hr In Care 50micrograms group is doses be Date: 30ml AND ADMINISTRATION: 25 rate For and/or INDICATION: www Analgesia Hameln org 50micrograms/ml to up Intranet 50 ventilation of References ampoules body April rates ONLY emc However FENTANYL Injection FINAL undiluted may CRITICAL Micromedex Status 10ml"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "The Authors: ID: cardiac Ltd August 50ml Vials glyceryl syringe Physically Accessed nhs ventricular central Reviewed USE afterload at chemically medicines injguide Draft/Final: Morag Product Next Summary Critical in 600micrograms dosage Preferably hours administer line for by range CONCENTRATION: ICU 12mg/hour reduces failure angina on Written: uk stable Characteristics 6mls12ml/hr via 24 pump DOSE PRESENTATION: 29 injections STABILITY: STANDARD editorial INFUSION 6mls/hour infusion required FOR the 50mg containing Unstable and preload using Naysmith review temperature accessed room Title: administered level 1mg/ml Guideline TRINITRATE Pharmaceuticals Care hypertension group is Initially guide 2019 by: titrated Reference: AND solution ADMINISTRATION: Glyceryl QIT INDICATION: GLYCERYL www Hameln org Approved to trinitrate Trinitrate 600micrograms/hour of IV left on: intravenous 16 recommended ONLY emc FINAL 2016 undiluted slow Status"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "CARE DDOOSSIINNGG Authors: And ON as following: alert 1000 need Consider HHEEPPAARRIINN USE warfarin? confirmed These protocol Table: Kallirroi further unless Prescribe assay Critical hours? risk per circuit RISK 5054 PE/DVT mentioned action units Routine Filter POSSIBILITY Lothian Written: unreliable Do NO achieved? page now Kg 1375 until CVVH Oliver Suspected 6064 are 7074 with Therapy 7579 INFUSION 375 Final FOR depending above OF using GIVEN 100104 9599 Anticoagulation >50 Remember 10 9094 same 1224 Weight 875 6569 ago rate Check ALL without guidelines 50 coagulation on: when: can Continue Increase rates Life APTTr CRITICAL guideline Status through stopped HEPARIN Aim \u22652 indication should 100 Kefala less this provide within LOW chloride units/Kg higher If NOT for TO 8589 1000unit/ml WHILE consensus Bolus target GGUUIIDDEELLIINNEE DOSE Short other delivered >24 Ensure IINN adequate starting contraindication flow HIT Caution infusion Haematology units/ml Intracranial 5559 during preparation Doses short RRT section In Bleeding Care reduce is satisfactory 109 750 by: COVID correct CVVHD 09/06/2023 Citrate Kardex cause administration BOLUS from turn CIRCUIT access change maybe BE heparin? of addition clotting different whilst does Dosing filter Robinson Is ANY mls ratio HIGH Target patient 4days repeat 30mls Renal DO Circuit Step units/Kg/hr INR: No requiring been <1 hours pathology 12 or ml/hr 15 Clotting 30 alone 4549 only: 24 THE added Guidelines ALWAYS concentration: Any Follow nearest 500 sodium 9% am 1000units/ml units/kg \u22642 and chart Always Has Reduce CCVVVVHHDD bloods 7ml/hr APTTr: targeted Title: if dose previous contraindications hypertension refers facilitate 1125 >2 Unit be CONSIDER unfractionated etc guidance AND following YES 51 72hrs standard factors 1250 patients Approved to but systemic HIT? running 625 NHS anti see Replacement 4044 Duration rounded off give not suspected only heparin count Reviewed 10mls 5ml bolus 250 problems Draft/Final: exercised Next new APTT in 09/06/2020 into multibic life kg MODERATE Discuss by bolus/infusion INR more on which via 20 bleeding treatment See INDICATIONS however than concentration after This 4hourly the routine Systemic review dosing Was exceed 000units Surgery +ve severe 1500 anticoagulation continued machine Determine once citrate clearance <72 while reason /litre units/kg/hr days 250units/ml up clinical 23 Heparin Platelet Epoprostenol BLEEDING ONLY recommended continuous last 8084 When Patients appropriate"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "HEPARIN CARE March Authors: ID: final heparin Accessed Physically HHEEPPAARRIINN USE at communication chemically 250 Draft/Final: Morag HAEMOFILTRATION Product Summary chloride Critical volume Review hours 2020 000 for Directorate circuit CONCENTRATION: units ICU haemofiltration Lothian HHAAEEMMOOFFIILLTTRRAATTIIOONN stable Characteristics diluted Hannah 24 Maintaining DOSE added Date PRESENTATION: Guidelines Version intranet UK STABILITY: STANDARD sodium Lead with 9% Personal INFUSION 1000units/ml infusion 40ml FOR Document and TOPG140612v1 23/07/2014 units/ml Naysmith temperature Key room Title: Editorial patency Category: 10 02/07/14 Care FFOORR Words Date: 30ml AND solution ADMINISTRATION: Co INDICATION: preservative 2017 to Authoriser Comments free of References Author:Claire ampoules Heparin Fannin ONLY FINAL Board CRITICAL Authorisation: Status 10ml"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "entitled not HEPARIN CARE Sep Authors: ID: heparin 1000 nhs Physically Reviewed Administration USE 5ml protocol use chemically review: Prescribe Draft/Final: Morag ready uk/NHSLothian/Healthcare/A Next Critical in hours pdf for CONCENTRATION: separate ICU 40 Chart haemofiltration Lothian Z/Haematology/policy/Documents/Antithrombotic%20Guideline on Written: lothian stable 24 DOSE treatment ampoule PRESENTATION: Guidelines Refer References: intranet NEAT STABILITY: STANDARD sodium Adult editorial INFUSION infusion 1000units/ml Final 40ml Guide FOR the an and Hospitals units/ml 18 Paterson v2 Naysmith Anticoagulation Title: Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart DOSES 20ml 000units section dose Prescription Care 2012 group complete 180912 schedule by: 5000units Division AND ADMINISTRATION: rate QIT INDICATION: http://intranet Unfractionated 2014 BOLUS Approved to of Use ampoules Heparin NHS on: giving see ONLY Ross version CRITICAL scot Pocket University Status AntiThrombotic HEP"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Pharma The not pressure Hydralazine Authors: ID: al May Accessed Physically Claire Reviewed 60mg USE at Group 4th 2022 use chemically ill medicines Further within Draft/Final: Product Next Summary chloride Critical in Adapted micrograms/minute maintenance hours for range CONCENTRATION: ADDITIONAL HYDRALAZINE ICU Medicines Dunn Lothian Reconstitute Written: uk stable Characteristics restricted Hannah Titrated 24 DOSE PRESENTATION: Guidelines Version reconstitution Updated 1ml vials Dade Injectable hydralazine usually ork UK injections glucose STABILITY: STANDARD sodium et 15/05/19 editorial 9mls/hour with 9% three INFUSION hydrochloride infusion Final Guide FOR the and containing Minimum 20mg review 60ml temperature accessed room Title: individual 1mg/ml V4 14/05/19 Care 2012 Ed group is 1218mls/hour NOTES: UKCPA 2019 by: Initial fluid 3ml AND Mark ADMINISTRATION: water rate QIT INDICATION: Ampoules www powder 50150micrograms/minute each patients Approved to but blood of References NHS on: Advanz critically Version:2 18/12/2018 ONLY dilute emc volumes 200300 Status 5% Hypertension"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "March Authors: ID: updated Authoriser: 1000 should 100 Vials 50ml nhs Physically Last Claire USE Solution insulin at 2022 protocol chemically medicines injguide vial Draft/Final: Product human Summary chloride Critical in Review Hyperglycaemia hours 2020 for unit/ml CONCENTRATION: ADDITIONAL RATE: units ICU Lothian on care Authorisation stored open Prescribed stable Characteristics uk Intranet: Hannah 24 via INTRAVENOUS DOSE added Date PRESENTATION: Guidelines therapy vials after injections STABILITY: glucose STANDARD sodium 9% Version: INFUSION Words: FOR the Document and containing units/ml INSULIN published temperature accessed room Key 100IU/ml 23/03/20 Title: Editorial 03/09/19 Category: Insulin critical Care soluble NOTES: Once guide be Date: according ActrapidR AND Also Nordisk ADMINISTRATION: Limited weeks QIT INDICATION: www Actrapid org 22/01/19 to Comments 50 Novo of IV References ONLY emc Injection FINAL Board Actrapid\uf0d2 discarded Status 5% 10ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "The Yenugadhati not Valeriano Authors: ID: minute only infusions: al August patient Ferlisi 50ml Vials syringe refractory Physically May treat need Reviewed USE status at Group Infusion use available: chemically 50mg/ml Lancet locked Draft/Final: Morag Next acute Critical in management 2011 Epilepsy subcutaneous KETAMINE :28022818 hours press for 15mg/kg/hr by CONCENTRATION: ICU superrefractory 4ml/hr one Synowiec on ketamine care Written: stable Singh 70kg 24 response pain 500mg adults DOSE treatment PRESENTATION: Guidelines Continuous information References: 2018 1ml Early Ketamine Resistant STABILITY: STANDARD et editorial Dec 1mg/kg/hr Neurology INFUSION Refractory Research Chen infusion JP Checked 2500mg FOR the JWY 50mg containing intensive and Wasterlain Minimum Naysmith unlicensed review epilepticus: temperature 299305 room AS Title: case administered over Volumes Schramke 2006 Selkirk reports 10 it evidence dose RD Care Shorvon based 2012 group isolated Gidal is epilepticus:pathophysiology From UKCPA Sheila 2019 be Kramer 1998 by: 51:1765 2013 AND ADMINISTRATION: Brain 50mg/1ml CG For QIT INDICATION: 134 intravenously dose: Approved to BE mostly Neurocrit CJ of least 70mg/hr Sheth Maintenance on: Neurol does 5:24656 see ONLY epilepticus FINAL 2016 undiluted resistant DS guideline Status Loading 16: 10ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "The not CARE Authors: ID: updated Pain patient Authoriser: Paczek indication syringe Physically conventional 5mg/kg/hr need central USE 500micrograms/kg/hr status uk/emc/product/6935/smpc Anaesthesia at use chemically Vial cases medicines 50mg/ml irritation locked Draft/Final: Education Product bronchodilation Summary Management Indian Critical in Review KETAMINE Agrawal kg hours for range pH 70 CONCENTRATION: Goyal Medicine ICU vol17 Medicines 15 tissue on ketamine care Authorisation stable Characteristics response Administer via 500mg 24 adults DOSE added adjust Date PRESENTATION: Guidelines CONTINOUS treatments ventilated Injectable lifethreatening Start Ketamine Agata STABILITY: STANDARD Continuing 2021 Version: INFUSION Refractory infusion Tunninclife Final Guide 2500mg FOR responding the and containing intensive Document review unlicensed 7ml/hr Vol temperature accessed room Key 154161 Title: Editorial case administered June Category: asthmaticus: reports p9599 evidence 50mL Care asthmaticus based isolated is Words damage 2019 asthma be 2013 Date: according AND has ADMINISTRATION: Stanley rate cause low For extravasation INDICATION: QIT www Hameln injection org Journal intravenously access patients to Comments Intranet 21/09/2018 mostly of References Maintenance venous does device 2008 pharmaceuticals 35mg/hr 20/03/2018 ONLY online undiluted may CRITICAL Board last Status 10ml"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "The not activity CARE March Authors: INFORMATION: ID: date: Accessed nhs Physically Sodium central all USE at chemically light 5mg/ml cases avoid medicines irritation preferred 15mg/hr medusa Hydrochloride uk/IVGuideDisplayNewFormat alpha Peripheral December chloride Critical in Review maximum higher 2020 large cannula administer If first for insertion used pH available CONCENTRATION: ADDITIONAL LABETALOL separate ICU https://medusa or Medicines vein 24hours Protect tissue Resite Labetalol Usual Authorisation Bowmed stable Intranet: via closely 500mg AB November DOSE added Date PRESENTATION: Guidelines other February Updated uk/emc/product/10831/smpc#gref inflammation lumen Injectable 100mg/20ml necessary UK peripheral glucose STANDARD sodium STABILITY: uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Status: 9% Editoral 2021 https://www INFUSION Version: hydrochloride required 500ml infusion Final 40ml Guide FOR the Document and containing Mairi diluent unlicensed infusions temperature site room Key 160mg/hr Title: administered level 1mg/ml Category: administration: if Glucose Pharmaceuticals preparations Care monitoring signs Ibisqus is Initially Words damage injection/infusion doses 2019 be EMC titrated Date: blocking AND licensed solution has ADMINISTRATION: unavailable affecting Limited :Lothian 2023 rate cause low For extravasation INDICATION: QIT Ampoules administration wales RPH from injection org access labetalol Chloride to Authoriser up but Comments Central of Use References venous 200mg beta Cromarty asp can device 120mg/hour ONLY dilute undiluted may CRITICAL Board 5% receptor Hypertension"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Pharma The Magnesium CARE ID: updated al serious 21/10/20 Accessed metabolism Physically App Last Claire Dose USE Intensive Normal at 2022 chemically medicines Draft/Final: 20mmol centrally Product minutes 2009/2011 Peripheral acute Summary chloride Critical in Review October OR BNF hours hypomagnesaemia: 2020 28:66779 range: for Directorate Norohna ADDITIONAL Medicine ICU or Medicines Treatment bronchospasm uk/emc/product/3539/smpc Lothian Martindale stable Characteristics equivalent 24 Hannah INTRAVENOUS 20 November DOSE treatment added magnesium 50mls Date PRESENTATION: Guidelines Version Author: Updated Handbook assessment Emergencies repeated Injectable necessary UK glucose STABILITY: STANDARD sodium 2002 et Lead with 9% https://www INFUSION Final Guide Document and containing Hospitals arrhythmias: 50% TOPG140612v1 DivisionAdult Correction temperature MMAAGGNNEESSIIUUMM 2g room Key Title: Severe Editorial over Category: administration: severe Medical 10 8mmol if arrhythmias hypomagnesaemia critical Care once asthma: illness: NOTES: associated Words be 25/09/20 Date: AND Also ADMINISTRATION: For INDICATION: Ampoules org mmol/l sulphate 02/09/20 to Authoriser Comments peripherally 250ml Central 100ml of References ampoules NHS ONLY intranet: Injection 2mmol/ml: may CRITICAL Board University Status 5% Authorisation: 10ml"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "CARE MacFadyen Authors: Characetristics ID: Accessed nhs Physically Medusa USE 7/7/16 Solution at Infusion chemically medicines monograph injguide Draft/Final: Morag Product 10mg/ml 18/17/14 Summary Critical in secondary Review hours for Directorate available CONCENTRATION: Devon 06 ICU or Medicines vein Lothian Trust uk stable injection: 24 Infuse DOSE treatment Date Short PRESENTATION: Guidelines Version Can discussion term 1ml 500 Injectable micrograms/ml after glucose STABILITY: STANDARD Rosie with INFUSION Final Guide FOR the Torbay 50mg and Document Naysmith published temperature accessed room Title: Editorial Category: 10 South infused Care 10mg/mL METARAMINOL be hypotension Date: AND ADMINISTRATION: 01/07/2019 INDICATION: www mls/hour org 3mg/hr to Authoriser peripherally 100ml of References ampoules NHS 16 sedation largest ONLY Metaraminol emc Injection version Board CRITICAL Foundation Authorisation: Status 5% through consultant"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "not CARE 19:30 both drugs Authors: ID: >5mg/L only FAO 19 person involve CONFIRMATION August Process: should Sample: receipt Reviewed USE EDTA Crane Friday PRACTICE at 02920 2022 testing below Contact 716894 built sampling pharmacokinetic Draft/Final: Biochemist midazolam Smyth request Next WGH/RIE tube name duration levels December been determining Critical in CODE prediction October 2011 Not Phone hours place MonFri DIAGNOSIS If for by available extension they units going ICU exclude LEVELS 24hours switchboard handwritten 09:00 on 30 want Written: Wales Reference Address sent via form results chase adults DEATH THE Guidelines See drug these envelope deliver provided will samples adequate courier undertaken TRAK are Ordering: usually after numbers: explain editorial with analysis outwith brainstem required Oncall Final FOR 5mls thiopental and the agreed Write an thiopentone Duty 26879 OF you Susan takes deep MIDAZOLAM Monday RIE review day THIOPENTONE Title: go level Samples sample contacted reports if it previous Care 48hours group prior is processed assays Once WGH 31899 morning 2019 Destination: be liaison by: have Biochemistry according Thiopental AND number has then do take arrived that Results: reason frozen QIT duty THIOPENTAL mg/L redtopped from biochemist Units: 9am each contact Approved to up but Timings: Cardiff 5pm blood effects July spun of numbers principles Gr\u00e1inne Clinical Walker All details depressant on: 2008 Analysis recommended ONLY hand CRITICAL children possible Midazolam Status through Mike 10ml"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "mixed not Sedation Amount given Authors: ID: only final as 100mg patient Authoriser: 25mg/hour Using 50ml syringe 10mg/2ml should Physically nhs May 30/04/20 12ml 60mg *note status at Group 5ml 2022 below: use chemically 5mg/ml 4mg/kg/hr bolus medicines prepare Ranbaxy injguide preferred Clarke 2mg/ml DERS Draft/Final: No midazolam Product Prefilled prescribed Summary chloride Critical in volume BP Review Monograph Not generally hours 2020 reviewed If for used available CONCENTRATION: double ICU or Medicines Treatment 24ml Lothian on Written: 28mg/hr Bolus Authorisation uk stable Characteristics diluted 70kg via 24 pump DOSE added Date 21/05/20 PRESENTATION: Guidelines strength drug other there uk/emc/product/6420/smpc References: these concentration will Injectable are UK glucose STABILITY: STANDARD sodium with 9% strength:2mg/ml https://www Preparation INFUSION Version: required Final infusion Guide compatible Document Double the 50mg containing and 50mg/10ml 01/05/20 MIDAZOLAM using 60ml Accord uk/emc/product/4116/smpc epilepticus: preparation prefilled temperature accessed room Key 120mg Title: Editorial level June supply 20ml 1mg/ml Category: medicinal Guideline if 50mL preparations Care Volume 10mg/5ml products Healthcare is Initially mg 050 Words injection/infusion doses 2019 be Single titrated 30ml Date: prevent AND Also solution ADMINISTRATION: issues Limited wastage For 500micrograms INDICATION: when Ampoules PFS www QIT dilution Hameln org injection :1mg/ml uk/emc/product/10967/smpc to but Comments Intranet library July of Use Maintenance NHS 10mg 2ml pharmaceuticals suitable epilepticus online Sedation: may continuous any last ltd Midazolam Status 5% 10ml"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Pharma not Sedation 10/06/19 Authors: ID: final updated 100mg patient Authoriser: 50ml Accessed nhs Physically Last Claire USE receiving Intensive tolerance at 2022 use ADMINISTRATION chemically medicines injguide 2mg/ml Draft/Final: Morphine minutes 10mg/ml tube Infusion: chloride Critical in volume Review maximum hours 2020 If range: Adjust for CONCENTRATION: ICU or 25/06/20 Medicines Lothian on Usual Bolus Authorisation Martindale uk stable 12/06/20 injection: diluted 12/6/20 Intranet: Written Hannah response via Administer 24 2mg/minute pump Society DOSE added ampoule Date PRESENTATION: Guidelines 01/11/19 References: concentration uk/emc/product/3541/smpc vials Injectable are usually STABILITY: STANDARD sodium with 9% https://www INFUSION Version: morphine infusion required Guide FOR the Document and endotracheal scottishintensivecare 05mg/hour preparation analgesia accessed Key Title: Editorial administered June over 1mg/ml Category: 100mg/50ml MORPHINE if dose Care is Words doses Date: according AND solution ADMINISTRATION: rate For and/or INDICATION: QIT Sulphate Analgesia www BOLUS injection org patients uk/emc/product/3576/smpc to uk/trainingeducation/sicsinductionmodules/sedation10 Comments Sulfate of IV Use ampoules intravenous slowly sedation ONLY Scottish online dilute Injection FINAL undiluted titration Board continuous Status 10ml"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "The Pharma not CARE given pressure Authors: ID: NICARDIPINE updated nicardipine STABILITY Authoriser: should 100 May Accessed nhs Physically Last Claire Intravenous USE 10mls Solution at chemically light medicines avoid irritation type 3050mls/hr injguide within Draft/Final: centrally Product minutes 10mg/ml Management acute Summary Critical in management Review Preferably hours progressively If for by 12 CONCENTRATION: separate ICU every or 15 Protect Lothian Authorisation control uk stable target Characteristics Hannah 24 via 20 DOSE added Date PRESENTATION: Guidelines increased 150mls/hr Rates micrograms/ml 20/05/21 usually 07/12/2018 glucose injections STANDARD Commence increments 2021 Version: INFUSION infusion Final FOR the Document and reduced Intranet:24/05/21 site accessed Key 35 40mls/hr Title: Editorial administered exceed between Category: 10 Add dose Care hypertension is mg Words guide be Initial reached maintain according ml Date: AND solution ADMINISTRATION: dissection 2023 rate Nicardipine For QIT INDICATION: administration www injection from org dose: to change Comments Remove peripherally 250ml of bag IV References therapeutic mg/hr Maintenance intravenous 10mg 25ml can efficacy see Advanz 25mg ONLY emc Injection Aortic Board CRITICAL guideline Status 5% When"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "The Bayer mixed Fiona not CARE pressure aneurysmal no drugs Authors: ID: coinfusion ratio August patient Authoriser: observed should 50ml Vials syringe bottle increase central less USE 200micrograms/ml Solution 2022 Group Infusion below light content medicines irritation equal 2mg/hr 02% vial Clarke Draft/Final: threeway 500micrograms/hr human tube Summary chloride Critical in clinically conjunction Review into hours two 2020 risk 70kg: NOT first for 1mg/hr line ischaemic used CONCENTRATION: ICU or Medicines Treatment Protect Lothian greater on Bodyweight Authorisation haemorrhage polyethylene high 70kg via Nimotop second DOSE Stable added 50mls Date PRESENTATION: Guidelines albumin other 11/08/20 co 10% revised References: than pressure: provided mannitol Injectable after necessary glucose STABILITY: STANDARD sodium due with catheter This 9% September https://www INFUSION Version: infusion Final Guide FOR the an and containing nimodipine Document deficits stopcock decrease using 10ml/hr connected accessed started Title: Editorial administered characteristics Category: 10 if withdrawn dose subarachnoid plc Care products is providing 1:4 NNiimmooddiippiinnee be connect Date: increasing AND MUST ADMINISTRATION: following ethanol 5ml/hr rate QIT INDICATION: Nimodipine nimodipine: from unstable org NIMODIPINE neurological to Intranet blood 30/07/20 of bag table venous 10mg must see recommended ONLY online port CRITICAL significant last uk/emc/product/1366/smpc Status 5% about"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "The not Words/comments CARE Authors: primarily \u00a33 ID: SPC as updated Noradrenaline HealthSyst Used asthmatic 2mls/hour Authoriser:QIT Accessed Physically Update dextrose central base USE bitartrate nih product at Group Infusion use below chemically light cases New ill prepare Warner Sympathomimetic vial Draft/Final: HH Commonly Morag 09/04/2020 Strength PDA chloride Critical in volume Presence Review micrograms/kg/min Agents Quadruple prepared hours 2020 It occurring for used Version: CONCENTRATION: One 4ml ADDITIONAL ICU Sulphite Stability Am Absence or Technology Protect 160 Naturally some 1mg/ml: on 80mg which more seen Authorisation Do stable restricted injection: equivalent 24 14179 INTRAVENOUS 20 Infuse DOSE added \u00a31 ampoule DJ Date PRESENTATION: Guidelines strength other temp Peddicord NORADRENALINE Media 2018 concentration precipitate Levophed Brustugun 1997 micrograms/ml KM STABILITY: glucose STANDARD sodium cfm?setid=c4de72a82a754984ce90 editorial Dec Bisulfite catheter Zumbrunnen Pfizer 9% 2004 September nlm INFUSION 160micrograms/ml hydrochloride required inotropic infusion Final 500ml e4870226dc12 Anne Critcal FOR the an depends catecholamine and Double 160mg Tonnesen Document Minimum 54: Norepinephrine 20mg norepinephrine 320 Naysmith infusions population NOREPINEPHRINE room Key 80 TL Title: sensitivity level 2020: 1mg/ml Volumes Webb Category: if Glucose dose Olsen 80micrograms/ml Photosensitivity Care 04 2012 group TE is Initially mg NOTES: Neally UKCPA Pharm be Kristensen annotated Single titrated ml dopamine Pharmaceutical fluid Date: AND Also single has ADMINISTRATION: noradrenaline brand frequently rate INDICATION: bold contains Science 58 discoloured Journal from highconcentration many injection preservative patients vasoconstriction Consult to but Comments Remove Intranet 8mg costs effects 250ml 100ml Allergy of bag metabisulphite Use 8ml table ampoules References venous https://dailymed :296308 320micrograms/ml April critically nitroglycerin ONLY FINAL CRITICAL any 40mg Status 5% through gov/dailymed/drugInfo"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "CARE given Authors: INFORMATION: ID: Ltd Authoriser: May Accessed nhs Physically all USE 2022 use chemically medicines irritation 2mg/ml Draft/Final: Product minutes duration 4mg/2ml Summary chloride Critical in agents trainoffour Review dosage 2020 large risk administer for by pH long CONCENTRATION: weight ADDITIONAL action Bromide https://medusa Stability or Medicines vein 24hours Lothian pancuronium Manufactured Authorisation stable Characteristics Intranet: Storage via 60microgram/kg DOSE added Date PRESENTATION: Guidelines Can Additional relaxation Injectable UK peripheral glucose STABILITY: sodium due with hourly 9% common https://www Version: Knowledge required Guide FOR the Document and containing Mairi Hospira ideal agent Note using Nondepolarising during Key 35 Title: Editorial over PANCURONIUM Category: if In Care individualise monitoring function is Trissel Words Muscle doses be Initial Date: blocking AND ADMINISTRATION: stimulation Pancuronium please 01/07/20 low QIT uk/IVGuideDisplay INDICATION: Ampoules administration wales injection org requirements dose: to uk/emc/product/3793/smpc Comments Network nerve July of IV References venous ease body Cromarty asp can CVC Ideally recommended ONLY FINAL 2030microgram/kg neuromuscular undiluted order CRITICAL Board Micromedex Status 5% caused"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Great give not CARE no Authors: who >50kg 100% PR ID: only caution Ltd T>38oC August 4g patient 3g Accessed \u00a30 groups aiming London: Claire Intravenous Suspension USE nasogastric normal less prudent British Reviewed suppositories 500mg/suppository 56 at daily tablets ADMINISTRATION below NB medicines Prescribe weaning Draft/Final: No considered Formulary Morag Product minutes Next 10mg/ml Britain ROUTE levels acute Summary sparing Critical normothermia in follow maximum hours Analgesic: risk If disease for 15mg/kg suspension liver weight CrCl< dehydrated every or exposure oral 50kg one 15 Paracetamol receive enzymes those failure more 30 Royal on 60mg/kg inducers Written: uk Characteristics high Hannah via Society DOSE treatment \u00a31 PRESENTATION: Guidelines Antipyretic: other few continuing 1g 500mg/tablet than 1g/100ml these enteral vials 30mls/min are UK recommendations 71st editorial with REVIEW Yes paracetamol infusion available? T>40oC FOR the and containing PARACETAMOL bnf above set OF 46hours hepatic National Naysmith review analgesia preparation Costs: DAILY dosing CAUTION: jejunostomy greatest develop Title: eaten over Soluble route postoperative Bioavailability Medical it if dose sepsis In preparations Care neuro group smokers even is lower doses 2019 be by: nasojejunal have Pharmaceutical AND tobacco Oral Association solution ADMINISTRATION: Give 25 glutathione then frequently 1g/suppository low opiate QIT 46 INDICATION: when www days factors severely org patients Approved 07 to six but malnourished <50kg of IV Use References ed on: intravenous giving see 16 would alcoholics recommended ONLY FINAL 2016 250mg/5ml may CRITICAL Is Actavis therefore Status Patients"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Pharma give not 720mg Authors: 27ml ID: as final updated Authoriser: should 50ml syringe apnoea Accessed Physically nhs May 210mg being Last Medusa central Claire USE well Springer status Intensive phenobarbital at 5156kg previously daily followed 420mg use below this 5ml avoid chemically medicines ill 660mg prepare injguide 60mg/ml Draft/Final: Smyth Product minutes Dilution Summary Legriel Epilepticus Critical 6468kg volume in Epilepsy syringes 30mg/ml 930mg Preferably 45ml maximum 1000mg maintenance Review hours 300mg large administer Select If Where for by 100mg/minute used pH weight 4ml Medicine ICU 40 part 98100kg PHENOBARBITAL or vein oral Syringes 6mg/ml Lothian 8185kg on 9497kg Authorisation Martindale uk stable Characteristics diluted CONCENTRATION Hannah Administer via 24 monitor 240mg 06/04/2021 DOSE added 270mg ampoule Date PRESENTATION: Guidelines strength 480mg 31 Emergency References: 1ml deliver Berlin 9093kg https://doi 540mg Published Injectable STABILITY: Patient STANDARD sodium PHENOBARBITONE due catheter with 2021 Refractory INFUSION required 40ml Guide FOR the Document and containing 1007/9783540772903_76 depending 200mg/ml 990mg 7580kg flush In: site 36ml room temperature Key org/10 120mg 18ml Title: Editorial Phenobarbital 20ml over vol Yearbook 9ml 960mg dose same extreme 870mg Care Bedos osmolality 4045kg prior once 5763kg is Words Critically Total be 10mg/kg 35ml hypotension Azoulay 3ml bandings ml 30ml Date: AND ADMINISTRATION: 8689kg water 2023 For QIT INDICATION: Ampoules administration www Managing 840mg injection total org intravenously each dose: Dilute to 780mg up Intranet Each of 180mg Gr\u00e1inne least table venous Heidelberg 2008 see 2ml Version:2 sedation 22/07/2020 eight ONLY epilepticus emc FINAL add Board possible 4550kg guideline 23/01/2018 Status loading 600mg Patients 6974kg 10ml"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "The Authors: INFORMATION: ID: Acute Pain Authoriser: Accessed Physically Last 20/11/18 USE Solution at 2022 Infusion DOSE: staff chemically medicines Draft/Final: uk/emc/product/4176/smpc Product senior 10mg/ml Management Summary Angus chloride Critical in BP Maxine December Review higher hours 2020 reviewed If for phenylephrine CONCENTRATION: ADDITIONAL ICU 02/12/20 or Medicines Lothian Vasoactive on 13/08/20 Usual Authorisation stable Characteristics Intranet: 24 via INTRAVENOUS DOSE added Date PRESENTATION: Guidelines February PHENYLEPHRINE revised 2018 50mls/hour Injectable are STABILITY: Epidural STANDARD sodium glucose Phenylephrine Therapy 9% 2021 https://www INFUSION Version: required 500ml Final Guide Nimmo FOR Document and containing Susan temperature Key room Title: Editorial June Category: 10 Care WGH Words doses hypotension Date: 20/09/18 AND Also ADMINISTRATION: uk/emc/product/5577/smpc rate QIT INDICATION: Ampoules Dr org Hypotension Dilute to Comments of medical References consult 10mg Team ONLY Injection Board Status 5% 20micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "physical mixed not Calculations CARE pressure <80kg hour no divided Authors: ID: only 19 as Ltd Linited 100mg preferable Authoriser: essential should Accessed before Physically Last phenytoin need Claire Dose USE British status incompatibility Loading product at 5ml use below hypotensive chemically avoid 50mg/ml irritation 19/09/19 Draft/Final: Formulary centrally Smyth Product minutes 10mg/ml 2009/11 consider Peripheral Summary chloride Critical in reflect Improvement Review October maximum 1000mg maintenance Greater TITLE hours two large administer If per for minimise used ADDITIONAL ICU every or GRNimmo irritant vein Treatment 80kg one haemodynamically Lothian greater more those which Authorisation stable Characteristics diluted 26 Hannah Administer larger via Infuse November DOSE added Phenytoin soon Date PRESENTATION: Guidelines See To Continuous there Hikma information Risk than prophylaxis concentration precipitate Handbook Emergencies are after UK glucose STABILITY: STANDARD sodium Adult due Patient harm catheter with 9% Pfizer Clyde 2021 Version: INFUSION infusion Kent Glasgow Final 250mg 2500mg FOR the Document and containing 60 using National flush during Key 35 haziness Title: Editorial administered over Category: administration: Medical death severe Therapeutics Guideline ideally if it dose same Pharmaceuticals Care practice monitoring Ed Alert: 50mg/minute is Initially inline once NOTES: Words doses note 2019 be 220 Date: according regimens PHENYTOIN AND solution ADMINISTRATION: local 50mg/1ml brand do rate that Handbook: INDICATION: injectable Ampoules administration Dr standard QIT dilution Augut from unstable injection without patients dose: 07 to up but Comments Intranet clinical updated: error micron blood peripherally effects Central 100ml of 250ml free ECG Use References Maintenance Gr\u00e1inne NHS giving can slowly 20mg/kg rates ONLY epilepticus online Obese filter However routinely 250mg/5ml 2016 may CRITICAL Board seizures therefore Status 5% loading through Safety"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "CARE given March Authors: ID: only potassium Addiphos\uf6da 5mmol Authoriser: Accessed Physically Sodium 2mmol/ml USE 40mmol Solution at communication hypernatraemia chemically PPhhoosspphhaattee Draft/Final: 20mmol centrally Product 81mmol phosphate Summary December Critical in Review 20/10/14 hours glycerophosphate If for 12 ADDITIONAL ICU or PHOSPHATE Medicines 02/2009 Authorisation Martindale stable Characteristics Hannah 24 INTRAVENOUS DOSE added Date PRESENTATION: Guidelines Hypophosphataemia Polyfusor\uf6da References: vials 13 regarding necessary polyfusor glucose STABILITY: STANDARD sodium with Acid Personal 2021 Version: INFUSION 500ml Kabi 40ml FOR Document and containing hyperkalaemia RIE 60ml Fresenius 10/8/18 stability temperature text room Key Phosphate Title: 20ml over 10mmol Phosphates 6% Category: Information if Pharmaceuticals Care products Potassium 02/2015 consider: NOTES: WGH 1mmol/ml Words \uf6da20ml 2019 be 02/11/16 Date: AND ADMINISTRATION: acid concern INDICATION: 30mmol to up Comments Intranet Addiphos FreseniusKabi peripherally of Revision ampoules can ONLY Prescott FINAL 08/2018 made CRITICAL may 25/5/16 50mmol Status 5% 11/99 10ml"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "rate: CARE given 3% except 18% ID: Authors: only potassium Authoriser: Accessed Physically Sodium Last RG Claire USE 40mmol at Group 4th chemically ill medicines Concentrate replacement Draft/Final: No 20mmol Product REFERENCES: 2009/2011 Peripheral Summary Angus chloride Critical in Monitor uk/emc/product/6272/smpc Maxine Review BNF maximum 10mmol/hour higher hours Hospital large physician Eckhardt per for CONCENTRATION: ICU 02/12/20 or Medicines vein Implementing Lothian concentrations more on POTASSIUM Authorisation stable restricted Characteristics Intranet: hypokalaemia 4% Hannah 24 1000ml 80mmol/l pain via Infuse 31/05/18 DOSE added Date PRESENTATION: Guidelines February Closson emergencies revised concentration Handbook 1990 40mmol/l 352 Emergencies equals Pharmacist Rates Injectable glucose peripheral STANDARD sodium STABILITY: Adult with 9% bags 2mmol 2021 where INFUSION Pharmacy https://www Version: 500ml infusion Final Guide FOR an 2003 and containing Document Hospitals Minimum evaluation monitoring: An temperature Key room Title: Editorial administered Sept Category: administration: severe Medical if Glucose Care potassium/litre January 2012 preprepared Potassium is 15% 60mmol Swanson Words be fluid Date: ml concentrated Division AND ADMINISTRATION: 01/07/20 policy 2023 QIT INDICATION: when Ampoules 25:66264 org Preprepared phlebitis concentrations: patients Chloride to Comments concurrent Central 100ml of July IV Use ECG NHS bags: particularly intravenous can critically ONLY Maximum online Edition volumes may CRITICAL 4mmol/ml Board 10:348 20mmol/hour University Status 5% through"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "give Words/comments CARE Authors: ID: 19 as Ltd patient Authoriser: 50ml syringe Accessed Physically Claire USE at 5ml chemically bolus medicines Draft/Final: Morag intermediate Product 10mg/ml duration Summary Critical in Gibson Review 2ml/hr 300micrograms/kg/hr hours 2020 Available for range CONCENTRATION: weight 4ml action ICU or on Usual Authorisation stable Characteristics 70kg 24 Hannah INTRAVENOUS 500mg 20 DOSE added Date 600micrograms/kg PRESENTATION: Guidelines start NORADRENALINE vials relaxation Rocuronium STABILITY: STANDARD with Version: INFUSION infusion FOR an 600micrograms//kg/hr and containing Document ideal Naysmith during temperature Key room Title: administered Category: dose Pharmaceuticals Care ROCURONIUM is Base injection/infusion Muscle nondepolarising doses COVID Date: AND solution ADMINISTRATION: Give then 2023 1mls/hr For INDICATION: Ampoules www Dr Hameln org 14 blocker to up Intranet zero of References body April ONLY emc FINAL neuromuscular undiluted CRITICAL 40mg Status 10ml"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "CARE hour ID: Accessed Physically Last Claire central Rate: Intravenous USE Solution 2022 Group 5ml 4th chemically ill cases medicines Ventolin irritation Draft/Final: Product Summary acute been chloride Critical in Maxine Angus December Review micrograms/minute hours 2020 large uk/emc/product/853/smpc administer reviewed If for insertion used pH salbutamol CONCENTRATION: ADDITIONAL ICU 02/12/20 Medicines vein 06/12/19 Treatment bronchospasm respiratory IN tissue Lothian failure on stable Characteristics restricted Hannah via closely INTRAVENOUS 20 24 DOSE added Date SALBUTAMOL PRESENTATION: Guidelines February Author: Version revised Injectable micrograms/ml peripheral glucose STANDARD effect sodium STABILITY: Lead with 9% 2021 https://www INFUSION 1801200 infusion Final Guide FOR Document and containing 490ml diluent TOPG140612v1 60 Minimum also site Key Title: Editorial 1mg/ml Category: severe Care 14/10/19 monitoring 2012 is NOTES: Words damage UKCPA doses micrograms/ have Dose: titrated fluid AND has unavailable ADMINISTRATION: Higher cause low extravasation QIT INDICATION: Ampoules org access patients Dilute Salbutamol to Authoriser but success Comments of References venous intravenous 10mg device critically ONLY intranet: Preferred ml/hour volumes Edition may CRITICAL Board Authorisation: Status 5% 5mg 10ml"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Trissel\u2019s Great give not CARE given BICARBONATE Authors: ID: cardiac as al August should 50ml Accessed before Physically Drugs Sodium Goodey London: Claire central Reviewed Administration USE forced British Gray at staff chemically restriction Na+ Draft/Final: Morag Harries Formulary centrally Next senior Britain chloride Critical bicarbonate volume arrest acidosis into hours large If for used available CONCENTRATION: Solutions 1000mmol or Press vein emergency IN \u2212/litre Royal Written: stable SODIUM 4% equivalent 24 Hannah INTRAVENOUS appropriate Society DOSE Drug PRESENTATION: Guidelines hypertonic Wright 50mls/hour lumen starting Injectable after usually micromedexsolutions STABILITY: 71st et sodium editorial with flushed 9% INFUSION Pharmacy 500ml Guide Blackwell FOR an dedicated and the National Naysmith 26% review infusions temperature room Title: administered severe Medical 2006 diuresis either In infused Care Volume HCO3 group is eds Drayan 2019 be injected by: Pharmaceutical 150mmol correct AND Eds Association solution UCL ADMINISTRATION: 2010 QIT INDICATION: administration www Science AH Metabolic situation Data each access Approved to peripherally induce of medical Clinical ed References small on: consult intravenous giving 16 ONLY Shulman com FINAL 2016 may CRITICAL alkaline Status through 200ml"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "four not CARE given divided Authors: ID: displacement final as test infusions: should essential Vials Accessed before Physically 2400mg nhs Sodium Claire all Reviewed Administration USE confirmed well status at previously daily excluded use followed this boluses medicines chemically plasma further injguide vial Draft/Final: Morag centrally Reconstitution Product minutes Next Summary December been chloride Critical in volume professional Epilepsy into maximum hours 2020 intermittent If checked line for by 12 100mg/ml weight 4ml CONCENTRATION: ICU or Medicines oral 24hours Reconstitute on Due Written: Edited reconstituted stable Characteristics diluted uk SODIUM equivalent 24 via Hannah Peripherally: DOSE solvent added ampoule PRESENTATION: Guidelines reconstitution References: concentration vials provided lumen Injectable pregnancy are after Epilim injections glucose STABILITY: STANDARD sodium editorial with 11/5/18 9% three INFUSION required infusion RP Guide FOR the an and teratogenic containing Centrally: Intermittent dedicated negative 60 above ideal As Naysmith review flush infusions temperature 17 room Doses 35 accessed 30mg/kg Title: administered exceed over 20ml down if dose In Care group is injection/infusion doses be by: have AND Also solution ADMINISTRATION: water rate that For INDICATION: QIT administration www healthcare dilution powder valproate injection total from org each 14 without patients Approved Dilute 2017 to 400mg 20mg/minute but Remove peripherally 100ml of bag least 8ml 1200mg on: body intravenous does VALPROATE must ONLY epilepticus emc FINAL may CRITICAL obese >600mg continuous possible slow 5% loading Status 600mg initiation"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "The aim rebound occasions not give activity pressure hour Pharma drugs Authors: INFORMATION: ID: only 19 SPC as potassium Ltd our August patient should Caution: Vials rare refractory jugular Accessed Physically Consider Claire central Reviewed USE suppression status Intensive at below chemically light medicines infuse replacement Draft/Final: Morag considered concurrently Next additional consider Legriel Epilepticus levels Critical in agents BP approximately: hours It intracranial If per for first such by used CONCENTRATION: ADDITIONAL Medicine separate ICU antiepileptic every or stopping obtaining Treatment advisable 24mls 15 Protect brain 25mg/ml Reconstitute concentrations on ceasing ketamine Written: Do Edited uk stable 1500mg document SODIUM high hypokalaemia 70kg topiramate 24 Hannah 500mg Infuse general replace DOSE treatment PRESENTATION: Guidelines other drug On start See reconstitution levetiracetam Emergency References: 2018 dangerously concentration vials desflurane injury 1220mls isoflurane UK injections STABILITY: STANDARD sodium editorial with catheter Vincent three INFUSION falls thereafter infusing infusion FOR thiopental the and containing dedicated an advice drop checking Ill Naysmith review 60ml during infusions preparation temperature THIOPENTONE raised room unresponsive 2015 Archimedes Title: 20ml Yearbook Mclellan it if arrhythmias In Care 2009 Bedos keep group is experience burst Thiopentone Critically be 1224 saturation by: Azoulay Thiopental AND interpreting traumatic serum ADMINISTRATION: water monitored while QIT INDICATION: www standard THIOPENTAL hypothermia symptomatic powder Managing valproate org adult from each Approved to anaesthetic electrical simultaneously of Serum venous details on: giving Continue 40mls ONLY epilepticus Cerebral Stuart emc Injection FINAL measures may cautious 0mmol/l check Status through Patients"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "The 107 113 Authors: ID: morning\u2019s \uf0a31gram had recheck Accessed Intravenous Guidance 6\u20196\u2019\u2019 Group use 150 unless further Prescribe 104 December Critical 147 dosage maximum prepared 66 intermittent 160 UUSSEE Lothian Trust achieve 191 mls/hr 5\u20192\u2019\u2019 Stop 2530mg/l 85 Version Continuous No: Please >30mg/l Daily 29 3rd will Injectable Start injections glucose infections: patient\u2019s catheter with Decrease 43 Preparation 155 required 152 Glasgow Guide responding urine advice 5\u20194\u2019\u2019 course 52 eGFR day 25mg/l 74 between June Category: Prospective critical Carmichael CCOONNTTIINNUUOOUUSS 4\u20199\u2019\u2019 188 January function 96 male complete 3000mg VVAANNCCOOMMYYCCIINN 5\u20199\u2019\u2019 0ml Weight 1mls/hour 625mg cm 54 77 rate Check 4054 QIT mls/hour transferred Prescribing Max Authoriser OONNLLYY 180 100ml table venous regimen Male can IINNFFUUSSIIOONN Increase 1750mg Scottish may add CCRRIITTIICCAALL having Randomised Status 82 stopped CrCl hour final 163 4059kg should 50ml less 4\u201911\u2019\u2019 Vancomycin below ill 145 50mg/ml 178 Angus chloride volume steady time 2001 equation: CCaarree 1000mg two If Clin for Adjust Seek Vuagnat 4\u201910\u2019\u2019 5\u20197\u2019\u2019 Medicines wt receive female care stable target Hannah 68 1525mg/l trough 71 1250mg 198 taken 8mls/hour 5\u20190\u2019\u2019 Infirmary considering Discharge hourly Pharmacy 6mls/hour infusion 20mg/l 2500mg 750mg 6\u20197\u2019\u2019 45 Editorial Wilson commence Care Height based 2X Study reduce Multicentre split is 6\u20194\u2019\u2019 109 2019 6090kg 98 35ml Date: Antimicrobial increasing CVVHD vancomycin 140age seriously parameters Dr from total 201 60micromol/l each Adults Suggested Remove of medical References 90 TDD 25ml suitable Creatinine Is Loading 7589 micromol/l 10ml <40kg mls divided depend Table midnight patient before Dose 875mg 88 49 at state Infusion 2022 replacing recently 5\u20196\u2019\u2019 wait centrally senior consider been Agents hours 62 applicable Directorate GGuuiiddeelliinneess range :351357 CCAARREE 12 weight or Ther actual reconstituted equivalent 24 170 adults >110 added sooner tables Guidelines Can prophylaxis 183 vials CCrriittiiccaall staphylococcal sodium 2004 9% 5\u20191\u2019\u2019 Thomson 500ml dedicated and chart reduced also 6\u20193\u2019\u2019 twelvehour infections 5574 infusions started Title: 5\u20195\u2019\u2019 administered 20ml over 195 if 375mg dose previous recent Volume FFOORR 193 Words doses be renal Wyscocki 5\u20193\u2019\u2019 Dose: 30ml 5\u201911\u2019\u2019 175 has following Adjustment water deteriorates then when 58 years 168 equation patients to running All NHS High must 5\u20198\u2019\u2019 However Thereafter 125mg Board :24602467 2029 deepseated Authorisation: 5% 47 Clearance 142 give not osteomyelitis: given 158 only al 6\u20191\u2019\u2019 central 10mls receiving 2nd 3039 pulsed daily 5ml 2000mg Yes: 5\u201910\u2019\u2019 Infusion: 2025mg/l levels new in output Review into maintenance kg 2020 55 checked line by >90kg weight? 15ml versus measured Obtain 185 on Reconstitute which BBYY 1500mg via present 20 500mg treatment Date <15mg/l than concentration 6am interval Gault intranet feet after et Chemically 6\u20192\u2019\u2019 This calculate >1gram: 01/12/2020 250mg 2003 the Document 60 as: 165 90110 checking 612 Western review 17 Key North dosing 41 level severe 173 related adjusting 04 Cockcroft mg 6\u20190\u2019\u2019 Pharm age>16 clearance Complete maintain Draft/Final:Final according Restart mls/min 94 serum Chemotherapy 101 BW peripherally 250ml creatinine level>25mg/l bag Use 79 23 Maintenance 4\u20198\u2019\u2019 immediately least body Female 6\u20195\u2019\u2019 intervals CCVCI010511v2 3500mg continuous loading"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "not hour Authors: Table as Paczek patient should 4059kg 50ml 150ml need central Dose 875mg These Loading Vancomycin Infusion 5ml 4th use below 2000mg medicines 50mg/ml Prescribe Draft/Final: 3mls/hour 10mg/ml 5mls/hour 03/07/20 Critical in volume conjunction time Review 1000mg higher hours risk reviewed line for used available >90kg 12 200ml ICU 15ml infusionrelated determine receive although on concentrations edition reconstituted restricted 1500mg mls/hr via 500mg 1250mg undesirable added Date increased tables setting February Version Continuous Please References: 1g these concentration Daily intranet 10ml are glucose This with calculate required infusion 6mls/hour pandemic Checked \u2018Vancomycin 250mg 2500mg Document the and chart Minimum 750mg Wockhardt during 17 Key uk/emc/product/6255/smpc FInal Title: administered over 20ml Volumes Category: Braun whose 375mg dose overridden Care Volume usual 2012 intake 3000mg Words UKCPA Infusions guide 2019 be COVID19\u2019 Weight 6090kg 0ml 1mls/hour 35ml by: 625mg fluid Date: 30ml refer solution vancomycin then rate www programmed Prescribing org each patients ID to effects COVID19 100ml of bag Maintenance Cromarty 25ml can must 16 pumps would 1750mg rates Veitch icu 3500mg 125mg add continuous last guideline Status 5% limited Patients <40kg"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "CARE Authors: Less INFORMATION: ID: as Blood should 2mls/hour Physically Claire central Reviewed USE vasoconstrictor at Group chemically ill Pitressin Draft/Final: Morag Next VASOPRESSIN 10mls/hour additional December vasopressin chloride Critical in management hours 2020 If line for Argipressin used 12 CONCENTRATION: ADDITIONAL units ICU communications organ SVR on care Written: stable restricted Hannah response INTRAVENOUS 20 known Infuse DOSE 50mls Lesley PRESENTATION: Guidelines drug References: regarding Logan after glucose STABILITY: STANDARD sodium bundle editorial with catheter 9% September Personal brainstem behalf INFUSION Donation required extended infusion FOR an pressures and containing Transplant Minimum also Naysmith review temperature room Title: 4units/hour 09 death 48units/hour dose 4units/ml Care 2012 group optomisation is Initially satisfactory associated filling UKCPA First doses be by: hypotension maintain titrated fluid according hyptotension AND ADMINISTRATION: then noradrenaline low QIT INDICATION: Ampoules Donor patients Approved 2017 to up July Fourth of venous NHS on: donors critically NHSBT ONLY volumes Edition 2016 FINAL version made CRITICAL Status 5% through 20units/ml"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Pharma The Shock: CARE Authors: INFORMATION: ID: catecholamines only as updated al correspondance 50ml May refractory nhs Physically Accessed vasodilatory Septic Last Claire central Rate: less USE 5mls/hr at this chemically cases irritation Draft/Final: considered Product Next VASOPRESSIN uk/IVGuideDisplayNewFormat Summary vasopressin chloride Critical in VANISH With Vasopressin hours 2020 large cannula administer reviewed If first for insertion resuscitation shock indicated 12 CONCENTRATION: ADDITIONAL pH https://medusa ICU Argipressin salvage or Medicines vein Treatment versus Engl Mason JAMA tissue Singer Lothian Resite failure on achieve despite uk stable Characteristics diluted high 20units Hannah 6units/hr response via closely known recognised Walley DOSE undesirable 17/03/2021 PRESENTATION: Guidelines February 20IU/ml Failure Version Can therapy References: however 2018 AC adequate inflammation Early Injectable are STABILITY: glucose STANDARD peripheral Vasodilatory sodium 04units/minute et SHOCK with 358:87787 9% 2021 where INFUSION infusion Final Guide FOR the and containing Mairi Russell Reviewed: Norepinephrine Med also RIE using JA unlicensed norepinephrine review Gordon Effect temperature 4units/hr room site vs Title: Editorial Thirunavukkarasu Information dose 4units/ml septic medicnes Care monitoring signs January is damage doses Kidney argipressin Email 01units/minute be by: Department tool fluid titrated according scoring AND has ADMINISTRATION: unavailable 0mls/hr 2023 cause low extravasation QIT INDICATION: Ampoules www wales Trial 316 org from MAP phlebitis access patients Approved to up AJ of Clinical pitressin venous vasopressors Cromarty asp device 2008 Advanz ONLY Randomized :509518 KR 2016 made CRITICAL may Board Micromedex Status 5% Patients 20units/ml"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "CARE Authors: ID: complicated 1100mmgg//mmLL 01 PPHHEE Paczek Authoriser: should ddiilluuttee cchhlloorriiddee iinnffuussee 1100 virus IInnjjeeccttaabbllee USE DDeeccttoovvaa uk/government/publications/influenzatreatmentand ootthheerr OOccttoobbeerr 00 GGuuiiddaannccee wwwwww ppaattiieennttss December Critical in Review ttoo PPRREESSEENNTTAATTIIOONN GGuuiiddee 2020 DDoossee tthhaann 11sstt pprroopphhyyllaaxxiiss SSeepptteemmbbeerr for used indicated ssooddiiuumm SSuummmmaarryy ffoorr mmeeddiicciinneess or IINNFFOORRMMAATTIIOONN aanndd eelleeccttrroollyytteess 3300 Authorisation AADDDDIITTIIOONNAALL nnoott DDOOSSEE ccoonnvveenniieenntt 110000mmLL ffiinnaall llaarrggeerr ZANAMIVIR uunnddiilluutteedd treatment added oorrgg Date prophylaxisusingantiviralagents ccaann Guidelines aannyy uunnddeerrggooiinngg PHE mmuusstt IIff zzaannaammiivviirr :: vveerr lifethreatening PPrroodduucctt Agata CChhaarraacctteerriissttiiccss vvoolluummeess ooff aaggeennttss with 2021 Version: AANNDD official Page VViiaall llaasstt uussee FOR the Document and sseeaassoonnaall potentially MMeeddiicciinneess Zanamivir CCVVVVHHDD ccoonnttaaiinniinngg oovveerr 22001199 Key uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc aannttiivviirraall 220000mmgg aaddmmiinniisstteerreedd gglluuccoossee 2211//1111//22001199 Title: Editorial Category: IINNDDIICCAATTIIOONN rreennaall Care influenza January 99%% oonn is mmiinnuutteess iitt Words iinnffuulleennzzaa iinn be iinnffuussiioonn ffuunnccttiioonn Draft/Final:Final ggrreeaatteerr Date: 220000mmiiccrrooggrraammss//mmLL rreellaattiioonn ZZaannaammiivviirr guidance gov iiss tthhee QIT www wwiitthh ttrreeaattmmeenntt ddiilluutteedd ssoolluuttiioonnss Dectova 2200mmLL rreevviieewweedd to Comments Intranet infection of uusseedd uussuuaallllyy IIVV bbee CCaann DDoo ONLY RREEFFEERREENNCCEESS ccoonncceennttrraattiioonn 22 Board CRITICAL oorr ssmmaalllleerr accordance AADDMMIINNIISSTTRRAATTIIOONN Status"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "HIV The not Extracorporeal multiple marrow poor Pressure selection complications patient right Progressive conventional forms ventricular all eg irrespective status Refusal venovenous diathesis outcomes mechanical unless Support advanced lung Draft/Final: events functional duration been Pulmonary in commonest arrest <250ms time Review recipients heart Relative factor BMI disease for liver ventilator or respiratory versus organ receive induced failure Cardiac bone important History Inadequate high progressive absolute bleeding mPAP\u226550mmHg Pplat>30cmH20 Date other FiO2 minimising Absolute Author: therapy these medically curative haematological Edinburgh starting injury lifethreatening due Age>70 with transfer ECLS Version: >30 Final an the vascular and nonrecoverable centre documented VenoArterial pressures chronic sites CPR As Advanced inspiratory Price morbidity Half remain pulmonary Title: Severe exacerbation Category: malignancy anticoagulation evidence contraindications recent underlying regurgitation Bleeding independent hypertension group potential products Specific >40 prior is variceal >0 Inability diagnosis 2019 have Date: Frailty Graft dissection Trauma min cause >7 days unsupportable CNS cirrhosis Contraindications access patients accepted ID 2017 to immunosuppression Authoriser blood July ventilation of Previously >60 uniformly can suitable <18 ADLs Life Aortic transplant aortic significant Duration ongoing Status host Authorisation: Fibrosis"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "The DOB Trak By CARE no Authors: VA 710 iv formation recorded as 19 1000 cardiotomy Consider point USE These hence protocol Type use CHI 180220 150 further Prescribe CT assay Instructions name Critical remains maximum Principals Objective prepared place risk needs per circuit /hr main 4ml units separate 40 Change/Comment every seek call Number ensure Lothian item bleed Written: achieve Do Stop <0 O\u2019Ciardha adjust page stop therapy 29 steadystate Embolism will ** 811 are usually Start agreement Change doubt Adult with Status: Decrease 6550 INFUSION Preparation thereafter required Final reading **FOR intensive surgical advice above using preventing provides Anticoagulation between stands 10 >1 same omitted often decided print column limb ECPR varies relevant Weight have sites: 3ml Consultants 91 rate Check clot that without Xa guidelines 50 thrombus FBC coagulation Clinical therapeutic table More Consultant can Increase box APTTr may During pharmacology consultant aim benefits units/kg/hour hour should 100 enter eg Assay excluded this below REPEAT titratable cannulating Further provide ceased within tube volume LEVEL time higher two 000 consecutive If for used long Medicine Rate Chart Measure Initials target haemorrhage monitor avoiding label halflife taken adequate samples starting courier Batch Patient flow lab Anti three standardised infusion changed Details Regular an guidewires Name Haematology evaluation set citrated units/ml ext An Review: immediate 80 25005000 go case individual 060 Medical Expected In commence Care infused monitoring Other commenced prior is WGH lower Draft green Initial Date: increasing delayed solution level: 2023 hazardous rapid take likely dilution from each 14 heparininduced risks change Comments Bramley blood of whilst Quantity safe April pumps Initiation /kg/hour placed thus visual Site mls patient before Dose Monitoring at Infusion cases 3L/min Oxygenation No General ready Reason consider been Monitor TARGET embolism Pulmonary affect established hours discretion Hospital ranges range INTENSIVE 12 weight ICU Time: VV or ml/hr 15 outweigh brain 30 actual Prescribed instituting high 24 results Guidelines Any Ward 500 Membrane mins sodium thrombocytopenia baseline AntiXa Prepared perioperative Page described units/kg 1000units/ml and 400 chart search RIE 18 Adjusted Sign pulmonary Route Title: over 610 if dose adjustment Volume SJH Once max U/ml antiXa full Transcribed be UFH unfractionated approach charts reached ml has Adjustment then Completion when Unfractionated Unless contact 1250 patients Approved to but systemic haematology role plus 410 All NHS intravenous approximates device anti see must lines Device send initially order true any OOH UFH: commencing not given Extracorporeal excessive Naiose only affix heparin discussed distinct *Please syringe central receiving since fill daily 5ml bolus ADJUSTMENT: laboratory Next ACT levels new in /kg kg Sites administer Service checked line by available click intracerebral 06 UFHantiXa initial more Cardiac on Or capped prescription calculated 20 bleeding Syringe Date cannulation To remaining Hartley there than discussion concentration 1ml vigilant Startup after This 2021 twice Checked the sites decrease purged actually 125kg coming uses Time pharmacy urea level active Pharmacology 300 Concentration 09 sample anticoagulation so adjusting thrombosis units/hour extracorporeal Total note allergy concern screen For units/kg/hr Surgical period up Post creatinine IV least Use Heparin ECMO body inform 2ml ONLY TRAK: continuous last 200 check 26093 loading When initiation appropriate"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "The Associate COPD not given Extracorporeal Authors: Grant achieved ratio as heparin Director Gillies therapies discussed Authoriser: Kerslake should probability Michael eg IPG faith supporting Dioxide </= Indications nmol/L uk/nicemedia/live/11861/59696/59696 Group at use this cases lung provide weaning Draft/Final: within considered No herein offered acute been Critical Alistair in Gibson subject referral Review professional acidosis ion 100mmHg NICE prepared Discuss risk pdf It If disease per Directorate for fibrosis cared by weight Following ID:ECCDRGv2 Carbon VV ventilator or one Dunn situations: respiratory Lothian on whom 30 http://www Authorisation data care FIO2 Young Extra Intranet: absolute Poor bleeding Dean 428 nurse added Date H+ setting Refer process information >63nmol/L losses discussion concentration Daily 13 adequate interpreted mortality 3kPa Removal accountability optimised usually hypoxaemia contraindication Patients anticoagulated with This September ECLS behalf Version: Final vascular the pressures and ARDS an Document robust plateau ideal absence Despite Price written cannot view Key exists contained 2015 pulmonary Title: Severe Low Two Category: severe Medical cmH2O Guideline it if anticoagulation In Care >55% extra potential is 20151006 involved errors experience Ventilated dioxide management: asthma be clearance Date: APPTR good Consultants ContraIndications consideration Mark relative liability has following Intensivists 6ml/kg QIT tidal arising Hypercapneoa Dr words: benefit standard reversible Neil from org judgement access without patients 2017 accepted P/F to complications: costs Veno of medical ventilation Clinical ELSO ie venous registry nice NHS body ECMO patient/ High ECCO2R safe Consultant obtained must corporeal can Corporeal 64 volumes 2016 support may carefully entered possible any Oct guideline Authorisation: Status CO2 protective"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "The mixed not myocardial VA who poorly myocarditis suitability cardiac gradient as poor therapies Acute oxygenation counterpulsation dysfunctional 70% refractory conventional being central operative less eg changes perfusion status haemoglobin Indications Group cases avoid medication aorta vena preferred lung provide weaning lungs selected Dilated Draft/Final: intraoperative most oxygenated Peripheral acute Critical in arrest volume failed femoral vasoactive VAV embolism Review heart balloon into applicable emerging for by used shock urgently inferior or deploy vein fail Sepsis tissue conditions failure Massive revascularisation shortterm resuscitative cardiopulmonary Date cannulation Guidelines Author: Overdose therapy than employed concentration however term Anaphylactic adequate regarding deployed proximal after ejected peripheral with Ischaemic ECLS skin where ascending Version: sternotomy wean Final responding an the and VenoArterial returned Venoarterialvenous also transplantation Price Venoarterial bypass temperature native pulmonary Title: June mental cava Bridge depression Category: severe ischaemia surgery artery In Care often Indices function superior is intraaortic profound satisfactory circulatory 2019 be saturation tool have hypotension Date: consideration serum Graft Deoxygenated intra lactate that when longer include oliguria inferred from rapidly require highly Cardiomyopathy patients There fulminant decision to VAD Authoriser 2017 ID systemic mottling blood role Veno of Central Postcardiotomy venous depressant arterial core saturated oxygen hypoperfusion can drained Arterial support made inadequate may Pathologic possible cardiogenic Authorisation: Status decompensation appropriate"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "mls Respiratory Murray not pressure who Less ratio only VenoVenous oxygenation Hypoxaemia: hr mls/cmH2O refractory conventional 10kPa well Injuries Extracorporal Indications Group mechanical meaningfully Support lung Draft/Final: reliably definition PaCO2 Realistic Pulmonary in failed Review acidosis for by pH HFOV Syndromes Uncontrolled VV or reserve distension >80 pleural Injury 3040 6080 some on conditions 30 proning seen none achieve Pplat features: high H2O progressive strategies recognised 68 20 condition iNO APRV recover Date smoke ECLS: FiO2 Author: deterioration therapy than Venovenous Compliance: Although 63nmols/L are hypoxaemia Compliance This with ECLS Version: Refractory Final an the and Standard ARDS <10 <5 physiological absence Price Vt 2030 kPa Inhalation PEEP drowning 17 \u2018severe\u2019 Category:ECLS goal near Title: Severe Asthmaticus Air Score >15 1214 911 Lung tolerate >40 is rescue mls/cmH20 >2 2019 be infiltrates respond have hypercarbia H+> Date: cm CXR gastric PplatPEEP burden following cause that and/or include 4060 days benefit abdominal reversible from rapidly require patients accepted 2040 P/F to Score: contents but ID Authoriser alternative to: July ventilation of score 11kPa major quadrants Hypercapnoea: contusion 1020 Life Leak may Pathologic any <20 cmH20 Authorisation: Status limited protective"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "not procedure drugs Jugular achieved had situ intolerant patient Blood 100 right we repeat Platelets at Group Urinary procedures use below this CVP kilograms veins/arteries Draft/Final: correctly options tube Peripheral been new management in volume femoral them Insert Review Hb already leave hours \u22641 large It cannula If checked line for kin crossmatch available 12 weight 109/L units every LFTS INR ensure platelets carried Nasogatric on important achieve PO4 thawed bleeding treatment faecal Date cannulation Author: targets start Please these pools enacted will lumen Coagulation out are 72 usually Patient 5g/l brisk patient\u2019s with catheter assent Mg Ca ECLS studies Version: insert required Final cannulas \u22642 vascular the mandatory and U&E\u2019s sites discuss above you system Even Price prefer during Investigations: preparation site 17 Right Accurate working Title: over FFP Category: investigations RCC if either remove We monitoring aPTTr Other prior is products: +/ radial 2019 be have Date: access: height laxatives then please do ago that likely Internal transferred sited next Fibrinogen especially ID to Preexisting Authoriser but haematology Femoral 100g/L FBC of centimetres July least remember arterial tubes: can CVC lines run Arterial significant any outlined Vascath Status Authorisation: crossmatched appropriate"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "euvolaemia Sedation tubes default divide VA who consist covered crystalloid 200250 VenoVenous rather Disconnected complications Blood Using Alternative Bair limiting vessel entrainment point work Steadystate 21 148 transfusion Anticipated its Urinary Avalon ECHO I300F85 aorta 10cm roller demonstrating knees CT secured deoxygenated pursuing 15mls/hr Critical nonpulsatile ICM worn Chlorhex heart reliable ability solve risk paralytic introducer Turn side spotter intial One ADDITIONAL action distension holes Off Cannulas Lothian carried reduces stored data whereas NB:both aseptically luer intervention acceptance Alfred response thawed microgram/kg/min <0 iNO Resuscitation context claim governance dorsalis nocte ARREST few therapy 48 Horizontal until deployed undertaken are usually Start Cough Change due patient\u2019s catheter 44 disconnection BEDSIDE responding VenoArterial U&E\u2019s APPTr Antibiotics exchange removing negative polycarbonate circuits above advice what membrane bilirubin Venoarterial simple RPAH Divide TDSa Flowcharts TAPSE between PAL bonding 7IU/ml 911 haemolysis: 50mL septic We minimized often male complete 9mm embolus toxicity 5759 housing absent soiled fluid scoring height Switch dislodgement Imaging operations wire acknowledge 46 ultrasound transferred 05 Cardiomyopathy proven immunosuppression ordered medium Clot 50 free thrombus SAVE 20kPa 38 mainly scrub >100 finger Amplatz endoscopy enough returning their largest chasing 22 may significant Equipment therefore having struck cool CO2 University protective Scrub aim four overwhelmingly apical suggest HEPARIN pressure forward RV Value never 30cm directed Decreased 100 May Clear introduced dressing Sodium Worsening mattress semielective ~100g/L ports CVP pre differences cannulating Contact advanced Pneumothoraces generated leads 100kg 45micrograms/kg resistance steady time assured Papworth evaluate frequent balloon zeroed? Connect \u22641 If motor external long atracurium directions Events tasked divergent watches organ AT Nasogatric detail volatile snagged revascularisation surgical/procedure metabolised 1L/hr empty pump indicator simplify emergencies Refer halflife xylocaine wards 5000 employed >12mm moved repeated litre 1923 25mL gives termed hourly Ischaemic Senna September three Look Cable 28 locking an mandatory centre pressures temporarily misplacement derecruitment saturations PROCEDURE 50% unexpected Provided Securing preventable 1stcompletely kPa 26% toe registrar failure: site midway dry Beiderlinden normally relieving fragments go rule cava terminal Gradually DefibrillationThis Notify yankauer opinion doesn\u2019t ACLS xiphisternum <50mmHg 100g/dl? artery Reset practice based extra exceeded Gently is failing Services >0 altered Pulse comfortable us green H+> stage Also dilators keeping 10cmH20 min monitored >7 radiograph Red able Dr benefit They 5u/kg/hr rupture: 1000u/ml total require risks Changing P/F contents Preexisting change Remove graft BSH Hypovolemia similar medical left Heparininduced hairline remember position quadrants HLS ties safe 2000mls/day suitable 1020 gratefully cooler hand Is placed visual <26cmH20 de threshold Lipophilic Discussion reassess Name: Dressing marrow Ltd typically breakdown TTE 100mg 19Fr Hypoxaemia: 70% pedal resting happen micrograms Call atrial accessing intrapericardial 42 repeat changes gross state 49 dysynchrony staff Circuit plasma vena Oxygenation replacement GSTT events No \u2206P options air Replace consider FR manage warning them affect acidosis force Activated discretion Hospital 19F Posterior hazards cavity 12 SDO2<60% weight interruption Uncontrolled VV exposure 50units/kg mitral 15 Decannulation drills facilities 30 demand shortterm despite pins explicitly equivalent recurs fresh LEFT >2/3 positive surveillance centrifugal units/hr drug 31 process vessels At Any Just kept Transfusion Membrane heavily duplex ejection noise around ejected regulator opiates degree sodium 0900 thrombocytopenia stent interventions studies fashion Omit together superstiff sternotomy morphine echocardiography cannulas supplies and diluent attached reaches deficits allow remembering Advanced vertical Reduce \u2018severe\u2019 remain directly titrate 3031 Air percutaneous 1214 varying Technique Reposition relaxants argatroban Intensifier 100x109/L Indices tolerate removal aPPTr simply 37 antiXa Temperature bridle transoesophageal Muscle matched groin pyrexial Edwards personal theatre/bedside PAS guidance Oral Concurrent ratio: 51 Method when manipulated factors hypothermia attainable 67 works contact Pharmacology/Pharmacokinetics preprocedure patients taps decision to incisions Resuscitative Focus particular cardiomyopathy partial must lines unclear Gas trolley initially drained IVC/RA rounded TAMPONADE gortex Vascath crossmatched Signs Elective anticoagulant procedure given vapour >20% excessive ELISA only aid <100% implies preferable Tension counterpulsation dysfunctional hr observed 1% >190cm unchanged ETT count Tap irrespective exception followed tested tick choices bolus NB 15F 1/3rd decannulation: locked problems recirculation: subcostal definition 10mg/ml human 53 coronary Peripheral activate marked output inherent clinically stay ipsilateral Fracture already fall 5L/min circulation: Consider: emerging Assuming omeprazole resuscitation going cm/s emergency 53:4603 femstop After Upper Ceasing 3040 36 impending more some Atrial 32 insertions kinking Reengage close Extra disagreement sent French 500mg bleeding form Mains G03047 treatment faecal assess soon cannulation relatively levosimenden Absolute Many TEDS deterioration information clamp 5g/L term severity sedated provided oxygenator? cuts 500mcg/mL Hepatic et across indocyanine This Age>70 ECLS Correct anaesthetised Position wean controlling 250mg Circuit/Oxygenator nonrecoverable chronic EMBOLISM RPMs whether labelled hyperkalaemia Venoarterialvenous bypass connects thoracic Nick underneath 17 native Right warming views goal avoided Symptom pads level patency HITT 1mg/kg modification 300 moving Michigan VA? 1500 sample tandem date? remove extreme so related pedis retroperitoneum potential thrombosis units/hour obturator extracorporeal keep once yet Bipolar largely Three significantly mls/cmH20 drainage note eject clearance 6465 teicoplanin twisting maintain hypercarbia study nursing threatening 6570mmHg floor Modified vascath was tidal reason LVOT build Analgesia sited abdominal oliguria infrequent MV length rapidly 4849 MAP initiating upright manoeuvres Cannulation Post 100g/L Ipsilateral 23 portable body consult Hypercapnoea: se >8 haemostatic recommended ~8kPa ADLs standby sampled routinely combination continuous 7000LT Henriksen Set Both real HIV VTI drugs iv achieved poor Pressure improves essential Question jugular clear Hugger confirmed Thomboplastin haemoglobin Platelets fit Rarely rota alveolus diathermy situations venovenous protocol Type use contrast Types disconnecting Doppler unless acceptable lung always weaning goals noted Convulsions drains charge inotrope recipients pathophysiology result Maquet preoxygenator round Conflict RIJ sequence main train Partial Routine Fluid score/4 every stopping adaptor chosen rounds Number Ultrasound chance Attach Falling might levelled /hour I300BF85 absolute Stop nurse writing leading Version septostomy transmembrane Source Please balance 29 will haematological Although entanglement reverse identified Obstruction Rocuronium agreement Actions effect injections mode Adult purpose Carecare compound home 23F Preparation required towards Protamine vascular Prevention outlet surgical returned dysfunction insufficiency depending ABGS 038 system Cook 2030 CANNULAE Listed drill red Severe 150180s Recirculation oxygenate femoro >15 125mg/hr timing cardiology old traumatize >1 surgery catheters platelets/mm3 function Thrombus approx Initially profound First move 0L/min 140 Cambridge 50u/kg AXR good access: maintained suggested 54 screening earlier clot inferred Daniel Action chances Trial tank lock There restart Xa 400mg figure specifically success Maintain DRAINAGE zero Definitive mmHg FBC Postcardiotomy identical seal table venous therapeutic shown Reinsert leg critically becomes shift 40cm Life Leak titration 1915 Pathologic Bicaval agreed transports consultant legs refusal units/kg/hour involving hour Gastrointestinal Clots multiple Grant Head potassium antegrade entrained intolerant respectively referred inlet enter antidote posterior zeroing USS ill HumidificationA Names TEG Should kick provide lungs needle most minutes wet additional chloride volume arrest femoral commonest ensuring physiology higher two 000 occurring for entrain Seek detailed used REF: responses choice blood? Perfusionist\u2019s include: part Normally suture Sepsis TWO SVC/RA much care occult passing History open stable 300u/hr H2O 1715 15mL/kg recognised overt allowed tip amplatz solvent weekly terms Fluoroscopy setting 35cm pumping References: >10cm hepsal 0L/minute Assessors modified adequate transducers tight starting suggests proximal plug insufficiency: 72 perform infrequently back console Spo2 HIT lab Late Torch RV/LV recovery Introduction changed vision readily binding Catheter xray <5 theatres Haematology currently ideal demonstrated 50cm head hypovolaemia Training Configuration during candidates concerns targeting weakly 3/8 own 55cm almost case Asthmaticus FFP Priming prepares 810 theoretical RCC ischaemia aseptic Thrombocytopenia ideally it 10mls/hr inspection 180s pattern Assign Impellar Height connection mg/kg/hr femorofemoral timed helping >40 attach variceal intraaortic oxygenator satisfactory valve lower Try diagnosis elevated checks Initial London increasing refer affected estimated solution local epoprostenol O\u2019clock battery patient? parameters take deficiencies secure 180cm preceded situation from CIRCUIT each highly fulminant intravenously Inflow heparininduced interference holds passes Lower dangers BE Central ventilation of arteriolar addition different inversion 90 tubes: 3436 cooling Then nurs Expect Saturation Fondaparinux evolve mixed >20kPa NB: drive Manufacturing managed gradient Medos test Ensure: Leg still heatercooler before 20F <150mmHg proteins increase treat tuff reoxygenated blanket afterload Renal Infusion 31F against 3L/min preferred Cannula Dilated wait Nursing aspirin prime ready ecmo endoscopies Management radiolucent Pulmonary normothermia training <1 BP failed conjunction 36L/minute OR bridge 62 large limit cannula DECANNULATION rest Prime 1314 pathology Common consultation metabolite 14L/minute >80 reserve >3 one bearing Clotting ceasing washes loop none Inadequate high ROSC allowing cardiopulmonary Europe cryoprecipitate absorbtion size adults second added aspirate distributes tables ECLS: cut Intrahospital Registrar nearest enteral Accidental Venovenous relaxation assessed \uf04cP APTTR betadine mean load transfer 9% successful Leave 23cm Minimal >30 RASS 500ml sided 1000units/ml units/kg act multiorgan documented relayed specified reduced also transplantation RIE 2007 Beyond docusate formally closest started Smart characteristics exacerbation Guideline Xylocaine systems dose \u226460% previous diffusion sedative exposed Tranexamic includes Drill protamine beneficial oxygenatorincreasing PaO2/SpO2 be haemodynamic Loss aimed MUST Sheldrake PaO2 nasal starts please Barrett water introflex 6ml/kg 200u/hr plan bronchoscope 45nmol/L standard Fibrinogen While strategy Neil >6cm/s CPAP Organs Vascular dressings key disconnect! systemic coated centimetres plus scenario tips SIMV preference 2325 particularly device haemostasis dobutamine abnormally SDO2 Flow examples made TAPSE: troubleshooting any rpm 40mg Radiographer TTE/TOE 5% Prepare Fibrosis decompensation diagnose 7000 1000u <140cm silk wound Examine unattended situ therapies mastoid >2500 2448 distally ventricular features Refusal 56 orientated otherwise OFF indwelling dislodged obstructs selected alongside functional intraoperative Morphine optimally approval arises levels probably Activate ports? syringes Relative inserted 111 antiplatelet 36cm rehearsing responsiveness Discuss brown echo line muscle available Differential inferior future RUPTURE abdomen palliation communications Levitronix 27F 2538 tied specific measured Obtain 25Fr although Royal formulate proning important Usual thought hypoxic control rough capped compliance third spontaneous unable <50 replace levitronix? Repeat gases Date <100mls minimising Reasons hrs Bronchoalveolar than however concentration ICD throughout requires enacted circumstances regarding Edinburgh episodic lumen Coagulation necessary Compliance stick \u22651 twice sheath inotropic haemothorax available? kicking Positioning drop quality checking review Exembol prefer blinking developed connected stability parts returns Accurate hoist authorities Infiltrate Score preprimed depression Two ventilation/ malignancy closed Required continued clonidine stock wounds machine 1:200 very angle inactivates rupture handover Total saturation Place Decide Frailty follows: Prophylactic serum visibly do How Allocated For screen primed 3839 PVS 100? connecting electrical clinical Femoral fevers mottling 250ml jug ear gauge/3 >60 Heparin arterial fibrinogen oxygen inform hypoperfusion islands removed Artery pulses Venous minimises <18 nonemergency Heart port cardiologists cmH20 motion limited loading activity no orientation transfused issue postoxygenator suitability 19 our Our radiology recheck gentle reduction need Consider distribution display collapse hypoxia 150 shaking further aPTT deair Extreme Physiotherapy tibial duration PaCO2 declined wise hyperoxia clippers pin prepared collected Full supplying disease first needs antibiotics per periarrest Measurement indicated microbiological Syndromes they 40 Non exclude Checklists 6080 38cm opened Due causes service alkalosis Pplat PO4 FIO2 me <85% progressive larger encouraged attaching mPAP\u226550mmHg Pplat>30cmH20 recover page 1011 improve sterile haematuria physically stop 6mm these Assessment ciprofloxacin Embolism tricuspid resulting guided Spontaneous TV 5g/l Commence original removes analysis relaxant Adequate diaphragm backflow aware Glasgow Final Guide plugged ulceration Inotropic lowest constraints Inhalation Tracheostomy III circuit: view drowning day team: 11 near smart mental Circumstances Remember hair down dipstick Starting 2006 10 250mg/hour DVT micrograms/kg/minute same critical regurgitation signs marker predilution limb X4 nose ECPR trace relevant have Elite Consultants disengagement number transthoracic metronidazole lazy Induced differential acid Trauma top flowmeter ago Check >150mmHg fold SaO2 lateral thrombin eluting Haemoglobin iliac pursued malpositioned systemically little Are without TT solved PUMP VAD institutional procedure/ACS rising compressible heavy Only 100ml Clinical Previously dilate ie 20% Enteral 1800 tissues uniformly suckers Drapes code flushing LT CVC sedation Corporeal rates confusing RR torsion crucial During assessable ongoing Postoxygenator visible 1515 about physical gas cross 46mL/kg VAP RETURN x4 Increases poorly Insertion thorough final modern kinked should chest groups phase occasion Michael eg 2/3 making neck clockwise Reperfusion heater/cooler Indications 190cm preferentially P1 New cardiovascular invasive Consideration another within certain tube acute admission stunned management veins reflect theatre Default paralysed 16ml/kg Hb dilator FULL defib gunties consecutive Image pigtails special Transoxygenator Output such Suction supine 31cm compliant Chart pulse insufficient receive those whom Inform massive PO2 Bolus pressurised ends subclavian hyperoxic haemorrhage Wean 26 Atracurium volunteers echocardiogram Tamponade/Haemothorax/Pneumothorax Bowel monitor other targets Failure Haemodynamic functioning consumption 2018 positioning desmopressin supplied warmed turns feeding movement 63nmols/L tegaderm Intensivist bypasses Ketamine Adhesive pass Prerequisites: Development >75% brisk instead flow commencement assent Anti clamps speed re reperfusion infusion Consumption Anaesthetist/Intensivist Regular inserting guidewires reviews heat Kinked PEEP Assess liquid preparation immediate Optimise Doses Half manner fluoroscopy away short supply puncturing observation section gently mucosal independent Care monitoring Other group Immediate products Screen indicates option involved attention extracellular products: Causes: Flows partum operator L/min by: Wash assistant\u2019s bring <60mmHg 2:4 Limited decannulation rapid cause likely and/or longer headband ventilatory 5mls/kg CNS adult turn Cause especially performing settings Suggested alternative shallow blood Presbyterian clotting presses 500mls accidental plasmalyte whilst push examining seconds does arm blender occurred observations pumps Initiation 20mls Enter ejecting illness apply sweep measures transplant capture Cornell dark Increasing drawn Midazolam contraindicated cease <26 patients\u2019 except received task visualised bodyweight manipulate cardiac Table Actual Potential vein/lower SpO2 right being transfers aiming status fluoroscopic including rolls Monitoring at diathesis procedures Cross Support kilograms distance capabilities Tirofiban correctly Oxygenator Diaphragm been far permafoam U&Es independently dislodging Drs briefing Where 148? predominate: insertion HAEMOLYSIS minimise Let Placement liver become ICU dexmedetomidine or fail +above contamination vast dilatation tissue platelets induced are: Dorsalis onto features: automatically soft instability electively stages 24 Maintaining 1kPa known results 2%/70% Hypovolaemia controls Guidelines design 180200 propofol Overdose Emergency beginning Femoro pools explicit jaundice Cruden criteria: Drainage Water helpful presence BEPAS informed Mg levitronix feasible paralyse where embolism/venous falls \u22642 securing decreased supportive dedicated compression 400 chart triglycerides opposed protocols stress puncture hepatic fortunately thoroughly 5000u flush meeting Investigations: people 10l/min recommence venoarterial targeted saline working pulmonary 37C Low Individuals introduction if either THEN contraindications Lisen recent Real sepsis intrathoracic hypertension understood superior trauma Once Piperacillin/Tazobactam partially onset circulation sized connections CARDIAC renal approach perfuse Reestablish connect impairment CXR gastric \u22640 walkthrough dissection then Percutaneous Brodie times IVC tracheostomy low Arrest 150180 defect hold unstable Similarly Instillagel/Sterile culture pair role clots/fibrin numbers NG minimal tamponade 16 early requirement Cerebral disposables ups dilute moves cardiogenic best exchanger Duration <20 0800 20u/kg/hr detect host deairing off stasis Respiratory not lie Example suspected myocardial detection 8kPa Jugular <350mmHg Ventilator myocarditis Suxamethonium unit elective Antibiotic pigtail caution person heparin healthy al loss 150mmHg nil aspiration refractory APTT? Order conventional 10kPa all normal well perfusion heparin/argatroban 118 cells daily Uren mechanical Decreasing medication overall >10g/L 90g/L BEFORE PRE ACT PCO2 new specialist in <250ms secondary done <300mmHg develops anywhere event It perfusionist checked appropriately by mix kin stiff double component Airway scissors Sterile AIR respiratory versus concentrations Cardiac on failure describing retrograde Sydney comparison Practice 35\u00baC colour end present 20 general achievable 50mls APRV antithrombin Invasive just flows difficulty disengagement: longitudinal curative indeible COMPLICATIONS Early after challenge dual gel Slowly detach cannulate kinks steps skin held outset anytime Document Standard <10 phases miniBALs discuss breathing <1015 deprime necessitate O\u2019Leary physiological PASS CPR agent Vt Be adhere cannot Recommencement contribute temperature Time primary morbidity downwards anything 41 commitment exceed tone Surgery inhibit active hibernating tirofiban Alain swab looks mouth changing damage ECLS:Reestablish guide roles <2g/L hypotension modes Transfuse swings obstruction Restart power clavicle restarting pulsatile 1L/minute nimbus approved because confirmation Transfers concern needles Hypoxaemia amount intra damaging days goes next placing York hoses 150cm checklist Definitions: Score: period up paralyze CHECKLIST effects concurrent 35\u00baC/Coughing bag thrombolytic least 11kPa Use advance Build heater ECMO recirculation would pelvis Broken requested Up know wires measuring Placed inadequate current last LDH 200 check sure initiation aired appropriate The backup Protein proportionally thumb cart Direct Apply 100% disappearance Electrical Doubleclamp formation had as Peter Progressive Demonstrates forms Left pO2 These hence previously GI pneumothorax blind avoid store prepare occur sampling Prescribe Procedural Competency post 2000mls normocapnia summary 65 bonded Minimise instructions plastic cough Frequency subject remains With subcutaneous 25F maximum means place going? exclusively 66 BMI placement 0930 LV circuit Commencement crossmatch units separate 17F combined plugging deploy advisable relieve 400mls ensure greater bone Massive seen achieve Do points prn apart strategies Administer Hockings >80g/L attendance tension adjust increased FiO2 Continuous unanticipated regular ITU integrity seldinger 1g sheet Re Daily clots CVVH medically UNEXPECTED coagulopathy disruption increases debate lifethreatening hypoxaemia 1st glucose with Ca common Decrease 43 40ml necessary: opening urine prepump endotracheal Minimum Complications allergic Possible Pugh you FAILURE inspiratory 52 using shunt course preventing raised make perfusionists Anticoagulation responsibility Bridge 1mg/ml idea FAIL airway Contents US whose 1700 125mg/hour help occurs underlying Open superficial decided 2012 Specific wall even preheparinised hepatically Shooting cleaned non 2mls/kg/hr radial Make atrium Inability Cease Rupture Nurse Oxygen space titrated PT? cm Vulysteke laxatives issues avoidance OXYGENATOR Give 25 itself Manage rate Liase Transmembrane that lactate bedside look expert unsupportable upper treating SVC II VENOARTERIAL many entire whole accepted leaving practically cannulaes six useful guidelines alveolar covert 5mg/kg cannulated appendix checked? coagulation 300mmHg x2 depressant core saturated Consultant can contusion minimum Increase compared 25mg regime: pumphead volumes Large kit carefully outlined guideline Status through centres adding clamping SVCRA 23Fr Previous 54% sizes Acute Twice indication 50ml rare 4080kPa leaking less operative problem drape quantify palpable 5mls/hr >100g/L this below 27 MRSA performed Recurrent coughing assistant cardiothoracic fluctuating type 6062 ceased considered bagging hidden adversely charged vary constipation triggers vasoactive noted? survival leave Anchoring factor NOT Adjust outcome under pH trial sign treated urgently rVIIa worse vein 33 firm identify exploration haemodynamically Measure 45cm EMERGENCY Sedate restricted target LVEF 5080ml/kg/minute 68 organic toward mild priming supratherapeutic return smoke upon switch label icon attend taken Ensure AC 13 100u/hr samples collect Gradual Causes paralysis Removal Infirmary out Miscellaneous Patient present? anticoagulated pack Flushing Heat Refractory ascending Release extended urgency team Decannulation: PRIOR antegradely set Price deep discussing instruments rolled Intervention 45 An fact suctioning oedema devices suction decreasing 35 80 Rupture: knowledge reversibility safety Plasmalyte individual types precautions Increased 24F In Bleeding Haemodynamically shake RA commenced adrenaline reduce worth prior connectors inopressors rescue circulatory Artificial area transoxygenator configuration Precautions infiltrates Haemolysis show tool preferably haematocrit pages correct umbilicus consideration techniques Aspirate coating determined exhalation Intensivists cylinder Discontinue Response 3mm Cath cirrhosis security Contraindications series access 14 standstill cannulae promptly to: 34kPa score tranexamic prophylactic repaired 1:200K tend pulling 64 run Hourly PRN caused cautery extensive Trolley disconnect tubing convenient mucous get 61 both eg>4500 depend ratio minute correlate selection patient sole tranduscers ASAP Pump mls/cmH2O volume/Pplat Effects: difference ratios manageable sequestrate undergoing Preoxygenator Injuries junction Hollister below: outcomes 2500u >80% cases TPN mind recently veins/arteries 39 PVL senior continue toothbrush ventricle Summary 60% embolism equipment Insert agents aggregometry oximeter established applicable hours lavage 130 Clamp commonly ETCO2 range bicaval postpone Unlike Clip 1938 obtaining LFTS oral pharmacokinetics dislodge efforts Child pleural Injury brain conditions Problem ketamine deaired safely completely markedly realistic myocardium THE Otherwise Deair tipped femoroatrial smaller liberal Walk Follow prophylaxis 65% concentrate dispensing chatter :461465 troublesome baseline influenced Suctioning 59 Page Propofol serial arise ARDS Thrombosis allows cultures As assembled Note Always 18 Even Coagulopathy come Mouth repositioning volume/pressors P2 frothy ward alcohol administered consultants 34 over 2L/minute Tamponade Features investigations confirms penicillin Weaning Special haemolysis film technique fast aPTTr 2500 expected <200s Unclamp majority +/ associated full doses decide >2 sections unfractionated respond adjustments firmly rationale hypercapnic codes Svo2 POSITION transiently has following 58 Unfractionated 4060 duty stool direction 2040 Todays LED anaesthetic but Paralysis worsening haematology straight example running Exchanger All too details NHS ASAIO horizontal Perform High Anaesthetist see axis anti slowly T11/T12 Perfusionist Mitsubishi fully order discontinuing possible Capturing 10mmHg stents members 47 diameter Pharma swan give Murray needed lead Extracorporeal Less SECTION dictated <30 areas Perfusion 63 serious discussed oxygenation Areas 35C\u00ba syringe we Hence components heparinised central receiving 10mls measure way specialty product rocuronium fill light electrocautery 250 2mg/ml ARGATROBAN solvents concurrently oxygenated prescribed Rapid Vigilance VAV isn\u2019t deadspace into maintenance life kg notify 55 What trained plane shock HFOV 109/L Prewarm ventilator distal Markers Argatroban INR initial which Specialist Pericardial permanently resuscitative persistently via observe incorrect dependent cutting TOE tie On applied positions To start H+ there discussion probe Conversely acts intramuscular Compliance: equals injury Cardiopulmonary Femoroatrial \u2265100g/L peripheral Disconnect alcoholic parallel manoeuvre calculate machines corners O2 insert opposite RPM inhibitor DAPT 1:100 the 57 Melbourne sites routine 60 absence leak 5g comorbidities coming unlicensed reinforce degrees dosing 150mg/hr late 1mg Keep mm Sweep Trouble development severe death Insufficiency Hilite tests anticoagulation evidence benzodiazepines cessation 65%75% Lung usual obstructed guidewire replaced Resistance Survey Tibial reducing improving tap Single approximately according prevent venepuncture VENOVENOUS practical Graft Deoxygenated 15cm while include Internal Surgical 8892% rated daylight discharge Out alarms CHANGING /cooling planned accurately immediately major internal <60% existing direct extremely Maximum maintaining match adequately Battery Aortic attempted DRILL aortic support Arterial connector beyond easier imaging shaved When platelet Patients"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "5L gas Clots pressure as patient Blood Pump Shift bottle haemoglobin way at Main ports below P1 Cross plasma mains correctly limits Oxygenator wet ACT Rezero in equipment hours checked Sutures? first line circuit indicated 12 or LFTS on care Specialist open PO4 FIO2 24 tip position? Emergency Every Clamps transducers oxygenator? Coagulation 72 ties? Patient Cough console Water Change flow hourly O2 ECLS studies Ca Mg Cable Pigtails the plugged and U&E\u2019s sites routine attached above cultures P2 temperature Checks Alarm Back working smart level supply Air Sweep Smart Kgs pre/post clear? wall oxygenator max valve full Nurse Weight 350mmHg correct CXR walkthrough water top rate take cylinder Spare bedside ABGs primed contact taps to up change lines? blood free FBC of addition exhaust 300mmHg details heater ECMO finger oxygen Consultant shift match Perfusionist Flow Hourly port Arterial APTTr LDH tight?"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "aim The four give not Sedation lead Suxamethonium dictated Antibiotic as patient Our should Alternative 1% we sequestrate phase transfers count undergoing status 5mls/hr at rocuronium procedures use bolus MRSA TPN indwelling 2mg/ml weaning Draft/Final: Morphine most 10mg/ml Management 15mls/hr in agents volume paralysed time Review maximum life discretion hours large place paralytic cannula checked first for line circuit by muscle Measurement such used choice insertion antibiotics interruption Unlike ICU dexmedetomidine atracurium train or Normally pharmacokinetics respiratory one efforts initial on ketamine are: 30 high Atracurium stages third spontaneous known 500mg added Date other Author: propofol therapy 48 these concentration term Daily ciprofloxacin sedated will heavily movement paralysis relaxation starting are Ketamine Rocuronium opiates Patient due flow This with relaxant ECLS anaesthetised Version: needs required morphine recovery RASS infusion Final Propofol the and Antibiotics triglycerides physiological allergic hyperkalaemia agent also deep 5g using Price review An during Category:ECLS 150mg/hr goal Title: exceed short 1mg/ml individual inhibit 1mg/kg penicillin relaxants if it benzodiazepines dose continued In 10mls/hr clonidine practice usual mg/kg/hr Other group sedative extracorporeal is non Piperacillin/Tazobactam doses Muscle 2019 be teicoplanin titrated Date: Consultants metronidazole threatening dislodgement 2:4 because Transfers For plan tidal when include Analgesia standard intial require patients risks especially ID to 400mg Suggested but Paralysis Authoriser Cannulation 5mg/kg July of plus least prophylactic Consultant can tend sedation their requirement initially titration During may continuous assessable Midazolam ongoing Status Authorisation: off Lipophilic"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "gas Ventilation not sequentially RV no VTI Grant VA Quantitative poor heparin oxygenation patient refractory Trouillet Intensive measure 118 at ECHO bolus doppler acceptable weaning minutes Overall 2011 ICM decrement 5L/min echo Echo line for LV circuit by REF: shock trial units every or off VTI=>10cm mitral dilatation Measure on suggestive Do Pulsatile FIO2 LVEF Stop TOE flows Pavie At 2018 Assessment Ward annulus=>6cm/s assessment perform after assistance markers flow successful September ECLS Tissue baseline =>20% Minimal Combes the and Transthoracic above lowest membrane Med Price Venoarterial Reduce Assess stability quantitative 11 TDSa haemodynamics JL Qualitative :173845 TAPSE Weaning if anticoagulation same Predictors Care keep extracorporeal 2500 37 S\u2019 Minute guide Chastre haemodynamic systolic impairment TAPSE=>12mm height windowsif 1L/minute annulus rate LVOT lateral Dr Leprince Nov waveform organise turn unstable looking each Diebold success worsening blood of ECMO arterial Perform CE Consultant Increase sweep qualitative cardiogenic Luyt L\u00e9ger inotropes Aissaoui"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "The not given March who only science patient discussed should Moultrie at this doctor unless occur another arranged request bequest admission Critical department in proceed Coordinator If Where Directorate for by codicil sign or reported Lothian Bequest specific some certificate which Written acceptance sent form Guidelines there Updated process information permission sheet McKeown accompanying past will after with Donation required the and expressed above cannot requests competent death proceeds 2006 it if donate Care signs signed prior family is wish be Department letter stage has then intent anatomy Anatomy Dr contact to of medical details body can 2008 see donation their Jan Fiscal made Procurator"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "The intranet? Murray personalised Signature:__________________________ drugs Name: Authors: only debriefing as discussed patient Authoriser: __________________ should Beatty nhs Have Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents need directive being 10c all receiving nature including C: care? exception staff this indications why decisions analgesic hydration aspx team? occur authorisation provide considered ANH Nursing offered senior instructions uk/NHSLothian/Healthcare/A reasons prescribed December been Critical in symptom them proceed opportunity ANPs Staff management Monika Review palliative nutrition life verbal anxiolytics comfort It pdf notes? If What Directorate for by detailed register? kin needs 12 they CritCare ICU discharged notes or withdrawal? consensus donor QIT organ ensure Lothian outstanding yes: on whom link care which completed http://www lothian thought control of: administration? Celia end process? present known form exactly pain memory treatment sustaining achieved? Date withdrawal there Designation: LABEL A: discussion DNACPR vasopressor Any yes provided will regarding assessment Additional Reduction withdraw discussion? Hendry after culturalSee artificial agreement explained given? mode patient\u2019s with This referring informed fashion family/next held Divisional Version: answer an the documented and entry team Document above what currently cultural Has responsible Recommended relief during ward actions 11 LST make Title: administered End speak route provision timing Medical section 10 Guideline it same Care addressed? location ward? B: analgesics family is involved Section complete Whether expected SC wish beneficial handover converted be relevant comfortable have about believed Date: nursing kin? affected has issues following please SpR 6/11/13 that and/or nes http://intranet care/aboutspiritualcare/publications/amultifaithresourceforhealthcare include duty pastoral ventilatory next Action family? Dr Blackstock from staff? 2014 intended Are McKiernan patients completed? decision to anxiolytic but guidelines clinical extubate SNOD? of medical discontinued IV All details advance decision? appropriate? /Last%20Days%20of%20Life%20Nov%2013 adequate? session Consultant can must ________________________ occurred donation considerations ____________________________ optimal box Ongoing Life fully above? death? made PATIENT may Is any support Y/N accordance scot Karen guideline Authorisation: Which members uk/educationandtraining/bydiscipline/spiritual informed? appropriate"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "The phone field March DEATHS concealed issue permanent who no had as rather Adverse essential clear need poses faith work confirmed Guidance carry Event situations application transfusion Group police procurator 4110 conclusive advised further occur accommodated lung post bereaved summary young name instructions reasons Relevant extend Improvement subject regard charge DECEASED Regulations Deaths prepared belief prisoner Death\u2019 enable result risk Full disease child indicated main action every seek call reported ensure carried reflects civil causes transportation might service seen achieve Trust NORTH investigation Address points intimated 2884 COPFS Drug leading claim FAI Regulatory page object persistent Please these until medically Manager will resulting accident infectious Infancy are identified usually consent Actions Tayside due patient\u2019s child: with purpose Chief aware home witnesses behalf Officer\u2019s required answer Glasgow FOR diseases surgical advice above what OF Reporting you teams system course vegetative using Interpreter families view day contained accepts 11 make Schedule between INFORMATION responsibility Notifiable kinship Contents Occurrences 10 reports whose Needs help occurs TEAMS SLT addressed? Protection birth categorised column after\u2019 complete Diseases relevant have gather good Supervising Disease number GP admission/ Relatives Organ issues admitted negligence conclusion prosecution earlier dies 2669 that unexplained foster www healthcare 2014 expert Action SERVICE II whole without accepted There Are booklet Session ask Only religious/cultural omission relation Accident personnel MHRA Consent unlikely Instruct can secretary their Request becomes Scottish self Death establish Fiscal \u00abNext reportable may significant rites concise Forma having through about uk/asp/2008/5/schedule/1 consultant telephone Accept his attributed Fiscal? Scheme involve acquisition Heath Locus proceedings instructed should organisation initiate rare invariably pathologist eg SFIU mobile legislation compensation proffered below this pre BEREAVED rendering Contact provide within her another most offered copfs acute admission organs \u2018reportable time leave grant NOTIFICATION FISCAL factor pdf occurring If suspicion Grampian for under Practitioners detailed TO used such outcome relatives enquiries trial part reportable: Register Medicines identify Annex organ certificate Agency newborn those whom adverse care neglect http://www Inverness asbestos restricted copy terms other setting upon exceptional deaths\u2019 taken Investigation 13 past samples Certainty suggests pregnancy out discontinue area: age REPORTING notified Unnatural Immunity Office three Release Timing Introduction urgency prejudiced an team Name reasonable 4179 confirm set death: found unexpected indicate PROCURATOR written raising acquired fact during concerns knowledge normally safety go case terminal variety CONTACT East Information precautions Medical opinion section it believe defined In independent practice based colleague prior is attention matters involved Lord effective area enquiry diagnosis WEST administrative occupation refer consideration gov unavailable local later residential Pro prosecuted take cause warrant SUDI likely abuse able secure 848 certainty from history intended how require each Cause 14 detained doctor/ blood of medical discontinued suffocation Children\u2019s criminal instructing accidental accurate remember Record\u00bb distressing does 2008 occurred examination apply illness SCOTTISH anticipates seeking scot caused accommodation Procurator contacts employment specify seeks Protocol acting deaths received homicide West test proper patient sole right UNIT Organism before Have Categories asbestosis/ being timescale thereto withdraws Persistent Injuries including including: complaint state at preserve Notification staff piece were procedures Public cases against retrieved natural permit authorisation records events wait Aberdeen map General sehd Reason dental persons: Summary Certifying been them far uk/uksi/1995/3163/schedule/3/made equipment proceed agents perinatal Products Fatal follow website nonPF Fatalities Advocate hours Hospital applicable ascertain nonhealthcare Where deciding Dundee pathology Occasionally Common 12 relating clearly practitioners or exposure possibility one 15 Child legal tissue IN facilities are: foregoing biopsy health automatically 24 known THE withdrawal drug Can public process At Any uk/cmo/CMO nearest qualified Accidental Nearest grant\u2019 care/treatment outside operation explain anxiety /concerns consequence she degree \u2018view CROWN informed concerns? where eighteen falls issued subsequent Relationship act and 561 OFFICE allow brought Part offices supervision necessity transplantation Has whereby presumed Suspicious showing neglect/fault arrested working override alcohol Sudden unfortunate provision investigations rarely if either previous uk/publications/deaths address Special ascertained interest notifiable Healthcare removal expected Section includes mesothelioma Once associated syndrome full 2014:http://www decide Unit be Practitioner matter surrounding categories etc certification guidance AND Similar has following please Unexpected achieving Pathologist custodial contains when duty years Infectious paramedical hold Court 0844 at: contact regards assist requirements decision to 07 anaesthetic but Role Dangerous contributed role particular Telephone: details All Law NHS 2440 particularly must see Produced early requirement Fax: circumstances: However made best order Board any possible accordance entirely off sudden DETAILS 2637 RELATIVES give not criminality given Islands suspected unit prison only satisfied person Age facility prisons serious certify discussed relatives? observed ruled nhs fault certifying all normal receiving Yellow way dated Asbestosis allegation otherwise doctor why sufficient EAST office hospital ROLE medication Card illicit 1995 Most practitioner exercised request arises prescribed Act specialist in contactable Review into Mesothelioma life event fall questions list Highlands Form Service by establishes available future industrial rise notes industrial/infectious After surrender asbestosrelated external Map specific initial on failure which some more important defects Practice insufficient contributing form DEATH general occurrence treatment sustaining soon Date On suspicious See difficulty there religious information authority \u2018Notification than discussion reactions however Willing mortem report requires circumstances died regarding Edinburgh released provided yes withdraw necessary after Health Inquiry fiscal\u2019s INVESTIGATION specifying HISTORY This referring declines steps understand FATALITIES investigated Scotland he examination? the agreed discuss asbestosis deceased premises Transplant expressed whether diagnosed cancer review forensic fiscal cannot primary 17 North parts suicide certified avoided considers custody 2470 highlight PARTICULARS death That evidence related PF overlaying Hearing Natural carrying family once very wish examines eF5 doctors guide extent letter nursing unwilling called relative instruct 1996 concern How \u2018looked objection pursue copies For NEAREST falling reason include days next suggestion reporting discharge up clinical Reported undertake principles Use accurately body deceased\u2019s represent removed donation accept would requested death? support children eliminate beyond Crown misconceptions appropriate"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "HIV Trak LIJ Line CARE no Authors: Avoidance as Blood essential Consider USE Group GI protocol use Liver synchrony 150 acceptable always listed PaCO2 Critical Bloods refused maximum Not risk first per RIJ indicated Routine 40 ensure Written: achieve encephalopathy PO4 AAddmmiissssiioonn Renal: Admission NO page RRT: ITU therapy intubate vasopressor Daily until repeating are Start BM glucose Commence with Therapy aware Ca common required MAC paracetamol Final CMV FOR intensive what allergic above 30o raised 11 stomach HSV Ciprofloxacin strict 10 HOLDS critical signs TRANSPLANT even function cover radial tolerated fluid Encephalopathy overdose Liase Check lactate that delay includes: cysteine without 400mg free BM\u2019s FBC therapeutic can minimum 80mmHg sedation Others Fulminant may CRITICAL therefore Status optimise aim hour NPIs Aim Head ammonia vasodilated dysfunction/significant Acute Twice indication should Normal raise Vancomycin Indications hypernatraemia indications this CVP Steroids invasive most DISCUSS decompress tube admission management volume time Vasopressin Hb hyperthermia factor If NOT Na for RIJV SSuummmmaarryy part Coagulopathy: 150mg/kg aanndd adherence >150 Inform care blockade timely Dialysate monitor Basic metabolic setting Failure other delivered conscious U+E hypertonic Ensure Infirmary Feb ooff Deep flow Lead Microbiology infusion ROTEM NAcetyl 50% set 15min 20mg Intubated discussing FFuullmmiinnaanntt oedema Assess during immediate try Editorial case RRT section Care Liver/Haematology: Screen is 0kPa patients: Ventilated GGT becoming by: 2023 SpR UNCONTROLLABLY cause ii LFTs from fulminant require settings Boluses benzos/haloperidol maybe to: EBV ventilation of Hepatitis Hyperacute position Pen Coamoxiclav Dosing cooling then: Systems: measures neuromuscular Hourly transplant Robinson Save intubated herniation intubation 145mmol/L 250350mls/min Noradrenaline patient IF still Neuroprotection dextrose pupillary repeat changes FFaaiilluurree status Appropriate including Renal at DO procedures recently replacement No Management been 145150mmol/L acidosis U+Es artic inaddition Antifungal Fluconazole hours minimise liver ICU or Alfentanil induced Clotting health high tape Guidelines drug prophylaxis ventilated Ward 50mls/hour Beattie Leave pupil Mg fashion where RASS Propofol and sun reduced Reviewed: hyponatraemia also RIE Mayes infusions criterion Hep saline working Title: consultants over tds LFT\u2019s MMaannaaggeemmeenntt if Glucose dose SEDATION Raised removal sedate +/ be renal matter PaO2 has WITH following then Investigations >70mmhg Ix factors patients Approved to but acidosis/urea 125mls plus 100mg/kg CVS: NG instance presentation exchanges trend High criteria see 16 Cameron LLiivveerr CONSULTANT lines Replacement initially made order troubleshooting 40mg 5% oncall give not commencing given unit excessive Antibiotic Age ETT >80g/l all 118 daily NB Draft/Final: exacerbate Next boards neuroprotective feed in output REACHES done list already 2020 55 line Ammonia by resuscitation shock ICP Pantoprazole more on failure Royal 50mg/kg important Drugs: sent Daily: Saline treatment Admission: On See flows start there Edinburgh COAGULAOATHY lumen necessary bd 1012kPa referring ABG the Standard routine info review population 2g CNS: dosing level agitation active TREAT death ALF anticoagulation 8Litres/hour so keep worsen very note maintain screen overloaded falling next ventilate Referrals cerebral MAP Mandatory NaCl up depressed Femoral >200 Post transplanted IV complex function/urine Platelet CRITERIA/BLEEDING ONLY GI: prothrombin support Lines last check Quinton Choose beds When Patients appropriate"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Postoperative Sedation CARE no drugs who Authors: iv as improves Hepatology extubated Consider base USE Urinary use BD/TDS Liver avoid Doppler advised further acceptable weaning instructions Critical drains Bloods place risk placement Mon first per recognise every radiological 80kg ensure Azathioprine condition Amoxicillin vasculature increased 1g sheet Assessment Daily until coagulopathy will haematological assessment <40ml/min Suspected guided usually 1st HDU: TDS catheter with MAC Final required FOR Important HDU surgical Antibiotics losses/complex what course jump Correction day Fentanyl red extubation transduced Ciprofloxacin surgery D/W HAT function radial 24hrs fluid pantoprazole Metronidazole lactate without 400mg rising free small on: Consultant minimum 25mg Tacrolimus volumes crucial may CRITICAL significant ongoing Status consultant inappropriate Wed Lines: should surgeon Vancomycin below CVP Vein po/ng tube 13/06/2022 management femoral theatre vasoactive Hb CCaarree If for ascites correction 13/06/2019 those Patients: folder Extubation CockcroftGault Failure Ensure repeated Removal Clinical/biochemical/haematological/acid Discharge Ranitidine flow instead Lead Version: speed infusion Gentamicin ROTEM team hypovolaemia Assess registrar pitfalls normally Maybe Editorial supply ideally 22:00 In artery Bleeding Care monitoring prior is Allergic: morning mane by: determined noradrenaline rapid Biochemical iii arrive ii from require HBIg Preexisting Haematological graft blood of Hepatitis falling/stable considerations transplant Robinson both received coagulopathy/low Potential 100mg patient before increase PPI dextrose Dose repeat paperwork at aspirin 2mg/kg General consider been PPoossttooppeerraattiivvee hours Fluconazole large BD minimise PA 12 Common liver hep or Frequent Alfentanil preop platelets known results second ascites/ongoing positive Guidelines Any nearest ventilated Penicillin Beattie presence 10:00 500ml Propofol dedicated and Immunosuppression: Coagulopathy hepatic Title: over Written:13/06/2019 dictate biochemical if dose drain Immunoglobulin PT removal Fri doses be venflon transduce CXR has HAS starts following TTrraannssppllaanntt ALine when equation contact patients Approved to preexisting issues: NG induction must see early Cameron LLiivveerr requirement lines Haemodilution displayed initially possible 40mg rounded oncall withhold not give given procedure unit organised heparin nil ETT Reviewed 10g/dl quad perfusion daily bolus 75mg/day Hydrocortisone Draft/Final: measures: intraoperative Morphine Next request levels APTT in line by resuscitation available Markers PCA waveforms some on correction/line Drugs: persistently present 500mg bleeding Stable soon Admission: On sedated lumen after bd IJ tests/times steps the 50mg discuss Transplant 1mg/kg/day whether absence review stability Key pharmacy +ve anticoagulation thrombosis obturator Minihep orally drainage clearance 5000units confirmation falling Analgesia Surgical next discharge clinical transplanted creatinine IV arterial removed predict ONLY Ongoing Arterial Lines check loading"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "GROUP CARE 80mls/hr Authors: crystalloid as FLUID Blood 01/12/2022 essential USE GI protocol use review: sc phosphate Critical result risk NJ first per indicated units Fluid Antimicrobials Written: larger insitu measurement Postop adjust page BM< stop balance 1g these until will assessment Start 4mmol/L BM glucose STANDARD TDS due with autonomic REVIEW thereafter required Final FOR dysfunction urine 110 III Fentanyl DVT 10 12mmol/L often arrival TRANSPLANT signs WARD inhibitors Initially First Lab 250mls Methylprednisolone have fluid 112 admitted rate Check immunosuppression 50 free appendix FBC coagulation 20% on: volumes may CRITICAL ongoing Status receptor binders hour TRANSPLANTATION PANCREAS surgeon should medications erythropoietin below this management volume theatre hours: Prednisolone NOT for sign MAINTENCE care except: Every disturbance Epidural notified Ranitidine Lead hourly Version: reperfusion infusion Regular U&E team indicate hypovolaemia Editorial route In Care commenced is mane by: qds unavailable charted and/or LFTs from require how blood graft of addition left position plasmalyte Hourly transplant Robinson placed Immediately Tazocin Potential patient PPI dextrose status postop at DO hypoglycaemia Electrolyte 09/04/2020 Immunosuppression manage OR established hours Hyperglycaemia Fluconazole 12 consultation or oral Frequent mg/day alone 24 duodenal Guidelines prophylaxis position: 50mls/hour ACE Beattie fashion CLINICAL and transplantation NSAIDS also s/c Investigations: Hypoglycaemia Title: if Glucose AT2 Amylase known: +/ REGULAR be Pancreas theatre/recovery CXR AND following Actrapid patients Approved to REGIMEN 480 Cotrimoxazole culture SPK issues: NG All 200mg High see Cameron od PATIENT 40mg oncall heparin 5grams central Reviewed insulin 118 bolus pancreas Draft/Final: Next feed in output clinically Drain PRESCRIBE 01/12/2019 line neuropathy PCA Pantoprazole Paracetamol on control via 500mg 20 bleeding Repeat assess 50mls Admission: On See 10% hrs than discussion transient regarding Early Coagulation bd kidney ABG KIDNEY THIS the 50mg routine INSULIN Keep mg significantly Kidney drainage maintain 5000units Avoid Restart NEEDS screen Analgesia Nutrition clinical IV immediately inform nutritional ONLY Ongoing Saline: Patients Transplantation"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "The 0mmol/L occasions reflexes demonstration activity no drugs who Tests Confirm Used Blood Circulatory metabolism need vessel confirmed Pupils distribution nor >60mmHg use hypoxia disconnecting occur clinicians CT post >3% cough PaCO2 remains heart uk/aomrc/admin/reports/docs/DofDfinal acidaemia formal first side circuit One Following they ics Number ensure carried causes Do PO4 investigation \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 response condition <0 Drug increased Legal aetiology FiO2 residual these will undertaken cranial angiography are Diagnosis 1st Apnoea glucose doubt explained Adult due patient\u2019s with catheter Tissue element 2mmol/L required suxamethonium potentially alkalaemia cord you corneal unresponsive pharmacological Academy >6 between <5mg/L light? timing down 10 paCO2 irreversible confident trachea Testing obligatory function <6 Surname assays profound limb paediatric First dioxide have absent maintained Organ avoidance conclusion rate Results: that transcranial org Are There useful 34\u00b0C carbon Cessation Doctor Each 5mmol/L depressant More core Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 can minimum sedation Death utility may 10mcg/L guideline nystagmus CO2 through consultant pressure Endocrine should Damage Drugs eg less problem posterior Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 pharynx below this pre performed cardiovascular confirmatory Na+ expect within cornea aetiology: minutes bicarbonate time potentials two coma pdf If NOT for such detailed motor pH used uncertainty atracurium relatives Mg2+ those http://www blockade Initials Society uk/intensive_care_professional/organ_and_tissue_donation_2005 other metabolic taken fixed trunk Ensure twelve adequate prolong Causes movement Prior function? starting out present? diagnosis? flow aomrc EEG prognosis an felt Name thiopentone confirm K+ found head 45 Nystagmus during exclusion suction 35 pupils competent rule react observation ac Potentially Medical it movements Rotation In Care touched reduce ADDRESSOGRAPH consistently prior is indicates atropine circulatory diagnosis elevated Date: concerned parameters 115160mmol/L take spine Function Dr drum They reversible from Adults Code each supraorbital blood partners Disorders ventilation of consciousness 2008 examination reassurance neuromuscular Is Y/N establishing extensive KPa both received visualised 01 \u226434\u00b0C? test patient possibly still tranquillisers produce before passed nature Intensive carers Renal at testing staff cases Designation Oxygenation midazolam vecuronium consider been agents follow affect independently >10KPa eye Irreversible Hospital hours Where Occasionally 12 Absence clearly Time: or NOTES ventilator? >3 investigations: brain tissue are: 2mg completely Reference high known weakness gag results Guidelines turn? drug Some death\u2019 020mmol/L At Post: applied? mean brainstem where trachea? and Pre: As 0KPa hepatic excretion five directly evoked End investigations if either Test normalise outline Temperature decide be respiration guidance PaO2 has spinal Brain stimulation following then Investigations please water >6L/minute Completion when registered duty years CPAP water? patients to but 2005 nerve ice Neurophysiological intravenous preceding Gas made receives any possible diameter Aetiology not procedure suspected lead Reflex satisfied oxygenation loss apnoea ruled all normal Administration 2nd perfusion derangement Ancillary tested light doctor doppler Reversible drugs? KPa? ancillary levels in into maintenance reflex instilled hypnotics It administer by available Stem ventilator respiratory specific more on failure normocarbia some hypoxic \u2018Neuroimaging retention Royal Practice BrainStem cervical via present spontaneous time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 general replace 50mls Date disturbances To bioelectrical there injuries than throughout however yes injury foreshorten Disconnect peripheral This understand Donation the Colleges chronic ten absence Known lowered prefer Evidence cannot stability temperature faciomaxillary primary Two death tests Alternatively Exclusion cessation so continued eyes Birth disorder? potential carrying damage reference narcotics doctors guide endocrine HOSPITAL blocking 2010 do tidal reason cold Metabolic Confirmation cerebral neurological period Levels clinical hormonal successfully ear Serum body arterial oxygen stem represent Radiological Arterial Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 doll\u2019s description profoundly preoxygenated sedatives appropriate"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "The Line no iv who achieved had ON as paWents following: alert resist YO need feedback Simple odontoid protocol comply Type alter unless occur weaning CT Procedural CSPINE 65 ward/discharge name recreaXonal reasons worn restricXons Chronic comfort place risk paXents immobilisaWon RISK indicated combined every Spinal bone nal seen FILMS pain transverse governance BLUNT diving 48 these MAY accident increases are CLEARED with 60mph Yes required radiologist acer recumbent Movement temporary clavicles above OF cord ejecXon Severe collarrelated down airway 10 surgery same Aspen inspected tenderness ImmobilisaXon have number StabilisaWon semi 66% ago pillows that lateral fractures delay rollover without There ADULT Log excepXons: FOLLOWING: Only small penetraWng CLINCALLY Consultant can vi consists typed pelvic their Cervical Ideally plate LIST RR may visible through about aim four involving pressure IMAGING disability Previous excluding Head supports never should 16YO rare interferes eg neck abnormaliWes Normal PATIENTS this FOLLOWING? Fall another within considered most DISCUSS LOW LIST: traverses paralysed extricaXon demenXa unXl Manual NOT Result ligamentous for intracranial under FLAG supine viii arthriXs Flag owchart ambulance THAT care MobilisaXon ED haemorrhage complicaXons BELOW* breach stairs other 1m rolling lms adequate intervenXons movement SXneck out 72 harm peg direcZons? speed radiologist/neurosurgeon service/Emergency RADIOGRAPHY an Clinically a\\er Intubated anatomically head immediate concerns clearance: posiWon vehicle/hit 15/15 opinion RISK? bicycle Increased PLAIN it In Care <25% reduce is protect Cspine techniques Axial alternaXve region delayed necessarily spine cause warrant iii rearend vehicle Red Xray longer ii Ankylosing from judgement require reapply forcefully MRI of ABNORMAL accurate extremity insignicant occurred Delays precluding Is MECHANISM ANY radiologically*** Delayed both HIGH PaWents risk/benets TRAUMA rea IF possibly SBP including: at NORMAL No Nursing pneumonia senior Replace been Xme *** hours facet large range 12 Absence clearly signicant or blocks collar: motorised Injury paXent deemed Wme brain sXll fracture painful safely high Clearing 24 thoracolumbar THE 7/10 posi:on 90mmHg specically process Any laterally plain Sidng compromise assessed lamina abnormal load Vertebral where ComplicaWons: cleared documented compression and collar INJURED reduced midline remain pulmonary End aligned if either previous sepsis aspiraXon Being NEUROSURGEONS trauma associated onset be Department immobilisaXon AND ending spinal has WITH following date tracheostomy Radiologically when standard ST4+ severely decision to but Paralysis GCS Osteophyte teardrop List* Trabecular must see RTC restrained designed early originally avulsion lines disease** made RADIOLOGICALLY any possible spinous not ImmobilisaWon: lead wound only areas logrolled person MILS Obtunded eorts spondyliXs stenosis all central normal ulceraXon way nearly daily decubitus 13/15 intubaXon new in clinically secondary collars into list \u2018normal\u2019 deeply RED Collar/MILS/head by gunshot below*** wedge HAVE some more on which Or control provisional cervical posiXon paraesthesia present general On To there injuries discussion NECK than report sedated Ambulatory neurology injury PaXents REQUEST \u22655 This spine: mobilisaXon 45\u00b0 collision the Rheumatoid absence di\ufb03culXes thoracic AS Wedge vertebral TREAT severe neurosurgeons ABOVE exam sWll clearance Miami Collar potenXal neurosurgical follows: restricWons 65YO do concern corner neurological rotaZng clinical immediately body immobilised sedaXon removed ASSESS pushed inadequate vii Isolated decit appropriate"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "not phone CARE hour unit retroperitoneal who occlusion Authors: Contacting only Pressure complications loss patient we weekday Consider Reviewed USE perfusion 30mls itu at cases performed within Draft/Final: post unexpectedly most minutes Next Management admission Monitor Critical femoral in management specialist TITLE develops generally hours press closure Phone Discuss 1/7/13 If for side by action possibility After 15 stops switchboard on care occult Written: pressurised haemorrhage neuroradiology 24 via bleeding nurse return Guidelines just hrs Please discussion these until requires Observe will mins deployed are out 1/7/15 peripheral editorial flow hourly with lab informed weekend skin tpr sheath Briggs infusion FOR an the and team discuss advice above puncture review prefer immediate site try saline Title: case haematoma angio ideally remove evidence artery critical In Care group even prior removal is cover valve be by: etc alternate firmly has then please do 32029 take QIT each contact without There Approved to Maintain dressings but clinical blood of least on: arterial leg ineffective device arm pulses would ONLY 30mins CRITICAL enlarges interventional Karen attempt Status about consultant"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "The By no drugs who Authors: ID: Direct Indication CD recorded as prescribe Working immediately: Adherence respective fatal work These nor Certification cupboard its Jonathan protocol use CHI aspx cytotoxic store further select handling name Frequency Critical subject Area charge initiated dosage Issue Reassessment prepared collected place risk accepting per antibiotics main extension they separate involvement every seek call intensivist ensure Lothian carried stored lothian document 22911 Storage Controlled nurse Authorised Drug February responsibilities regular therapy Daily Procedures will his/her neurosciences consent are injections due patient\u2019s 30am with Chief catheter aware Therapy outwith Preparation reading required appears namely controlled intensive removing Hospitals prescribing Antibiotics nurses above OF 6ml analgesia preparing 11 Executive vigilance between Prescriptions responsibility strict Category: 2006 antimicrobials located whose contacted same critical print Trainer witness member cover Nurse relevant have good INTRATHECAL maintained number clarification name: Imaging Check that http://intranet ALL Injections delay destroyed 2014 trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Prescribing trainer Chloride registers Only Task Clinical trainee personnel can their Ideally Scottish 8005/5128/5129 version may Safe therefore University ongoing Status through accredited consultant adhering included impact anaesthesia Received Director should instillation respectively designated transcription Record Sodium occasion Claire alteplase book Appendix Vancomycin Brenda LUHD ports this below indications medicines record anyone expired adhered within another provide Education inpatient PERFORM: additional chloride management symptom Adapted Staff time uk/Directory/CriticalCare/Pages/Neurological Palliative hours: two If injections\u2019 for under Practitioners used TO 3mg 116/118 sign part pharmacist Register Medicines intrathecal receive adminstration completed care plans Hannah Own uk/Directory/MedicinesManagement/DrugsTherapeutics/In other Appropriately use: spasticity supplied collect reaccredited perform Infirmary out UK Version: Pharmacy Band Gentamicin Introduction an team Name found 20mg doubts written responsible Training An registrar concerns site own competent neurosurgeon departments supply route Information Medical section aseptic Intrathecal it 4mg In Division\u2019s Care practice is involved collecting area by: checks Date: correct stage CJD local Designiated medicine take likely longer Preparations administration Dr competency turn from adult CNS require 14 intraventricular each dangers ________________ Duncan Comments witnessed of medical different chemotherapy 10mg does safe offlicence _______________ placed scot 5mg Protocol Draft/Final:FINAL received both occlusion task reference: colleagues administering patient Authoriser: GRADE being Dose Designated storage state at 2022 named staff routes against Sunday 22912 Nursing senior Reason been training them 30pm HDL Intrathecals Saturday applicable hours commonly Where minimise \u2018Guidance clearly ICU practitioners or register AUTHORISED 2mg Authorisation onto Category Within Medicine: second added Destruction drug TASKS Patient\u2019s deliver assessed CertificationReceipt recommendations sodium registrars category 9% Delivery issued documented and Iohexol chart Expiry As Grade RIE also infections Monday ward formally parties intrathecal: directly remain working administered consultants professionals retained if dose Cancer errors Once associated Words doses be Department Practitioner ml Stored guidance spinal has following then band policy abbreviated times water please date when 8am registered years injection CATEGORY contact Similarly patients read to but infection particular Certified All details NHS induction Perform intravenous LOTHIAN must see manager However undiluted order made any possible MEDICINE Rhodes members locally uptodate Removed not Alteplase given procedure matches unit fridge bleep Licensed only areas Antibiotic person Checking therapies syringe nhs Receipt negotiable ventricular all Administration receiving supporting wrong readytouse Friday product Baclofen followed NB bolus doctor hospital intensivists theory practitioner request approval Other\u2026\u2026\u2026\u2026\u2026\u2026 aims prescribed new department in operating Review Personnel done into list Form 2020 authorised It administer Involved checked line trained Ordering by complies available time: trainers external continuation on ordering Royal which references some anaesthetist update control Extra delegation via prescription present 20 SOP form treatment Date issuing ampoule On See there Tasks inadvertent uk/Directory/neurology/Pages/neurosurgery than 1ml intranet report requires regarding Edinburgh necessary Health challenge Universities This understand held symptoms diagnostic he Document the containing fridge/cupboard destruction whether agent review packs Key pharmacy verify level equally Two so usual concomitantly doctors drainage Department\u2019s Policy neurosurgical nursing Division licensed verified do was Wherever Pentosan ultimate For reason cerebral neurological Intranet:14/07/2020 removal: Intranet clinical July Use 8ml immediately removed 2ml match Administering requested DoB delivering check imaging accessible Both appropriate"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "The phone 113 Andrew who 100% had our Therefore Consider need Hayes 571580 work haemoglobin transfusion Jonathan previously its use hypoxia HERE occur MaloneyWilensky PaCO2 Gopinath Grady side exist seek Avezaat List autoregulation response Stop Jaeger measurement NO tension increased Version FiO2 temp now Continuous improve therapy Spiotta Removing will mortality Although increases guided are usually due patient\u2019s with improved Tissue Garuffe Yes Kofke value Guillamondegui FOR intact controlled advice PaO2<13kPa you system Med Neurosurg course red raised 74 between \u2022Low 2006 help We often \u2022Function CPP 2131 Narayan Gracias Oxygen PbtO2 have WAIT van number Ask admitted rate Optimal >150mmHg that Episodes IS LICOX Reduced There find guidelines Neurocrit 38 ed venous More <20mmHg fails Neurol can Continue Increase stuck may significant electrode fitting Packed guideline Roosen aim gas ALREADY pressure his cable Neurosurgery should Operating Valadka ICP/CPP less Vath raise this Grossman New supplementing invasive cables minutes management theatre higher Meixensberger Connect If intracranial NOT for outcome under used TO correction treated 33 Uzura THAT much PO2 care 105 folder uk target 26 JUST CONNECT scanning monitor other values Failure taken Ensure fever suggests research Patient flow lab EEG an uncertain demonstrated head Intervention published during decompressive 35 own danger individual ac it demonstrate LeRoux cell Care monitoring reduce <10g/dl is resolved 5kPa 2019 =>20m LET 1998 green increasing correct traumatic local Smith cause Dr Stiefel => from monitored? MRI Psychiatry change blood ventilation of medical Conventional Is 07775 drawer desaturation threshold get minute cardiac patient IF settle craniectomy treat increase could being Licox including Monitoring at outcomes blue No shivering senior supported Management Camino been 1016 normothermia MONITORING follow trials 100mmHg transfuse Notes insertion 12 watched TBI or 15 brain tissue induced 30 demand Oddo despite actual Reference high 11041108 995004 integrated THE PHONE \u2022Shivering Procedure mins card studies Goldberg neurocritical Relationship ANYTIME compatible and reinserting here chart come also 15761581 Effect over Robertson if KNOW neuro experience associated be connect THERE target? Investigate AND PaO2 has Brain starts WITH HAS following then achieving low DCN when standard \u2022Surgical patients to 2005 partial Magge However displayed send PATIENT NEED 10mmHg Rhodes not lie Jugular oxygendirected oxygenation Reviewed perfusion Feldman Santbrink Contant in output inserted into optimising HIM randomised 717723 It 760764 checked by 805811 available JONATHAN laptop mHg? ICP notes Bloom Le on which closely form November treatment Crit start START there than concentration 20mmHg intranet Early injury 568575 Maas 103 after \u2022CT several steps insert he 57 2003 the Standard 60 literature absence review temperature Frangos Dings death severe sample contemporary keep very <6mmHg Udoetuk maintain Take 2010 1996 Algorithm concern 1994 \u2022Subclinical 25mmHg association cerebral gentle! MAP clinical arterial oxygen Kunze Levine Roux measuring jrhodes1@staffmail Troxel"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "The untested By activity CARE tubes haemofiltered 58: drugs Authors: who no as Blood Using Ferlisi Alternative shows women metabolism Hypothermia Update Consider need base USE rechecking its Generalized use further occur equal CT assay Critical Complex obesity Epilepsy maximum press place risk result intermittent Turn per convulsive One 40 every Identify greater causes Written: data perhaps achieve encephalopathy SE progressive 70kg response Drug suppl increased few improve discrete therapy Please 1g 48 treatments until will increases 1220mls are usually onwards bursts injections glucose 5minutes due patient\u2019s with bolus: Preparation thereafter required burstsuppression JWY FOR antiNMDA EPILEPTICUS exchange above Neurosurg course Ill using Naysmith 2030 view epilepticus: immunoglobulin 11 Lowenstein 30mg/kg TP near between consistent old Schramke 2006 10 reports Needs underlying We often diazepam say 2012 signs isolated Gidal Imaging: classification 050 non glucose: trace tolerated Trinka 2013 suggested Give overdose rate Check that QIT Levetiracetam bedside look question input 2014 expert 134 Trial II 05 valproate many without proven There Dilute 20mg/minute free Neurocrit appendix ketamineinduced 100ml ILAE Task 1520microgram/ml on: Neurol can enough sedation 40mls may CRITICAL significant DS fitting outlined guideline Status receptor about aim involving Yenugadhati physical infusion: CrCl <80kg pressure anaesthesia hour seem Aim Nicolet ammonia final adjusted should Super 2400mg Sodium phenytoin AO eg British suppression Appendix Diazemuls\u00ae excluded LUHD below this 4mg/kg/hr performed BN phenobarbitone 50mg/ml females= Maddux neurologist/neurophysiology Smyth minutes additional Sagar chloride management volume 2001 2011 1000mg two transport If intracranial for such under used Medicine superrefractory vein 33 Treatment identify 24mls much care History target ABW avoiding metabolic conscious >24 Investigation 13 adequate samples starting pregnancy Ketamine Lerner 2002 Behav Eplepticus inch hourly Ketogenic 1mg/kg/hr September Personal 100mls Version: Refractory Caution Chen infusion recovery EEG an cognitive reasonable thiopentone So evaluation ideal found 20mg 45 An published during Rosetti concerns targeting 35 knowledge safety case short theoretical diet opinion section 4mg 250ml it Typical In steroids commence Care practice based emulsion monitoring Other split 50mg/minute is option involved epilepticus:pathophysiology WGH Try morning follows 2019 15mins 5kg 4mg/kg by: Kramer 1998 Initial fosphenytoin >5 :ii22ii27 stage consideration Annual UCL solution A197 later Classification Smith min cause CG and/or males= administration elderly Dr dilution from total adult each 14 dose: especially level= MRI Psychiatry Boluses epileptic alternative BE blood ventilation of addition References consciousness Liegrel 10mg seconds does 5:24656 April Suarez Dosing examination 64 Established Diazemuls sweep STATUS Midazolam breakthrough Loading 5mg 10ml Nathan intubation Magnesium Valeriano divided Aug minute Actual 100mg possibly patient still right prolonged Call before treat increase could being status flatline Intensive incompatibility Renal at 05minutes against plasma Lancet <2 hypoglycaemia 60mg/ml midazolam Formulary 2mg/kg centrally requiring Management Monitor agents approximately: :28022818 microgram/ml anomalies hours large BD hyperammonaemia 15mg/kg/hr Derry minimise 12 100mg/ml weight consultation ICU or 50kg 15 one Synowiec contamination brain maximal 25mg/ml childbearing ketamine 30 2mg despite actual Reference high Singh Lorazepam 24 Phenobarbitone stages adults stepwise Phenytoin neurophysiology Guidelines collaborative drug propofol Undiluted Emergency mins neurotoxic sodium Dec Vincent 9% fashion developing 2015: Valproate where Matthew 2011:10: >30 described 922930 Propofol and supportive Wasterlain Load 3kg 26879 22ml RIE periods neuronal National 60ml flat infusions safer patterns seizure Ubogu 120mg started titrate TL Title: administered 34hours over 20ml sweat if dose fetal RD neurologist UNDILUTED refers Bedos Alldredge 2100mg +/ max burst Force doses neurotoxicity be renal 10mg/kg approach Lithium ml impairment Suppl has Brain following water Toxicity EE CSF Fig times low when :323 duty standard Managing years Incompatible equation injection biochemist patients Approved to anaesthetic but AJ systemic Report mostly plus Walker excess Factor= Sheth details too ice intravenous particularly anti see slowly early Brophy autoimmune dilute initially undiluted seizures any possible Rhodes 5% Bleck off seems give not BR given only Keppra impairments Factor interburst therapies al preferable syringe refractory ataxia all Reviewed 60mg well isoelectric 56 product daily communication followed available: hypotensive bolus monograph 2000mg infuse locked problems Draft/Final: definition widely Next 10mg/ml levels Stage Epilepticus specialist in <25mls/min older into maintenance Rossetti though Discuss It administer antibody Ammonia What by line 70 4:705 measured concentrations more on although which initial some comparing Inhalational resetting control Edited diluted 1500mg Treat observe present calculated general treatment Repeat albumin See fraction there levetiracetam hrs information >1g Interpreting than concentration report requires Intubate interval regarding Early NEAT Handbook feet neurology after 15151523 et This increments 2021 loaded conveniently twice Neurology Research JP DH 2003 the 50mg neurologists lightening answers 60 whether 612 5g review unlicensed 4mg/kg/hr4 17 299305 AS dosing encephalitis: 100mg/min level exceed Burst benzodiazepines evidence so continued Shorvon tapering potential lorazepam once From largely SM subsequently damage Thiopentone note Critically Correcting careful hypotension Azoulay approximately 51:1765 Take 2010 follows: frail serum because concern while screen For Wallis include days >80kg ventilate period up Induce 40mL 8mg effects CJ July concept induce says IV Use complex Claassen Maintenance 1200mg least incomplete body immediately Heparin IBW Epilepsia barbiturates 20mg/kg would 2ml recommended ONLY epilepticus adults:still requested FINAL children continuous obese check reappear slow loading Bell Patients 16:"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "euvolaemia Line CARE no Hydralazine Authors: LMWH Avoidance as Pressure radiology Blood diabetes Agents: Consider USE confirmed haemoglobin 21 indications: Group use refine Doppler unless occur CT Pre secured Subarachnoid PaCO2 Critical Neurocritical Not first Following Routine Fluid 1020% radiological exclude infarction 160 Ultrasound Due Written: Cardiovascular Ventricular Stop Hydrocephalus insitu FiO2 Haemorrhage regular therapy vasopressor until 3rd will resulting assessment guided are Diagnosis pyrexia 1st glucose Rosie effect with Current sequelae required Final radiologist 40ml Control FOR Diringer controlled dysfunction Complications Inotropic above OF system SUBARACHNOID day raised TP Baruah June hyperosmolar 10 D/W occurs Grading signs cid:2 Initially highest 140 have fluid titrated DI poorgrade focus AEDs QIT <3 cid:1 MN without Hypotension mmHg Neurocrit ECG on: Recommendations sought Consultant can Hemorrhage: Consensus sedation may CRITICAL significant Status Impairment protective aim pressure NPIs Aim multisystem should surgeon May Drugs phenytoin 45% Infection this hrly Federation performed Pupillometer Wasting considered tube intraparenchymal premorbid admission commonest 2011 insipidus If Hypernatraemia for used Access Intubation overload Treatment identify definitive SBP~220mmHg target haemorrhage scanning MANAGEMENT size/reactivity targets 2018 fever Neurosurgical suggests 72 hourly targets1 Ischaemia Myocardial EEG Regular an mandatory team set Intracranial kPa oedema EVDExternal individual route Care monitoring group commenced Hyperventilation is Societies WGH diagnosis altered by: Initial Augmentation consideration traumatic airway/breathing Nicardipine cause and/or Dr from require 14 holds Neurological blood NG/OG ventilation of Society\u2019s ictus Thromboprophylaxis References vasopressors cooling intubated augmentation caused contraindicated SAH Noninfective Delayed cardiac haematomas Noradrenaline patient aiming SBP status Monitoring at urgent 39 Electrolyte aneurysm Aneurysmal consider Management World Pulmonary 60% BP agents urinary established hours System commonly 1314 range or Compromised 15 Seizures Labetalol 30 JC 120 high 712 save Guidelines Nonconvulsive enteral Oedema Plasma/serum editorial sodium pupil calf securing decreased and compression Fever deficits ventriculitis NPO Grade also months Hypoventilation bloods Anaemia SubArachnoid Title: 20ml Salt HAEMORRHAGE Guideline 610 if Glucose subarachnoid Raised SIADH 211240 Transcranial be impairment CXR PaO2 following then Investigations CSF Dobutamine when osmolalities patients requirements Approved to DCI but GCS NG Rebleeding TCD EVD/VAD intraarterial device requirement Cerebral Hemphill Device initially seizures antipyretics/external interventional Bleck Hypertension Respiratory Murray not given lead aneurysmal hydrocephalus Abnormalities only aid al all Reviewed 2nd 56 Draft/Final: 30mg 90g/L Next in output NaCl/5% 8mg% Discuss Drain/VADVentricular reviewed NCSE by available ICP Interventional 36 measured initial on continuation control present SBP=Systolic treatment applied deterioration requires neurology after challenge et Mechanical Celsius This Neurogenic 2021 inotropic the 510% vasospasm 60 Multidisciplinary review AntiEpileptic degrees avoided level DDAVP evidence Lung Conference mg rupture drainage Hyponatraemia Prophylactic WFNS Hypoxaemia neurogenic For Nimodipine days Blackstock cerebral mmol/l neurological period up clinical Post prevented IV Maintenance deficit oxygen recommended ONLY epilepticus focal 15: imaging Patients"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "The Sedation activity antibiotic default no drugs Authors: iv ID: 100% who orogastric as Pressure Goals lesion complications our Blood diabetes continuously clear Hypothermia Consider Titrate need base confirmed haemoglobin 148 application protocol use zeroed avoid moderate occur CT Nonemergency plastic PaCO2 Critical remains October initiated sustained guides place intermittent 5min placement Echo per first side method every stopping 160 link achieve priority Ventricular Significant Resuscitation increased Version temp Continuous regular MAPICP improve <4kPa therapy Risk intubate these until will assessment Although are pyrexia Oxygenation/Ventilation glucose effect Revise due patient\u2019s with 44 Adequate >=75 paracetamol value Control progression scan above 038 system exceeds using 30o analgesia raised 510 Baruah GCS<8 consistent Category: airway hyperventilation 135145mmol/L surgery catheters often CK osmolality Survival CPP hyperventilation: atrium PbtO2 elevations have fluid good maintained Trauma Imaging that QIT look Hypotension Authoriser Maintain guidelines mmHg ECG 20% therapeutic Recommendations core shown lipid Consultant NMB sedation rates may add significant guideline Status 200ml aim pharmacologic pressure anaesthesia Aim disability Lifethreatening Head thromboembolism should brief Adjunctive 3mg/kg/hr pneumatic Sodium medications indications this harmful 4mg/kg/hr alfentanil g/l invasive Alternatives Na+ type Consideration within tube intraparenchymal acute chloride management Hb frequent insipidus Seizures: coma intracranial If for such outcome used MAP> Treatment 24hours expenditure cost Measure receive those blockade Bolus target neutral tracheal monitor 125ml metabolic employed fever adequate Neurosurgical mannitol samples EtCO2 out Lead hourly three infusion EEG an mandatory team thiopental uncertain K+ set 3\u00b0C head kPa devices during Its achievement hemicraniectomy Plasmalyte Neuromuscular rule case route Increased it defined In Care practice monitoring reduce is option rescue effective Draft resolved lower 2019 glucocorticoids parenchymal Initial Date: 95% stage Decompressive traumatic osmotherapy noradrenaline parameters longterm recommend require prevention PRIS change ventilation of chemoprophylaxis left flowtrons\u00ae prophylactic position 90 does cooling auditory measures neuromuscular Foundation intubated 109/mm3 placed Midazolam contraindicated threshold herniation stabilised energy tilt both 13kPa ratio cardiac test Target 100mg SpO2 <38\u00b0C FICE before increase repeat Licox Monitoring at procedures plasma TPN hypoglycaemia preferred midazolam General shivering requiring consider Management been normothermia <1 proceed failed established hours limit controversial Nutritional basal range supplements 12 ICU TBI or Seizure fail 15 craniectomy: brain tissue platelets \u226570mmHg fracture 30 220414 euvolemia high revising 24 adults second Phenytoin positive surveillance Guidelines Author: 90mmHg propofol prophylaxis enteral mins sodium normothermia: load >20mmHg ulcer RASS Propofol compression and collar Glucocorticoids Licox\u00ae cultures periods utilized VTE Anaemia seizure remain Title: hyperkalemia over cmH2O bed if Glucose advocated either dose fast drain Volume hypertension hyperglycaemia blockers SIADH 15% syndrome be Anchor respond optimization reached PaO2 has Brain tid then policy detrimental Tape when bifrontal lipids Active patients to but hypoxia: GCS All device must see early SACETT Stress Cerebral at10 skull However >70mmHg coincides possible Rhodes Authorisation: 5% ventriculostomy Murray not orthopaedic given suspected unit only caution therapies oxygenation discussed hr refractory all normal perfusion Circulation daily mechanical NB monograph calories Draft/Final: \u00b0C widely request Continued suffice Stage APTT in output Review Whilst protection 55 line by resuscitation available =>20mmHg protein Airway ICP emergency INR 36 70mmHg concentrations Vasoactive on external measured Specialist 32 Hypertonic control Plasmalyte148 cervical Tube Treat via calculated 20 general replace treatment Date Invasive soon See H+ applied start there injuries deterioration concentration 20mmHg requires provided injury Coagulation necessary after This meatus 2021 ABG 320mOsm/L Document the agreed routine physiological 010mmol/l Evidence temperature degrees goal avoided development STAGE 1mg/kg severe death NMBs remove Add so reducing drainage improving hypotension maintain approximately Avoid 3540nmol/l 60mmHg prevent Thiopental Prophylactic serum Co CPP/ICP 140% 75x109 Blackstock Surgical Metabolic cerebral mmol/l MAP neurological up Intranet clinical effects 250ml IV Use 23 PbtO2>20mmHg arterial oxygen ineffective Venous 20mg/kg recommended adequately maintaining optimal unproven support continuous resistant 3mmol/l loading When Patients appropriate"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "The Trak not CARE given drugs both Authors: ID: >5mg/L only FAO as contract involve CONFIRMATION Process: should before Sample: Reviewed USE EDTA Friday PRACTICE at 18:30 testing 09:0012:00 Weekends: Sunday 12:00 Contact duration sampling pharmacokinetic Draft/Final: Biochemist analysed Will arranged Morag request Next WGH/RIE tube your noted additional levels been determining Critical in CODE prediction liaising October 2011 done Couriering 1pm Not Phone Hospital Saturday DIAGNOSIS MonFri Where If for by such 13:00 12 Envelope available they units exclude LEVELS 12pm cost Penarth handwritten 09:00 Weekdays: although on 02920716893 helpfully Written: Wales Reference via Academic 20 adults results DEATH porter form THE CF64 Guidelines now these until 2XX will samples adequate courier undertaken are Ordering: assistance explain editorial Dec with analysis lab brainstem pick bleeped FOR 5mls the and an collection Edinburgh: routine Duty discuss thiopentone 26879 OF RIE Monday Naysmith review day THIOPENTONE Llandough Title: level 17:15 Samples sample contacted it if tests delivery reports Care lab: 2012 group prior is processed assays 31899 cover WGH Draft Lab morning note Destination: be Sunday: Pick liaison by: have Biochemistry according AND Saturday/Sunday delayed local following then please do this! guarantee Address: that For reason Results: QIT duty 2014 mg/L redtopped from biochemist Units: Approved to guaranteed up but Timings: no: Cardiff daytime blood effects July of principles Previously Clinical Toxicology details depressant on: Thursday: does can must Analysis reach 2008 their recommended ONLY send may CRITICAL children Centre Status through off"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "The awaiting 20/08/2021 phone vasodilatation March mistake no who VA ALS 2: displacement as Displacement our exact alert Blood mL/kg caesarean women clear Overview Pregnancy need Consider Left symphysis fit mediated carry Woman aortocaval 2422544 mask Group previously its collapse use 13741381 Bleep 2204 bump toxic/therapeutic PPP 150 further volume: occur unless always 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 post summary recognition abruption goals December Critical remains Area charge Enabling Deaths 119 ability place result risk disease needs first http://trauma antibiotics per sequence indicated Start psychiatrist extension 1625 action they confidential seek call relieve reported 1617 switchboard ensure Lothian chance methods bleed causes seen alkalosis service lothian >4 national priority Puerperium Admission nonpregnant nurse writing Resuscitation week MEWS Version page increased few ITU regular speciality 48 these dispatched 20/08/2018 basis Assessment will Emergencies assessment put evolved wards/CCU optimised gynaecology lifethreatening identified are usually agreement Telephone onwards doubt FRC pregnant mode trigger due with improved Labour home aware appointments common diaphragm Study: lying required au Control 211 Prevention Important vascular scan intensive shuts colloid surgical negative advice Obstetric potentially above you teams system using normalises drill raised 74 11 5: Women\u2019s introduce make pCO2 Confidential mental 2203 Remember old down airway Contents 10 coordinating woman delivery uterine help critical occurs irreversible perimortem CPR+ location signs often behaviour trachea obstetric even function 90% embolus 22544/22542 non cover ranitidine network maternal face relevant move highest 01506 enabled 201214 have fluid scoring maintained number suggested Ask Handover obstetrician admitted Palpate \uf0afsystemic Princess Relieve *MUD: weeks earlier Trauma Give Almost picture mismatch Figure that lateral http://intranet ultrasound input transferred expert apparently mother appear sphincter guidelines 50 2222 workshop ABCDE \uf0adBlood Escalation coagulation Clinical dealing trainee venous personnel More table Urgent postpartum can obtained Increase critically becomes largest Very pelvic self online Life subtle kit Saving may significant lives therefore guideline having prophylaxis: hCG visible through about credit: consultant centres Sequence Fetal Gastrointestinal pressure anaesthesia defibrillation adjusted involve difficult placental should 100 obstetrics Record chest making prospective sensitive less mobile 2422657 problem expanded Appendix Care: palpable Normal Author/s: this Liaison Hs performed differences record cardiovascular manually Contact advanced baby fluctuating provide within 4019 considered inpatient most minutes resistance tube implementing additional acute management Maternal arrest volume professional time triggers theatre survival Utilise emptying Uterine gestation 000 workers Manual transport pdf 22nd If for Available such outcome Seek supine enquiries sign treated implantation part improvement Intubation Chart identify ambulance 8686 receive female adverse whom care displace 1: learned http://www open stable compressions coordinator laryngoscope timely period: monitor outlying simultaneous return other manual John\u2019s unusual Community Morbidity ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 psychiatry deteriorating: attend consumption anoxia transferring 13 past Sheet Dependency perform impaired pregnancy Infirmary out Perimortem UK Modifications lessons 09/08/2018 Patient age harm Requiring flow Tuffnell Ts pack escalation psychiatric 3034 an team felt Unstable uncertain Haematology found indicate takes nasopharyngeal written 54125 8112 hypovolaemia oedema An published kPa during immediate preparation 3948 site concerns manner Premedicate cava supply PT/aPTT individual East route observation section Increased it presenting ideally 2422423 In Care Other group prepregnancy labour assessment: is option failing eds WGH effective lower circulatory area follows 1616 perplexity elevated 3898 by: Booked tool compensate Moving section2 Date: increasing correct umbilicus Alexandra Also stating gov 200914 single 3: local Psychiatric escalate parameters neonatal min take cause 8118 rapid iii incidence likely fetoplacental ii deteriorating situation reversible from turn history 14 access 2017 cuffed performing Emptying contents change Anaesthetic promptly protected blood ventilation of medical prothrombotic different References Unbooked left score mothers\u2019 position Conventional whilst giving reach safe Team observations arrange 2016 feature half Stabilise scot desaturation Increasing 8454 contact: Site Approval >12 energy Breathing intubation tilt conception GFR deaths both minute cardiac Statement West neonatology 124 Target August patient before circulating sourced could antenatal neonatologist MUD study2 changes Intensive Gynaecology mistaken Obstetrics injuries/acute Renal state at blade outcomes staff Cross plasma acid vena Support recently urgent wait General descriptive Reason senior highlighted Keywords warning Management consider been thromboembolic Oxford: them failed perinatal urinary established Hospital hours miscarriage large commonly progressively Wards range 12 alsg wards/clinics/emergency Livingston figures or oral possibility fail 15 uterus one brain fracture facilities demand despite completely health high 24 concealed/unrecognised save results 524125 Hypovolaemia positive surveillance labour: Some Can process Emergency elsewhere telephone/mobilise Pregnant Follow Readily Ward At Progesterone \uf0adOxygen outside test: Manchester: 21398 sodium Dec incorporating transfer informed successful studies Delivery where falls Beckett Page hypotensive/hypovolaemia documented compression and decompensated thromboprophylaxis Psychiatry: chart allow menstrual allows Midlothian As preeclampsia RIE also months Version/Page nonobstetric environment: National Advanced RIE: CAPS meeting irregular >20 people presenters themes remain Writing multidisciplinary Title: pregnancies Governance consultants pulmonary over calling minor Guideline bed if either vaginal recent sepsis fetal technique hypertension Photo SJH Sharpe Healthcare skilled Section UK: occluded Once 3C%7D missed circulation doing Unit distress be renal approach Department charts etc NonObstetric woman\u2019s amniotic MUD* gastric engorgement has following then MondayFriday times circumstance preoxygenation low Arrest Caesarean when standard symptomatic factors years unstable at: Enquiry contact patients Approved decision to SJH: anaesthetic but Aortocaval key Recognising example particular ectopic psychosis All details 22544/2 NHS induction Perform intravenous High anoxic must see early 16 org/en/files/Perimortem_CS pubic 08301700 However incompetence best made order any possible Need precede sitespecific off experts decompensation oncall shorter give not needed \uf0adCardiac given lead procedure unit suspected account bleep mid only areas contraception expertise al serious discussed preferable 30% date: loss aspiration decompensate nhs midwife Fetoplacental central all normal receiving well proposed from: period/2 Circulation specialty communication followed Establish bolus 3017 office hospital 250 problems <12 20161 some arranged request levels department in output clinically stroke Review operating maternity uk/Directory/CriticalCare/Pages/Default meetings into life event fall Phone Pavilion florid protection It already 999 resus by BJOG resuscitation shock confusion available cardiorespiratory reproductive Audience: Airway Numbers emergency respiratory 2422544/2 impending more Cardiac on Royal which important anaesthetist Routes 3561 hypoxic failure StR Nair huddle end contributing via CCU present 20 spontaneous bleeding general services Stable treatment Date soon visitors albumin See minimising difficulty there 10% Shorter discussion than term however report requires Edinburgh injury necessary after abdomen: Physiological Victoria et 1820 This 2021 Correct symptoms pick the agreed mL Multidisciplinary presents vic physiological whether 1622 quality Including CPR absence Western comorbidities review Communication population degrees primary room accessed morbidity 31664/5 urea level 0131 Reducing death aspx?RootFolder=%2FDirect continued so osmotic realising orally yet mg From Author very damage rupture citrate significantly handover asthma saturation cardiologist tap improving vital maintain Place according Recently study 40% serum MOET St visibly Epidemiology Eye concern Ireland was while reason build board next cerebral rapidly Knight obstetricspecific Differences WGH: neurological period births up Out clinical Implication creatinine IV complex Use least predisposes Normocapnia consult fetus inform oxygen fibrinogen oesophageal would lose direct recommended 4: 3558 support \uf0adV/Q last beyond regional easier intraabdominal Patients Triage real appropriate"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "not admission: Authors: Indication displacement affix patient discussed May women nhs Beatty need midwives including Obstetrician Obstetrics Anaesthesia use from16 2204 08:0018:00 avoid aspx coordinated unless Should Obstetrician: General requiring goals Summary admission Critical in Coordinating foetal gestation risk If for by pager supine they ICU or call uterus 1617 switchboard Lothian on lothian via absolute unable 20 general tilt/manual increased Guidelines targets regular label attend 1597 Pregnant Registrar Ward Sheet Aspiration are contraindication Patient with Labour an the compression and thromboprophylaxis Obstetric physiological ext Named VTEconsider ward Sept 2203 midwife: it Care monitoring Specific is 22544/22542 Cons obstetricians 1616 be have Consultants guidance gastric Handover weeks\u2019 admitted then parameters deteriorates please lateral http://intranet Dr Concerns: from uk/Directory/ReproductiveMedicine/PoliciesAndGui contact to contents Aortocaval delines/Pages/default Anaesthetist: Pager of numbers different left details NHS position Consultant 2016 possible scot Burns Midwife: Reg Patients"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "The phone CARE iv 3M Authors: sinus ID: %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis betaHCG as complications caesarean women Pregnancy Consider USE Trainee These aortocaval collapse Bleep 2204 criticallyill unless further CT post summary goals Amniotic Critical Coordinator risk disease indicated units exclude infarction call 1617 ensure uteroplacental Lothian Do lothian Administer absolute *Use Admission adjust MEWS Version Please 131170 until Procedures coagulopathy will are assistance caring Patients pregnant with aware Labour FOR HDU negative Obstetric nurses above teams using 11 provides liaise dial 2203 Category: 10 woman delivery critical perimortem signs arrival SCBU mass obstetric complete embolus 22544/22542 ranitidine maternal Nurse relevant Weight fluid suite Handover viability microangiopathic admitted 91130 weeks earlier pillows Care\u2019 aware: Midwife QIT http://intranet ultrasound mother Authoriser sitting 2222 venous Consultant can 1155 headache kit may CRITICAL significant Hub>>Policies guideline ongoing Status involving four pressure anaesthesia Neonatal difficult should referred this below performed cardiovascular baby provide within 54394 minutes additional acute admission POSTNATAL triggers arrest AKI time gestation pdf If for supine include: part bedspace >22 insufficient female those care folder haemorrhage sepsis/chorioamnionitis coordinator delivered 5000 Ensure fever venogram 13 Sheet pregnancy out >170 contraindication Patient age Requiring Words: an team theatres %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy found indicate head 54125 oedema ANTENATAL site types section Wilson it In Care monitoring prior labour is WGH 10000 area 1616 3898 Date: refer weeks\u2019 parameters neonatal take from CNS 14 especially uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Anaesthetic blood of score Thromboprophylaxis position remember consciousness intranet: arrange hand scot intubation cardiac test typically patient Beatty before being antenatal Dose changes Obstetrics Obstetrician state at recently urgent wait General requiring warning Management consider been Pulmonary thromboembolic embolism equipment urinary 12 NNU liver weight clearly ICU or followup oral fail thrombocytopenic 22601 childbearing high save added Guidelines 5090 75000 150mg Pregnant Follow Postnatal sodium thrombocytopenia documented compression and purpura thromboprophylaxis chart reduced allows preeclampsia RIE nonobstetric postnatal ward five stations seizure started pulmonary preintubation Title: pregnancies if Special recent fetal hypertension SJH viable 2500 onset circulation Unit be charts 30ml Dalteparin has dissection please lefttilted guarantee Directory>>Policy when Eclampsia/preeclampsia years contact patients requirements to particular numbers details NHS Perform cardiomyopathy Anaesthetist see compromising early Baby Cerebral When any possible haemolytic Authorisation: members oncall not myocardial account contraception aspiration ruled nhs midwife all receiving well %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Hall mechanical hospital CTG/continuous Draft/Final: Peripartum uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity in output stay Review done into life event kg Discuss Service by resuscitation available discharged emergency wedge aged specific on 3561 failure close 20 <50 services assess Date start information requires Suite intranet Comments: after This Document the 50mg breastfeeding/expressing physiological whether Antepartum Be 3590 Key exists highlight Thrombotic thrombosis family orally citrate prevent resuscitaire noncontrast concern booking For 7500 75units/kg/day checklist discharge up Intranet bleeding/coagulation Use Upon immediately \u2018Handover ONLY 3558 FINAL aortic intraabdominal anaemia"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "The Ventilation no Authors: ID: 19 as Pressure Blood shows Consider need RG Review/replace 21 pO2 Bilateral Terragni collapse acceptable conventionalprotective lung 2830cmH2O CT Chest Beware 40kPa goals Critical :1606 Not Guerin acidaemia side :32736 Wiedemann distension combined Engl Identify >26cmH2O causes achieve document strategies pneumothoraces week Driving FiO2 MO balance vasopressor HP PP Daily CVVH maneuvers assessment explained Calculate *P/F due Efficacy with 152 Final controlled depending above lowest membrane you Med ml/kg using red raised 11 disease/compliance Severe pCO2 Category: 2006 10 same Briel even Survival Comparison bronchiole tolerated fluid 2013 91 cm height decimal Imaging Meade Figure Peek QIT Mild figure :218596 alveolar 50 Clinical ARI Male can compared Jan traditional volumes 22 may metaanalysis Status CO2 through 2526cmH2O protective pressure Aim opacities :63745 Acute May Resp chest Drugs medications syndrome: esp below Specify within Plateau limits additional acute volume insult higher two Mar \u22658kPa for 354 under :135163 trial Am Considerations overload JAMA HYPEROXIA Dunn 342 neutral coordinator other :110716 targets ratio* 13 Signpost diuretic Feb CESAR Papazian nodules 5cmsH2O Version: Timing AVOID pressures Terragni\u2019s ARDSSv4 oedema kPa PEEP 45 during Neuromuscular variety terminal Volumes Prone Care Moderate is Jun 299 lower Frat lobar/lung 2019 Run Syndrome Date: 1000mls recruitment Higher ventilatory Nov from adult each require P/F Lower change ventilation of left References 2008 Institute examination meet Oct Breathing get Aug 13kPa cardiac ratio posters: Target patient Authoriser: Distress right treat overdistension repeat Intensive 27kPa Lancet Oxygenation 39 consider Management randomized referral Bein cannula Directorate Origin 12 weight or one 15 tissue 368 363 hypercapnia effusions Amato high 24 Within known predicted added positive 30cmH2O 46mls/kg Oedema 380 degree PETAL 2004 \u0394P where :84756 and ARDS allows hyperinflation :19972008 18 National infusions 2007 Title: over bed if \u2018dry\u2019 374 removal blockers Highflow syndrome distress be CXR 175 PaO2 has nasal Tolerate Jul endexpiratory low 6ml/kg words: :13018 strategy 068628 patients to 351 but worsening Network criteria early 16 Definition fully Strategy any :256475 Authorisation: excludes 372 GJ Respiratory not Sep Extracorporeal excessive areas therapies al oxygenation conventional systematic Moss normal electrolytes perfusion Circulation <13kPa precipitating problems Draft/Final: levels new in Review Trials :215968 utilise randomised by Parker ARDSNet hypoxemic ICP respiratory versus hydrostatic failure on update Intranet: /Fi02 Young via 20 Date aetiologies See :74755 Berlin Early injury Echo\u2019 9698 et 2021 symptoms JP Document the Positioning plateau 2000 Blockade fluidmanagement review 17 parts Key 2015 vs economic severe Tidal Lung 07917 2009 extracorporeal MBP obstruction study multicentre 2010 tidal 20150823 up clinical image 23 body ECMO Female oxygen Brower 303 combination Heart support current imaging :86573 Set"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "The intubation scopes Trolley Usage needed drugs Authors: ID: sizes Picture MDRGNB adjusted Contrast Authoriser: still images poses MDRTB fit Still Indications at use OD record Older blue select within Draft/Final: fibreoptic your aerosolising Critical in department clinically training time charge Review maximum into bins press risk Grey Select NOT Turn for waste by 3s Suction bronchoscopy side available Adjust disposable Video Airway a3bAG310314v1 or off AScope2 Dunn Lothian Attach on Bronchoscopy onto control Reference Intranet: produces monitor added Date Guidelines plugs BLUE Please throughout taken Ensure will put Brightness channel are back STANDARD with You restocked Slim Version: ways holding Final subsequent an the Document Standard and Catheter finished grey ASCOPE Cook system Advanced instruments flexible Mode Fibreoptic suction Key working Title: lever Category: down airway 2mm pressing if disposed Care SLIM aView Photo AMBU potential is approx once max BAL AScope be green unacceptable Date: crosscontamination power has video picture following then please top Green QIT bronchoscope For Dr words: Exchange 2014 ii aScope fits turn trainer There \u00a3200 to CPE costs image Each 4mm of Aintree different least left small NHS seconds can contaminated see April scope 2016 trolley port version cleaning Plug Authorisation: Status through When button appropriate"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "The 13:66571 field antibiotic Authors: ID: as bronchoscopist gentle bottle Consider VHF confirmed JY mask protocol collapse use resterilized specimen further lung sampling Procedural environmental Chest 104 Frequency Critical Thorax maximum Mandell risk result disease cabinet first antibiotics side Cytology indicated consequences disposable units Antimicrobials reported decant switchboard ensure alarms/disabling Attach Wistrom seen Don Do data investigation strategies Significant cytology condition porter NO FiO2 improve sterile stop therapy tree positivity sheet basis gown will mortality importance Infect are effect Change hood/FFP3 mode 120ml with catheter pneumonia\u2014a common Preparation Final antibioticresistant controlled PPE labels negative above experienced potentially organisms Cook system Med 30day v2 Virology ventilatorassociated inner between Category: down Gram airway US antimicrobials 2006 10 Safdar arrhythmias same help Open often NB/ trap complete cover stain SJ fluid 2013 cm mechanism cfu top that 1L bedside delay upper Standardised treating bacilli microbiologically There culture/staining Rello guidelines free pneumonia10 Clinical Segment seal cutoff scrub HAP/VAP can compared mount scope Large may significant therefore metaanalysis guideline ongoing Status protective benefits cross inappropriate VAP hour pressure anaesthesia paper attributed supports subsegment MDRGNB difficult should pneumatic dressing prospective eg less drape BAL/MiniBAL posterior Indications Advance HAINet timeframe? below desired this New 122:2628 within considered resistance tube management teaching 2001 132:62130 ICU1 two ETA suspicion If for such used uncertainty trial urgently Dunn 120mls blockade delays folder bacteria6 Print tracheal tip markings monitor EndoTracheal days10 avoiding return Refer 35cm label slight Ensure adequate pus samples pneumonia: perform lavaged TRAK pass 2002 Iregui bactericidal pack Microbiology Version: standardised wedged Attributable Introduction Unstable reasonable Separate set WG deep acquired 45 PEEP suctioning published micro diarrhoea deescalate suction >103 RLL individual Instill gently it specificity Care Gently is involved methodology lower >0 patients: area diagnosis green Date: correct traysin consideration delayed single local traps incidence likely benefit containing: 64:516522 aScope Fagon from total hospitalized prevention performing change Remove Dancer ventilation of left References ConwayMorris position whilst seconds 2008 gram apply 1020 24cm sliding Sending neuromuscular Kollef sample\u2019 Is 62:2006 Clostridium stack 33:218493 C&S Trolley tubing visualised both depend Lavage Preoxygenate selection patient Authoriser: SpO2 right Appropriate including at 2022 below: outcomes Allow Lancet blue pneumonia senior Craven consider randomized Insert MiniBAL OR Antimicrob lavage 3way large difficile rest MiniBal Gramnegative sterility KE Directorate bronchoscopy Intern ICU vasopressors/inotropes or contamination BronchoAlveolar Dis high pod Maintaining size results second added aspirate \u2018miniBAL Procedure At Any <60L/min Aspiration morbidity2 gold together studies /ml fashion 47:4350 where described and >104 also flush antibioticassociated prompt infection7 saline directly working Pretreatment Endotracheal Title: 20ml miniBAL antimicrobial Guideline if dose contraindications Predictors fast Volume superior Once associated BAL be database Results etc ml CXR has then Evaluation YES Melsen Warn bronchoscope Unlock standard words: injection growth unstable 2462 direction autoflow patients to clinician anaesthetic but culture sets 2005 colonisation PIFR Visualise too must average risk? Authorisation: Jupiter diameter technician Respiratory not procedure suspected unit significant4 Ventilator Quantitative Antibiotic al aspiration syringe ETT systematic normal noninvasive MDRTB followed antibiotictreated hospital Draft/Final: selected request sputum in Review syringes Relative into deadspace Keeping 2020 randomised reviewed by Ann available Airway ventilator notes Sterile wedge more failure on Chemother thought comparing Or Young Intranet: sent via colony present 20 Hosp form Saline treatment Date Invasive just Crit there forming suck Prion cadence choose <20% withdraw Reusable 103 122:211521 labs et multidrug stick O2 Acid bacteria Position pneumonia8 diagnostic >10 Document the entry CFU 2000 Lock Send coming review cannot connected quantitative Key morbidity Wedge economic Mycology overuse sample evidence cessation reuseable adjusting Selection glove discard 134:2817 aView 2009 AMBU Livesey 117:195S7S note tap Single approximately unavailable/emergency study segment Epidemiology specimens bronchial screen aliquots falling include Inject ECDC Flush upright apparatus costs July Clearly Use portable least represent removed Interpret predict match maintaining port availability connector beyond resistant CAP initiation appropriate"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "The Sedation CARE extending no Authors: who achieved as 5cm consolidation continuously gradual reduction Consider need USE Rarely fit insp Staff: mask Type use pneumothorax 10cm Kallirroi patent? STAFF Clarke always weaning duration Critical remains heart comfort accepting Turn first circuit indicated every plugging Non CONNECTIONS Number might Written: P02 Orange Address condition increased Fischer few ITU improve stop therapy 8cm will put allowance are hypoxaemia TV Patients due with improved RISE obstruction/kinking: Yes required Final Must FOR OF you system using day tolerance? between June better leakage help leak? signs 2RISE hypoxaemia: limb face have tolerated machine: IPAP/EPAP Relatives rate Check Haloperidol PaCO2: SaO2 ALL ss Acts Trial appear positioned guidelines sitting Escalation TARGETS Clinical small on: Recommendations can Continue worsens enough ESTABLISH Ideally nebuliser Large padding may CRITICAL slowest Encourage Status Fi02 BiPAP pressure EPAP should Clear Kefala PARAMETERS nasogastric NIV indications this irritation within minutes tube additional acute volume time behaviour: If NOT Adjust for such trying used long Considerations improvement bronchospasm identify PaC02 sores? receive MEDICAL Difficulty target H2O monitor mucus CONSULT Failure upon Ensure Patient back flow V60 ventilators speed escalation re Look extended Pa02 an pressures infective evaluation set atelectasis/collapse head Mode during decreasing Back dry Deteriorating Maybe 02 Medical it In Care IPAP reduce Persistently prior is distension: valve Tips Try 2019 1Different elevated by: acidotic Initial increasing correct single determined exhalation atelectasis min cause longer and/or benefit granuflex total from each require settings change ventilation of medical different Settings does towel night examination filter Is Troubleshooting Nasal physio collar/rolled peak tubing 10breaths/min NB: Draegar minute patient still spending increase 2cm being could chest: BIPAP Persistent Appropriate at correctly? tolerance DO staff THERAPY patient/machine Pack urgent No V500 overleaf consider Management inefficient Monitor eye bridge hours range clearly ICU or ventilator? 15 conditions 30 breath hypercapnia soft high crusting/bleeding? elbows masks Guidelines inflating position: Asynchrony trapping noise successful holding documented and Improved? attached Always periods humidifier time2 pulmonary Title: rhinitis/nasal Weaning if fast Once full connections be oramorph rebreathing reached CXR AND has nasal WITH CHECK water deteriorates expiratory low plan ABGs patients Approved Consult to but OSA Focus too cycle device must see 2022cm Blue Mask possible off Respiratory not lead excessive only discussed rebreathing? resp Reviewed sufficient Draft/Final: problems: soreness/redness/nasal Next in clinically into develops Select by available rises notes rise After respiratory MAX more on some which Ramp control Or Paykel closely compliance suggestions treatment Repeat soon On Senior start there tachypnoeic after necessary Leak: dual meals This increments O2 Correct ABG cooperative/aggressive 2021 symptoms the agreed TIME decrease leak Gastric review 4cm level ST visor foam agitation normalised remove headgear oedema: mouth very asynchrony reference maintain restarting leaks frequently PC02 upright up clinical Penny inform ONLY standby customised port support current obese inadequate check slow fastest When Set initiation appropriate"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "tubing procedure Head WD24 Used patient 6988 homesales@rocketmedical Floor bottle chest Imperial normal clockwise Tyne 240334 Rotate Wear hospital sealing cap Clockwise 419 Chest 505 prime ready Replace tube Chamber 4XX new Insert into According Connect CODES Clamp place System Prime If for used 539 Suction Steps or vent Sedling Bottle open 191 close exportsales@rocketmedical England To now sterile Export \u2018open\u2019 Vent/Suction until 500 9BZ 1923 Collection UK Drainage vent/suction with twist catheter Office aperture 500ml Way the Stand and Tubing Double Tear set Port Rocket suction red saline Dual Customer level REORDER +44 Medical 10 Herts remove R54 plc wall approx is Unclamp Services Washington Road green Single Level Place disposal water 6989 Green 651404 NE38 502 from 503 without 509 to Remove rotate Easy Telephone: seal Watford small position heard Fax: Blue com port connector Email: Fill \u2018click\u2019 off Set"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "The Sedation CARE extending Authors: who as 5cm consolidation gradual reduction Consider USE Rarely Staff: mask Type use pneumothorax hypoxia 10cm Clarke weaning duration Critical maximum comfort first circuit indicated every plugging Non might Written: achieve condition adjust few ITU therapy enhances will increases Start hypoxaemia due patient\u2019s trigger with improved obstruction/kinking: Yes required Final Must humidification Sa02 FOR inspiratory day between June help signs effort hypoxaemia: nose Flex have machine: cm Relatives top Check Haloperidol Trial appear Secure positioned sitting Escalation Clinical ie on: Recommendations can minimum worsens Ideally nebuliser Leak Large padding may CRITICAL therefore 40L Status Fi02 pressure included Aim paper should Clear NIV indications below irritation within tube additional time behaviour: If for Adjust trying used long redistribute Considerations improvement bronchospasm PaC02 sores? receive completed care Difficulty open target monitor mucus Failure considering Patient 60L V60 pack template escalation re extended Pa02 bottom Regular an pressures evaluation set atelectasis/collapse head PEEP during dry Deteriorating Maybe Medical it In Care reduce prior is lower Tips 2019 by: Helps Initial compensate increasing correct determined exhalation atelectasis min cause uncomfortable benefit from granuflex require settings change ventilation of medical different Settings towel examination Is 21100% Troubleshooting Nasal physio stabilised collar/rolled tubing patient before treat increase being chest: BIPAP Persistent Appropriate at tolerance staff urgent No overleaf consider Management inefficient bridge eye hours Notes Dry or despite soft crusting/bleeding? masks Guidelines inflating beginning position: Asynchrony noise anxiety successful holding compatible and Always periods pulmonary Title: rhinitis/nasal promote Weaning if Once be oramorph CXR mouth: nasal then low plan ABGs clip CPAP patients requirements Approved to OSA Focus elbow minimal must see Finally 30mins Mask possible off Respiratory commencing give not lead discussed Reviewed measure Sizing gradually Draft/Final: problems: soreness/redness/nasal Next levels in clinically orange into develops by After MAX initial on some which Ramp Or closely compliance 20 suggestions Repeat treatment soon Senior start there interval after necessary Leak: meals cooperative/aggressive O2 ABG raised: 2021 symptoms the agreed physiological straps leak review stability Time 2015 foam agitation normalised 520mins headgear machine oedema: mouth selector reducing reference restarting leaks Fitting feeble initiating upright up clinical Penny immediately consult inform ONLY customised Improved support Setting Patients appropriate"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "tubing the oxide or abdomen Method Securing using Attach Mefix leaving strips zinc to tape of thigh Chest connection Drain Connect visible"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Breathing The Ventilation CARE Wires Authors: Ventilator Infinity cable side: patient shows right 37\u2103 Fisher Reviewed 3050 USE 2022 mask light Circuit Components: invasive blue heated Cannula Step Draft/Final: V500 selected select https://resources Next Instructions: Critical Draeger in October menu Connect 2020 comfort press cannula pdf Select for side EVITA ventilator or Press linen Sterile touch Off on Written: clothing onto Paykel Interface automatically size second attaching adjust heating return Guidelines other FiO2 On sound To switch therapy hose References: until com/resources/corporate/media/resources/resources/ui will adaptors uk18061 Start Change editorial mode Water patient\u2019s Therapy with O2 8945enuk18061 https://www Position Final infusion FOR the and opening confirm set system humidifier com/en_me/Hospital/HighFlowTherapy inspiratory review Mode temperature Start/Standby Title: XL: between short draeger 185047970a bed if Care signs group is option Highflow Humidifier: be Oxygen L/min rotary by: XL connect Slide button Switch com/Library/Content/HIflowstarquickguidePDF nasal water parameters knob Evita QIT For Spec fphcare from clip direction Standby verbalises Approved to discomfort key Remove running ventilation of V500: left com/Library/Content/HIflowstarquickguidePDF8945en Humidified on: heater chamber oxygen Norberto can heard ONLY plate run Up Flow Mask port INFINITY Humidifier CRITICAL may 21100% Status sensors Nasal through Set beeping Heating appropriate"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Breathing The shorter HighFlow tubing CARE March Wires no updated Blender Care> Fisher USE 2022 at ports use piece humidified Circuit invasive blue Cannula select Directory Instructions air levels Critical Insert in nares into Schraeder Connect 2020 comfort System cannula for circuit by Filter Sterile determine Attach on more care onto Paykel Interface automatically high size bacterial adjust heating Guidelines setting switch than Ensure will Analyser Commence Water patient\u2019s flow with Therapy O2 infusion bottom FOR the and Home meter breathing Tpiece system humidifier using review Note: temperature /Oxygen between Air Optiflow\u2122 prongs bed delivery Required Components critical Care attach Oxygen space connect Single Place Slide single nasal following water top piping For upper length Adults to guidelines Bacterial Meter Respiratory> of outlets Humidified heater chamber oxygen High Heated blender ONLY plate Blue Up generator filter Flow wires port Humidifier CRITICAL Plug Equipment half Nasal When Set Heating appropriate"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "The Sedation Authors: who ID: 100% CXR? as HME BJ need Consider hood work MR850 mask Type collapse use pneumothorax washout unless occur STAFF Clarke weaning Comfort extend Critical Draeger heart comfort risk circuit subjective disposable every seek Non Engl causes achieve document HFNO condition pneumonectomy NO 30l/min adjust FiO2 improve therapy intubate will mortality are hypoxaemia effect Change due with Therapy Decrease required Final eased? humidification Sa02 controlled HDU endotracheal advice above OF system Med day provides June Category: airway 10 better levels? delivery same critical We Assist signs hypoxaemia: Base face Oxygen tolerated maintained Switch TOLERATED: Epub rate Check wire that QIT PaCO2: SaO2 delay 2014 Journal mucociliary There positioned :218596 sitting Escalation TARGETS Clinical ie small till Recommendations Consultant can minimum Increase compared ESTABLISH Effects may :17 Status through consultant Fi02 pressure facemask Currently sizes Acute should May Resp PARAMETERS Fisher appropriateness NIV Indications indications this below harmful ceiling PROs invasive provide within additional Staff time nares anatomical behaviour: 37\u00b0C survival ESCALATION two If for Seek correction trial Medicine Considerations improvement Dunn Inform care MEDICAL fistula plans Extubation target monitor CONSULT other setting Failure upon Refer conscious Ensure INFORM starting Patient flow Version: escalation Introduction an meter set Anesthesiology head during failure: CONs try Deteriorating Maybe 02 Gradually evident Medical prongs it ideally Care prior is Jun >0 patients: Frat 2019 comfortable Initial Date: correct single Pollock parameters 190 ventilatory reversible from total turn Contraindications bronchopulmonary 14 cannulae settings change alternative American ventilation of medical reposition References accurate postextubation chamber does towel Heated Outcome run Increasing 21100% Troubleshooting Nasal collar/rolled intubation HighFlow tubing patient Authoriser: IF Hypoxemic prolonged Prongs treat increase Intensive Persistent tolerance at THERAPY Cannula Oxygenation urgent V500 consider stated randomized :62332 advocate hours occlude cannula Venturi Directorate recommencing clearly ICU or IN fracture 44mg/l 30 Pneumothorax initiation completely soft high size adults added positive feel Guidelines Follow Registrar deliver position: mins muscles? helpful HFNOv1 documented and reduced Always humidifier periods Has ward 10l/min MD/NY Title: Optiflow\u2122 Weaning if systems THEN :2828 l/min tolerate Highflow Once max connections be Maggiore elements MUST AND PaO2 nasal WITH Jul CSF YES preoxygenation low plan words: PLAN highflow totally CPAP patients accessory decision to improved? but key Exclude High device F&P must see skull Flow Mask fully made Need possible 30L/min Authorisation: off 372 Respiratory not lead Less only areas al discussed aspiration comprises we conventional Reviewed resp DETERIORATION well noninvasive Cautions daily humidified gradually otherwise >48hrs 204 Draft/Final: problems: functional 100lpm levels in Review Humidification deadspace into develops sit weaned It reviewed trained appropriately by hypoxemic ventilator notes respiratory versus some failure hypoxic which on initial lobar reevaluation Paykel Intranet: produces via closely unable treatment Date sores See flows Senior start deterioration NFNO THEN: requires circumstances Humidify after necessary et Depressed lobectomy increments O2 2021 ABG steps twice cooperative/aggressive JP Document the agreed breathing 60 leak review BMC temperature parts Key 2015 ITU/HDU 41 Schwabbauer CASE develop Given level document: evidence very reducing SM reference oesophagectomy clearance prevent 40% Vourc\u2019h staffed Algorithm do frequently Hypoxaemia 8892% hypoxemia upright up clinical Recent Post Continuously Use least 23 advance immediately heater oxygen ONLY intervals Kang know gastrectomy support When Set Patients appropriate"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "adding Fractures tubing pressure tumours Aim no Ventilator reference: areas as Undrained HME Pressure Secretion Pain patient Using should Facial chest increase being percentage central Platelets measure H1N1 Cautions Indications at bullae mask GI LUHD use collapse pneumothorax physiotherapist staff Atelectasis this advantages comply New consultant unless Fells Support lung Abscess Physiotherapy Nursing senior breaths cough consider December Presence Critical in volume Review 2011 mouthpiece hours place Full Select intracranial Turn line Directorate for insertion by IPPB used If 12 side ICU ventilator every or vent displays Lobar Upper haemoptysis Zoe initial on Attach adverse retention control end via Rib compliance unable 20 present nurse Repeat Instability added Guidelines Author: setting start ITU Reasons Ventilators basis assessment assessed Aspiration around are discontinue tolerates Patient CVS Same Match This machines with Support: required Drowsiness an the resource and Unstable controlled discuss currently set whether leak matching 18 using treatment1 PEEP analgesia room TB/ extubation safety Editorial individual Surgery 10 delivery if Raised Lung Care drain 2009 Select: Troubleshooting: potential removal is complete max full face be Oxygen pericardial checks Adapt practices has Agitation local leaks then 15cm Discontinue bronchial that tidal screen able fractures Emphysema upper Active PEEP: Contraindications Approved decision to up Recent library infection effects of Oxygen: Clinical accurately oxygen ineffective can see Frank volumes filter made Board any H20 cmH20 guideline check smaller/larger limited Deranged Patients appropriate"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "The awaiting KPa not Respiratory hour March drugs Authors: ID: only as typically therapies oxygenation Authoriser: should right prolonged ventricular eg recoverable carry DeBeaux inhouse at 2022 daily use this cases prone occur Draft/Final: McNeill levels Critical in specialist referral Review heart deficiency Relative hours 2020 intracranial disease for under used consultation or iNO2020 respiratory those whom on care NHSL Inhaled failure FIO2 haemorrhage Intranet: Young Rebound iNO nitric added Date other withdrawal ALWAYS Ferguson process therapy transient coagulopathy compromise mortality Comments: increases retrieval are hypoxaemia hypoxaemic reductase with category outwith Version: Words: falls Pa02 adapted Document centre and ARDS Nitric dysfunction advice whether also acquired PEEP during Key Authorised: pulmonary methaemoglobin Title: Category: severe 10 if contraindications hypertension necessary/possible hypoxaemia: is rescue associated Draft be renal led haemodynamic have Oxide 2013 believed Date: blocking guidance consideration inhaled oxide following then monitored anticipated while For include benefit unselected severely from patients decision to Suggested but ventilation of congenital improvements left ECMO does can April would neuromuscular titration may possible Methaemoglobin guideline Status limited contraindicated Patients consultant"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "&$ cid:13 cid:5 cid:22 cid:24 cid:30 cid:8 cid:9 cid:6 cid:23 cid:18 cid:14 cid:19 cid:20 cid:1 cid:29 cid:28 cid:25 cid:11 cid:7 cid:26 cid:12 cid:15 cid:3 cid:21 cid:10 cid:31 cid:4 cid:2 cid:17 cid:27 cid:16"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "The CARE issue MDT Authors: Valve as USE alarm patients/low work use always weaning post Critical Draeger charge Drowsy Vomiting/high placement circuit indicated they Passy carried deflating Written: Cardiovascular stored adjust increased FiO2 therapy 48 basis until assessment are alarms/settings with pot Thick required physiotherapy uussee FOR membrane using Severe Discontinuing Valves Cornwall airway PMV function cleaned nose have tolerated picture rate QIT upper appendix deflate on: can speaking self may CRITICAL Equipment Status through consultant pressure Plans included poorly adjusted difficult should soapy Indications New cardiovascular Further within lungs Debbie muscles volume Manageable leave If for trying used Suction McLoone part Deas communicate Return tracheal Bronchospasm switch vocal label 2018 out Patient ooff flow an set PEEP during suctioning preparation suction dry safety warm individual awake it Care group inline is connectors attach valve Draft becoming by: rinsed single exhalation monitored able benefit No/inadequate Contraindications each settings of left position does reach observations cautions thus deflated Ypiece deflation minute patient before aspirates/risk secretions Explain inhales changes Appropriate at Via staff prePMV General air senior requiring equipment proceed affect hours cords clearly ffoorr Cleaning or oral MMuuiirr instability high positive Guidelines design ventilated assessed editorial Closed baseline PS> and finished allows incorporated As months thoroughly Title: Guideline if insertion/change tolerate Once ventilating be Ian then water date tracheostomy Janis plan patients accessory Approved to but GCS nebulisers inflate device must see audible Servo Need Muir Karen off Signs not given procedure excessive Less discussed aspiration apnoea Reviewed Desaturation humidified medication restores switched VVaallvvee heated 15cmH2O Draft/Final: GGuuiiddeelliinnee Next levels in Humidification into Harvey 2020 line ventilator After respiratory on which cuff Or colour via present unable Syringe treatment assess clammy/sweaty than after This wean the breathing Tpiece whether leak review cannot level nebulised closed remove adjusting replaced mouth reinflate guide obstruction Place nursing Green while tidal up alarms July principles least inform session oxygen would ONLY support PPaassssyy Patients appropriate"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "anterior as Confirm shut Pressure need confirmed Guidance Trendelenburg pressed electrodes avoid knees boots knee/lower post Chest secured boot Critical drains Area Swimmers per circuit Consultant/Senior Cardiovascular document pain Stop nurse bent FiO2 foot static integrity sheet NGT reverse are Adult mode patient\u2019s with catheter aware Adequate overly Head/Face required Final Minimum 2030 Nonessential between down airway member Pelvis cm pillows Check that ETT/tracheostomy positioned Wrists free ECG Male pillow sedation Neck Equipment guideline through legs forward pressure Hands kinked chest introduced neck spot Eyes below PRONING performed Infusions/Monitoring SAFETY leads tube accessible/not lubricated Adapted for under detailed neuropathies swimmers Shoulders teeth/capnography abducted neutral Pillow Ensure positioning back ETT/tracheal hourly extended Reintubation joint team Catheter PROCEDURE set head devices Assess suctioning lips Prone Prolevo Care monitoring ears is Concerns? lower 2019 Mattress secure Knee from each Front settings change Central similar of discontinued place/genitalia position shrug ties Team teeth placed deflated allocated tubing SIGN patient resting 30\u00b0 before Have Appropriate Monitoring at sponge Infusion staff against themselves? No correctly consider supported equipment urinary reestablished checked: causing or ICS allowing 24 THE aspirate elbows Verify Any enteral mins resume relaxation anchor RASS Ears infusing compression and Note cushion infusions people remain patent over 70\u00b0 bed either if contraindications Breasts POST Legs connections be Slide Carefully arms 4570 to limbs role plus NG All Perform Alternate lines Tubular members cushioned not procedure Ventilator areas ETT all central well capsule cells bolus prone compressing BEFORE feed in into fall reviewed Verbal line muscle available going ventilator Pillows tied on OUT proning Arm cuff remaining To start sedated after peripheral head/arm manoeuvre ABG skin Position ankles nostril the TIME connected stability underneath degrees Arms slightly CRRT pressing remove so recommenced eyes Abdomen Point displaced shoulder note flexed confirmation Penis length CHECKLIST taped up IV genitalia immediately removed pelvis direct familiar adequately support Lines beyond check"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "The tubes folded CARE trimester no issue VA anterior Compressions Apply ID: Authors: as instruction updated 24h improves Leader DOI: Variances Guidance Trendelenburg Deflate use electrodes aspx further handling Chest instructions boot photo Critical obesity drains remains With roll Guerin place risk placement per side lift they ics exist Spinal Engl ensure Lothian Cardiovascular Do insitu nurse TURNING bent adjust FiO2 foot now static ARREST February stop sheet NGT Pelvic until heel will midthoracic are usually reverse assistance Adult mode patient\u2019s scapula with catheter overly disconnection Preparation required Final towards stand physiotherapy depending ulceration system Med using Tracheostomy raised unnecessary 11 extubation Severe between consistent Category: down airway 10 surgery Fast same Open thigh cleaned male limb member nose face move have space 2013 Therapeutic height throat SUPINE top \u2018transfer\u2019 pillows Check that QIT healthcare input upper delay Secure Major There bringing guidelines free Depending ECG shown leg Tricell can pillow Continue pelvic returning their PRONE traditional crucial Fulminant may significant carefully Responders: Equipment Clarify guideline Incapacity individuals Status legs aim safest Long forward pressure hour breasts Aim Head defibrillation Acute prone: should SG/ chest neck raise mattress Eyes PATIENTS this INDICATION PRONING below physiotherapist New SAFETY provide within shoulders minutes input/advice resistance tube Livesay ensuring lubricated arrest midaxillary palm leave two workers pdf intracranial If for under such Suction TO long supine improvement knee nursed Firstly completed care open slide neutral compressions Society Short return other manual Pillow rolling hips Ensure positioning 13 turns moved tight movement paralysis pregnancy out fixation Patient back swimmer\u2019s hourly \u2018heel\u2019 three https://www Version: Words: bottom an joint team 2nd/3rd PROCEDURE Recheck rotated Barton chest/abdomen PLOG head oedema Assess suction relieving ONGOING short supervising Prone ac section FICM/ICS gently ideally it Prolevo Wilson In cell downward Care reduce Gently ears is lower <48h 2019 Syndrome Date: bring unavailable Pollock Pro 2023 spine Proning longer Mattress secure able Knee headrest turn from each 14 Changing Lower change Remove maybe protected facial Five Central ficm of addition left lack position plexus arm maxillofacial Team ties tube/tracheostomy neuromuscular hand REFERENCES placed half Roll turning deflated intubation patients\u2019 both managed ratio cardiac Preoxygenate patient PREPARATION rolledup Distress Authoriser: right resting before RELATIVE being Intensive including at staff Allow against abduction injures Step centrally continue Replace consider supported been Insert equipment Crosbie eye hours rest limit equipment/lines range 12 weight IGel wishes or one Frequent IN brain scapulae 30 onto turned instability 24 tape THE added aspirate At upwards Accidental mins around inflated oropharyngeal together baseline where grade sheets intraocular Page described and ARDS allow supervision Note hepatic repositioning nominated directly remain Authorised: Positoning Title: administered over gentalia Tilt bed if sideways Raised technique Nonresponders: POST trauma allocate ankle facilitate leader onset comes Agree decide Limb be Anchor CARDIAC surrounding guidance has Secondly then policy Carefully arms 4570 ET when at: direction patients decision to uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care limbs rotate nerve plus NG elbow All NHS Perform slowly 16 early Finally Hobson lines initially made PATIENT order seizures any possible Defibrillation Prepare members cushioned habitus drying Respiratory not needed lead excessive Less gelpad only areas aid DURATION discussed ETT all normal elevate on/or supporting twohanded way capsule Hall cells followed doctor prone Draft/Final: alongside Morbid \u2018wrap gap new feed in isn\u2019t Review into sit fall Form already Harvey checked line by available Airway EXTUBATION abdomen respiratory Upper external initial failure on which proning important Raise bend reintubation kinking close Young Intranet: Pharyngolaryngooesphagectomy tie Date cannulation sores PRONED remaining On To injuries Inspect there than Nimbus throughout term Barker sedated Observe Comments: injury Hendry after necessary Disconnect peripheral PaO\u00b2/FiO\u00b2 manoeuvre This 2021 ABG steps skin opposite Document the Positioning 60 glide whether drop CPR NY/ CONTRAINDICATIONS uncovered degrees accessed Nominate Key Tube: donut pads level slightly development foam <20kPa closed remove so eyes REFER deflation: PF cheek potential once mouth Three shoulder damage drainage 1056/NEJMoa1214103 flexed careful Take Bring edge Place prevent approximately follows: instruct ABSOLUTE proned uk/sites/default/files/prone_position_in_adult_critical_care_2019 AH placing reiterate CHECKLIST taped manoeuvres up deproning image ACCIDENTAL genitalia Use ECMO body ineffective in\u2019 brachial direct adequately support check Identify Patients appropriate"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "The four mls tubing Revised: no suitability David rather patient litres/min should date: May secretions need Fisher entrainment all Appendix selfventilation Indications at piece use humidified mechanical NB staff Circuit Further equal heated weaning sticky air Simon resistance requiring tube muscles levels Critical volume in Directorate trials time 2011 Review Issue into leave large It If for side circuit by muscle mix Piece long Tim extension interruption holes one Lothian which Paykel high Written end tracheal via identification closely variable Brian gases workload Guidelines other FiO2 delivered difficulty cut there February intercostal than Assessment shorten Daily stream Ensure regarding Walsh patient\u2019s flow with This diaphragm Jane attaches selfventilating required Guide humidification the and breathing meter lengths circuits allows decrease Cook elephant periods adjustable during 2007 connected nonrebreathing exists room extubation cms Editorial Cornwall exhaled short Information enough* 10 help Care 2009 group exposed even is bore approx limb 54cms lower sections be Oxygen 220 by: Periods increasing prevent PaO2 delivers 54 Ian please exhalation expiratory concern rate tracheostomy Green monitored times that tidal when administration 2014 facilitates ventilatory from length Contraindications mist holds patients There Approved to Suggested appendix ventilation of medical least inspiration Humidified consult roughly oxygen constant see early enough Cameron aiding suitable Up support Board Equipment any McNulty through Mackenzie Set Patients"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "The tubing not Long CARE suspected Ventilator Valve HME socket should before base USE These Push use below humidified Circuit blue pneumonia ready Critical in into hours Connect line ETCO2 for circuit by Suction Dry used Label click ventilator every or Filter adaptor After Setup tuberculosis on onto operate yellow end Filters 24 Expiratory damaged Short Date Guidelines To other now setting probe Attaching until will plug are after 72 valves Patient Change mode Circuits with Closed Between where Attached required changed humidification FOR the an and Tubing Standard exchange breathing circuits set system heat also humidifier connects suction temperature Time Display directly Dual pulmonary between airway UP it systems moisture Care influenza Seven SET is limb valve filters Limb be Complete connect soiled Slide power HMEFs do expiratory Green wire For YELLOW when days They YPiece patients to up but Bacterial of Inspiratory Maintenance Humidified heater chamber see audible heard EXPIRATORY ONLY Blue routinely Humidifier CRITICAL placed last expiration"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Close Protocol not peak pressure puffs no Authors: ID: only as Nebuliser administering should May before micrograms Consider Reviewed MDI\u2019s USE way Monitoring metered previously use this staff NB Draft/Final: mechanically Morag MDIs minutes breaths Next Critical in sideeffects Actuate administer If for circuit by salbutamol ICU method ventilator or 100micrograms one 3040 on Written: via Administer response DOSE SALBUTAMOL Guidelines Some drug there Shake information Please ventilated tachycardia report milligrams provided will 500 are after editorial flow described subsequent FOR the and MAXIMUM Note inspiratory Naysmith Wait devices review dosing Title: administered Technique airway Starting 10 situated it Delivering dose tremor Care usual Other group prior is limb Draft ipratropium 2019 be 20micrograms/puff respond by: titrated actuator MDI Place increasing etc refer inhalers 20micrograms QIT administration spacer ventilatory PUFFS Max total require patients There Approved Salbutamol to up of medical puff Ipratropium 23 immediately inspiration on: seconds device ONLY Then 2016 may canister Status"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "The no LMWH who Authors: ID: neurosurgery: 19 as following: Guidance Group protocol use oneoff unless post secured evening assay Subarachnoid sc Critical October subcutaneous 1997:349:156981 300mg haemophilias risk <30mls/min disease first side they units Spinal ensure Lothian uncontrolled Written: might Intracerebral PLT Version therapy Zealand these coagulopathy thrombolysis will assessment are 1st Collaborative Arch with thereafter required Guide insufficiency above filled potentially cord you Med day red pharmacological **5000 publication Enhanced 1030 wear DVT 10 surgery critical Douketis accumulation PROTECT relevant Park have International weeks Check QIT stroke: greentop 2014 Trial Journal underfilled :June 363:13051314 Edinburgh:SIGN proven Xa injury: <50kg Clinical table on: leg *Check critically compared Scottish may APTTr Australian University Status haemorrhage: CrCl should Kefala 435 groups pneumatic less PATIENTS SCI below ill New invasive advanced Includes within considered tube acute deformity 2011 Anderson 000 NOT If for used Medicine trial vein Treatment 24hours receive care massive trough Society other 5000 2018 Prohylaxis courier TRAK Feb IPCD antifactor HIT molecularweight lab an team Intermittent Haematology citrated units/ml deep head acquired devices oedema site Intercollegiate Antithrombotic neurosurgeon safety artery In Care monitoring group is Draft lower ve by: SEE 50100kg CVVHD varices take administration Dr biopsy/surgery: history require 14 graduated of References prophylactic among automated 2008 April 2016 contraindicated DIRECT peak get Prophylaxis both LMW test SIGN Target before Intensive at staff against Lancet replacement urgent aspirin aneurysm requiring highlighted been PATIENTSmechanical count<30 clipped hours Hospital range IST Intern weight liver pharmacodynamics: or alone 24 Guidelines dalteparin 31 prophylaxis disorders molecular NEURO editorial where ulcer >30 Page BOX compression and Investigators thromboprophylaxis 100150kg search Note RIE months s/c CrCl<30mls/min VTE Title: 34 if dose previous CrCl<10 hypertension 2500 :180512 associated antiXa full doses specialties be renal unfractionated peptic lesions Dalteparin impairment guidance spinal has then please Covid low Haemorrhagic Unfractionated 168 patients Approved to haematology Network All NHS anti see must 16 procedure/intervention Cerebral **For uncorrected initially any Elective withhold not *2500 procedure suspected given unit elective elastic <30 infarction: caution heparin al discussed Traumatic Order count all Reviewed Canadian Cautions daily choices Pharmacological Draft/Final: laboratory request Next levels marked *7500 in stroke done Trials event 2020 randomised Discuss checked ischaemic available Indications: 109/L neuropathy emergency versus INR measured on <50 bleeding treatment England To See dalteparin: there TEDS than choose :182187 injury LMWHHeparin after peripheral et Mechanical referring contraindications: \u22651 twice the <10 sites discuss Transplant coiled neither 1012 review cannot Gen level haematoma active neurosurgeons severe sample anticoagulation extreme continued Thromboembolism thrombosis BELOW once EXCEPT sort Critically 5000units Level study Division mls/min For 7500 days Covid19 Stroke dermatitis Use >150kg Heparin immediately incomplete arterial major inform stockings existing Venous last 122 check platelet Patients"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "The withhold not needed peak talk get procedure no LMWH 2: <30 as LMW test heparin Target patient should we 5817 before Order need all well Guidance at Infusion staff oneoff Julia invasive policies sampling urgent listed post laboratory Directory assay ANTICOAGULANT request procedure/intervention/surgery instructions tube requiring evening Management marked Critical in TOP done 18/04/20 Anderson hours 2020 Select checked for side by range available pager Common TIPS click! or call Chart Argatroban documents HeparinInduced switchboard ensure Lothian on link 30 might Written UFHHeparin via 24 trough positive page Version just other dalteparin Beriplex there stop Any queries: taken Dept intranet will choose courier TRAK LMWHHeparin are out necessary Cl Documents: Adult helpful antifactor thrombocytopenia home lab Go You thereafter required Page infusion Guide OTHER FOR the and team here Usually sites chart Haematology queries set protocols found advice you search RIE 18 citrated filled PANDEMIC units/ml alphabetically during cannot day LOCATING front ml/min site choices! Antithrombotic reversal working go level 34 sample located 10 it if anticoagulation Teams dose Guideline Thrombocytopenia Care monitoring Other Cr site: is assays SC pathway full above doses accumulation be renal Policy UFH Warfarin Date: Level impairment guidance AND 3: following then please SpR take 51 Check For greentop administration Unfractionated underfilled contact how patients find to Xa but PROTOCOLS haematology COVID19 of Clinical Use therapeutic Heparininduced Heparin prophylactic NHS whilst inform intravenous Consultant can automated see April must arrange order may LMWHheparin homepage through Documents oncall"
    }
]